data_1iox_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iox _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.052 0.454 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -133.29 125.21 28.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.473 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.58 120.98 32.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 110.05 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 33.4 m -57.19 116.0 12.27 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.62 168.38 24.91 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.9 1.474 . . . . 0.0 110.453 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -27.95 67.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -13.86 60.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -121.09 17.24 11.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 110.229 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -90.08 47.62 1.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.403 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.06 -18.5 32.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 109.135 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.9 p90 -90.64 0.52 57.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.086 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 3.1 m -160.14 91.47 0.95 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 51.7 mt -62.08 -53.31 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.123 -0.986 . . . . 0.0 110.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.17 57.39 0.62 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.14 159.78 31.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -101.85 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -1.149 . . . . 0.0 110.068 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 37.1 t -158.89 126.55 4.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 110.731 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -106.34 122.51 46.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.734 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -110.51 112.42 24.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.987 . . . . 0.0 110.577 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 63.5 t -89.73 118.68 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.94 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.9 t -77.63 -64.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.744 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -46.6 4.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.345 -0.847 . . . . 0.0 109.376 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.6 tt0 -109.74 87.92 2.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.9 tt0 -34.76 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.361 0.6 . . . . 0.0 111.116 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -148.73 84.66 6.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -77.98 84.22 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.09 1.574 . . . . 0.0 110.128 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.454 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 28.9 t -89.88 140.36 29.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.068 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 12.0 p -129.04 110.77 12.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.415 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 20' ' ' ARG . 3.6 t -99.17 159.96 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 0.0 109.686 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.516 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 10.6 m -135.53 162.31 33.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -57.08 122.95 13.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 109.956 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.3 mt-10 -41.58 -37.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 110.168 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.68 48.17 3.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -123.26 162.17 23.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.023 -1.281 . . . . 0.0 110.38 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 38' ' ' TYR . 29.6 mm -142.29 156.03 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.212 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.55 150.96 25.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.57 80.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -1.15 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -89.65 8.06 33.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.02 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.494 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 6.9 m 64.64 58.15 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.39 -0.819 . . . . 0.0 110.153 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.76 -31.1 9.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 110.275 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.422 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 7.0 mtt180 -94.64 171.08 9.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.058 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 110.475 -179.853 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.555 ' CD1' HG12 ' A' ' 24' ' ' VAL . 27.4 m-85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.318 0.58 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.05 143.2 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -80.95 127.08 32.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.309 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -59.65 130.04 87.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.2 Cg_endo -72.47 160.53 46.53 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.899 1.473 . . . . 0.0 110.356 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -61.65 -30.2 70.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.177 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -29.52 70.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.453 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -99.23 0.07 42.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.23 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 49.0 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.72 -20.25 29.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.021 -1.05 . . . . 0.0 109.352 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' OH ' ' SG ' ' A' ' 21' ' ' CYS . 4.4 p90 -90.35 1.24 56.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.131 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 101.46 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 38.7 mm -74.22 -69.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.523 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -89.85 58.61 4.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.16 136.0 4.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.464 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 8.6 mpt_? -93.92 128.95 40.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 110.038 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 6.4 p -126.35 147.67 49.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.61 144.94 35.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 109.808 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -121.73 108.7 13.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.555 HG12 ' CD1' ' A' ' 5' ' ' PHE . 3.9 t -83.42 120.12 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 46.2 t -81.87 -65.18 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.712 -0.617 . . . . 0.0 110.233 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.37 -34.55 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -128.14 92.04 3.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 11.1 tm0? -36.24 91.41 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.743 -0.598 . . . . 0.0 110.919 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' GLU . 17.7 m -147.55 81.49 8.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.419 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.415 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -78.85 91.2 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.168 1.615 . . . . 0.0 110.321 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -89.26 145.38 25.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.2 p -123.98 132.09 53.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 0.0 110.591 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 66.5 t -127.25 111.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.879 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -81.94 152.34 26.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -57.39 124.96 20.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' ASP . 1.4 mm-40 -42.15 -42.73 3.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.459 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.4 48.02 3.1 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -119.44 169.4 10.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.268 . . . . 0.0 110.348 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.507 HG21 HD13 ' A' ' 39' ' ' ILE . 44.1 mt -150.49 141.37 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.87 147.52 7.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.8 52.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.131 . . . . 0.0 110.074 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.419 ' C ' ' SG ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -94.97 20.66 8.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 110.345 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.496 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 2.4 m 63.42 67.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -102.94 -44.03 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 111.399 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 12.9 ptm180 -112.45 134.42 53.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.899 -1.126 . . . . 0.0 110.599 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.278 0.561 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -117.07 123.7 47.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -79.92 112.42 17.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -43.36 122.13 3.33 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.294 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -71.63 167.13 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.915 1.482 . . . . 0.0 110.427 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -53.57 -43.13 68.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -0.906 . . . . 0.0 110.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.87 -32.64 67.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.476 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -90.98 -12.05 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 45.57 1.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -86.16 -17.18 35.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.123 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.2 p90 -90.5 2.17 55.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.221 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.7 m -159.31 97.94 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.121 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 53.1 mt -63.61 -70.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.9 . . . . 0.0 110.309 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -91.86 64.31 4.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.08 153.44 24.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -114.18 140.67 48.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -1.141 . . . . 0.0 110.144 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 11.4 t -130.3 128.28 41.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.472 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -92.53 122.06 34.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 109.943 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.99 109.78 21.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 110.402 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 13.8 t -80.15 120.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 93.4 t -78.9 -64.38 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 110.344 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.28 -43.94 3.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.375 -0.828 . . . . 0.0 109.483 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.9 mt-10 -118.33 88.35 2.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.96 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.363 0.601 . . . . 0.0 111.01 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 32.9 m -143.29 85.6 9.51 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.256 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.98 87.21 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.145 1.603 . . . . 0.0 110.557 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 p -90.49 109.03 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.87 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.529 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 32.0 p -99.24 142.15 31.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.554 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.9 t -140.58 120.51 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 109.969 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.572 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 12.7 m -88.04 156.18 19.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.238 -0.914 . . . . 0.0 110.322 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -48.85 121.52 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -50.21 -43.69 52.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.302 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.59 39.1 3.12 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.572 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -113.12 178.36 4.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 110.341 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.498 HG21 ' N ' ' A' ' 40' ' ' GLY . 17.7 mt -150.23 158.76 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.498 ' N ' HG21 ' A' ' 39' ' ' ILE . . . 105.44 168.97 23.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.59 -44.66 11.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.338 -1.095 . . . . 0.0 110.137 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.488 ' CB ' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -91.73 14.76 14.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 4.1 m 68.82 51.96 0.56 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.336 -0.852 . . . . 0.0 110.333 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.488 ' OE2' ' CB ' ' A' ' 42' ' ' ARG . 14.0 mt-10 -105.37 -34.96 7.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 17.2 mtp180 -85.23 160.85 19.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.516 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 4.4 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.294 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.189 0.518 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.31 134.82 48.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 110.301 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -88.21 147.53 24.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.15 143.97 43.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.22 164.84 34.25 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.04 1.547 . . . . 0.0 110.468 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -62.98 -31.58 72.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -21.46 66.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.108 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -102.61 1.38 34.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.235 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 16' ' ' CYS . 14.4 mtpt -87.41 54.38 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.325 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -18.87 31.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.941 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.467 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 1.8 p90 -90.56 -2.75 57.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.017 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 10.3 m -158.92 109.06 2.0 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.853 . . . . 0.0 110.053 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 29.6 mm -72.66 -54.87 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.019 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 7.8 ptmm? -106.41 53.02 0.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -151.5 147.09 16.58 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -101.99 141.23 35.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -1.196 . . . . 0.0 110.065 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 34.8 t -115.92 123.63 48.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 110.456 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -96.42 107.77 20.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -91.02 111.9 23.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.855 . . . . 0.0 110.443 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 27' ' ' GLU . 88.2 t -81.27 117.11 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.028 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 99.9 t -80.88 -56.61 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.657 -0.652 . . . . 0.0 110.386 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.64 -42.97 2.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.49 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 29' ' ' THR . 35.3 tt0 -125.46 97.35 5.15 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -34.5 90.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.764 -0.585 . . . . 0.0 111.172 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 27' ' ' GLU . 14.0 m -148.66 85.69 6.06 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.444 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.507 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -73.47 100.16 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.056 1.556 . . . . 0.0 110.412 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.448 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 18.6 t -97.16 133.77 41.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.1 p -113.98 102.27 10.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.423 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.33 122.67 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.883 . . . . 0.0 110.012 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.476 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 18.1 m -95.51 155.62 16.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.369 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 2.0 m-20 -43.84 124.27 3.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.127 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.71 -49.42 28.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.339 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 46.63 3.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.4 OUTLIER -111.6 171.29 7.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -1.204 . . . . 0.0 110.317 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.426 HG12 ' C ' ' A' ' 38' ' ' TYR . 25.3 mm -144.69 153.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.53 156.39 16.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.78 57.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -1.134 . . . . 0.0 110.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 4.2 mmm-85 -97.05 12.57 32.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.42 55.93 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 0.0 109.874 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.81 -36.73 6.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.599 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -97.08 -179.49 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.499 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.447 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.7 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.362 -0.836 . . . . 0.0 110.078 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.236 0.541 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -131.04 129.76 42.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 8' ' ' CYS . 1.9 ttm180 -88.23 111.68 21.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 46.8 m -42.93 110.73 0.92 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.255 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HG2' ' CG ' ' A' ' 11' ' ' GLN . 45.6 Cg_endo -73.59 179.25 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.927 1.488 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.98 -36.32 84.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.441 ' CG ' ' HG2' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -59.88 -13.82 12.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.44 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.512 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.9 m-85 -120.07 -3.55 10.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.155 -0.966 . . . . 0.0 110.429 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.75 41.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.259 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -85.91 -18.41 32.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.024 -1.047 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.33 3.64 53.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.342 -0.848 . . . . 0.0 109.148 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.7 m -158.47 120.29 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.14 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.4 mm -80.46 -72.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.262 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.6 OUTLIER -95.23 65.01 2.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.028 -1.045 . . . . 0.0 110.33 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.25 171.82 33.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 11.7 mtp85 -131.99 133.43 44.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 109.807 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 7.9 t -121.7 137.05 54.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.75 126.28 51.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.51 112.86 26.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.546 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 58.3 t -84.18 116.59 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.059 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 26' ' ' ALA . 60.5 t -74.18 -64.55 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 110.4 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.93 -62.33 0.94 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.872 . . . . 0.0 109.34 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 21.0 mm-40 -97.82 87.77 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.88 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.742 -0.599 . . . . 0.0 111.072 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 27' ' ' GLU . 10.5 m -145.0 88.1 6.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.82 91.93 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.133 1.596 . . . . 0.0 110.364 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.88 122.11 41.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.174 -0.953 . . . . 0.0 110.037 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.446 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.6 p -102.7 137.32 41.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.475 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 24.6 t -129.4 164.35 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 109.847 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 6.0 m -133.26 163.51 29.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 110.397 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.551 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-20 -55.74 121.39 9.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -46.58 -43.19 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 44.81 3.28 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.4 169.48 10.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -1.159 . . . . 0.0 110.129 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 38' ' ' TYR . 3.3 mp -140.67 145.52 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.873 . . . . 0.0 110.217 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.37 167.3 16.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.95 -41.64 12.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 110.198 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.91 11.53 20.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.915 . . . . 0.0 110.216 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 66.9 49.59 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.304 -0.872 . . . . 0.0 109.827 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.455 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 28.8 tt0 -98.11 -34.8 10.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.9 mtt180 -94.02 157.36 16.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 110.092 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.255 0.55 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.2 m -124.25 131.93 53.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -91.36 145.44 24.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 110.151 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 139.31 33.17 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.9 . . . . 0.0 110.261 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.51 166.9 28.64 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.974 1.512 . . . . 0.0 110.4 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -61.63 -28.84 69.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.53 -29.45 69.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.295 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -98.03 6.75 47.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.379 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 51.82 2.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 110.357 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -21.78 28.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.5 p90 -90.49 3.91 52.59 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.072 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 119.61 2.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.189 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 17.1 mm -73.37 -82.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.192 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.4 ptmm? -93.06 64.46 3.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 110.033 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -153.53 144.52 11.42 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -94.3 153.46 18.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.268 -1.137 . . . . 0.0 110.053 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 31' ' ' SER . 9.4 t -130.44 127.0 38.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 110.152 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.14 107.56 18.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -93.82 112.2 24.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 110.37 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 4.7 t -80.27 115.52 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.99 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 12.7 t -79.2 -66.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.635 -0.665 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.32 -34.2 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 109.372 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.3 mt-10 -123.66 88.9 3.0 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 15.7 tt0 -35.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.801 -0.562 . . . . 0.0 111.143 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 31.4 m -150.27 91.31 4.22 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.288 -0.883 . . . . 0.0 110.288 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 47.8 Cg_endo -75.52 108.99 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.637 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 5.1 t -111.09 141.55 44.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 10.2 p -129.4 100.28 5.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.543 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.53 124.57 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.529 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 58.9 m -93.75 159.27 15.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.7 m-20 -53.25 116.97 2.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.55 ' HG2' ' N ' ' A' ' 37' ' ' GLY . 1.4 pm0 -51.64 -29.53 18.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 110.183 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.55 ' N ' ' HG2' ' A' ' 36' ' ' GLU . . . -90.85 35.39 3.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -115.26 172.67 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -1.124 . . . . 0.0 110.54 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 24.4 mt -149.49 156.25 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.13 170.9 20.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.47 -45.78 11.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.218 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 1.6 mmp_? -89.97 12.37 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 42' ' ' ARG . 3.8 m 69.59 47.42 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -101.0 -38.47 8.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.22 -0.925 . . . . 0.0 110.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 3.8 mtt180 -83.11 172.14 12.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.472 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.5 p . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.953 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.246 0.545 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 m -145.61 130.53 18.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.351 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -81.61 154.89 25.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.071 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -84.29 124.59 73.72 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 158.22 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.865 1.455 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -67.08 -24.46 65.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.473 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -64.4 -12.08 39.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.381 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -131.92 16.01 4.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -90.29 58.61 4.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -86.1 -12.89 48.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 109.46 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.461 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 12.2 p90 -86.73 -8.95 56.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.474 -0.766 . . . . 0.0 109.038 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 1.7 m -160.38 126.4 4.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.3 mm -76.66 -55.67 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.008 . . . . 0.0 110.42 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.515 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -116.39 70.62 0.77 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.049 -1.032 . . . . 0.0 110.362 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.47 166.06 30.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 17.3 ptt180 -114.2 121.11 42.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.129 -1.218 . . . . 0.0 110.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 6.2 t -105.16 128.76 53.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 110.369 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.21 109.88 22.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 109.87 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -100.75 112.66 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.379 -179.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 3.4 t -87.9 118.32 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.335 -0.853 . . . . 0.0 110.02 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 26' ' ' ALA . 16.7 t -75.96 -67.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 110.44 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.4 -50.56 3.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -0.839 . . . . 0.0 109.563 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -108.44 90.32 3.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.8 mt-30 -35.55 91.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.306 0.574 . . . . 0.0 110.925 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 89.9 m -143.67 78.83 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.497 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.2 Cg_endo -75.41 81.96 2.18 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.108 1.583 . . . . 0.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.463 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 6.3 p -90.01 137.84 32.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 109.682 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.449 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.1 t -115.05 130.71 57.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.084 -1.01 . . . . 0.0 110.666 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 4.3 t -124.47 158.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.586 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.7 m -110.06 161.62 15.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.138 -0.976 . . . . 0.0 110.568 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.0 m-20 -61.61 120.52 10.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 15.7 pt-20 -45.56 -43.63 12.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 110.183 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -90.14 47.4 3.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.9 174.95 6.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -1.15 . . . . 0.0 110.4 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.475 ' CG1' ' C ' ' A' ' 38' ' ' TYR . 8.5 mt -150.35 129.69 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 158.63 9.61 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.52 -46.35 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -1.151 . . . . 0.0 110.154 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.8 mtt180 -89.59 8.9 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m 67.43 61.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 109.997 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -106.25 -40.35 5.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.939 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.41 150.24 25.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.472 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.515 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.232 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.218 0.532 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.02 142.45 36.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 110.209 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 8' ' ' CYS . 10.1 mtp180 -103.9 107.5 18.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 32.0 m -42.08 121.24 2.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.901 . . . . 0.0 110.168 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.83 168.07 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.89 1.468 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.8 -27.96 68.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -66.53 -12.85 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -122.67 9.5 9.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.14 51.62 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -85.74 -20.12 29.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.917 -1.115 . . . . 0.0 109.217 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.6 p90 -90.3 -1.57 57.93 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.098 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.7 m -160.59 98.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.492 ' CD1' ' CD ' ' A' ' 44' ' ' GLU . 24.4 mt -77.74 -57.41 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -89.56 39.15 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.158 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.484 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -158.27 150.33 21.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HG3' ' HE2' ' A' ' 13' ' ' LYS . 3.5 mtt180 -110.4 144.74 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -1.097 . . . . 0.0 109.781 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 17.6 t -125.94 135.91 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.99 . . . . 0.0 110.864 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.04 138.78 34.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.832 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -117.5 117.37 29.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.03 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.6 t -85.62 118.82 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.854 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 35.7 t -80.84 -65.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.627 -0.671 . . . . 0.0 110.607 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.45 -33.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 0.0 109.66 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -132.17 89.04 2.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 tt0 -34.59 90.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.763 -0.585 . . . . 0.0 111.09 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' GLU . 20.4 m -144.97 91.77 5.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.219 -0.926 . . . . 0.0 110.47 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 134.71 9.86 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.144 1.602 . . . . 0.0 110.412 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.451 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -141.15 112.09 7.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 109.915 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 29.0 p -98.53 144.43 27.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.752 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.93 127.41 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.484 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 23.8 m -102.71 164.25 11.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 1.3 m-20 -63.47 116.41 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.459 -0.776 . . . . 0.0 109.979 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.5 pt-20 -42.7 -31.26 0.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.486 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.84 43.26 2.97 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.426 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -125.44 170.28 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.448 HD12 HG22 ' A' ' 39' ' ' ILE . 30.8 mt -149.95 144.2 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.96 151.43 8.17 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.43 47.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -1.148 . . . . 0.0 110.24 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 22.8 mtt180 -89.97 12.95 16.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.926 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 5.1 m 66.64 57.23 0.69 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 109.867 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.492 ' CD ' ' CD1' ' A' ' 17' ' ' ILE . 8.3 mm-40 -108.09 -13.7 14.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.576 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.48 173.31 6.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.117 -0.989 . . . . 0.0 110.455 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.6 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.258 0.551 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.5 m -128.62 135.81 49.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 110.239 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -94.57 130.32 41.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.77 126.61 92.91 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.132 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.85 169.4 22.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.944 1.497 . . . . 0.0 110.306 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.5 mmtt -57.88 -24.98 60.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -33.59 75.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.575 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 26.6 m-85 -106.11 12.21 30.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -89.59 40.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 110.241 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -85.91 -18.2 33.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.02 -1.05 . . . . 0.0 109.613 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.25 3.16 54.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.4 125.8 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 10.8 mm -79.95 -72.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.135 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 6.2 ptmm? -99.27 51.56 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.096 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -140.95 141.86 11.68 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -98.15 141.44 31.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -1.073 . . . . 0.0 109.898 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 37.3 t -117.01 123.21 46.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.564 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -94.14 104.35 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.6 t80 -92.39 117.73 30.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.494 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 59.1 t -84.48 118.45 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.8 t -81.72 -66.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.612 -0.68 . . . . 0.0 110.526 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.83 -36.37 0.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -124.59 90.16 3.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 27' ' ' GLU . 21.0 tt0 -35.92 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.774 -0.579 . . . . 0.0 111.052 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 16.3 m -150.15 89.48 4.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.9 Cg_endo -74.49 115.92 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.144 1.602 . . . . 0.0 110.545 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.77 123.24 46.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.7 p -103.12 135.48 44.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.3 125.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 24.3 m -92.58 163.08 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.444 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -51.74 129.56 26.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -48.75 -48.35 40.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 45.61 3.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -111.88 162.15 15.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -1.217 . . . . 0.0 110.005 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 38' ' ' TYR . 33.4 mm -143.82 146.52 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.32 158.62 10.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.47 -43.71 38.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -1.099 . . . . 0.0 110.235 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 22.6 mtt-85 -89.89 8.73 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 5.0 m 68.36 48.79 0.84 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 0.0 110.011 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.8 -26.11 10.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.929 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -91.64 178.69 5.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.171 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.278 -179.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.484 ' CD1' HG13 ' A' ' 24' ' ' VAL . 73.8 m-85 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.102 0.477 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -130.36 118.03 20.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.033 -1.042 . . . . 0.0 110.137 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.24 121.36 26.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 110.142 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -54.76 123.31 45.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.097 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.18 162.4 41.78 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.897 1.472 . . . . 0.0 110.392 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -58.03 -25.87 61.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.61 -35.7 78.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.485 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.18 9.85 38.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -90.07 48.01 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -85.86 -17.29 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.446 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 5.2 p90 -90.45 -0.3 57.6 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.224 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 110.83 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.952 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.2 mm -81.7 -66.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 43' ' ' CYS . 1.8 ptpp? -89.77 53.72 2.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.203 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.06 179.97 33.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.7 OUTLIER -133.01 171.86 13.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -1.129 . . . . 0.0 110.045 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 31' ' ' SER . 43.4 t -152.34 120.47 6.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.8 ttp85 -90.45 111.38 22.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.998 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.59 108.1 20.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.406 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 4.3 t -84.17 115.22 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.983 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ALA . 70.3 t -80.3 -60.42 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.8 -35.6 1.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.264 -0.897 . . . . 0.0 109.4 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -127.18 94.76 4.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.516 -0.74 . . . . 0.0 109.047 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -35.75 91.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.72 -0.612 . . . . 0.0 111.234 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 9.9 m -150.02 80.19 7.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.547 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.6 Cg_endo -77.6 89.86 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.067 1.561 . . . . 0.0 110.756 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.1 p -91.23 124.98 35.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.008 . . . . 0.0 109.811 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.7 p -114.88 110.15 19.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 0.0 110.752 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' ARG . 57.8 t -107.66 163.99 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.798 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.47 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.1 m -127.64 161.61 28.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.082 -1.011 . . . . 0.0 110.407 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.561 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.81 127.72 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 22.4 pt-20 -50.64 -43.27 57.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 110.316 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -89.17 42.09 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -113.87 171.18 7.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -1.115 . . . . 0.0 110.253 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 39' ' ' ILE . 45.9 mt -150.08 127.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.16 144.22 5.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.75 88.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -1.128 . . . . 0.0 110.315 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 20.3 mtt180 -98.74 13.67 31.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 16.4 m 60.33 58.71 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 12.5 pt-20 -108.0 -31.1 8.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.32 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 13.6 mtp-105 -99.13 160.86 13.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.235 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.458 ' CD1' HG21 ' A' ' 24' ' ' VAL . 56.4 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.153 0.501 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -134.42 124.01 24.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.249 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.06 128.78 34.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -73.3 135.03 79.54 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 159.1 47.34 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.42 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -32.0 68.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -61.65 -33.86 74.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.73 -2.37 44.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 0.0 110.147 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HD2' ' HB3' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -90.02 55.53 3.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 0.0 110.41 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -86.32 -16.41 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.956 -1.09 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.435 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.9 p90 -90.1 2.63 55.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.428 -0.795 . . . . 0.0 109.115 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -155.68 111.75 3.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 18.9 mm -78.05 -73.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 110.43 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -89.89 57.5 3.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.117 -0.99 . . . . 0.0 110.364 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.52 155.74 26.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -111.88 140.42 46.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 31' ' ' SER . 21.1 t -115.59 123.32 48.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.492 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.6 108.27 20.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.1 112.7 24.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 40.3 t -82.07 113.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.81 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 26' ' ' ALA . 43.0 t -76.04 -64.21 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.526 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.25 -51.86 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 109.666 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 tt0 -109.0 92.43 4.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 108.964 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.7 OUTLIER -35.55 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.596 . . . . 0.0 111.065 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 7.8 m -149.61 85.67 5.64 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.15 95.74 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.077 1.567 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 92.8 p -95.08 128.39 41.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 110.049 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.4 p -107.42 96.98 6.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.481 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -90.87 148.44 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.118 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 18.5 m -128.24 160.34 32.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 16.9 m-20 -57.97 120.46 8.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.92 -32.49 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.97 42.18 2.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -123.7 168.52 12.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -1.123 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 38' ' ' TYR . 61.6 mt -149.55 152.01 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.869 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.03 173.48 19.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -44.18 11.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -1.125 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.2 mtm180 -92.79 18.53 8.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 12.9 m 61.61 41.68 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.6 pp20? -98.72 -25.27 14.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 110.435 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.452 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -90.91 161.5 15.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.085 -1.009 . . . . 0.0 109.969 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.241 -179.938 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.268 0.556 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -138.78 131.16 28.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.857 . . . . 0.0 110.173 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 124.3 32.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 119.8 77.67 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 178.52 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.865 1.455 . . . . 0.0 110.488 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 4.3 mtpt -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.358 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -59.27 -19.41 45.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.155 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -117.81 -0.95 11.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.3 ttpt -90.05 51.79 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -86.54 -14.09 43.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.044 -1.035 . . . . 0.0 109.31 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.3 2.54 55.4 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.51 -0.744 . . . . 0.0 109.082 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -159.87 112.61 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.932 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 24.0 mt -66.03 -76.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.412 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -96.77 69.43 2.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.423 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.3 152.57 23.37 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -111.69 141.69 44.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.899 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.472 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 7.4 t -126.19 134.4 51.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.638 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 31' ' ' SER . 10.6 mmt180 -101.96 120.12 39.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.81 116.19 32.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.267 -0.895 . . . . 0.0 110.34 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 29' ' ' THR . 2.2 t -90.42 125.73 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.079 -1.013 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 39.6 t -79.54 -64.64 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 110.324 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.68 -49.84 4.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.161 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -105.44 71.69 0.94 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -29.99 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.376 0.608 . . . . 0.0 111.322 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' GLU . 9.8 t -149.94 105.77 3.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.86 91.62 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.061 1.559 . . . . 0.0 110.113 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 22' ' ' ARG . 89.0 p -90.14 101.7 14.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 110.034 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.472 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 26.3 p -90.08 131.65 35.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.445 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -130.62 135.23 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.926 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.587 ' CB ' ' CZ ' ' A' ' 38' ' ' TYR . 16.7 m -102.2 160.94 14.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 38.0 m-20 -54.66 115.06 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.841 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.8 OUTLIER -41.59 -39.5 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.891 . . . . 0.0 110.488 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 46.95 3.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.587 ' CZ ' ' CB ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -127.36 172.83 10.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -1.155 . . . . 0.0 110.32 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.415 HG13 ' C ' ' A' ' 38' ' ' TYR . 56.8 mt -148.17 149.56 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.9 161.45 12.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -43.04 20.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.218 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mmm180 -93.04 15.32 15.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 8.7 m 64.38 39.72 6.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.338 -0.851 . . . . 0.0 110.428 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.22 -22.43 17.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.617 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.432 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -100.18 162.43 12.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.295 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.454 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 7.2 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.297 0.57 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.97 139.56 21.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.0 160.4 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 141.66 33.09 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 110.162 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.82 156.38 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.402 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -57.5 -30.28 64.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.385 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -35.32 78.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.951 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.497 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -96.11 0.29 51.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 47.63 1.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.442 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.29 -13.18 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 0.0 109.196 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.497 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.34 -0.67 57.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.514 -0.741 . . . . 0.0 109.38 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 122.16 3.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.8 mm -77.66 -78.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.999 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -89.85 52.99 2.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.057 -1.027 . . . . 0.0 110.29 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -142.26 137.72 8.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.94 134.92 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -1.169 . . . . 0.0 109.899 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.472 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.0 t -115.73 132.4 56.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.591 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -95.78 128.34 42.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.42 -0.8 . . . . 0.0 109.798 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.562 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -117.9 109.68 16.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.279 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.1 t -85.95 123.48 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.126 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.4 t -79.01 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.633 -0.667 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -50.23 3.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.397 -0.814 . . . . 0.0 109.525 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 38.0 tp10 -115.41 96.6 5.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -36.46 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 110.875 -179.083 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 26.6 m -138.46 79.21 30.61 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.547 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.562 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.7 Cg_endo -78.54 80.58 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.207 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 77.9 p -90.22 132.45 35.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 29.7 p -106.65 128.04 53.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.8 122.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.353 -0.842 . . . . 0.0 110.199 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.538 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.7 m -89.16 159.11 17.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 7.0 m-20 -52.97 121.05 6.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -45.2 -40.85 7.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.86 3.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -122.05 170.19 10.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.17 . . . . 0.0 110.279 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 38' ' ' TYR . 56.6 mt -149.37 160.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.153 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.444 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 109.08 175.85 21.45 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.92 -44.94 10.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 3.2 ttm-85 -100.59 25.71 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 9.7 m 63.69 50.88 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.85 -34.68 8.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.607 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 164.46 14.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.504 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.883 . . . . 0.0 110.031 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.8 m -149.9 139.08 21.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.873 . . . . 0.0 110.232 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.436 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -93.21 147.77 22.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.309 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 56.8 m -89.93 109.36 32.13 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 47.4 Cg_endo -73.38 175.62 10.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.915 1.482 . . . . 0.0 110.46 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.1 ptmt -67.54 -26.16 66.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.03 14.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.502 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.52 13.9 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.982 . . . . 0.0 110.403 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 25.7 mtpt -90.04 47.2 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -85.61 -20.78 28.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.013 -1.055 . . . . 0.0 109.231 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.467 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 4.7 p90 -90.58 1.29 56.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.114 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -160.27 91.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.488 HG23 HD12 ' A' ' 17' ' ' ILE . 23.9 mm -54.13 -81.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.18 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -91.27 68.87 5.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.07 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.16 142.41 8.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 133.45 42.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.331 -1.1 . . . . 0.0 109.821 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 31' ' ' SER . 9.3 t -125.67 138.81 53.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.674 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.16 133.36 53.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.7 113.95 24.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 110.589 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 5.1 t -88.23 115.84 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.0 t -79.85 -59.62 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 110.349 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.84 -36.03 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 109.421 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -128.53 93.11 3.56 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.9 mt-30 -34.45 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.236 0.541 . . . . 0.0 111.239 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 53.8 m -146.8 84.28 7.65 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.368 -0.832 . . . . 0.0 110.376 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.84 96.05 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.122 1.591 . . . . 0.0 110.263 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 6.7 t -99.07 132.42 44.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.907 . . . . 0.0 110.259 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 30.6 p -118.75 124.41 47.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.53 117.93 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 26.0 m -92.41 163.21 13.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -49.71 126.41 13.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.35 -43.01 33.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 44.31 2.93 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -116.32 165.86 12.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -1.193 . . . . 0.0 110.249 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.48 HD12 HG22 ' A' ' 39' ' ' ILE . 39.7 mt -146.94 165.1 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.63 154.71 21.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.37 -13.61 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -1.208 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 29.2 mtt180 -120.9 16.65 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 8.7 m 64.16 27.8 14.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.212 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.69 -7.71 39.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.411 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.449 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -107.65 158.85 16.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.414 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.449 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 13.2 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.022 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.559 ' CE1' HG13 ' A' ' 24' ' ' VAL . 44.9 m-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.226 0.536 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.53 151.69 38.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.84 133.33 52.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.912 . . . . 0.0 110.32 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 142.88 98.41 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.3 Cg_endo -73.55 167.35 27.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.052 1.554 . . . . 0.0 110.469 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -31.82 73.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -21.96 66.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.35 6.64 35.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 52.82 2.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.445 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -86.14 -14.83 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.99 -1.069 . . . . 0.0 109.171 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.477 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.35 -2.25 57.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.293 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 4.0 m -160.18 103.63 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 62.5 mt -55.37 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 0.0 109.904 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -93.55 66.68 3.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.908 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -155.96 147.45 16.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.4 mtt85 -105.62 135.93 46.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.975 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.477 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.5 t -108.38 132.85 53.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.513 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -97.83 105.57 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -97.15 112.2 24.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.387 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.559 HG13 ' CE1' ' A' ' 5' ' ' PHE . 23.9 t -85.52 117.43 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ALA . 8.3 t -77.88 -63.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.92 -56.12 2.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.5 tp10 -103.89 91.33 3.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.017 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.1 tp-100 -34.95 91.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.766 -0.583 . . . . 0.0 111.151 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' GLU . 58.0 m -148.23 82.78 7.48 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.3 Cg_endo -76.44 93.13 1.05 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.02 1.537 . . . . 0.0 110.355 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 27.7 t -101.27 141.19 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.2 p -110.89 134.05 52.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.338 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.09 120.75 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 110.061 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 27.0 m -87.63 159.89 18.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.467 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -47.58 120.06 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -44.78 -44.8 9.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.456 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 47.04 3.15 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -121.75 171.03 9.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 110.252 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.528 HG23 HD11 ' A' ' 39' ' ' ILE . 27.0 mt -149.66 146.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.89 169.41 14.41 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.8 -40.72 13.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.1 mtt180 -93.49 9.69 35.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.118 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.487 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.5 m 66.84 56.75 0.68 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 0.0 110.157 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.14 -25.7 8.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.421 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.496 ' HD2' ' CG2' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -89.61 151.2 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 110.203 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 110.063 179.878 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.332 0.587 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.95 140.01 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -86.35 150.23 24.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 6.7 m -83.9 127.1 68.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 163.65 36.98 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.891 1.469 . . . . 0.0 110.53 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 1.4 pttp -63.02 -29.95 71.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.131 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.406 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -62.46 -25.9 68.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.86 . . . . 0.0 110.32 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.411 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.6 m-85 -114.03 8.31 17.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -90.32 49.75 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.091 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.28 -11.43 52.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 0.0 109.472 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.482 ' OH ' ' CB ' ' A' ' 8' ' ' CYS . 12.6 p90 -87.18 -9.56 54.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.51 127.38 4.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 110.073 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 25.6 mt -86.98 -65.0 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.522 ' CG ' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -90.14 50.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 0.0 110.425 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.98 137.3 5.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -89.71 -179.8 5.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -1.118 . . . . 0.0 109.575 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 12.9 t -160.19 125.95 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.898 -1.126 . . . . 0.0 110.892 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.31 114.07 26.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.87 111.48 23.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.451 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 10.4 t -84.0 118.02 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 9.6 t -74.04 -66.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.69 -62.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.4 tp10 -98.18 88.46 4.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.336 -0.853 . . . . 0.0 108.983 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.5 mm-40 -34.64 92.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.348 0.594 . . . . 0.0 110.968 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 27' ' ' GLU . 13.8 m -144.22 83.62 9.96 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 110.556 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.97 84.43 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.094 1.576 . . . . 0.0 110.451 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -89.92 134.42 34.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.92 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 7.7 t -114.35 119.27 36.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 110.609 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 t -103.85 115.11 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.803 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 19.3 m -88.46 158.08 18.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -53.3 125.18 16.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.891 . . . . 0.0 110.032 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' ASP . 3.0 mm-40 -42.64 -45.97 4.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.429 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.45 49.35 3.18 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.5 ' CD2' ' HB3' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -117.81 158.81 24.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.265 . . . . 0.0 110.518 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 38' ' ' TYR . 33.5 mm -142.47 150.46 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.16 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.36 170.35 14.87 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.56 -48.11 11.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -1.146 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mtm105 -98.18 23.69 7.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.254 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.522 ' HB3' ' CG ' ' A' ' 18' ' ' LYS . 20.2 m 61.04 76.22 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.135 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -40.16 2.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 110.379 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -97.39 179.8 4.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 110.262 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 110.232 -179.806 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.223 0.535 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.81 121.54 41.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 110.308 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.96 132.53 35.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.104 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 131.2 79.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.124 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.7 Cg_endo -73.31 173.04 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.956 1.503 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -67.63 -34.04 76.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.54 -8.68 35.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.441 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -116.1 -0.72 12.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.15 62.2 5.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -85.55 -21.05 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.089 . . . . 0.0 109.278 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.484 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 7.1 p90 -90.34 -2.18 57.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.105 178.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.67 126.95 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.3 mm -89.04 -69.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.991 -1.068 . . . . 0.0 109.759 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' CD ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -93.12 63.63 3.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.158 -0.964 . . . . 0.0 110.054 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -155.32 143.67 10.15 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -101.38 124.79 47.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.206 . . . . 0.0 110.281 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.1 t -114.87 127.96 56.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 0.0 110.492 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -103.76 120.69 41.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -103.94 113.89 27.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.489 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 3.4 t -82.51 119.15 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.7 t -79.0 -64.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.678 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.34 -45.46 2.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -117.4 92.05 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -34.69 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.772 -0.58 . . . . 0.0 110.943 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.8 m -143.52 85.84 9.19 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.247 -0.908 . . . . 0.0 110.552 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.86 114.48 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.568 . . . . 0.0 110.533 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.451 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 17.6 m -119.03 126.38 51.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -0.91 . . . . 0.0 109.85 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 23.7 p -116.06 103.87 11.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.931 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.99 132.51 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.481 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 21.7 m -102.19 157.35 16.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -52.64 116.9 2.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 110.104 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.5 mm-40 -41.82 -48.19 4.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.373 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 50.74 3.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -121.64 171.6 8.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.098 -1.237 . . . . 0.0 110.361 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 38' ' ' TYR . 3.6 mp -147.19 138.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 110.135 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.14 159.17 9.45 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.69 -48.51 25.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.1 mtt180 -98.33 21.4 11.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.189 -0.944 . . . . 0.0 110.118 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.514 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 6.3 m 64.64 61.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -101.41 -31.19 11.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.134 -0.979 . . . . 0.0 110.62 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -108.37 163.54 13.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.456 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 10.2 p . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 110.057 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.574 ' CE1' HG11 ' A' ' 24' ' ' VAL . 72.7 m-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.977 0.418 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.42 129.23 26.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.986 -1.071 . . . . 0.0 110.253 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.417 ' HG2' ' N ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -86.09 142.12 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 110.17 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 4.0 m -78.61 126.95 81.9 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 110.074 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.6 Cg_endo -74.21 148.33 38.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.887 1.467 . . . . 0.0 110.409 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.2 ttpt -58.93 -29.93 67.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -61.44 -34.18 74.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.364 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.459 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 10.9 m-85 -101.43 7.09 42.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.31 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' A' ' 8' ' ' CYS . 2.2 mttt -86.16 60.98 6.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.082 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -85.69 -19.11 31.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.004 -1.06 . . . . 0.0 109.31 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.0 p90 -90.72 -1.95 57.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.45 -0.781 . . . . 0.0 109.187 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.3 106.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.1 mm -81.63 -64.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.219 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.82 49.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.314 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -152.58 175.85 31.01 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.1 157.18 33.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -1.05 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 43.6 t -141.41 119.51 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -95.97 109.5 21.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 109.862 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -96.82 105.53 17.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.466 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 5' ' ' PHE . 57.6 t -84.49 114.6 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' ALA . 59.9 t -72.9 -59.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -65.77 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 109.415 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 tp10 -95.67 93.24 7.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 27' ' ' GLU . 4.8 mp0 -34.67 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.346 0.593 . . . . 0.0 111.151 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 4.5 m -147.0 78.98 10.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.454 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.2 Cg_endo -79.39 86.03 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.093 1.575 . . . . 0.0 110.279 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.453 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 t -90.53 133.4 35.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -129.33 101.65 6.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.31 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.97 166.6 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.298 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.454 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 34.1 m -112.88 164.33 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.306 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.531 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.9 m-20 -64.63 117.38 7.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.367 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -44.47 -41.45 6.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.12 46.07 3.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.38 175.74 7.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -1.171 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 37.5 mt -146.44 152.1 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.055 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.58 161.29 19.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.8 -49.52 12.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 21.1 mmt-85 -90.25 15.65 10.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.981 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 4.2 m 67.7 50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.801 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -101.27 0.22 36.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.466 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.28 164.05 23.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.384 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.087 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.247 0.546 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.7 m -136.61 130.43 32.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.983 . . . . 0.0 110.312 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.65 124.25 31.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -52.39 129.3 42.7 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.119 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.2 155.71 51.67 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.98 1.516 . . . . 0.0 110.388 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -25.1 64.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -63.17 -33.08 74.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.248 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.548 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 m-85 -103.61 10.37 36.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -90.05 43.29 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -86.13 -13.71 46.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.41 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.45 2.59 55.52 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.763 . . . . 0.0 109.185 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.3 m -157.41 125.5 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.136 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 35.7 mm -83.02 -81.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.409 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -89.69 57.47 3.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.134 -0.979 . . . . 0.0 110.268 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -149.04 160.08 28.27 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 20.9 ptt180 -116.81 139.23 50.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -1.087 . . . . 0.0 109.694 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.2 t -114.31 135.3 54.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.791 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 ttp85 -97.96 124.0 42.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.5 t80 -112.09 110.78 21.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.566 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 12.5 t -90.12 123.01 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.926 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 97.1 t -83.06 -56.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.69 -29.79 0.1 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 0.0 109.648 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.6 mt-10 -141.41 96.53 3.0 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.5 mt-30 -33.6 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.212 0.529 . . . . 0.0 111.301 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' GLU . 91.0 m -140.64 83.15 15.03 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.308 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.469 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.0 Cg_endo -82.4 83.84 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.174 1.618 . . . . 0.0 110.409 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 26.8 t -89.82 134.05 34.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.9 p -101.68 132.38 47.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 3.5 t -126.96 151.23 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.332 -0.855 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 19.5 m -123.47 162.0 23.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 110.388 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -57.66 121.05 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.206 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -44.39 -38.95 4.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.168 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 46.05 3.06 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.33 163.92 20.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -1.157 . . . . 0.0 110.187 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.9 mt -137.41 160.46 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.18 166.95 31.49 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.51 -35.88 16.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -91.55 7.2 42.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.14 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 4.9 m 69.25 44.68 0.94 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.404 -0.81 . . . . 0.0 110.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -100.28 -25.64 14.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 3.2 mmt180 -92.41 163.49 13.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.576 ' CD1' HG13 ' A' ' 24' ' ' VAL . 52.7 m-85 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.166 0.508 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 m -119.07 135.19 54.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.171 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.12 109.11 21.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.305 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -48.61 120.35 8.84 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 43.4 Cg_endo -70.67 175.57 8.68 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.858 1.451 . . . . 0.0 110.525 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.27 -41.6 93.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.551 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.98 -19.6 66.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.441 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.473 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -99.98 -9.37 22.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.193 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 2.1 ttpt -87.82 57.55 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 110.145 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -85.76 -17.4 35.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 6.3 p90 -89.98 -2.53 58.16 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.147 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.36 127.75 4.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 45.5 mt -82.23 -74.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 110.424 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -89.78 64.43 6.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 0.0 110.471 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 13' ' ' LYS . . . -160.15 133.19 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -95.48 132.75 40.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -1.167 . . . . 0.0 109.765 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.527 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 32.1 t -118.75 132.31 56.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.004 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -98.15 124.02 42.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.466 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -111.89 112.81 24.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 110.498 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.576 HG13 ' CD1' ' A' ' 5' ' ' PHE . 11.6 t -84.72 117.36 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.202 -0.936 . . . . 0.0 109.975 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.4 t -80.86 -63.05 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 110.436 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.17 -39.43 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.613 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -123.0 92.37 3.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -35.04 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.21 0.529 . . . . 0.0 111.077 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 3.8 m -148.25 83.37 7.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.233 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.8 Cg_endo -82.79 132.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.145 1.603 . . . . 0.0 110.431 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 p -148.81 118.13 6.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.863 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.527 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 12.1 t -95.83 153.88 17.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.645 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -139.57 121.6 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.491 -0.756 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.579 ' CB ' ' CE2' ' A' ' 38' ' ' TYR . 8.6 m -96.94 158.22 15.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -49.51 128.47 17.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -46.5 -47.4 19.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.331 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.14 45.4 3.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CE2' ' CB ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -113.28 163.86 14.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -1.191 . . . . 0.0 110.1 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 31.6 mm -138.76 153.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.97 144.97 11.97 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -34.27 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -1.109 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mtt180 -93.76 4.86 53.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.503 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 4.1 m 68.18 43.89 1.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.99 -13.14 15.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.446 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -109.51 166.99 10.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.864 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.223 0.535 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m -138.35 137.54 37.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -100.3 113.94 27.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 124.95 78.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.176 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.42 178.03 7.18 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.859 1.452 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -65.98 -25.65 67.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -19.91 66.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 4.3 m-85 -110.92 11.06 22.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 110.207 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 34.2 mmtm -88.93 47.6 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -85.49 -23.15 27.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.993 -1.067 . . . . 0.0 108.918 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.9 p90 -90.39 -0.76 57.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -160.68 116.19 2.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 109.901 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 32.6 mt -76.65 -63.97 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.517 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -104.36 73.8 1.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.098 -1.001 . . . . 0.0 110.417 179.764 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.31 178.27 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 1.7 mtt180 -131.15 119.89 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.164 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 31' ' ' SER . 15.1 t -107.09 132.3 53.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -104.64 120.8 42.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 109.993 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -104.49 106.72 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.477 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 24.2 t -81.58 119.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.13 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 26' ' ' ALA . 25.7 t -80.75 -62.99 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.499 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.3 -49.74 2.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.4 -0.812 . . . . 0.0 109.749 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 5.4 mt-10 -113.32 91.95 3.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.48 -0.763 . . . . 0.0 109.0 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -33.54 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.273 0.559 . . . . 0.0 111.322 -179.075 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 41.0 m -147.92 82.71 7.72 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.03 86.69 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.113 1.586 . . . . 0.0 110.352 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.459 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -89.65 143.85 26.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 109.791 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 20.2 p -124.03 132.5 53.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 58.6 t -125.45 169.68 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 109.801 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.3 m -140.67 162.32 35.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.39 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.555 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.4 m-20 -49.22 123.67 7.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -47.86 -45.79 30.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.71 3.02 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -115.44 174.0 6.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 110.217 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 38' ' ' TYR . 4.2 mp -150.48 147.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.141 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.99 152.97 10.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.44 -30.91 57.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -1.104 . . . . 0.0 109.975 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.16 5.33 44.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.501 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 3.9 m 68.92 66.3 0.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 -30.88 2.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.002 -1.061 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -95.97 107.07 19.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.963 -1.086 . . . . 0.0 110.506 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.517 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 12.2 p . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 110.447 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.477 ' CE1' HG13 ' A' ' 24' ' ' VAL . 25.2 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.329 0.585 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.62 134.67 47.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.486 ' NH1' ' HG2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -90.56 133.32 35.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.139 179.926 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -73.99 152.8 88.76 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -72.63 158.06 51.34 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.005 1.529 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -26.78 65.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -6.22 26.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.48 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -120.02 4.95 10.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.349 179.964 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.523 ' NZ ' ' OH ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -81.48 75.16 8.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -85.25 -25.45 27.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.018 -1.051 . . . . 0.0 109.407 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.523 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 3.3 p90 -90.45 2.97 55.15 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.95 178.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 1.7 m -160.81 119.77 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 43.1 mm -75.52 -71.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -99.95 68.82 1.51 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.256 179.768 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -159.97 141.25 7.32 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.9 ptp180 -96.37 143.57 27.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -1.13 . . . . 0.0 109.878 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' SER . 10.4 t -123.22 125.25 44.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.5 117.75 30.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.901 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.93 112.71 25.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.322 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 5' ' ' PHE . 9.0 t -85.55 119.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.134 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 58.1 t -77.41 -67.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 110.382 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.76 -45.98 3.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.423 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.8 tt0 -112.53 86.94 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.314 0.578 . . . . 0.0 110.992 -179.164 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 80.9 m -145.01 85.76 8.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.0 Cg_endo -76.39 84.44 1.85 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.033 1.544 . . . . 0.0 110.146 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.454 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 68.1 m -90.09 128.39 36.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.258 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 24.7 p -107.23 97.05 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' ARG . 98.4 t -89.63 120.78 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.023 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -86.94 157.71 19.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -48.75 118.33 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.129 179.934 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -45.93 -41.27 11.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 110.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.96 43.04 2.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -120.41 176.3 5.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 21.9 mt -150.33 136.94 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.41 166.15 12.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.77 -38.43 18.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -1.081 . . . . 0.0 110.05 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -99.34 17.55 19.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.002 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 8.2 m 63.62 43.65 5.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.1 tt0 -93.7 -32.7 13.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.47 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -95.07 158.9 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.01 . . . . 0.0 110.199 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.443 ' HB ' ' HD3' ' A' ' 18' ' ' LYS . 7.3 p . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.274 0.559 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.31 143.78 34.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 142.32 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.78 137.31 92.67 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 46.3 Cg_endo -72.68 164.39 35.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.046 1.551 . . . . 0.0 110.382 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -62.61 -30.98 71.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 110.24 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.46 ' NE2' ' HB2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -66.45 -19.96 65.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.358 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -109.94 5.64 22.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.88 50.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 110.035 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -86.15 -17.55 34.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 109.115 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -91.15 0.57 57.5 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.069 178.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.43 98.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.6 mt -65.69 -73.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.953 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ptpm? -89.61 52.78 2.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -0.924 . . . . 0.0 110.12 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -148.66 165.96 29.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -123.35 130.28 52.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -1.187 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 32' ' ' CYS . 9.3 t -118.27 128.1 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.447 -179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.81 139.66 30.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 110.02 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -117.56 110.87 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 63.9 t -82.02 116.88 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -78.7 -63.88 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.652 -0.655 . . . . 0.0 110.221 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.26 -49.6 5.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -111.35 90.21 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.914 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.8 tt0 -35.45 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.238 0.542 . . . . 0.0 111.041 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' GLU . 18.0 m -148.36 86.96 5.79 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.892 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.02 93.47 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.093 1.575 . . . . 0.0 110.5 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.425 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 72.3 p -93.29 124.3 37.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 31.3 p -105.93 128.0 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.78 158.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 110.109 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.562 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.1 m -125.41 159.2 32.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 110.33 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -52.99 118.61 3.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 35' ' ' ASP . 43.3 mm-40 -42.44 -40.94 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.96 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.05 47.48 3.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -125.0 172.47 9.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -1.203 . . . . 0.0 110.281 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 41.9 mt -146.52 140.89 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.22 160.88 11.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 -40.49 22.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.117 . . . . 0.0 110.23 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 6.2 mpt_? -93.25 9.65 35.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.131 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.489 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.49 47.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -0.843 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 8.7 tt0 -104.17 -18.23 14.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -101.18 156.2 17.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.834 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.372 -179.865 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.158 0.504 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.461 ' OG ' HG22 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -119.91 128.46 53.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.419 -179.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -83.37 141.78 31.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.033 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -84.08 129.97 56.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.946 . . . . 0.0 110.177 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.18 157.47 50.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.93 1.49 . . . . 0.0 110.29 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -18.33 64.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -65.18 -19.19 65.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -119.76 21.1 12.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.201 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.29 50.25 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.883 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -86.11 -16.85 36.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.053 . . . . 0.0 109.313 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' C ' ' CD1' ' A' ' 15' ' ' TYR . 3.5 p90 -90.4 4.2 51.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.237 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -158.74 109.25 2.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.21 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 10.6 mm -64.3 -70.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 7.9 ptmm? -105.73 55.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -146.83 150.8 23.11 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 179.42 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 0.0 109.856 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 8.4 t -154.73 132.9 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HD2' ' OG ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -107.9 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 109.803 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.89 110.6 22.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.583 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' CG2' ' HD3' ' A' ' 22' ' ' ARG . 48.3 t -84.43 111.86 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.461 HG22 ' OG ' ' A' ' 6' ' ' SER . 37.7 t -74.09 -59.83 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.667 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.34 -59.51 1.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.466 -0.771 . . . . 0.0 109.499 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 63.1 mt-10 -104.0 92.45 4.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 108.97 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.1 tt0 -33.62 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.811 -0.556 . . . . 0.0 111.153 -179.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 19.2 m -149.42 88.49 4.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.35 91.75 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.024 1.539 . . . . 0.0 110.396 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.456 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 2.3 p -90.06 148.82 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.841 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -135.13 116.43 14.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.701 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.06 157.18 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 19.3 m -122.44 161.3 23.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.357 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.2 m-20 -49.64 124.43 9.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -47.05 -41.65 17.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 110.258 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 43.29 2.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -117.04 168.27 10.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -1.19 . . . . 0.0 110.257 179.82 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 38' ' ' TYR . 48.8 mt -150.37 156.92 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.24 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.64 162.02 18.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.74 -28.77 30.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -105.69 17.57 23.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.466 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 16.7 m 61.68 35.69 16.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -100.29 -17.0 17.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.4 170.18 8.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.057 179.873 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.305 0.574 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -124.44 125.21 43.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.198 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.71 118.73 23.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 124.37 83.57 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.053 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.19 160.99 45.86 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.312 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -51.52 -24.03 4.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.35 -45.35 93.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 110.308 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.539 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.6 m-85 -94.24 10.56 33.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' A' ' 10' ' ' LYS . 37.8 mttt -84.93 46.63 1.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -86.21 -13.93 45.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.407 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 7.8 p90 -90.53 -5.13 56.35 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.089 178.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.8 OUTLIER -156.03 132.58 10.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -0.918 . . . . 0.0 110.372 179.472 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 30.7 mm -80.35 -71.89 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.942 . . . . 0.0 110.141 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -101.77 69.11 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 0.0 110.303 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -155.36 159.35 29.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.421 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.39 140.68 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -1.155 . . . . 0.0 109.945 179.833 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.454 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -116.29 138.2 51.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -110.1 104.0 12.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.79 113.14 24.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.376 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 7.1 t -86.12 121.45 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.879 . . . . 0.0 109.933 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -74.86 -62.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.619 -0.675 . . . . 0.0 110.524 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.26 -66.98 0.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' THR . 26.3 mt-10 -97.95 92.15 5.66 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 108.893 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -33.62 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.289 0.566 . . . . 0.0 110.993 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.9 m -137.4 80.92 32.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.485 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.1 Cg_endo -74.48 83.09 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.111 1.585 . . . . 0.0 110.042 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.441 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 36.8 t -90.16 145.74 24.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.328 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.454 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.8 t -119.16 145.59 45.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.911 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 76.5 t -143.21 153.54 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 109.888 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 15.5 m -125.45 157.58 36.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.975 . . . . 0.0 110.353 -179.692 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 19.4 m-20 -51.92 118.65 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 3.6 tp10 -43.24 -37.2 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.962 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 45.86 3.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -125.17 160.93 27.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -1.151 . . . . 0.0 110.297 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.509 ' CD1' ' O ' ' A' ' 38' ' ' TYR . 19.3 mm -142.7 158.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 109.923 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.12 174.77 19.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.37 -47.68 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -1.145 . . . . 0.0 110.35 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -90.01 18.78 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.175 -179.894 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 9.6 m 62.65 38.11 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -98.46 -13.71 20.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.255 -0.903 . . . . 0.0 110.326 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -103.38 169.94 8.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 8.0 p . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 110.347 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.197 0.523 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.5 m -130.71 130.12 43.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 150.54 24.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.446 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -89.68 119.66 69.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.902 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.405 ' C ' ' HE3' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -72.72 173.91 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.809 1.426 . . . . 0.0 110.446 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.449 ' N ' ' HE3' ' A' ' 13' ' ' LYS . 17.0 mttm -66.52 -24.89 66.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 0.0 110.381 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.65 -10.96 30.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.295 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.526 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 12.5 m-85 -129.2 10.9 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.304 -0.873 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HE3' ' N ' ' A' ' 10' ' ' LYS . 19.0 mttt -86.21 45.96 1.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.227 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.28 -14.4 43.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.046 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.04 -1.06 57.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 178.38 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.8 m -160.28 129.25 4.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.035 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 5.0 mt -87.42 -63.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.074 -1.016 . . . . 0.0 110.108 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CD ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -103.11 60.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.257 179.574 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.17 162.38 33.17 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -107.57 -178.83 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -1.19 . . . . 0.0 110.031 179.86 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -160.46 126.91 4.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -104.41 115.43 30.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -100.06 116.03 31.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.542 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 52.6 t -87.26 115.56 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.97 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.6 t -75.36 -61.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.19 -62.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.607 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -99.82 93.18 5.66 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 108.927 178.767 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 28' ' ' GLN . 2.1 pt20 -34.92 91.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.74 -0.6 . . . . 0.0 111.143 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 9.0 m -146.19 86.22 7.12 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.506 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -76.42 98.08 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.067 1.561 . . . . 0.0 110.643 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.446 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 4.0 m -100.41 138.98 36.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.6 p -121.14 110.72 16.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.143 -0.973 . . . . 0.0 110.628 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ARG . 60.8 t -93.91 155.32 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.0 109.886 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 7.1 m -127.92 157.3 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.222 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.4 m-20 -48.76 125.76 10.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.55 -47.21 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 110.085 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.26 46.26 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.79 175.32 5.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -1.169 . . . . 0.0 110.328 -179.952 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 38' ' ' TYR . 3.5 mp -145.05 130.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.82 155.51 9.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.51 -41.04 40.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -1.179 . . . . 0.0 110.208 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 9.6 mtp180 -89.59 7.68 35.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.505 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 6.7 m 64.2 72.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.799 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' CA ' ' HD3' ' A' ' 18' ' ' LYS . 7.0 pt-20 -119.65 -25.09 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.658 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.429 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -112.49 95.15 5.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.787 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.492 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 14.9 p . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.491 ' CE1' HG12 ' A' ' 24' ' ' VAL . 86.8 m-85 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 120.928 0.395 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.54 146.67 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.933 -1.104 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -79.98 154.46 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -81.93 136.32 47.61 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.68 156.54 49.0 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.986 1.519 . . . . 0.0 110.426 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -63.22 -27.86 69.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -20.5 27.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 110.271 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.5 m-85 -125.4 6.38 7.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -86.5 39.62 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.054 179.759 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -86.13 -12.48 49.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.04 -1.037 . . . . 0.0 109.604 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.6 p90 -90.12 1.56 56.26 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.457 -0.777 . . . . 0.0 109.288 178.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -159.67 109.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 46.5 mm -70.14 -74.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -96.28 60.39 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.973 -1.079 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -148.39 141.99 9.6 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.7 45.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -1.166 . . . . 0.0 110.155 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 31' ' ' SER . 8.5 t -113.94 126.5 55.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.428 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.12 111.75 23.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 110.032 179.704 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -96.01 112.67 24.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.0 110.552 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG12 ' CE1' ' A' ' 5' ' ' PHE . 38.5 t -86.58 115.73 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.95 . . . . 0.0 109.976 179.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 26' ' ' ALA . 62.5 t -73.08 -60.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.573 -0.704 . . . . 0.0 110.494 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.84 -66.73 0.3 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.1 tp10 -99.13 93.67 6.1 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.894 178.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tt0 -34.51 91.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.761 -0.587 . . . . 0.0 111.141 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' GLU . 39.6 m -143.71 84.19 10.06 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.438 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.7 Cg_endo -77.35 89.22 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.076 1.566 . . . . 0.0 110.446 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.461 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 78.4 p -89.76 131.5 35.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.069 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.415 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 23.5 p -113.91 108.5 17.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.628 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -109.66 130.39 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.969 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.568 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.1 m -94.35 162.28 13.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.185 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 18.1 m-20 -56.91 117.68 4.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.72 -38.01 2.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.55 45.7 3.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.568 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -126.49 171.06 11.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -1.14 . . . . 0.0 110.282 -179.959 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 2.3 mp -147.39 150.56 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 167.83 16.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.53 -37.41 16.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 46.5 mtt180 -96.55 18.72 13.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.038 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 12.1 m 61.42 41.1 13.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.451 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -93.98 -37.3 11.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 110.671 -179.597 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -85.44 163.99 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.256 -179.729 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.23 -179.879 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.53 133.43 22.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -96.31 152.0 18.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.877 . . . . 0.0 110.382 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' O ' ' CE ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.13 134.05 32.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.163 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.12 161.53 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.866 1.456 . . . . 0.0 110.425 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -31.54 72.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -64.09 -12.22 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 110.328 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.68 -3.23 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.143 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.517 ' CE ' ' O ' ' A' ' 8' ' ' CYS . 18.1 mttt -84.38 62.82 7.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.322 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -85.67 -19.56 30.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.911 -1.118 . . . . 0.0 109.246 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.523 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.8 p90 -90.39 -2.9 57.99 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.046 178.253 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.68 106.72 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.496 HG23 HD12 ' A' ' 17' ' ' ILE . 18.2 mm -78.53 -62.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.112 -0.993 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -90.4 57.37 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 110.374 -179.834 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 13' ' ' LYS . . . -160.05 152.53 23.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -108.56 120.92 43.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -1.122 . . . . 0.0 109.993 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.471 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 10.0 t -99.97 128.71 46.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.653 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -100.5 109.73 21.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 109.718 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.96 104.75 16.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 21.0 t -80.66 120.93 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.071 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.3 t -76.67 -71.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 110.382 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.08 -47.36 4.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.4 tt0 -108.7 81.79 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -33.8 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.391 0.615 . . . . 0.0 111.105 -179.114 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 79.7 m -143.77 82.62 11.09 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.39 84.55 2.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 23.4 m -93.0 151.52 19.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.144 -0.972 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 31.5 p -127.44 127.88 44.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -116.76 148.54 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 70.6 m -116.41 144.52 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-20 -56.36 119.15 5.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.75 -37.98 4.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 45.02 2.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.27 172.23 9.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -1.163 . . . . 0.0 110.313 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.0 mt -150.0 157.49 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.122 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.65 154.6 20.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -42.15 55.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.031 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -90.05 8.46 32.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.886 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 4.4 m 68.73 43.41 1.28 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 109.996 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -101.84 -22.28 14.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.309 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -95.52 169.7 9.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.262 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.934 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.416 ' CD1' HG13 ' A' ' 24' ' ' VAL . 37.7 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.226 0.536 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -132.79 130.12 39.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.156 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.46 130.73 34.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 127.05 90.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.277 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.76 167.48 27.1 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.921 1.485 . . . . 0.0 110.458 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.447 ' HG2' ' HE2' ' A' ' 13' ' ' LYS . 5.4 mttt -66.16 -27.24 67.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.186 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -20.44 49.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.238 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -123.71 2.68 8.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE2' ' HG2' ' A' ' 10' ' ' LYS . 5.1 ttpt -87.03 54.75 3.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -86.33 -15.02 41.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.097 -1.002 . . . . 0.0 109.309 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.442 ' C ' ' CD1' ' A' ' 15' ' ' TYR . 4.5 p90 -90.2 1.93 55.93 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.524 -0.735 . . . . 0.0 109.128 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HA ' ' SG ' ' A' ' 43' ' ' CYS . 1.5 m -157.42 79.12 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.834 . . . . 0.0 109.999 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 83.7 mt -48.7 -55.15 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.427 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 5.9 ptmm? -112.24 60.95 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.478 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -157.49 141.24 7.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 123.51 40.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -1.113 . . . . 0.0 109.936 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' SER . 11.0 t -111.0 127.68 55.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.111 -0.993 . . . . 0.0 110.587 -179.595 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.61 119.39 34.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.868 . . . . 0.0 109.822 179.604 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.31 106.16 17.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 21.3 t -80.24 118.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' ALA . 73.1 t -80.28 -58.44 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.703 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.49 -50.73 3.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 mt-10 -116.06 96.6 5.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.3 tp-100 -34.84 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.78 -0.575 . . . . 0.0 111.201 -179.089 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' GLU . 3.9 m -146.17 82.66 8.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.253 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.437 ' HD3' ' OE1' ' A' ' 28' ' ' GLN . 51.1 Cg_endo -79.56 89.06 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.108 1.583 . . . . 0.0 110.43 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.456 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -94.65 131.15 40.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.993 179.83 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 27.4 p -113.87 114.38 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.2 129.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.848 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 8.3 m -101.85 161.76 13.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.126 -0.984 . . . . 0.0 110.42 -179.388 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 63.0 m-20 -58.85 119.8 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 37' ' ' GLY . 10.3 pt-20 -43.9 -33.43 1.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' A' ' 36' ' ' GLU . . . -90.28 43.83 2.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -126.24 170.65 11.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -1.2 . . . . 0.0 110.414 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 29.3 mt -150.15 151.7 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.64 169.57 17.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -40.82 13.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 110.237 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.8 mpt_? -91.02 10.9 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 6.3 m 66.54 41.45 3.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.872 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 5.6 pt-20 -100.11 -28.29 13.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -84.88 163.24 19.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.231 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.467 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.4 p . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.27 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.102 0.477 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -147.28 134.89 20.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 110.292 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -91.0 126.69 36.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.64 133.95 95.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.8 164.97 34.06 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.943 1.497 . . . . 0.0 110.432 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -66.36 -26.65 67.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.263 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -8.65 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 7.65 5.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 0.0 110.227 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -89.94 46.27 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.32 -11.81 51.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.534 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.41 0.93 57.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.187 178.421 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.9 m -159.54 123.63 3.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.464 HD12 ' HB2' ' A' ' 44' ' ' GLU . 57.8 mt -75.38 -76.52 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -98.72 65.06 1.53 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 0.0 110.814 -179.615 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.505 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -152.87 148.36 19.09 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -101.9 132.7 47.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.13 . . . . 0.0 110.098 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 9.0 t -107.63 126.63 52.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.458 ' CG ' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -96.49 106.89 19.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.48 115.38 27.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.585 -179.601 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 17.9 t -91.64 120.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 109.944 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.7 t -79.59 -64.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 110.563 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -38.3 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.807 . . . . 0.0 109.561 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -124.51 91.49 3.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.912 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 pm0 -36.2 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 110.93 -179.078 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -146.28 83.6 8.36 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.858 . . . . 0.0 110.462 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.3 Cg_endo -78.8 88.42 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.164 1.613 . . . . 0.0 110.431 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.448 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.9 OUTLIER -89.6 145.46 25.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.92 179.837 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 8.9 p -128.03 105.59 8.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.114 -0.991 . . . . 0.0 110.978 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 34' ' ' CYS . 97.3 t -106.8 151.8 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.125 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.517 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 13.5 m -119.55 166.12 13.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.613 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.99 117.39 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.964 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -42.62 -37.25 1.63 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.213 -179.909 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 46.36 3.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -124.61 165.73 17.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -1.202 . . . . 0.0 110.38 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.4 mt -149.42 151.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.235 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.24 149.94 10.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.48 66.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.012 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -90.67 -0.39 57.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.9 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 42' ' ' ARG . 5.2 m 69.89 38.18 1.65 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.825 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB2' HD12 ' A' ' 17' ' ' ILE . 6.5 tm-20 -101.39 -17.34 16.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -97.27 163.95 12.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.821 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.436 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 8.9 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.28 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.25 0.548 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -142.7 121.51 12.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.41 137.28 35.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.183 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 136.41 93.19 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -179.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.43 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.5 Cg_endo -72.89 161.93 42.4 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.055 1.555 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -67.46 -31.52 71.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.952 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.67 -10.83 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.43 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.7 m-85 -126.5 2.83 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.843 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -89.98 57.06 3.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.11 179.889 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -86.45 -12.68 48.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 109.422 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.486 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.3 p90 -90.17 -1.65 57.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.089 178.427 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.486 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.24 104.27 1.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 110.103 179.837 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 47.5 mm -69.29 -72.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.529 ' CE ' ' HB2' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -91.16 52.8 2.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -151.42 135.9 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -99.62 125.95 45.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -1.134 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 11.0 t -105.66 125.8 51.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.251 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.03 112.16 23.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -94.77 104.7 16.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 21.5 t -80.52 115.13 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.266 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 27.9 t -78.13 -62.1 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.558 -0.714 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.53 -44.8 4.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.281 179.523 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -115.37 90.47 3.35 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.842 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -35.01 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.778 -0.576 . . . . 0.0 111.005 -179.133 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' GLU . 34.2 m -150.37 83.46 5.97 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 -179.882 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.5 Cg_endo -80.8 100.08 1.18 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.065 1.56 . . . . 0.0 109.953 179.419 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.3 p -112.15 132.72 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.096 -1.002 . . . . 0.0 110.454 -179.741 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 29.2 p -104.79 131.45 52.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.5 116.95 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.579 ' CB ' ' CE2' ' A' ' 38' ' ' TYR . 19.4 m -93.97 156.1 16.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 110.126 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -50.3 124.18 9.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 179.895 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -45.52 -40.78 8.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.18 46.24 3.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CE2' ' CB ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -120.82 166.62 13.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.339 179.899 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 9.6 mt -146.46 150.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.69 145.02 9.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.98 62.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 110.253 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 4.3 mmt85 -112.78 5.66 17.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 4.0 m 68.34 45.22 1.22 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.131 179.704 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.48 -33.5 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 110.678 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.441 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -86.07 151.68 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.379 -179.704 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.04 179.954 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 47.4 m-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.312 0.577 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.7 128.66 35.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.164 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.91 125.66 45.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.33 127.45 92.13 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 -179.931 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.8 Cg_endo -74.2 161.27 41.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.914 1.481 . . . . 0.0 110.247 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -64.41 -32.67 74.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -65.57 -8.69 21.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.471 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.459 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -123.86 0.98 8.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 8' ' ' CYS . 27.2 mttt -87.99 73.85 9.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.372 -179.788 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -85.74 -17.82 34.79 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.207 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 14.6 p90 -82.58 -10.08 59.12 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 178.502 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.2 m -160.3 137.81 9.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.0 mm -94.37 -70.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.41 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.511 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -89.89 62.41 5.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.102 -0.999 . . . . 0.0 110.506 -179.925 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.35 141.96 7.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.753 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 5.3 mpt_? -95.4 150.56 20.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -1.178 . . . . 0.0 109.505 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 26.5 t -132.55 130.31 40.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.552 -179.685 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -99.49 122.18 42.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 109.994 179.619 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -111.98 103.49 11.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.211 -179.804 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' A' ' 29' ' ' THR . 22.3 t -81.42 124.67 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.1 t -79.68 -69.25 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 110.306 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.94 -44.45 3.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -112.53 93.97 4.69 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.886 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tp-100 -38.93 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.533 -0.729 . . . . 0.0 110.796 -179.148 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 7.6 m -139.18 73.15 38.25 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.218 -0.927 . . . . 0.0 110.459 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.584 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.3 Cg_endo -78.43 72.86 6.12 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.025 1.539 . . . . 0.0 110.033 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.439 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 4.0 p -92.56 137.91 31.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -179.695 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.7 t -114.01 107.83 16.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 20' ' ' ARG . 45.0 t -94.08 116.24 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 9.0 m -83.6 158.54 21.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.964 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.54 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -46.45 120.18 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.762 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.0 tt0 -40.83 -54.09 2.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.66 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.48 52.79 3.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.57 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -118.59 168.86 10.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -1.195 . . . . 0.0 110.655 -179.999 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 39' ' ' ILE . 3.3 mp -143.37 132.04 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.756 . . . . 0.0 109.806 179.5 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.8 136.43 3.62 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.01 72.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.304 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.0 19.89 18.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.963 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.496 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.6 m 63.54 72.74 0.47 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -107.9 -40.27 5.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.938 -179.3 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.475 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 9.1 ptp180 -118.56 168.86 10.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.986 -1.071 . . . . 0.0 110.546 -179.527 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.511 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 7.1 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.181 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.171 0.51 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.5 m -115.95 132.12 56.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -87.69 118.01 26.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 24.6 m -45.28 112.25 1.53 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 163.55 37.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.951 1.501 . . . . 0.0 110.319 179.739 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -60.32 -37.14 79.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.259 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -25.15 63.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 -179.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -110.17 -1.4 17.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.257 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -89.94 46.94 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.401 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -86.21 -12.79 48.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.047 -1.033 . . . . 0.0 109.402 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 9.1 p90 -90.3 -3.8 57.54 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.214 178.494 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.538 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.12 105.52 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.525 HG22 HD11 ' A' ' 17' ' ' ILE . 51.1 mm -70.41 -71.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.055 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HE3' ' CA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -89.69 64.0 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.488 ' O ' ' CE ' ' A' ' 13' ' ' LYS . . . -160.05 136.37 4.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 96.0 mtt180 -99.51 127.21 45.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -1.161 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 9.5 t -119.01 133.18 55.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.643 -179.664 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -102.51 123.96 47.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.853 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -105.66 116.24 31.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.458 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 53.4 t -86.56 116.88 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 110.133 179.714 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' ALA . 89.1 t -79.92 -61.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.543 -0.723 . . . . 0.0 110.549 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.0 -49.14 3.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.577 179.886 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.3 tt0 -114.5 92.83 4.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -34.47 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.262 0.553 . . . . 0.0 110.99 -179.084 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 4.4 m -149.11 86.81 5.52 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -79.23 122.5 5.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.985 1.518 . . . . 0.0 110.298 179.666 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.45 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -127.85 116.64 20.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 109.971 179.804 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.523 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.8 p -99.59 126.98 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.583 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 42.2 t -116.77 120.84 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.349 -0.844 . . . . 0.0 109.819 179.705 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.58 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 14.6 m -91.3 159.95 15.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.247 -0.908 . . . . 0.0 110.514 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -58.42 128.11 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.036 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -47.44 -49.12 25.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 45.76 3.02 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -113.04 172.85 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 110.226 179.864 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 15.2 mt -150.2 127.7 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.27 148.44 6.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.65 66.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 110.283 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' CYS . 81.0 mtt180 -89.58 13.47 13.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.507 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 3.5 m 63.36 62.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.324 -0.86 . . . . 0.0 109.762 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.521 ' CA ' ' HE3' ' A' ' 18' ' ' LYS . 10.4 tt0 -110.34 -28.82 8.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.74 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.466 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 13.2 ttm180 -111.03 109.58 19.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.017 -1.052 . . . . 0.0 110.317 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.959 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' CG ' HG21 ' A' ' 24' ' ' VAL . 36.2 m-85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.282 0.563 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.05 162.73 18.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.347 179.942 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -106.9 154.13 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 110.171 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.423 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -83.46 127.73 67.11 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 -179.907 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.67 162.21 40.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.868 1.457 . . . . 0.0 110.383 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -61.36 -29.04 69.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -63.86 -25.61 68.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.35 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -112.12 10.55 20.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.351 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -90.0 45.45 1.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.131 179.926 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.25 -13.45 46.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.032 . . . . 0.0 109.624 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p90 -87.96 -1.76 58.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.439 -0.788 . . . . 0.0 109.197 178.607 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.78 103.2 1.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 33.2 mt -63.73 -69.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 -179.956 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.7 ptmm? -97.94 64.43 1.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.21 149.31 18.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.96 162.05 13.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 109.793 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 32' ' ' CYS . 9.2 t -151.81 156.24 39.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.02 . . . . 0.0 110.621 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -125.99 125.82 43.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.456 -0.778 . . . . 0.0 109.602 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.07 118.06 36.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.648 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 37.6 t -83.56 115.72 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.814 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 6.0 t -82.2 -63.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.52 -0.737 . . . . 0.0 110.62 -179.506 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.01 -29.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.351 -0.843 . . . . 0.0 109.787 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' THR . 97.2 mt-10 -136.93 93.46 2.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.164 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 13.1 mt-30 -34.72 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.806 -0.559 . . . . 0.0 111.146 -179.124 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 27' ' ' GLU . 3.1 m -149.18 89.57 4.84 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 110.324 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.15 117.45 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.06 1.558 . . . . 0.0 110.395 179.666 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.0 OUTLIER -118.88 110.62 17.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.132 -0.98 . . . . 0.0 109.904 179.768 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.463 ' O ' HG23 ' A' ' 33' ' ' VAL . 26.7 p -92.15 155.14 18.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.735 -179.682 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 32' ' ' CYS . 99.3 t -149.12 120.44 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.472 -0.768 . . . . 0.0 109.806 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.583 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.0 m -93.72 156.47 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -179.526 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -54.85 125.53 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.038 179.772 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.47 -39.42 15.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.826 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 40.95 2.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.84 174.24 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -1.214 . . . . 0.0 110.326 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 38' ' ' TYR . 18.0 mm -149.51 148.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.031 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.61 157.45 20.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.03 -37.71 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.164 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -93.11 9.19 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.124 179.842 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.474 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.8 m 67.41 43.72 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.402 -0.811 . . . . 0.0 110.145 179.818 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -96.29 -34.44 11.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.585 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.47 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -96.7 -178.62 4.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.476 -179.757 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.469 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.8 p . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.861 . . . . 0.0 110.391 -179.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.173 0.511 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.76 140.17 23.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.17 119.81 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.23 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -55.86 136.61 72.54 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 179.878 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.9 Cg_endo -73.35 171.71 17.12 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.91 1.479 . . . . 0.0 110.415 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -63.72 -38.62 91.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 110.234 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -63.64 -19.23 64.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.192 179.982 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.443 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.2 m-85 -107.45 -1.97 20.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.1 55.73 3.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.427 ' CE1' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -86.16 -15.5 40.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.026 -1.046 . . . . 0.0 109.303 179.923 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.509 ' OH ' ' CB ' ' A' ' 21' ' ' CYS . 3.6 p90 -90.13 3.32 53.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.493 -0.755 . . . . 0.0 109.307 178.515 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.98 106.39 1.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.154 179.85 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 9.3 mm -63.25 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.108 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -96.29 63.4 2.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.221 179.987 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.43 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -159.76 155.54 26.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -101.77 -179.06 3.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 109.832 179.832 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.509 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 8.8 t -152.63 128.05 9.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.068 -1.02 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -102.28 105.07 15.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.074 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.29 115.44 28.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 41.2 t -89.91 117.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.817 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 53.8 t -75.24 -62.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.597 -0.69 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.46 -61.23 1.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.83 . . . . 0.0 109.436 179.779 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 29' ' ' THR . 47.7 mt-10 -99.62 90.6 4.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.483 -0.761 . . . . 0.0 109.008 178.891 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.8 pm0 -34.3 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.268 0.556 . . . . 0.0 111.046 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' GLU . 43.4 m -146.03 85.36 7.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.862 . . . . 0.0 110.348 179.912 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.6 Cg_endo -76.05 99.2 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.368 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.4 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -103.35 143.01 33.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.144 179.897 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 27.5 p -123.91 118.22 26.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.767 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 t -112.44 146.82 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.6 m -117.03 161.54 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -54.19 117.41 3.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 110.219 -179.893 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -43.97 -38.1 3.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.35 46.18 3.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.07 172.49 9.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -1.183 . . . . 0.0 110.339 179.965 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 46.2 mt -150.12 143.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.13 168.79 13.37 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 -40.26 16.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -1.15 . . . . 0.0 110.119 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -96.86 13.37 28.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 0.0 110.186 179.973 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.495 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 4.3 m 67.77 51.04 0.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -101.74 -39.92 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.06 165.44 18.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.074 -1.016 . . . . 0.0 110.477 -179.798 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.516 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 8.6 p . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.161 0.505 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 m -145.0 135.92 24.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.299 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 121.18 26.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.142 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -47.41 135.88 9.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.235 -179.982 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.86 173.65 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.996 1.524 . . . . 0.0 110.403 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -65.07 -31.37 72.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.89 -8.59 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -119.05 -1.26 10.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.939 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -90.12 39.39 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.263 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -85.85 -20.94 28.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 109.457 -179.832 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.21 1.1 56.82 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.009 178.124 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.45 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -160.33 92.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.884 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 75.4 mt -75.56 -55.89 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.45 42.74 1.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 110.026 179.772 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.97 -179.74 30.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.29 145.54 43.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.265 -1.138 . . . . 0.0 109.934 179.821 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 14.6 t -125.65 124.94 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.636 -179.538 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -90.2 113.15 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.789 179.602 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -95.41 116.4 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.477 -179.621 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 58.0 t -83.7 116.54 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 109.966 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 38.5 t -79.93 -59.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 0.0 110.494 -179.826 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.53 -47.92 3.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -118.08 95.17 4.78 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.755 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 56.1 tt0 -35.53 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.757 -0.589 . . . . 0.0 111.128 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.9 m -148.52 88.39 5.33 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -76.02 118.87 5.15 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.956 1.503 . . . . 0.0 110.387 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 4.3 m -122.36 115.22 21.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.894 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -98.31 154.16 18.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.72 -179.614 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 32' ' ' CYS . 41.6 t -146.94 159.34 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.883 179.68 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.494 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.4 m -121.43 157.16 31.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.031 . . . . 0.0 110.452 -179.653 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.8 m-20 -66.79 124.88 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.864 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -50.84 -40.53 56.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.31 -179.943 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.39 40.95 3.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER -117.92 176.84 5.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -1.145 . . . . 0.0 110.331 -179.879 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 39' ' ' ILE . 12.8 mt -147.0 117.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 110.245 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 150.94 5.82 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.35 -52.2 49.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -1.153 . . . . 0.0 109.959 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -92.48 17.78 9.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.827 179.691 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 8.6 m 64.65 80.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 110.143 179.936 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -113.68 -38.4 4.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -104.8 162.19 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.1 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.05 -179.952 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CD1' HG11 ' A' ' 24' ' ' VAL . 24.8 m-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.201 0.524 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -140.42 141.44 35.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 165.51 21.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.512 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -89.78 127.34 54.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 110.274 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 48.2 Cg_endo -73.99 166.05 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.465 . . . . 0.0 110.094 179.68 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -66.0 -36.04 82.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -12.2 16.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 110.458 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.42 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.4 m-85 -120.3 -6.0 9.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 52.08 2.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -86.28 -16.92 36.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.95 -1.094 . . . . 0.0 109.413 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.458 ' OH ' ' SG ' ' A' ' 21' ' ' CYS . 4.5 p90 -90.36 1.98 56.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 109.127 178.404 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.3 m -159.66 100.06 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 41.7 mm -72.61 -70.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.165 179.982 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -89.57 49.32 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 179.983 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -141.84 134.34 6.15 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -92.92 127.31 38.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.232 -1.157 . . . . 0.0 109.892 179.771 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 5.8 p -127.96 145.83 50.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 110.565 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.91 159.17 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.857 . . . . 0.0 109.527 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -138.51 109.14 6.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.029 . . . . 0.0 110.307 -179.751 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 7.9 t -80.46 116.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 5.8 t -78.95 -65.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.061 179.834 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.97 -42.71 3.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 109.376 179.608 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -115.95 88.95 2.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.919 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -35.06 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.235 -178.992 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.2 m -146.73 81.75 9.03 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 179.753 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.1 Cg_endo -79.12 107.67 2.25 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.061 1.558 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 136.05 53.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -120.28 129.43 54.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 t -126.34 116.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.079 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 14.9 m -89.54 150.28 22.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 -179.765 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.9 m-20 -45.62 124.26 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 110.093 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 19.2 pt-20 -51.79 -38.55 56.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -90.12 37.94 3.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -110.02 172.8 6.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 110.322 -179.932 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 39' ' ' ILE . 33.3 mm -144.98 141.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.237 179.886 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 145.97 10.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -1.188 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.1 mtm-85 -89.78 3.63 52.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 110.149 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m 67.55 51.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 109.598 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -99.42 -30.94 11.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.598 -179.565 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.475 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 82.1 mtt180 -105.6 173.76 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.402 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 179.964 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.211 0.529 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 m -137.5 146.86 44.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.61 150.82 25.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.888 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -83.65 130.12 57.04 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.958 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.56 172.34 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.959 1.505 . . . . 0.0 110.396 -179.926 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -63.76 -25.18 68.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.262 179.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -62.51 -10.27 11.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 -179.885 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.585 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 8.8 m-85 -131.73 4.35 4.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -85.53 44.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.461 -179.843 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -85.2 -25.19 27.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.845 -1.16 . . . . 0.0 109.602 -179.78 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 10.9 p90 -79.16 -6.01 55.53 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.292 178.566 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 1.7 m -160.3 138.14 9.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.54 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.518 ' CD1' ' HG2' ' A' ' 44' ' ' GLU . 9.8 mt -94.68 -72.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.197 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -89.78 63.92 6.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 110.312 179.987 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.2 139.75 6.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -100.39 125.45 46.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -1.163 . . . . 0.0 109.801 179.91 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.506 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t -111.28 129.17 56.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 -179.643 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -90.89 129.17 36.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.939 179.689 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -105.62 110.48 22.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 39.4 t -80.31 114.72 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 26' ' ' ALA . 42.5 t -77.03 -65.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.593 -0.692 . . . . 0.0 110.235 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.6 -48.5 4.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.49 179.813 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -112.83 87.62 2.63 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.511 -0.743 . . . . 0.0 109.013 178.844 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -33.89 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.126 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 6.0 m -149.23 88.35 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.336 -0.852 . . . . 0.0 110.412 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.08 91.81 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.04 1.547 . . . . 0.0 110.432 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.1 p -93.34 124.98 37.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 179.784 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.506 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 6.7 t -99.97 129.56 46.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 87.4 t -117.9 109.4 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 109.584 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.2 m -79.93 153.75 28.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.835 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 5.2 m-20 -49.57 117.8 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.811 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.05 -47.08 4.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.469 -179.897 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.24 49.67 3.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -121.84 172.82 7.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.142 -1.211 . . . . 0.0 110.283 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 14.5 mt -144.09 143.8 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.193 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.09 170.36 14.97 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.2 -46.43 9.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -1.176 . . . . 0.0 110.268 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.5 mtp85 -91.41 11.96 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.152 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.484 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.7 m 67.1 64.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.436 -0.79 . . . . 0.0 110.196 179.878 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.518 ' HG2' ' CD1' ' A' ' 17' ' ' ILE . 24.1 mt-10 -116.3 -14.05 11.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.883 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 14.2 mtt180 -117.71 176.0 5.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.234 179.999 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.082 0.468 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 m -127.64 120.76 28.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.869 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.03 129.69 34.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.435 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.74 132.28 72.11 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.891 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -73.72 160.24 44.12 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.519 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . 4.1 mttm -65.45 -30.66 71.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.257 179.974 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -64.03 -15.5 59.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.421 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -116.52 -1.4 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.312 -179.89 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HE3' ' HA ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.69 67.04 9.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 179.951 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -85.93 -17.64 34.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.04 -1.037 . . . . 0.0 109.37 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.423 ' C ' ' CD1' ' A' ' 15' ' ' TYR . 4.1 p90 -90.23 2.91 54.92 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.538 -0.726 . . . . 0.0 109.35 178.512 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.02 95.35 1.16 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.096 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.1 mm -55.57 -82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.364 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' NZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -89.89 66.05 6.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.017 . . . . 0.0 110.274 -179.853 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.67 154.87 25.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 10.1 ptt-85 -109.54 137.53 47.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -1.114 . . . . 0.0 109.992 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 47.6 t -124.48 123.33 39.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.41 110.45 23.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 179.764 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -95.76 110.28 22.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.355 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 9.5 t -79.89 118.89 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.109 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.2 t -79.72 -65.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.347 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.8 -46.75 3.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.86 . . . . 0.0 109.621 179.801 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 8.0 mt-10 -114.52 89.77 3.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.475 -0.765 . . . . 0.0 109.072 178.976 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.42 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.296 0.57 . . . . 0.0 111.109 -179.024 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 55.1 m -147.15 83.11 8.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.903 . . . . 0.0 110.38 179.75 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -77.63 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.515 . . . . 0.0 110.278 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -106.91 118.75 37.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.416 ' C ' HG21 ' A' ' 33' ' ' VAL . 21.9 p -98.27 148.24 23.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.973 . . . . 0.0 110.231 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG21 ' C ' ' A' ' 32' ' ' CYS . 21.4 t -145.17 150.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 33.1 m -120.93 161.68 21.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -57.62 127.66 33.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.991 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -44.0 52.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.166 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.92 43.69 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -114.84 170.66 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -1.162 . . . . 0.0 110.222 -179.963 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 21.0 mt -150.05 171.11 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.462 ' HA3' ' HD3' ' A' ' 45' ' ' ARG . . . 98.92 169.13 30.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.42 -41.75 14.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.188 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 16.6 mtt180 -96.45 21.03 9.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 -179.998 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.1 m 64.23 31.79 12.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 110.142 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.429 ' CD ' ' HB2' ' A' ' 42' ' ' ARG . 44.2 mt-10 -92.01 -18.73 23.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.551 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -97.85 163.89 12.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 7.2 p . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 -179.879 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.557 ' CD1' HG23 ' A' ' 24' ' ' VAL . 63.3 m-85 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.206 0.526 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.69 134.23 42.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.987 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -84.75 150.68 24.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.349 -179.93 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.41 132.8 34.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.135 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.3 Cg_endo -73.2 161.04 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.955 1.503 . . . . 0.0 110.574 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -30.21 70.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.379 -0.826 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -9.76 42.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.451 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.0 m-85 -122.62 6.14 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 19' ' ' GLY . 50.8 mttt -89.24 56.9 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.4 -179.887 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -15.14 42.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.03 -1.044 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.471 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.23 2.04 55.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.264 178.586 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.6 m -160.51 123.42 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 95.1 mt -81.34 -64.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 110.259 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 8.6 ptmm? -106.06 61.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -150.32 155.82 26.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.884 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -106.42 136.81 45.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.114 . . . . 0.0 109.634 179.601 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 18.0 t -120.82 148.19 44.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.126 -0.984 . . . . 0.0 110.627 -179.527 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -125.35 119.08 27.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.817 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.18 116.51 32.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.947 . . . . 0.0 110.477 -179.635 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG23 ' CD1' ' A' ' 5' ' ' PHE . 21.8 t -87.19 114.45 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.018 179.704 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.0 t -75.43 -62.05 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.403 -0.811 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.14 -59.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 109.505 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 64.1 mm-40 -103.51 89.0 3.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -32.81 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.34 0.591 . . . . 0.0 111.168 -179.105 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.7 m -145.57 87.75 6.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.292 179.892 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.19 94.43 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.095 1.576 . . . . 0.0 110.452 179.833 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.453 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -95.24 141.24 29.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 179.944 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.4 p -123.48 122.14 37.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.267 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.1 143.86 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.926 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 31.6 m -115.33 164.44 14.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.471 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.508 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -45.96 122.46 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.245 179.961 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.65 -52.93 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.53 -179.877 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.44 50.61 3.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -116.3 170.94 8.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.102 -1.234 . . . . 0.0 110.343 179.783 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.1 mt -150.03 158.54 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 179.951 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.468 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 107.87 143.7 10.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.977 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.33 -29.98 68.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.264 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.07 9.26 43.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.104 179.967 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 5.3 m 65.65 49.26 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -107.81 -31.09 8.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.443 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 62.4 mtt85 -85.18 157.62 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.27 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.216 0.531 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.95 149.88 43.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.57 110.37 0.32 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -171.59 93.09 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -1.128 . . . . 0.0 110.255 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -119.9 -152.05 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 110.035 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -133.29 125.21 28.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.473 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.58 120.98 32.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 110.05 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 33.4 m -57.19 116.0 12.27 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.62 168.38 24.91 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.9 1.474 . . . . 0.0 110.453 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -27.95 67.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -13.86 60.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -121.09 17.24 11.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 110.229 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -90.08 47.62 1.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.403 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.06 -18.5 32.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 109.135 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.9 p90 -90.64 0.52 57.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.086 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 3.1 m -160.14 91.47 0.95 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 51.7 mt -62.08 -53.31 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.123 -0.986 . . . . 0.0 110.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.17 57.39 0.62 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.14 159.78 31.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -101.85 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -1.149 . . . . 0.0 110.068 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 37.1 t -158.89 126.55 4.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 110.731 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -106.34 122.51 46.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.734 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -110.51 112.42 24.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.987 . . . . 0.0 110.577 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 63.5 t -89.73 118.68 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.94 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.9 t -77.63 -64.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.744 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -46.6 4.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.345 -0.847 . . . . 0.0 109.376 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.6 tt0 -109.74 87.92 2.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.9 tt0 -34.76 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.361 0.6 . . . . 0.0 111.116 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -148.73 84.66 6.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -77.98 84.22 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.09 1.574 . . . . 0.0 110.128 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.454 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 28.9 t -89.88 140.36 29.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.068 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 12.0 p -129.04 110.77 12.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.415 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 20' ' ' ARG . 3.6 t -99.17 159.96 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 0.0 109.686 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 10.6 m -135.53 162.31 33.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -57.08 122.95 13.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 109.956 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.3 mt-10 -41.58 -37.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 110.168 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.68 48.17 3.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -123.26 162.17 23.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.023 -1.281 . . . . 0.0 110.38 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 38' ' ' TYR . 29.6 mm -142.29 156.03 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.212 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.55 150.96 25.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.57 80.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -1.15 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -89.65 8.06 33.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.02 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.494 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 6.9 m 64.64 58.15 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.39 -0.819 . . . . 0.0 110.153 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.76 -31.1 9.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 110.275 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.422 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 7.0 mtt180 -94.64 171.08 9.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.058 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.51 141.36 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 110.475 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.461 ' HB2' HG13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -142.85 62.87 1.4 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.425 -0.797 . . . . 0.0 110.198 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 tt -101.6 37.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -0.99 . . . . 0.0 110.326 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER -44.54 -37.63 3.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 0.0 110.2 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 49' ' ' PHE . 5.7 m-85 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 1' ' ' ARG . 12.3 ptp180 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.214 0.53 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.95 -47.11 3.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.257 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 4' ' ' HIS . . . 140.17 162.19 9.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.54 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 0.0 OUTLIER 176.05 89.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 0.0 110.153 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.555 ' CD1' HG12 ' A' ' 24' ' ' VAL . 27.4 m-85 -113.78 -155.37 0.57 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.208 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.05 143.2 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -80.95 127.08 32.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.309 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -59.65 130.04 87.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.2 Cg_endo -72.47 160.53 46.53 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.899 1.473 . . . . 0.0 110.356 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -61.65 -30.2 70.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.177 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -29.52 70.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.453 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -99.23 0.07 42.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.23 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 49.0 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.72 -20.25 29.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.021 -1.05 . . . . 0.0 109.352 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' OH ' ' SG ' ' A' ' 21' ' ' CYS . 4.4 p90 -90.35 1.24 56.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.131 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 101.46 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 38.7 mm -74.22 -69.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -89.85 58.61 4.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.16 136.0 4.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.464 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 8.6 mpt_? -93.92 128.95 40.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 110.038 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 6.4 p -126.35 147.67 49.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.61 144.94 35.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 109.808 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -121.73 108.7 13.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.555 HG12 ' CD1' ' A' ' 5' ' ' PHE . 3.9 t -83.42 120.12 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 46.2 t -81.87 -65.18 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.712 -0.617 . . . . 0.0 110.233 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.37 -34.55 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -128.14 92.04 3.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 11.1 tm0? -36.24 91.41 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.743 -0.598 . . . . 0.0 110.919 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' GLU . 17.7 m -147.55 81.49 8.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.419 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.415 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -78.85 91.2 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.168 1.615 . . . . 0.0 110.321 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -89.26 145.38 25.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.2 p -123.98 132.09 53.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 0.0 110.591 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 66.5 t -127.25 111.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.879 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -81.94 152.34 26.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -57.39 124.96 20.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' ASP . 1.4 mm-40 -42.15 -42.73 3.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.459 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.4 48.02 3.1 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -119.44 169.4 10.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.268 . . . . 0.0 110.348 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.507 HG21 HD13 ' A' ' 39' ' ' ILE . 44.1 mt -150.49 141.37 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.87 147.52 7.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.8 52.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.131 . . . . 0.0 110.074 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.419 ' C ' ' SG ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -94.97 20.66 8.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 110.345 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.496 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 2.4 m 63.42 67.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -102.94 -44.03 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 111.399 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 12.9 ptm180 -112.45 134.42 53.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.899 -1.126 . . . . 0.0 110.599 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.4 p -91.45 159.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -97.96 70.33 2.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.232 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.13 138.65 26.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 0.0 110.271 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.31 -48.87 65.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.282 -0.886 . . . . 0.0 110.207 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.232 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.266 0.555 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -119.61 119.4 33.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.16 166.07 12.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.11 59.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -1.119 . . . . 0.0 110.268 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -90.09 -154.42 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -117.07 123.7 47.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -79.92 112.42 17.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -43.36 122.13 3.33 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.294 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -71.63 167.13 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.915 1.482 . . . . 0.0 110.427 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -53.57 -43.13 68.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -0.906 . . . . 0.0 110.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.87 -32.64 67.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.476 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -90.98 -12.05 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 45.57 1.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -86.16 -17.18 35.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.123 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.2 p90 -90.5 2.17 55.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.221 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.7 m -159.31 97.94 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.121 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 53.1 mt -63.61 -70.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.9 . . . . 0.0 110.309 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -91.86 64.31 4.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.08 153.44 24.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -114.18 140.67 48.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -1.141 . . . . 0.0 110.144 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 11.4 t -130.3 128.28 41.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.472 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -92.53 122.06 34.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 109.943 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.99 109.78 21.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 110.402 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 13.8 t -80.15 120.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 93.4 t -78.9 -64.38 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 110.344 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.28 -43.94 3.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.375 -0.828 . . . . 0.0 109.483 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.9 mt-10 -118.33 88.35 2.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.96 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.363 0.601 . . . . 0.0 111.01 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 32.9 m -143.29 85.6 9.51 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.256 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.98 87.21 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.145 1.603 . . . . 0.0 110.557 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 p -90.49 109.03 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.87 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.529 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 32.0 p -99.24 142.15 31.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.554 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.9 t -140.58 120.51 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 109.969 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.572 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 12.7 m -88.04 156.18 19.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.238 -0.914 . . . . 0.0 110.322 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -48.85 121.52 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -50.21 -43.69 52.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.302 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.59 39.1 3.12 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.572 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -113.12 178.36 4.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 110.341 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.498 HG21 ' N ' ' A' ' 40' ' ' GLY . 17.7 mt -150.23 158.76 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.498 ' N ' HG21 ' A' ' 39' ' ' ILE . . . 105.44 168.97 23.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.59 -44.66 11.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.338 -1.095 . . . . 0.0 110.137 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.488 ' CB ' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -91.73 14.76 14.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 4.1 m 68.82 51.96 0.56 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.336 -0.852 . . . . 0.0 110.333 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.488 ' OE2' ' CB ' ' A' ' 42' ' ' ARG . 14.0 mt-10 -105.37 -34.96 7.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 17.2 mtp180 -85.23 160.85 19.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.516 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 4.4 p -134.5 148.15 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.294 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -100.79 46.55 0.94 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' CD2' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -148.54 179.93 7.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -81.57 3.79 23.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.123 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.442 ' CE2' ' CD2' ' A' ' 48' ' ' LEU . 26.0 m-85 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.174 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' LYS . 4.8 tpp180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.22 0.533 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' ARG . 1.3 tttp 44.25 61.27 2.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.157 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.39 -151.55 6.18 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 t60 51.46 87.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -1.157 . . . . 0.0 110.167 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -94.94 -146.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.237 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.31 134.82 48.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 110.301 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -88.21 147.53 24.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.15 143.97 43.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.22 164.84 34.25 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.04 1.547 . . . . 0.0 110.468 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -62.98 -31.58 72.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -21.46 66.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.108 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -102.61 1.38 34.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.235 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 16' ' ' CYS . 14.4 mtpt -87.41 54.38 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.325 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -18.87 31.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.941 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.467 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 1.8 p90 -90.56 -2.75 57.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.017 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 10.3 m -158.92 109.06 2.0 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.853 . . . . 0.0 110.053 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 29.6 mm -72.66 -54.87 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.019 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 7.8 ptmm? -106.41 53.02 0.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -151.5 147.09 16.58 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -101.99 141.23 35.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -1.196 . . . . 0.0 110.065 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 34.8 t -115.92 123.63 48.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 110.456 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -96.42 107.77 20.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -91.02 111.9 23.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.855 . . . . 0.0 110.443 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 27' ' ' GLU . 88.2 t -81.27 117.11 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.028 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 99.9 t -80.88 -56.61 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.657 -0.652 . . . . 0.0 110.386 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.64 -42.97 2.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.49 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 29' ' ' THR . 35.3 tt0 -125.46 97.35 5.15 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -34.5 90.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.764 -0.585 . . . . 0.0 111.172 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 27' ' ' GLU . 14.0 m -148.66 85.69 6.06 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.444 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.507 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -73.47 100.16 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.056 1.556 . . . . 0.0 110.412 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.448 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 18.6 t -97.16 133.77 41.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.1 p -113.98 102.27 10.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.423 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.33 122.67 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.883 . . . . 0.0 110.012 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.476 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 18.1 m -95.51 155.62 16.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.369 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 2.0 m-20 -43.84 124.27 3.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.127 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.71 -49.42 28.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.339 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 46.63 3.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.4 OUTLIER -111.6 171.29 7.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -1.204 . . . . 0.0 110.317 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.5 ' CG1' ' HB2' ' A' ' 47' ' ' ASP . 25.3 mm -144.69 153.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.53 156.39 16.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.78 57.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -1.134 . . . . 0.0 110.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 4.2 mmm-85 -97.05 12.57 32.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.42 55.93 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 0.0 109.874 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.81 -36.73 6.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.599 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -97.08 -179.49 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.499 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.447 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.7 p -149.19 150.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -0.836 . . . . 0.0 110.078 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' HB2' ' CG1' ' A' ' 39' ' ' ILE . 48.3 t0 -114.36 83.05 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.321 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 HD21 HG23 ' A' ' 46' ' ' VAL . 1.4 pt? -112.85 2.92 16.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 0.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -66.21 0.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.4 t80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.25 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.443 ' NH2' ' HG2' ' A' ' 1' ' ' ARG . 11.4 mtp85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.18 0.514 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 155.03 17.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.06 42.62 0.77 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -125.22 75.07 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -1.131 . . . . 0.0 110.216 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -132.66 -141.46 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 110.021 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -131.04 129.76 42.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 8' ' ' CYS . 1.9 ttm180 -88.23 111.68 21.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 46.8 m -42.93 110.73 0.92 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.255 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HG2' ' CG ' ' A' ' 11' ' ' GLN . 45.6 Cg_endo -73.59 179.25 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.927 1.488 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.98 -36.32 84.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.441 ' CG ' ' HG2' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -59.88 -13.82 12.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.44 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.512 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.9 m-85 -120.07 -3.55 10.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.155 -0.966 . . . . 0.0 110.429 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.75 41.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.259 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -85.91 -18.41 32.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.024 -1.047 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.33 3.64 53.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.342 -0.848 . . . . 0.0 109.148 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.7 m -158.47 120.29 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.14 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.4 mm -80.46 -72.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.262 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.6 OUTLIER -95.23 65.01 2.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.028 -1.045 . . . . 0.0 110.33 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.25 171.82 33.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 11.7 mtp85 -131.99 133.43 44.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 109.807 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 7.9 t -121.7 137.05 54.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.75 126.28 51.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.51 112.86 26.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.546 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 58.3 t -84.18 116.59 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.059 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 26' ' ' ALA . 60.5 t -74.18 -64.55 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 110.4 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.93 -62.33 0.94 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.872 . . . . 0.0 109.34 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 21.0 mm-40 -97.82 87.77 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.88 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.742 -0.599 . . . . 0.0 111.072 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 27' ' ' GLU . 10.5 m -145.0 88.1 6.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.82 91.93 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.133 1.596 . . . . 0.0 110.364 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.88 122.11 41.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.174 -0.953 . . . . 0.0 110.037 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.446 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.6 p -102.7 137.32 41.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.475 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 24.6 t -129.4 164.35 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 109.847 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 6.0 m -133.26 163.51 29.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 110.397 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.551 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-20 -55.74 121.39 9.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -46.58 -43.19 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 44.81 3.28 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.4 169.48 10.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -1.159 . . . . 0.0 110.129 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.492 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 3.3 mp -140.67 145.52 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.873 . . . . 0.0 110.217 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.37 167.3 16.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.95 -41.64 12.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 110.198 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.91 11.53 20.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.915 . . . . 0.0 110.216 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 66.9 49.59 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.304 -0.872 . . . . 0.0 109.827 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.455 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 28.8 tt0 -98.11 -34.8 10.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.9 mtt180 -94.02 157.36 16.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 110.092 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.74 153.82 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.492 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 4.4 t0 -125.02 53.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.283 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.52 -42.38 2.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.944 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 50' ' ' TYR . 96.3 m-85 -89.99 25.8 2.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.845 . . . . 0.0 109.967 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' PHE . 2.8 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.302 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.321 0.581 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -153.08 115.96 4.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -0.932 . . . . 0.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.11 174.33 42.54 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.495 ' CD2' ' O ' ' A' ' 4' ' ' HIS . 0.6 OUTLIER -163.94 74.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -1.153 . . . . 0.0 110.283 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -108.23 -154.22 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.197 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.2 m -124.25 131.93 53.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -91.36 145.44 24.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 110.151 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 139.31 33.17 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.9 . . . . 0.0 110.261 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.51 166.9 28.64 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.974 1.512 . . . . 0.0 110.4 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -61.63 -28.84 69.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.53 -29.45 69.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.295 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -98.03 6.75 47.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.379 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 51.82 2.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 110.357 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -21.78 28.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.5 p90 -90.49 3.91 52.59 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.072 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 119.61 2.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.189 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 17.1 mm -73.37 -82.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.192 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.4 ptmm? -93.06 64.46 3.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 110.033 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -153.53 144.52 11.42 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -94.3 153.46 18.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.268 -1.137 . . . . 0.0 110.053 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 31' ' ' SER . 9.4 t -130.44 127.0 38.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 110.152 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.14 107.56 18.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -93.82 112.2 24.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 110.37 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 4.7 t -80.27 115.52 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.99 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 12.7 t -79.2 -66.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.635 -0.665 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.32 -34.2 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 109.372 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.3 mt-10 -123.66 88.9 3.0 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 15.7 tt0 -35.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.801 -0.562 . . . . 0.0 111.143 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 31.4 m -150.27 91.31 4.22 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.288 -0.883 . . . . 0.0 110.288 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 47.8 Cg_endo -75.52 108.99 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.637 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 5.1 t -111.09 141.55 44.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 10.2 p -129.4 100.28 5.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.543 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.53 124.57 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.529 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 58.9 m -93.75 159.27 15.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.7 m-20 -53.25 116.97 2.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.55 ' HG2' ' N ' ' A' ' 37' ' ' GLY . 1.4 pm0 -51.64 -29.53 18.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 110.183 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.55 ' N ' ' HG2' ' A' ' 36' ' ' GLU . . . -90.85 35.39 3.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -115.26 172.67 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -1.124 . . . . 0.0 110.54 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 24.4 mt -149.49 156.25 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.13 170.9 20.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.47 -45.78 11.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.218 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 1.6 mmp_? -89.97 12.37 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 42' ' ' ARG . 3.8 m 69.59 47.42 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -101.0 -38.47 8.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.22 -0.925 . . . . 0.0 110.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 3.8 mtt180 -83.11 172.14 12.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.472 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.5 p -145.87 152.61 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.953 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 1.6 t0 -129.3 47.33 2.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.487 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.78 -50.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.405 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.472 ' O ' ' OXT' ' A' ' 50' ' ' TYR . 3.3 m-85 -68.33 -36.26 79.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.388 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' OXT' ' O ' ' A' ' 49' ' ' PHE . 12.9 m-85 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.268 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.482 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 42.6 ptt85 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.212 0.53 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 1' ' ' ARG . 0.5 OUTLIER 175.21 -81.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.78 77.26 0.16 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -167.02 86.56 0.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -1.171 . . . . 0.0 110.232 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -111.4 -153.05 0.51 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.156 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 m -145.61 130.53 18.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.351 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -81.61 154.89 25.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.071 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -84.29 124.59 73.72 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 158.22 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.865 1.455 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -67.08 -24.46 65.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.473 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -64.4 -12.08 39.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.381 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -131.92 16.01 4.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -90.29 58.61 4.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -86.1 -12.89 48.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 109.46 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.461 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 12.2 p90 -86.73 -8.95 56.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.474 -0.766 . . . . 0.0 109.038 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 1.7 m -160.38 126.4 4.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.3 mm -76.66 -55.67 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.008 . . . . 0.0 110.42 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -116.39 70.62 0.77 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.049 -1.032 . . . . 0.0 110.362 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.47 166.06 30.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 17.3 ptt180 -114.2 121.11 42.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.129 -1.218 . . . . 0.0 110.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 6.2 t -105.16 128.76 53.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 110.369 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.21 109.88 22.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 109.87 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -100.75 112.66 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.379 -179.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 3.4 t -87.9 118.32 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.335 -0.853 . . . . 0.0 110.02 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 26' ' ' ALA . 16.7 t -75.96 -67.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 110.44 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.4 -50.56 3.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -0.839 . . . . 0.0 109.563 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -108.44 90.32 3.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.8 mt-30 -35.55 91.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.306 0.574 . . . . 0.0 110.925 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 89.9 m -143.67 78.83 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.497 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.2 Cg_endo -75.41 81.96 2.18 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.108 1.583 . . . . 0.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.463 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 6.3 p -90.01 137.84 32.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 109.682 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.449 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.1 t -115.05 130.71 57.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.084 -1.01 . . . . 0.0 110.666 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 4.3 t -124.47 158.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.586 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.7 m -110.06 161.62 15.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.138 -0.976 . . . . 0.0 110.568 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.0 m-20 -61.61 120.52 10.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 15.7 pt-20 -45.56 -43.63 12.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 110.183 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -90.14 47.4 3.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.9 174.95 6.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -1.15 . . . . 0.0 110.4 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.475 ' CG1' ' C ' ' A' ' 38' ' ' TYR . 8.5 mt -150.35 129.69 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 158.63 9.61 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.52 -46.35 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -1.151 . . . . 0.0 110.154 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.8 mtt180 -89.59 8.9 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m 67.43 61.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 109.997 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -106.25 -40.35 5.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.939 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.41 150.24 25.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.472 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.515 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 2.5 p -122.91 147.25 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.232 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -120.49 39.01 3.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -105.87 172.0 7.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.253 -0.904 . . . . 0.0 110.368 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -58.12 3.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.302 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.24 -179.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 4' ' ' HIS . 2.0 mmt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.206 0.527 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -55.85 110.78 0.78 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.52 56.61 3.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 1' ' ' ARG . 1.4 m80 -162.68 73.21 0.36 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -1.138 . . . . 0.0 110.199 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -123.93 -141.47 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.139 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.02 142.45 36.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 110.209 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 8' ' ' CYS . 10.1 mtp180 -103.9 107.5 18.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 32.0 m -42.08 121.24 2.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.901 . . . . 0.0 110.168 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.83 168.07 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.89 1.468 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.8 -27.96 68.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -66.53 -12.85 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -122.67 9.5 9.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.14 51.62 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -85.74 -20.12 29.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.917 -1.115 . . . . 0.0 109.217 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.6 p90 -90.3 -1.57 57.93 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.098 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.7 m -160.59 98.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.492 ' CD1' ' CD ' ' A' ' 44' ' ' GLU . 24.4 mt -77.74 -57.41 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -89.56 39.15 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.158 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.484 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -158.27 150.33 21.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HG3' ' HE2' ' A' ' 13' ' ' LYS . 3.5 mtt180 -110.4 144.74 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -1.097 . . . . 0.0 109.781 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 17.6 t -125.94 135.91 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.99 . . . . 0.0 110.864 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.04 138.78 34.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.832 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -117.5 117.37 29.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.03 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.6 t -85.62 118.82 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.854 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 35.7 t -80.84 -65.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.627 -0.671 . . . . 0.0 110.607 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.45 -33.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 0.0 109.66 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -132.17 89.04 2.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 tt0 -34.59 90.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.763 -0.585 . . . . 0.0 111.09 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' GLU . 20.4 m -144.97 91.77 5.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.219 -0.926 . . . . 0.0 110.47 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 134.71 9.86 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.144 1.602 . . . . 0.0 110.412 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.451 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -141.15 112.09 7.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 109.915 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 29.0 p -98.53 144.43 27.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.752 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.93 127.41 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.484 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 23.8 m -102.71 164.25 11.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 1.3 m-20 -63.47 116.41 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.459 -0.776 . . . . 0.0 109.979 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.5 pt-20 -42.7 -31.26 0.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.486 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.84 43.26 2.97 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.426 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -125.44 170.28 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.483 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 30.8 mt -149.95 144.2 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.96 151.43 8.17 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.43 47.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -1.148 . . . . 0.0 110.24 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 22.8 mtt180 -89.97 12.95 16.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.926 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 5.1 m 66.64 57.23 0.69 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 109.867 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.492 ' CD ' ' CD1' ' A' ' 17' ' ' ILE . 8.3 mm-40 -108.09 -13.7 14.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.576 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.48 173.31 6.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.117 -0.989 . . . . 0.0 110.455 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.6 p -144.46 155.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 22.1 t0 -130.3 81.15 1.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.903 . . . . 0.0 110.328 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.08 -156.18 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 110.247 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.94 2.52 17.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.192 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 3' ' ' GLY . 6.2 mpt_? . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.328 0.585 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 mttp 51.42 -89.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.917 . . . . 0.0 110.246 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 1' ' ' ARG . . . 168.56 160.2 15.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -130.47 77.26 1.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -1.178 . . . . 0.0 110.312 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -102.65 -153.21 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.002 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.5 m -128.62 135.81 49.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 110.239 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -94.57 130.32 41.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.77 126.61 92.91 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.132 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.85 169.4 22.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.944 1.497 . . . . 0.0 110.306 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.5 mmtt -57.88 -24.98 60.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -33.59 75.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.575 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 26.6 m-85 -106.11 12.21 30.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -89.59 40.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 110.241 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -85.91 -18.2 33.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.02 -1.05 . . . . 0.0 109.613 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.25 3.16 54.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.4 125.8 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 10.8 mm -79.95 -72.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.135 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 6.2 ptmm? -99.27 51.56 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.096 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -140.95 141.86 11.68 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -98.15 141.44 31.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -1.073 . . . . 0.0 109.898 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 37.3 t -117.01 123.21 46.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.564 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -94.14 104.35 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.6 t80 -92.39 117.73 30.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.494 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 59.1 t -84.48 118.45 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.8 t -81.72 -66.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.612 -0.68 . . . . 0.0 110.526 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.83 -36.37 0.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -124.59 90.16 3.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 27' ' ' GLU . 21.0 tt0 -35.92 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.774 -0.579 . . . . 0.0 111.052 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 16.3 m -150.15 89.48 4.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.9 Cg_endo -74.49 115.92 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.144 1.602 . . . . 0.0 110.545 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.77 123.24 46.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.7 p -103.12 135.48 44.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.3 125.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 24.3 m -92.58 163.08 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.444 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -51.74 129.56 26.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -48.75 -48.35 40.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 45.61 3.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -111.88 162.15 15.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -1.217 . . . . 0.0 110.005 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 38' ' ' TYR . 33.4 mm -143.82 146.52 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.32 158.62 10.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.47 -43.71 38.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -1.099 . . . . 0.0 110.235 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 22.6 mtt-85 -89.89 8.73 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 5.0 m 68.36 48.79 0.84 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 0.0 110.011 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.8 -26.11 10.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.929 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -91.64 178.69 5.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.171 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.3 p -144.31 150.94 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.278 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -98.41 67.7 1.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.871 . . . . 0.0 110.192 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -110.14 47.02 0.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.147 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -71.3 -8.37 53.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.888 . . . . 0.0 110.135 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.116 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.96 -176.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.91 165.56 43.85 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 4' ' ' HIS . 0.7 OUTLIER -156.63 74.1 0.8 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -1.187 . . . . 0.0 110.341 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.484 ' CD1' HG13 ' A' ' 24' ' ' VAL . 73.8 m-85 -109.23 -139.27 0.38 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 109.954 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -130.36 118.03 20.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.033 -1.042 . . . . 0.0 110.137 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.24 121.36 26.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 110.142 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -54.76 123.31 45.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.097 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.18 162.4 41.78 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.897 1.472 . . . . 0.0 110.392 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -58.03 -25.87 61.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.61 -35.7 78.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.485 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.18 9.85 38.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -90.07 48.01 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -85.86 -17.29 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.446 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 5.2 p90 -90.45 -0.3 57.6 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.224 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 110.83 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.952 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.2 mm -81.7 -66.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 43' ' ' CYS . 1.8 ptpp? -89.77 53.72 2.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.203 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.06 179.97 33.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.7 OUTLIER -133.01 171.86 13.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -1.129 . . . . 0.0 110.045 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 31' ' ' SER . 43.4 t -152.34 120.47 6.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.8 ttp85 -90.45 111.38 22.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.998 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.59 108.1 20.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.406 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 4.3 t -84.17 115.22 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.983 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ALA . 70.3 t -80.3 -60.42 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.8 -35.6 1.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.264 -0.897 . . . . 0.0 109.4 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -127.18 94.76 4.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.516 -0.74 . . . . 0.0 109.047 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -35.75 91.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.72 -0.612 . . . . 0.0 111.234 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 9.9 m -150.02 80.19 7.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.547 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.6 Cg_endo -77.6 89.86 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.067 1.561 . . . . 0.0 110.756 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.1 p -91.23 124.98 35.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.008 . . . . 0.0 109.811 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.7 p -114.88 110.15 19.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 0.0 110.752 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' ARG . 57.8 t -107.66 163.99 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.798 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.47 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.1 m -127.64 161.61 28.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.082 -1.011 . . . . 0.0 110.407 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.561 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.81 127.72 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 22.4 pt-20 -50.64 -43.27 57.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 110.316 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -89.17 42.09 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -113.87 171.18 7.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -1.115 . . . . 0.0 110.253 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 39' ' ' ILE . 45.9 mt -150.08 127.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.16 144.22 5.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.75 88.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -1.128 . . . . 0.0 110.315 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 20.3 mtt180 -98.74 13.67 31.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 16.4 m 60.33 58.71 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 12.5 pt-20 -108.0 -31.1 8.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.32 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 13.6 mtp-105 -99.13 160.86 13.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.235 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.86 146.74 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -90.78 -67.56 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.253 -0.904 . . . . 0.0 110.227 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.3 mt -114.49 97.81 6.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -42.29 -27.94 0.17 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 48' ' ' LEU . 84.9 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.152 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.209 0.528 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.62 -174.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.152 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.79 108.24 0.98 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -137.14 65.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.11 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.458 ' CD1' HG21 ' A' ' 24' ' ' VAL . 56.4 m-85 -113.08 -151.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.237 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -134.42 124.01 24.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.249 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.06 128.78 34.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -73.3 135.03 79.54 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 159.1 47.34 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.42 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -32.0 68.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -61.65 -33.86 74.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.73 -2.37 44.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 0.0 110.147 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HD2' ' HB3' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -90.02 55.53 3.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 0.0 110.41 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -86.32 -16.41 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.956 -1.09 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.435 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.9 p90 -90.1 2.63 55.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.428 -0.795 . . . . 0.0 109.115 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -155.68 111.75 3.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 18.9 mm -78.05 -73.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 110.43 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -89.89 57.5 3.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.117 -0.99 . . . . 0.0 110.364 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.52 155.74 26.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -111.88 140.42 46.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 31' ' ' SER . 21.1 t -115.59 123.32 48.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.492 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.6 108.27 20.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.1 112.7 24.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 40.3 t -82.07 113.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.81 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 26' ' ' ALA . 43.0 t -76.04 -64.21 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.526 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.25 -51.86 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 109.666 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 tt0 -109.0 92.43 4.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 108.964 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.7 OUTLIER -35.55 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.596 . . . . 0.0 111.065 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 7.8 m -149.61 85.67 5.64 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.15 95.74 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.077 1.567 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 92.8 p -95.08 128.39 41.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 110.049 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 25.4 p -107.42 96.98 6.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.481 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -90.87 148.44 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.118 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 18.5 m -128.24 160.34 32.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 16.9 m-20 -57.97 120.46 8.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.92 -32.49 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.97 42.18 2.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -123.7 168.52 12.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -1.123 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 47' ' ' ASP . 61.6 mt -149.55 152.01 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.869 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.03 173.48 19.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -44.18 11.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -1.125 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.2 mtm180 -92.79 18.53 8.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 12.9 m 61.61 41.68 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.6 pp20? -98.72 -25.27 14.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 110.435 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.452 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -90.91 161.5 15.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.085 -1.009 . . . . 0.0 109.969 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.69 161.33 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.241 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.435 ' HA ' HD11 ' A' ' 39' ' ' ILE . 23.9 t0 -98.1 -91.1 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.231 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -123.93 60.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.307 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -43.63 94.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.186 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.19 -179.899 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.24 0.543 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.4 -9.62 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 110.168 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.8 148.58 13.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 4' ' ' HIS . 30.2 p-80 -158.73 86.34 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -1.155 . . . . 0.0 110.23 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -104.18 -157.1 0.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.272 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -138.78 131.16 28.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.857 . . . . 0.0 110.173 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 124.3 32.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 119.8 77.67 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 178.52 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.865 1.455 . . . . 0.0 110.488 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 4.3 mtpt -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.358 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -59.27 -19.41 45.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.155 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -117.81 -0.95 11.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.3 ttpt -90.05 51.79 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -86.54 -14.09 43.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.044 -1.035 . . . . 0.0 109.31 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.3 2.54 55.4 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.51 -0.744 . . . . 0.0 109.082 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -159.87 112.61 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.932 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 24.0 mt -66.03 -76.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.412 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -96.77 69.43 2.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.423 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.3 152.57 23.37 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -111.69 141.69 44.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.899 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.472 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 7.4 t -126.19 134.4 51.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.638 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 31' ' ' SER . 10.6 mmt180 -101.96 120.12 39.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.81 116.19 32.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.267 -0.895 . . . . 0.0 110.34 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 29' ' ' THR . 2.2 t -90.42 125.73 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.079 -1.013 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 39.6 t -79.54 -64.64 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 110.324 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.68 -49.84 4.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.161 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -105.44 71.69 0.94 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -29.99 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.376 0.608 . . . . 0.0 111.322 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' GLU . 9.8 t -149.94 105.77 3.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.86 91.62 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.061 1.559 . . . . 0.0 110.113 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 22' ' ' ARG . 89.0 p -90.14 101.7 14.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 110.034 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.472 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 26.3 p -90.08 131.65 35.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.445 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -130.62 135.23 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.926 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.587 ' CB ' ' CZ ' ' A' ' 38' ' ' TYR . 16.7 m -102.2 160.94 14.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 38.0 m-20 -54.66 115.06 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.841 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.8 OUTLIER -41.59 -39.5 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.891 . . . . 0.0 110.488 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 46.95 3.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.587 ' CZ ' ' CB ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -127.36 172.83 10.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -1.155 . . . . 0.0 110.32 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.415 HG13 ' C ' ' A' ' 38' ' ' TYR . 56.8 mt -148.17 149.56 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.9 161.45 12.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -43.04 20.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.218 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mmm180 -93.04 15.32 15.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 8.7 m 64.38 39.72 6.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.338 -0.851 . . . . 0.0 110.428 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.22 -22.43 17.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.617 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.432 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -100.18 162.43 12.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.295 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.458 HG22 ' N ' ' A' ' 47' ' ' ASP . 7.2 p -133.33 151.05 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.458 ' N ' HG22 ' A' ' 46' ' ' VAL . 23.8 t70 -93.02 33.81 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mt -138.65 168.36 19.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.221 -0.924 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.06 -62.95 1.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.135 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.224 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.271 0.558 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -69.08 -71.13 0.23 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.567 ' HA3' ' CZ ' ' A' ' 5' ' ' PHE . . . -45.89 -31.06 3.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 3' ' ' GLY . 5.9 t60 63.12 76.08 0.38 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -1.111 . . . . 0.0 110.36 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.567 ' CZ ' ' HA3' ' A' ' 3' ' ' GLY . 52.7 m-85 -109.51 -153.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.97 139.56 21.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.0 160.4 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 141.66 33.09 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 110.162 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.82 156.38 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.402 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -57.5 -30.28 64.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.385 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -35.32 78.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.951 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.497 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -96.11 0.29 51.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 47.63 1.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.442 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.29 -13.18 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 0.0 109.196 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.497 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.34 -0.67 57.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.514 -0.741 . . . . 0.0 109.38 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 122.16 3.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.8 mm -77.66 -78.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.999 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -89.85 52.99 2.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.057 -1.027 . . . . 0.0 110.29 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -142.26 137.72 8.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.94 134.92 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -1.169 . . . . 0.0 109.899 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.472 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.0 t -115.73 132.4 56.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.591 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -95.78 128.34 42.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.42 -0.8 . . . . 0.0 109.798 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.562 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -117.9 109.68 16.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.279 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.1 t -85.95 123.48 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.126 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.4 t -79.01 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.633 -0.667 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -50.23 3.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.397 -0.814 . . . . 0.0 109.525 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 38.0 tp10 -115.41 96.6 5.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -36.46 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 110.875 -179.083 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 26.6 m -138.46 79.21 30.61 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.547 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.562 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.7 Cg_endo -78.54 80.58 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.207 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 77.9 p -90.22 132.45 35.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 29.7 p -106.65 128.04 53.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.8 122.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.353 -0.842 . . . . 0.0 110.199 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.538 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.7 m -89.16 159.11 17.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 7.0 m-20 -52.97 121.05 6.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -45.2 -40.85 7.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.86 3.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -122.05 170.19 10.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.17 . . . . 0.0 110.279 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 38' ' ' TYR . 56.6 mt -149.37 160.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.153 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.444 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 109.08 175.85 21.45 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.92 -44.94 10.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 3.2 ttm-85 -100.59 25.71 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 9.7 m 63.69 50.88 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.85 -34.68 8.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.607 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 164.46 14.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.504 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 p -117.29 161.69 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.883 . . . . 0.0 110.031 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' HB3' HD22 ' A' ' 48' ' ' LEU . 45.7 t0 -111.27 -71.25 0.77 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.92 . . . . 0.0 110.355 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.475 HD22 ' HB3' ' A' ' 47' ' ' ASP . 1.1 pt? -159.99 51.37 0.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 110.228 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.61 -40.95 40.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 0.0 110.215 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.132 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.539 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.84 -152.38 0.37 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.27 -174.46 1.0 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -123.97 46.1 2.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -1.133 . . . . 0.0 110.258 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -114.51 -153.18 0.52 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.8 m -149.9 139.08 21.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.873 . . . . 0.0 110.232 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.436 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -93.21 147.77 22.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.309 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 56.8 m -89.93 109.36 32.13 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 47.4 Cg_endo -73.38 175.62 10.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.915 1.482 . . . . 0.0 110.46 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.1 ptmt -67.54 -26.16 66.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.03 14.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.502 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.52 13.9 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.982 . . . . 0.0 110.403 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 25.7 mtpt -90.04 47.2 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -85.61 -20.78 28.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.013 -1.055 . . . . 0.0 109.231 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.467 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 4.7 p90 -90.58 1.29 56.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.114 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -160.27 91.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.488 HG23 HD12 ' A' ' 17' ' ' ILE . 23.9 mm -54.13 -81.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.18 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -91.27 68.87 5.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.07 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.16 142.41 8.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 133.45 42.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.331 -1.1 . . . . 0.0 109.821 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 31' ' ' SER . 9.3 t -125.67 138.81 53.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.674 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.16 133.36 53.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.7 113.95 24.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 110.589 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 5.1 t -88.23 115.84 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.0 t -79.85 -59.62 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 110.349 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.84 -36.03 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 109.421 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -128.53 93.11 3.56 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.9 mt-30 -34.45 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.236 0.541 . . . . 0.0 111.239 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 53.8 m -146.8 84.28 7.65 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.368 -0.832 . . . . 0.0 110.376 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.84 96.05 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.122 1.591 . . . . 0.0 110.263 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 6.7 t -99.07 132.42 44.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.907 . . . . 0.0 110.259 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 30.6 p -118.75 124.41 47.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.53 117.93 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 26.0 m -92.41 163.21 13.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -49.71 126.41 13.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.35 -43.01 33.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 44.31 2.93 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -116.32 165.86 12.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -1.193 . . . . 0.0 110.249 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 39.7 mt -146.94 165.1 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.63 154.71 21.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.37 -13.61 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -1.208 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 29.2 mtt180 -120.9 16.65 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 8.7 m 64.16 27.8 14.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.212 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.69 -7.71 39.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.411 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.449 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -107.65 158.85 16.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.414 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.449 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 13.2 p -127.29 154.24 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.022 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.508 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 33.7 t70 -117.07 61.53 0.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.374 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -93.64 -25.48 17.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 48' ' ' LEU . 92.4 m-85 -81.52 9.04 8.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.41 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 33.9 p90 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 110.168 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.051 0.453 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 1' ' ' ARG . 14.2 ptpt 38.44 -153.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.597 -0.689 . . . . 0.0 110.511 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.453 ' N ' ' HG3' ' A' ' 2' ' ' LYS . . . -135.07 -115.77 1.55 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 1.4 m170 58.09 75.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -1.201 . . . . 0.0 110.267 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.559 ' CE1' HG13 ' A' ' 24' ' ' VAL . 44.9 m-85 -98.22 -142.42 0.31 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 110.163 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.53 151.69 38.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.84 133.33 52.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.912 . . . . 0.0 110.32 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 142.88 98.41 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.3 Cg_endo -73.55 167.35 27.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.052 1.554 . . . . 0.0 110.469 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -31.82 73.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -21.96 66.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.35 6.64 35.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 52.82 2.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.445 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -86.14 -14.83 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.99 -1.069 . . . . 0.0 109.171 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.477 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.35 -2.25 57.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.293 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 4.0 m -160.18 103.63 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 62.5 mt -55.37 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 0.0 109.904 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -93.55 66.68 3.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.908 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -155.96 147.45 16.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.4 mtt85 -105.62 135.93 46.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.975 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.477 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.5 t -108.38 132.85 53.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.513 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -97.83 105.57 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -97.15 112.2 24.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.387 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.559 HG13 ' CE1' ' A' ' 5' ' ' PHE . 23.9 t -85.52 117.43 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ALA . 8.3 t -77.88 -63.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.92 -56.12 2.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.5 tp10 -103.89 91.33 3.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.017 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.1 tp-100 -34.95 91.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.766 -0.583 . . . . 0.0 111.151 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' GLU . 58.0 m -148.23 82.78 7.48 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.3 Cg_endo -76.44 93.13 1.05 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.02 1.537 . . . . 0.0 110.355 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 27.7 t -101.27 141.19 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.2 p -110.89 134.05 52.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.338 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.09 120.75 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 110.061 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 27.0 m -87.63 159.89 18.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.467 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -47.58 120.06 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -44.78 -44.8 9.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.456 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 47.04 3.15 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -121.75 171.03 9.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 110.252 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.528 HG23 HD11 ' A' ' 39' ' ' ILE . 27.0 mt -149.66 146.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.89 169.41 14.41 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.8 -40.72 13.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.1 mtt180 -93.49 9.69 35.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.118 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.487 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.5 m 66.84 56.75 0.68 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 0.0 110.157 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.14 -25.7 8.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.421 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.496 ' HD2' ' CG2' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -89.61 151.2 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 110.203 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p -127.18 140.41 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 110.063 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.51 65.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.363 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.6 -9.19 10.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.192 -0.943 . . . . 0.0 110.254 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -74.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.167 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.234 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.211 0.529 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -107.32 13.65 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.918 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 120.86 149.69 8.25 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.508 ' N ' ' CD2' ' A' ' 4' ' ' HIS . 3.7 p80 -168.82 60.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -1.132 . . . . 0.0 110.232 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -103.15 -155.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.171 -0.956 . . . . 0.0 110.168 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.95 140.01 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -86.35 150.23 24.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 6.7 m -83.9 127.1 68.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 163.65 36.98 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.891 1.469 . . . . 0.0 110.53 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 1.4 pttp -63.02 -29.95 71.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.131 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.406 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -62.46 -25.9 68.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.86 . . . . 0.0 110.32 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.411 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.6 m-85 -114.03 8.31 17.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -90.32 49.75 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.091 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.28 -11.43 52.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 0.0 109.472 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.482 ' OH ' ' CB ' ' A' ' 8' ' ' CYS . 12.6 p90 -87.18 -9.56 54.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.51 127.38 4.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 110.073 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 25.6 mt -86.98 -65.0 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.522 ' CG ' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -90.14 50.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 0.0 110.425 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.98 137.3 5.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -89.71 -179.8 5.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -1.118 . . . . 0.0 109.575 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 12.9 t -160.19 125.95 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.898 -1.126 . . . . 0.0 110.892 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.31 114.07 26.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.87 111.48 23.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.451 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 10.4 t -84.0 118.02 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 9.6 t -74.04 -66.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.69 -62.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.4 tp10 -98.18 88.46 4.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.336 -0.853 . . . . 0.0 108.983 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.5 mm-40 -34.64 92.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.348 0.594 . . . . 0.0 110.968 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 27' ' ' GLU . 13.8 m -144.22 83.62 9.96 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 110.556 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.97 84.43 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.094 1.576 . . . . 0.0 110.451 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -89.92 134.42 34.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.92 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 7.7 t -114.35 119.27 36.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 110.609 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 t -103.85 115.11 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.803 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 19.3 m -88.46 158.08 18.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -53.3 125.18 16.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.891 . . . . 0.0 110.032 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' ASP . 3.0 mm-40 -42.64 -45.97 4.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.429 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.45 49.35 3.18 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.5 ' CD2' ' HB3' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -117.81 158.81 24.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.265 . . . . 0.0 110.518 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.521 ' CG1' ' HB2' ' A' ' 47' ' ' ASP . 33.5 mm -142.47 150.46 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.16 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.36 170.35 14.87 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.56 -48.11 11.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -1.146 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mtm105 -98.18 23.69 7.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.254 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.522 ' HB3' ' CG ' ' A' ' 18' ' ' LYS . 20.2 m 61.04 76.22 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.135 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -40.16 2.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 110.379 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -97.39 179.8 4.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 110.262 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG22 ' N ' ' A' ' 47' ' ' ASP . 2.8 p -142.62 144.29 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 110.232 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.521 ' HB2' ' CG1' ' A' ' 39' ' ' ILE . 13.4 t0 -97.21 -94.57 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -0.874 . . . . 0.0 110.111 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.48 174.62 13.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 109.988 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.2 -39.07 13.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 110.377 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.243 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.3 ptt-85 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.253 0.549 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -115.05 -179.73 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.214 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.15 119.69 0.52 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -136.35 72.22 1.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -1.145 . . . . 0.0 110.064 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -102.89 -145.83 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.396 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.81 121.54 41.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 110.308 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.96 132.53 35.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.104 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 131.2 79.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.124 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.7 Cg_endo -73.31 173.04 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.956 1.503 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -67.63 -34.04 76.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.54 -8.68 35.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.441 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -116.1 -0.72 12.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.15 62.2 5.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -85.55 -21.05 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.089 . . . . 0.0 109.278 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.484 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 7.1 p90 -90.34 -2.18 57.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.105 178.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.67 126.95 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.3 mm -89.04 -69.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.991 -1.068 . . . . 0.0 109.759 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' CD ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -93.12 63.63 3.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.158 -0.964 . . . . 0.0 110.054 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -155.32 143.67 10.15 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -101.38 124.79 47.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.206 . . . . 0.0 110.281 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.1 t -114.87 127.96 56.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 0.0 110.492 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -103.76 120.69 41.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -103.94 113.89 27.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.489 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 3.4 t -82.51 119.15 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.7 t -79.0 -64.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.678 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.34 -45.46 2.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -117.4 92.05 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -34.69 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.772 -0.58 . . . . 0.0 110.943 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.8 m -143.52 85.84 9.19 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.247 -0.908 . . . . 0.0 110.552 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.86 114.48 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.568 . . . . 0.0 110.533 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.451 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 17.6 m -119.03 126.38 51.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -0.91 . . . . 0.0 109.85 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 23.7 p -116.06 103.87 11.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.931 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.99 132.51 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.481 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 21.7 m -102.19 157.35 16.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -52.64 116.9 2.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 110.104 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.5 mm-40 -41.82 -48.19 4.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.373 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 50.74 3.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -121.64 171.6 8.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.098 -1.237 . . . . 0.0 110.361 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 38' ' ' TYR . 3.6 mp -147.19 138.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 110.135 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.14 159.17 9.45 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.69 -48.51 25.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.1 mtt180 -98.33 21.4 11.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.189 -0.944 . . . . 0.0 110.118 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.514 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 6.3 m 64.64 61.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -101.41 -31.19 11.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.134 -0.979 . . . . 0.0 110.62 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -108.37 163.54 13.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.456 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 10.2 p -149.22 161.94 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 110.057 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.93 43.58 2.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.365 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.41 -168.54 1.4 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 110.089 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -7.88 51.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.157 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.302 0.573 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.59 113.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 110.148 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.7 124.1 0.08 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.8 68.46 1.45 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 110.285 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.574 ' CE1' HG11 ' A' ' 24' ' ' VAL . 72.7 m-85 -142.95 -136.05 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.94 . . . . 0.0 110.022 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.42 129.23 26.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.986 -1.071 . . . . 0.0 110.253 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.417 ' HG2' ' N ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -86.09 142.12 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 110.17 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 4.0 m -78.61 126.95 81.9 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 110.074 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.6 Cg_endo -74.21 148.33 38.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.887 1.467 . . . . 0.0 110.409 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.2 ttpt -58.93 -29.93 67.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -61.44 -34.18 74.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.364 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.459 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 10.9 m-85 -101.43 7.09 42.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.31 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' A' ' 8' ' ' CYS . 2.2 mttt -86.16 60.98 6.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.082 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -85.69 -19.11 31.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.004 -1.06 . . . . 0.0 109.31 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.0 p90 -90.72 -1.95 57.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.45 -0.781 . . . . 0.0 109.187 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.3 106.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.1 mm -81.63 -64.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.219 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.82 49.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.314 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -152.58 175.85 31.01 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.1 157.18 33.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -1.05 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 43.6 t -141.41 119.51 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -95.97 109.5 21.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 109.862 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -96.82 105.53 17.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.466 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 5' ' ' PHE . 57.6 t -84.49 114.6 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' ALA . 59.9 t -72.9 -59.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -65.77 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 109.415 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 tp10 -95.67 93.24 7.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 27' ' ' GLU . 4.8 mp0 -34.67 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.346 0.593 . . . . 0.0 111.151 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 4.5 m -147.0 78.98 10.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.454 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.2 Cg_endo -79.39 86.03 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.093 1.575 . . . . 0.0 110.279 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.453 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 t -90.53 133.4 35.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -129.33 101.65 6.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.31 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.97 166.6 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.298 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.454 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 34.1 m -112.88 164.33 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.306 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.531 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.9 m-20 -64.63 117.38 7.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.367 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -44.47 -41.45 6.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.12 46.07 3.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.38 175.74 7.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -1.171 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 37.5 mt -146.44 152.1 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.055 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.58 161.29 19.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.8 -49.52 12.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 21.1 mmt-85 -90.25 15.65 10.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.981 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 4.2 m 67.7 50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.801 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -101.27 0.22 36.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.466 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.28 164.05 23.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.384 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG21 ' N ' ' A' ' 47' ' ' ASP . 5.1 p -130.81 157.62 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.087 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.42 ' N ' HG21 ' A' ' 46' ' ' VAL . 31.5 t0 -102.26 50.7 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -141.03 -38.54 0.42 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.102 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.32 -30.81 71.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 110.231 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.16 179.954 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.19 0.519 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.45 116.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.878 . . . . 0.0 110.216 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.19 -179.09 20.35 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -169.06 95.46 0.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -1.148 . . . . 0.0 110.307 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -117.42 -150.58 0.46 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.107 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.7 m -136.61 130.43 32.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.983 . . . . 0.0 110.312 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.65 124.25 31.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -52.39 129.3 42.7 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.119 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.2 155.71 51.67 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.98 1.516 . . . . 0.0 110.388 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -25.1 64.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -63.17 -33.08 74.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.248 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.548 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 m-85 -103.61 10.37 36.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -90.05 43.29 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -86.13 -13.71 46.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.41 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.45 2.59 55.52 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.763 . . . . 0.0 109.185 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.3 m -157.41 125.5 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.136 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 35.7 mm -83.02 -81.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.409 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -89.69 57.47 3.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.134 -0.979 . . . . 0.0 110.268 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -149.04 160.08 28.27 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 20.9 ptt180 -116.81 139.23 50.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -1.087 . . . . 0.0 109.694 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.2 t -114.31 135.3 54.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.791 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 ttp85 -97.96 124.0 42.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.5 t80 -112.09 110.78 21.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.566 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 12.5 t -90.12 123.01 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.926 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 97.1 t -83.06 -56.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.69 -29.79 0.1 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 0.0 109.648 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.6 mt-10 -141.41 96.53 3.0 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.5 mt-30 -33.6 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.212 0.529 . . . . 0.0 111.301 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' GLU . 91.0 m -140.64 83.15 15.03 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.308 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.469 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.0 Cg_endo -82.4 83.84 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.174 1.618 . . . . 0.0 110.409 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 26.8 t -89.82 134.05 34.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.9 p -101.68 132.38 47.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 3.5 t -126.96 151.23 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.332 -0.855 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 19.5 m -123.47 162.0 23.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 110.388 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -57.66 121.05 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.206 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -44.39 -38.95 4.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.168 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 46.05 3.06 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.33 163.92 20.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -1.157 . . . . 0.0 110.187 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.9 mt -137.41 160.46 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.18 166.95 31.49 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.51 -35.88 16.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -91.55 7.2 42.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.14 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 4.9 m 69.25 44.68 0.94 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.404 -0.81 . . . . 0.0 110.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -100.28 -25.64 14.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 3.2 mmt180 -92.41 163.49 13.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG21 ' N ' ' A' ' 47' ' ' ASP . 2.7 p -141.49 146.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.425 ' N ' HG21 ' A' ' 46' ' ' VAL . 1.3 t70 -111.89 49.89 0.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.95 . . . . 0.0 110.329 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.35 -54.57 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.208 -0.932 . . . . 0.0 110.131 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.427 ' O ' ' OXT' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -57.93 -65.66 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.427 ' OXT' ' O ' ' A' ' 49' ' ' PHE . 16.4 m-85 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.234 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 2' ' ' LYS . 3.5 mtt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.265 0.555 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 1' ' ' ARG . 15.7 mmmt 55.56 163.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.329 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.92 134.54 12.3 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.43 ' O ' ' CG ' ' A' ' 4' ' ' HIS . 46.7 t-80 -146.13 49.01 1.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.141 . . . . 0.0 110.217 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.576 ' CD1' HG13 ' A' ' 24' ' ' VAL . 52.7 m-85 -120.01 -146.2 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.268 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 m -119.07 135.19 54.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.171 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.12 109.11 21.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.305 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -48.61 120.35 8.84 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 43.4 Cg_endo -70.67 175.57 8.68 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.858 1.451 . . . . 0.0 110.525 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.27 -41.6 93.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.551 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.98 -19.6 66.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.441 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.473 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -99.98 -9.37 22.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.193 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 2.1 ttpt -87.82 57.55 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 110.145 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -85.76 -17.4 35.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 6.3 p90 -89.98 -2.53 58.16 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.147 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.36 127.75 4.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 45.5 mt -82.23 -74.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 110.424 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -89.78 64.43 6.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 0.0 110.471 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 13' ' ' LYS . . . -160.15 133.19 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -95.48 132.75 40.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -1.167 . . . . 0.0 109.765 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.527 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 32.1 t -118.75 132.31 56.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.004 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -98.15 124.02 42.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.466 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -111.89 112.81 24.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 110.498 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.576 HG13 ' CD1' ' A' ' 5' ' ' PHE . 11.6 t -84.72 117.36 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.202 -0.936 . . . . 0.0 109.975 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.4 t -80.86 -63.05 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 110.436 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.17 -39.43 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.613 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -123.0 92.37 3.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -35.04 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.21 0.529 . . . . 0.0 111.077 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 3.8 m -148.25 83.37 7.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.233 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.8 Cg_endo -82.79 132.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.145 1.603 . . . . 0.0 110.431 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 p -148.81 118.13 6.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.863 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.527 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 12.1 t -95.83 153.88 17.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.645 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -139.57 121.6 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.491 -0.756 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' CB ' ' CE2' ' A' ' 38' ' ' TYR . 8.6 m -96.94 158.22 15.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -49.51 128.47 17.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -46.5 -47.4 19.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.331 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.14 45.4 3.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CE2' ' CB ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -113.28 163.86 14.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -1.191 . . . . 0.0 110.1 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.475 ' CG1' ' HB2' ' A' ' 47' ' ' ASP . 31.6 mm -138.76 153.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.97 144.97 11.97 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -34.27 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -1.109 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mtt180 -93.76 4.86 53.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 4.1 m 68.18 43.89 1.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.99 -13.14 15.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.446 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -109.51 166.99 10.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.508 HG23 ' N ' ' A' ' 47' ' ' ASP . 6.1 p -137.28 149.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.508 ' N ' HG23 ' A' ' 46' ' ' VAL . 14.5 t0 -107.81 57.27 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 110.356 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.64 168.61 18.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.923 . . . . 0.0 110.272 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -85.67 -1.39 57.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.422 ' OXT' ' CD1' ' A' ' 50' ' ' TYR . 6.2 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.252 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.246 0.546 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.39 -84.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.167 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.15 116.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -150.95 70.36 0.99 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -1.149 . . . . 0.0 110.25 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -92.19 -153.45 0.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.905 . . . . 0.0 110.166 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m -138.35 137.54 37.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -100.3 113.94 27.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 124.95 78.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.176 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.42 178.03 7.18 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.859 1.452 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -65.98 -25.65 67.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -19.91 66.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 4.3 m-85 -110.92 11.06 22.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 110.207 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 34.2 mmtm -88.93 47.6 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -85.49 -23.15 27.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.993 -1.067 . . . . 0.0 108.918 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.9 p90 -90.39 -0.76 57.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -160.68 116.19 2.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 109.901 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 32.6 mt -76.65 -63.97 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.517 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -104.36 73.8 1.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.098 -1.001 . . . . 0.0 110.417 179.764 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.31 178.27 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 1.7 mtt180 -131.15 119.89 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.164 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 31' ' ' SER . 15.1 t -107.09 132.3 53.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -104.64 120.8 42.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 109.993 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -104.49 106.72 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.477 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 24.2 t -81.58 119.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.13 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 26' ' ' ALA . 25.7 t -80.75 -62.99 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.499 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.3 -49.74 2.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.4 -0.812 . . . . 0.0 109.749 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 5.4 mt-10 -113.32 91.95 3.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.48 -0.763 . . . . 0.0 109.0 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -33.54 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.273 0.559 . . . . 0.0 111.322 -179.075 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 41.0 m -147.92 82.71 7.72 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.03 86.69 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.113 1.586 . . . . 0.0 110.352 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.459 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -89.65 143.85 26.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 109.791 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 20.2 p -124.03 132.5 53.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 58.6 t -125.45 169.68 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 109.801 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.3 m -140.67 162.32 35.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.39 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.555 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.4 m-20 -49.22 123.67 7.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -47.86 -45.79 30.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.71 3.02 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -115.44 174.0 6.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 110.217 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 38' ' ' TYR . 4.2 mp -150.48 147.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.141 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.99 152.97 10.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.44 -30.91 57.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -1.104 . . . . 0.0 109.975 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.16 5.33 44.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.501 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 3.9 m 68.92 66.3 0.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 -30.88 2.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.002 -1.061 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -95.97 107.07 19.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.963 -1.086 . . . . 0.0 110.506 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.555 ' CG1' ' CD2' ' A' ' 49' ' ' PHE . 12.2 p -89.35 154.7 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 110.447 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 15.7 t70 -90.97 18.62 6.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 110.235 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.51 64.66 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.251 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.555 ' CD2' ' CG1' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -87.58 -54.24 4.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.243 -179.996 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.263 179.93 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.212 0.53 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -54.94 136.91 46.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 67.1 -133.82 31.35 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.5 t60 57.63 85.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.477 ' CE1' HG13 ' A' ' 24' ' ' VAL . 25.2 m-85 -90.81 -156.75 0.45 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.89 . . . . 0.0 110.171 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.62 134.67 47.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.486 ' NH1' ' HG2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -90.56 133.32 35.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.139 179.926 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -73.99 152.8 88.76 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -72.63 158.06 51.34 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.005 1.529 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -26.78 65.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -6.22 26.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.48 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -120.02 4.95 10.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.349 179.964 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.523 ' NZ ' ' OH ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -81.48 75.16 8.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -85.25 -25.45 27.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.018 -1.051 . . . . 0.0 109.407 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.523 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 3.3 p90 -90.45 2.97 55.15 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.95 178.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 1.7 m -160.81 119.77 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 43.1 mm -75.52 -71.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -99.95 68.82 1.51 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.256 179.768 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -159.97 141.25 7.32 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.9 ptp180 -96.37 143.57 27.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -1.13 . . . . 0.0 109.878 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' SER . 10.4 t -123.22 125.25 44.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.5 117.75 30.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.901 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.93 112.71 25.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.322 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 5' ' ' PHE . 9.0 t -85.55 119.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.134 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 58.1 t -77.41 -67.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 110.382 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.76 -45.98 3.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.423 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.8 tt0 -112.53 86.94 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.314 0.578 . . . . 0.0 110.992 -179.164 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 80.9 m -145.01 85.76 8.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.0 Cg_endo -76.39 84.44 1.85 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.033 1.544 . . . . 0.0 110.146 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.454 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 68.1 m -90.09 128.39 36.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.258 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 24.7 p -107.23 97.05 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' ARG . 98.4 t -89.63 120.78 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.023 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -86.94 157.71 19.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -48.75 118.33 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.129 179.934 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -45.93 -41.27 11.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 110.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.96 43.04 2.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -120.41 176.3 5.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 21.9 mt -150.33 136.94 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.41 166.15 12.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.77 -38.43 18.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -1.081 . . . . 0.0 110.05 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -99.34 17.55 19.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.002 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 8.2 m 63.62 43.65 5.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.1 tt0 -93.7 -32.7 13.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.47 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -95.07 158.9 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.01 . . . . 0.0 110.199 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 47' ' ' ASP . 7.3 p -147.39 149.58 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.448 ' N ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -124.09 47.99 1.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.236 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.78 -71.71 0.72 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 110.187 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -75.24 -47.0 30.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 33.0 t80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.263 179.938 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.274 0.559 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -164.08 -50.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . 116.57 -88.1 0.45 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.425 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 1.8 t-80 65.2 68.11 0.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -1.16 . . . . 0.0 110.186 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.44 ' CE2' ' HA3' ' A' ' 3' ' ' GLY . 30.5 m-85 -103.06 -143.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 110.268 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.31 143.78 34.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 142.32 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.78 137.31 92.67 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 46.3 Cg_endo -72.68 164.39 35.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.046 1.551 . . . . 0.0 110.382 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -62.61 -30.98 71.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 110.24 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.46 ' NE2' ' HB2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -66.45 -19.96 65.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.358 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -109.94 5.64 22.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.88 50.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 110.035 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -86.15 -17.55 34.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 109.115 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -91.15 0.57 57.5 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.069 178.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.43 98.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.6 mt -65.69 -73.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.953 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ptpm? -89.61 52.78 2.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -0.924 . . . . 0.0 110.12 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -148.66 165.96 29.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -123.35 130.28 52.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -1.187 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 32' ' ' CYS . 9.3 t -118.27 128.1 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.447 -179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.81 139.66 30.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 110.02 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -117.56 110.87 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 63.9 t -82.02 116.88 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -78.7 -63.88 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.652 -0.655 . . . . 0.0 110.221 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.26 -49.6 5.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -111.35 90.21 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.914 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.8 tt0 -35.45 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.238 0.542 . . . . 0.0 111.041 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' GLU . 18.0 m -148.36 86.96 5.79 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.892 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.02 93.47 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.093 1.575 . . . . 0.0 110.5 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.425 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 72.3 p -93.29 124.3 37.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 31.3 p -105.93 128.0 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.78 158.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 110.109 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.562 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.1 m -125.41 159.2 32.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 110.33 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -52.99 118.61 3.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 35' ' ' ASP . 43.3 mm-40 -42.44 -40.94 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.96 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . -90.05 47.48 3.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -125.0 172.47 9.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -1.203 . . . . 0.0 110.281 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 41.9 mt -146.52 140.89 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.22 160.88 11.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 -40.49 22.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.117 . . . . 0.0 110.23 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 6.2 mpt_? -93.25 9.65 35.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.131 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.489 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.49 47.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -0.843 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 8.7 tt0 -104.17 -18.23 14.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -101.18 156.2 17.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.834 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 HG21 ' N ' ' A' ' 47' ' ' ASP . 7.7 p -115.26 149.12 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.372 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 9.4 t70 -93.07 -65.24 1.01 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.43 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 170.61 7.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.16 -0.962 . . . . 0.0 110.273 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.68 -57.24 3.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.342 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 18.2 t80 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.25 -179.948 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 2' ' ' LYS . 18.7 mtm-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.316 0.579 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 1' ' ' ARG . 0.1 OUTLIER 44.13 80.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 5' ' ' PHE . . . 54.69 -114.88 4.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.448 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER 66.73 75.13 0.33 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.279 -1.13 . . . . 0.0 110.271 -179.975 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CZ ' ' HA2' ' A' ' 3' ' ' GLY . 58.6 m-85 -116.03 -154.26 0.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.061 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.461 ' OG ' HG22 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -119.91 128.46 53.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.419 -179.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -83.37 141.78 31.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.033 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -84.08 129.97 56.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.946 . . . . 0.0 110.177 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.18 157.47 50.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.93 1.49 . . . . 0.0 110.29 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -18.33 64.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -65.18 -19.19 65.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -119.76 21.1 12.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.201 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.29 50.25 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.883 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -86.11 -16.85 36.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.053 . . . . 0.0 109.313 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' C ' ' CD1' ' A' ' 15' ' ' TYR . 3.5 p90 -90.4 4.2 51.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.237 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -158.74 109.25 2.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.21 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 10.6 mm -64.3 -70.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 7.9 ptmm? -105.73 55.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -146.83 150.8 23.11 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 179.42 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 0.0 109.856 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 8.4 t -154.73 132.9 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HD2' ' OG ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -107.9 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 109.803 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.89 110.6 22.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.583 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' CG2' ' HD3' ' A' ' 22' ' ' ARG . 48.3 t -84.43 111.86 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.461 HG22 ' OG ' ' A' ' 6' ' ' SER . 37.7 t -74.09 -59.83 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.667 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.34 -59.51 1.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.466 -0.771 . . . . 0.0 109.499 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 63.1 mt-10 -104.0 92.45 4.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 108.97 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.1 tt0 -33.62 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.811 -0.556 . . . . 0.0 111.153 -179.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 19.2 m -149.42 88.49 4.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.35 91.75 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.024 1.539 . . . . 0.0 110.396 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.456 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 2.3 p -90.06 148.82 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.841 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -135.13 116.43 14.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.701 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.06 157.18 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 19.3 m -122.44 161.3 23.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.357 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.2 m-20 -49.64 124.43 9.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -47.05 -41.65 17.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 110.258 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 43.29 2.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -117.04 168.27 10.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -1.19 . . . . 0.0 110.257 179.82 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 38' ' ' TYR . 48.8 mt -150.37 156.92 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.24 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.64 162.02 18.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.74 -28.77 30.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -105.69 17.57 23.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.466 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 16.7 m 61.68 35.69 16.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -100.29 -17.0 17.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.4 170.18 8.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 47' ' ' ASP . 3.3 p -139.03 155.01 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.057 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.452 ' N ' HG22 ' A' ' 46' ' ' VAL . 8.2 t70 -92.05 -76.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.357 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -160.32 -33.0 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.195 -0.941 . . . . 0.0 110.669 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.487 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -51.66 -73.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.046 -1.034 . . . . 0.0 110.269 -179.951 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.089 179.945 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.23 0.538 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -50.26 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.281 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.1 -95.56 2.04 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.95 93.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -115.9 -151.6 0.49 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.179 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -124.44 125.21 43.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.198 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.71 118.73 23.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 124.37 83.57 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.053 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.19 160.99 45.86 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.312 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -51.52 -24.03 4.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.35 -45.35 93.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 110.308 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.539 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.6 m-85 -94.24 10.56 33.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' A' ' 10' ' ' LYS . 37.8 mttt -84.93 46.63 1.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -86.21 -13.93 45.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.407 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 7.8 p90 -90.53 -5.13 56.35 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.089 178.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.8 OUTLIER -156.03 132.58 10.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -0.918 . . . . 0.0 110.372 179.472 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 30.7 mm -80.35 -71.89 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.942 . . . . 0.0 110.141 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -101.77 69.11 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 0.0 110.303 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -155.36 159.35 29.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.421 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.39 140.68 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -1.155 . . . . 0.0 109.945 179.833 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.454 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -116.29 138.2 51.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -110.1 104.0 12.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.79 113.14 24.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.376 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 7.1 t -86.12 121.45 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.879 . . . . 0.0 109.933 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -74.86 -62.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.619 -0.675 . . . . 0.0 110.524 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.26 -66.98 0.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' THR . 26.3 mt-10 -97.95 92.15 5.66 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 108.893 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -33.62 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.289 0.566 . . . . 0.0 110.993 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.9 m -137.4 80.92 32.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.485 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.1 Cg_endo -74.48 83.09 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.111 1.585 . . . . 0.0 110.042 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.441 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 36.8 t -90.16 145.74 24.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.328 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.454 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.8 t -119.16 145.59 45.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.911 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 76.5 t -143.21 153.54 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 109.888 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 15.5 m -125.45 157.58 36.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.975 . . . . 0.0 110.353 -179.692 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 19.4 m-20 -51.92 118.65 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 3.6 tp10 -43.24 -37.2 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.962 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 45.86 3.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -125.17 160.93 27.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -1.151 . . . . 0.0 110.297 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.509 ' CD1' ' O ' ' A' ' 38' ' ' TYR . 19.3 mm -142.7 158.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 109.923 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.12 174.77 19.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.37 -47.68 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -1.145 . . . . 0.0 110.35 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -90.01 18.78 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.175 -179.894 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 9.6 m 62.65 38.11 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -98.46 -13.71 20.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.255 -0.903 . . . . 0.0 110.326 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -103.38 169.94 8.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 8.0 p -148.36 151.58 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 110.347 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' N ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -115.75 71.35 0.77 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.179 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.53 110.48 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.329 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.61 -17.54 8.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.255 -0.903 . . . . 0.0 110.027 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.224 -180.0 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.206 0.526 . . . . 0.0 110.187 . . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.52 -89.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 110.195 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 1' ' ' ARG . . . 102.45 138.68 10.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -92.72 44.27 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.353 -1.087 . . . . 0.0 110.178 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -109.69 -152.31 0.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.858 . . . . 0.0 110.203 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.5 m -130.71 130.12 43.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 150.54 24.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.446 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -89.68 119.66 69.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.902 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.405 ' C ' ' HE3' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -72.72 173.91 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.809 1.426 . . . . 0.0 110.446 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' N ' ' HE3' ' A' ' 13' ' ' LYS . 17.0 mttm -66.52 -24.89 66.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 0.0 110.381 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.65 -10.96 30.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.295 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.526 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 12.5 m-85 -129.2 10.9 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.304 -0.873 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HE3' ' N ' ' A' ' 10' ' ' LYS . 19.0 mttt -86.21 45.96 1.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.227 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.28 -14.4 43.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.046 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.04 -1.06 57.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 178.38 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.8 m -160.28 129.25 4.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.035 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 5.0 mt -87.42 -63.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.074 -1.016 . . . . 0.0 110.108 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CD ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -103.11 60.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.257 179.574 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.17 162.38 33.17 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -107.57 -178.83 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -1.19 . . . . 0.0 110.031 179.86 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -160.46 126.91 4.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -104.41 115.43 30.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -100.06 116.03 31.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.542 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 52.6 t -87.26 115.56 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.97 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.6 t -75.36 -61.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.19 -62.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.607 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -99.82 93.18 5.66 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 108.927 178.767 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 28' ' ' GLN . 2.1 pt20 -34.92 91.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.74 -0.6 . . . . 0.0 111.143 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 9.0 m -146.19 86.22 7.12 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.506 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -76.42 98.08 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.067 1.561 . . . . 0.0 110.643 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.446 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 4.0 m -100.41 138.98 36.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.6 p -121.14 110.72 16.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.143 -0.973 . . . . 0.0 110.628 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ARG . 60.8 t -93.91 155.32 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.0 109.886 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 7.1 m -127.92 157.3 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.222 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.4 m-20 -48.76 125.76 10.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.55 -47.21 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 110.085 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.26 46.26 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.79 175.32 5.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -1.169 . . . . 0.0 110.328 -179.952 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 38' ' ' TYR . 3.5 mp -145.05 130.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.82 155.51 9.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.51 -41.04 40.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -1.179 . . . . 0.0 110.208 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 9.6 mtp180 -89.59 7.68 35.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.505 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 6.7 m 64.2 72.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.799 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' CA ' ' HD3' ' A' ' 18' ' ' LYS . 7.0 pt-20 -119.65 -25.09 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.658 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.429 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -112.49 95.15 5.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.787 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.492 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 14.9 p -89.98 154.75 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.27 47.89 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.56 41.45 0.87 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -55.47 20.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.199 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.225 179.912 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.25 0.548 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.567 ' HB3' ' CE1' ' A' ' 4' ' ' HIS . 0.0 OUTLIER -141.7 146.85 36.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.232 179.949 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.44 111.22 3.76 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 2' ' ' LYS . 32.2 m80 -119.46 -119.02 0.31 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.235 -1.156 . . . . 0.0 109.78 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.491 ' CE1' HG12 ' A' ' 24' ' ' VAL . 86.8 m-85 -97.85 -131.74 0.21 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 110.104 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.54 146.67 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.933 -1.104 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -79.98 154.46 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -81.93 136.32 47.61 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.68 156.54 49.0 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.986 1.519 . . . . 0.0 110.426 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -63.22 -27.86 69.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -20.5 27.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 110.271 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.5 m-85 -125.4 6.38 7.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -86.5 39.62 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.054 179.759 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -86.13 -12.48 49.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.04 -1.037 . . . . 0.0 109.604 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.6 p90 -90.12 1.56 56.26 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.457 -0.777 . . . . 0.0 109.288 178.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -159.67 109.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 46.5 mm -70.14 -74.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -96.28 60.39 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.973 -1.079 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -148.39 141.99 9.6 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.7 45.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -1.166 . . . . 0.0 110.155 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 31' ' ' SER . 8.5 t -113.94 126.5 55.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.428 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.12 111.75 23.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 110.032 179.704 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -96.01 112.67 24.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.0 110.552 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG12 ' CE1' ' A' ' 5' ' ' PHE . 38.5 t -86.58 115.73 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.95 . . . . 0.0 109.976 179.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 26' ' ' ALA . 62.5 t -73.08 -60.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.573 -0.704 . . . . 0.0 110.494 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.84 -66.73 0.3 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.1 tp10 -99.13 93.67 6.1 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.894 178.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tt0 -34.51 91.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.761 -0.587 . . . . 0.0 111.141 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' GLU . 39.6 m -143.71 84.19 10.06 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.438 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.7 Cg_endo -77.35 89.22 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.076 1.566 . . . . 0.0 110.446 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.461 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 78.4 p -89.76 131.5 35.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.069 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.415 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 23.5 p -113.91 108.5 17.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.628 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -109.66 130.39 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.969 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.568 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.1 m -94.35 162.28 13.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.185 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 18.1 m-20 -56.91 117.68 4.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.72 -38.01 2.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.55 45.7 3.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.568 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -126.49 171.06 11.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -1.14 . . . . 0.0 110.282 -179.959 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 2.3 mp -147.39 150.56 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 167.83 16.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.53 -37.41 16.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 46.5 mtt180 -96.55 18.72 13.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.038 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 12.1 m 61.42 41.1 13.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -93.98 -37.3 11.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 110.671 -179.597 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -85.44 163.99 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.256 -179.729 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.02 157.53 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.23 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' OD1' HD11 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -97.13 32.9 2.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.945 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.88 118.16 9.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.234 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -69.6 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.382 -0.824 . . . . 0.0 110.164 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.1 t80 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.182 179.956 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.239 0.542 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -157.39 133.91 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.591 ' O ' ' CE2' ' A' ' 5' ' ' PHE . . . -49.68 -70.68 0.75 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER 73.53 47.96 0.16 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.378 -1.072 . . . . 0.0 110.484 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.591 ' CE2' ' O ' ' A' ' 3' ' ' GLY . 81.0 m-85 -142.24 -148.6 0.24 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.357 -0.839 . . . . 0.0 109.567 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.53 133.43 22.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -96.31 152.0 18.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.877 . . . . 0.0 110.382 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' O ' ' CE ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.13 134.05 32.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.163 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.12 161.53 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.866 1.456 . . . . 0.0 110.425 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -31.54 72.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -64.09 -12.22 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 110.328 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.68 -3.23 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.143 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.517 ' CE ' ' O ' ' A' ' 8' ' ' CYS . 18.1 mttt -84.38 62.82 7.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.322 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -85.67 -19.56 30.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.911 -1.118 . . . . 0.0 109.246 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.523 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.8 p90 -90.39 -2.9 57.99 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.046 178.253 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.68 106.72 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.496 HG23 HD12 ' A' ' 17' ' ' ILE . 18.2 mm -78.53 -62.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.112 -0.993 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -90.4 57.37 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 110.374 -179.834 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 13' ' ' LYS . . . -160.05 152.53 23.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -108.56 120.92 43.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -1.122 . . . . 0.0 109.993 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.471 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 10.0 t -99.97 128.71 46.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.653 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -100.5 109.73 21.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 109.718 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.96 104.75 16.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 21.0 t -80.66 120.93 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.071 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.3 t -76.67 -71.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 110.382 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.08 -47.36 4.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.4 tt0 -108.7 81.79 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -33.8 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.391 0.615 . . . . 0.0 111.105 -179.114 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 79.7 m -143.77 82.62 11.09 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.39 84.55 2.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 23.4 m -93.0 151.52 19.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.144 -0.972 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 31.5 p -127.44 127.88 44.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -116.76 148.54 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 70.6 m -116.41 144.52 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-20 -56.36 119.15 5.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.75 -37.98 4.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 45.02 2.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.27 172.23 9.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -1.163 . . . . 0.0 110.313 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 47' ' ' ASP . 18.0 mt -150.0 157.49 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.122 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.65 154.6 20.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -42.15 55.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.031 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -90.05 8.46 32.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.886 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 4.4 m 68.73 43.41 1.28 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 109.996 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -101.84 -22.28 14.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.309 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -95.52 169.7 9.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.262 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.06 153.81 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.466 ' HB2' HG13 ' A' ' 39' ' ' ILE . 27.0 t0 -102.61 -86.87 0.42 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.277 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -95.33 -4.1 46.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.277 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.459 ' O ' ' OXT' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -82.73 6.88 16.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.137 179.916 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.459 ' OXT' ' O ' ' A' ' 49' ' ' PHE . 34.8 t80 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.18 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.259 0.552 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.498 ' HG3' ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -175.21 -143.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 179.967 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' N ' ' HG3' ' A' ' 2' ' ' LYS . . . -68.49 97.09 0.45 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.69 78.23 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -1.172 . . . . 0.0 110.174 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.416 ' CD1' HG13 ' A' ' 24' ' ' VAL . 37.7 m-85 -118.81 -157.29 0.68 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.89 . . . . 0.0 110.227 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -132.79 130.12 39.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.156 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.46 130.73 34.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 127.05 90.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.277 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.76 167.48 27.1 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.921 1.485 . . . . 0.0 110.458 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.447 ' HG2' ' HE2' ' A' ' 13' ' ' LYS . 5.4 mttt -66.16 -27.24 67.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.186 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -20.44 49.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.238 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -123.71 2.68 8.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE2' ' HG2' ' A' ' 10' ' ' LYS . 5.1 ttpt -87.03 54.75 3.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -86.33 -15.02 41.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.097 -1.002 . . . . 0.0 109.309 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.442 ' C ' ' CD1' ' A' ' 15' ' ' TYR . 4.5 p90 -90.2 1.93 55.93 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.524 -0.735 . . . . 0.0 109.128 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HA ' ' SG ' ' A' ' 43' ' ' CYS . 1.5 m -157.42 79.12 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.834 . . . . 0.0 109.999 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 83.7 mt -48.7 -55.15 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.427 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 5.9 ptmm? -112.24 60.95 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.478 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -157.49 141.24 7.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 123.51 40.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -1.113 . . . . 0.0 109.936 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' SER . 11.0 t -111.0 127.68 55.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.111 -0.993 . . . . 0.0 110.587 -179.595 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.61 119.39 34.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.868 . . . . 0.0 109.822 179.604 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.31 106.16 17.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 21.3 t -80.24 118.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' ALA . 73.1 t -80.28 -58.44 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.703 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.49 -50.73 3.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 mt-10 -116.06 96.6 5.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.3 tp-100 -34.84 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.78 -0.575 . . . . 0.0 111.201 -179.089 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' GLU . 3.9 m -146.17 82.66 8.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.253 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' HD3' ' OE1' ' A' ' 28' ' ' GLN . 51.1 Cg_endo -79.56 89.06 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.108 1.583 . . . . 0.0 110.43 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.456 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -94.65 131.15 40.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.993 179.83 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 27.4 p -113.87 114.38 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.2 129.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.848 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 8.3 m -101.85 161.76 13.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.126 -0.984 . . . . 0.0 110.42 -179.388 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 63.0 m-20 -58.85 119.8 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 37' ' ' GLY . 10.3 pt-20 -43.9 -33.43 1.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' A' ' 36' ' ' GLU . . . -90.28 43.83 2.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -126.24 170.65 11.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -1.2 . . . . 0.0 110.414 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 29.3 mt -150.15 151.7 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.64 169.57 17.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -40.82 13.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 110.237 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.8 mpt_? -91.02 10.9 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 6.3 m 66.54 41.45 3.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.872 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 5.6 pt-20 -100.11 -28.29 13.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -84.88 163.24 19.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.231 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.467 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.4 p -139.81 157.17 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.27 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -123.98 36.36 4.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.88 . . . . 0.0 110.119 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.75 71.61 0.8 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -88.88 -72.1 0.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.172 -179.837 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.234 0.54 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.65 88.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.899 . . . . 0.0 110.248 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.4 101.49 0.2 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 4' ' ' HIS . 6.6 p80 -150.28 58.48 0.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -1.133 . . . . 0.0 110.36 -179.781 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -112.52 -139.85 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.952 . . . . 0.0 110.062 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -147.28 134.89 20.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 110.292 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -91.0 126.69 36.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.64 133.95 95.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.8 164.97 34.06 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.943 1.497 . . . . 0.0 110.432 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -66.36 -26.65 67.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.263 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -8.65 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 7.65 5.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 0.0 110.227 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -89.94 46.27 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.32 -11.81 51.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.534 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.41 0.93 57.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.187 178.421 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.9 m -159.54 123.63 3.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.464 HD12 ' HB2' ' A' ' 44' ' ' GLU . 57.8 mt -75.38 -76.52 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -98.72 65.06 1.53 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 0.0 110.814 -179.615 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -152.87 148.36 19.09 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -101.9 132.7 47.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.13 . . . . 0.0 110.098 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 9.0 t -107.63 126.63 52.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' CG ' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -96.49 106.89 19.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.48 115.38 27.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.585 -179.601 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 17.9 t -91.64 120.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 109.944 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.7 t -79.59 -64.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 110.563 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -38.3 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.807 . . . . 0.0 109.561 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -124.51 91.49 3.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.912 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 pm0 -36.2 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 110.93 -179.078 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -146.28 83.6 8.36 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.858 . . . . 0.0 110.462 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.3 Cg_endo -78.8 88.42 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.164 1.613 . . . . 0.0 110.431 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.448 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.9 OUTLIER -89.6 145.46 25.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.92 179.837 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 8.9 p -128.03 105.59 8.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.114 -0.991 . . . . 0.0 110.978 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 34' ' ' CYS . 97.3 t -106.8 151.8 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.125 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.517 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 13.5 m -119.55 166.12 13.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.613 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.99 117.39 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.964 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -42.62 -37.25 1.63 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.213 -179.909 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 46.36 3.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -124.61 165.73 17.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -1.202 . . . . 0.0 110.38 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.4 mt -149.42 151.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.235 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.24 149.94 10.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.48 66.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.012 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -90.67 -0.39 57.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.9 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 42' ' ' ARG . 5.2 m 69.89 38.18 1.65 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.825 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB2' HD12 ' A' ' 17' ' ' ILE . 6.5 tm-20 -101.39 -17.34 16.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -97.27 163.95 12.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.821 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.436 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 8.9 p -150.11 155.13 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -121.46 80.36 1.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.242 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.42 71.96 1.18 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 110.197 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.17 -45.1 64.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 0.0 110.233 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.438 ' C ' ' CD1' ' A' ' 50' ' ' TYR . 6.4 p90 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.107 -179.939 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.255 0.55 . . . . 0.0 110.2 . . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 1' ' ' ARG . 13.4 tttt 64.72 123.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.46 74.55 0.2 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.475 ' C ' ' CG ' ' A' ' 5' ' ' PHE . 13.8 t-80 -87.07 55.04 3.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.18 . . . . 0.0 110.368 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.475 ' CG ' ' C ' ' A' ' 4' ' ' HIS . 59.3 m-85 -149.68 -155.38 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.965 . . . . 0.0 110.275 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -142.7 121.51 12.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.41 137.28 35.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.183 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 136.41 93.19 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -179.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.5 Cg_endo -72.89 161.93 42.4 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.055 1.555 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -67.46 -31.52 71.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.952 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.67 -10.83 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.43 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.7 m-85 -126.5 2.83 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.843 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -89.98 57.06 3.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.11 179.889 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -86.45 -12.68 48.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 109.422 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.486 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.3 p90 -90.17 -1.65 57.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.089 178.427 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.486 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.24 104.27 1.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 110.103 179.837 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 47.5 mm -69.29 -72.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.529 ' CE ' ' HB2' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -91.16 52.8 2.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -151.42 135.9 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -99.62 125.95 45.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -1.134 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 11.0 t -105.66 125.8 51.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.251 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.03 112.16 23.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -94.77 104.7 16.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 21.5 t -80.52 115.13 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.266 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 27.9 t -78.13 -62.1 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.558 -0.714 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.53 -44.8 4.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.281 179.523 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -115.37 90.47 3.35 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.842 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -35.01 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.778 -0.576 . . . . 0.0 111.005 -179.133 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' GLU . 34.2 m -150.37 83.46 5.97 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 -179.882 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.5 Cg_endo -80.8 100.08 1.18 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.065 1.56 . . . . 0.0 109.953 179.419 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.3 p -112.15 132.72 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.096 -1.002 . . . . 0.0 110.454 -179.741 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 29.2 p -104.79 131.45 52.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.5 116.95 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' CB ' ' CE2' ' A' ' 38' ' ' TYR . 19.4 m -93.97 156.1 16.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 110.126 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -50.3 124.18 9.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 179.895 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -45.52 -40.78 8.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.18 46.24 3.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CE2' ' CB ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -120.82 166.62 13.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.339 179.899 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.446 HD13 ' OD2' ' A' ' 47' ' ' ASP . 9.6 mt -146.46 150.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.69 145.02 9.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.98 62.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 110.253 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 4.3 mmt85 -112.78 5.66 17.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 4.0 m 68.34 45.22 1.22 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.131 179.704 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.48 -33.5 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 110.678 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -86.07 151.68 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.379 -179.704 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.49 144.54 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.04 179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' OD2' HD13 ' A' ' 39' ' ' ILE . 1.5 t0 -130.7 55.2 1.84 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -0.907 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.4 mt -134.19 136.16 43.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 110.209 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -89.48 30.39 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.175 -179.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 50' ' ' TYR . 19.8 p90 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.193 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.271 0.557 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -87.27 54.17 3.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.32 -0.863 . . . . 0.0 110.195 -179.905 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.89 59.52 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.89 31.05 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -1.134 . . . . 0.0 110.256 179.931 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 47.4 m-85 -138.13 -152.93 0.45 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.7 128.66 35.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.164 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.91 125.66 45.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.33 127.45 92.13 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 -179.931 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.8 Cg_endo -74.2 161.27 41.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.914 1.481 . . . . 0.0 110.247 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -64.41 -32.67 74.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -65.57 -8.69 21.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.471 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.459 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -123.86 0.98 8.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 8' ' ' CYS . 27.2 mttt -87.99 73.85 9.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.372 -179.788 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -85.74 -17.82 34.79 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.207 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 14.6 p90 -82.58 -10.08 59.12 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 178.502 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.2 m -160.3 137.81 9.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.0 mm -94.37 -70.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.41 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.511 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -89.89 62.41 5.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.102 -0.999 . . . . 0.0 110.506 -179.925 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.35 141.96 7.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.753 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 5.3 mpt_? -95.4 150.56 20.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -1.178 . . . . 0.0 109.505 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 26.5 t -132.55 130.31 40.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.552 -179.685 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -99.49 122.18 42.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 109.994 179.619 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -111.98 103.49 11.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.211 -179.804 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' A' ' 29' ' ' THR . 22.3 t -81.42 124.67 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.1 t -79.68 -69.25 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 110.306 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.94 -44.45 3.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -112.53 93.97 4.69 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.886 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tp-100 -38.93 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.533 -0.729 . . . . 0.0 110.796 -179.148 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 7.6 m -139.18 73.15 38.25 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.218 -0.927 . . . . 0.0 110.459 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.584 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.3 Cg_endo -78.43 72.86 6.12 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.025 1.539 . . . . 0.0 110.033 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.439 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 4.0 p -92.56 137.91 31.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -179.695 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.7 t -114.01 107.83 16.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 20' ' ' ARG . 45.0 t -94.08 116.24 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 9.0 m -83.6 158.54 21.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.964 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.54 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -46.45 120.18 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.762 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.0 tt0 -40.83 -54.09 2.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.66 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.48 52.79 3.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.57 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -118.59 168.86 10.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -1.195 . . . . 0.0 110.655 -179.999 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 3.3 mp -143.37 132.04 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.756 . . . . 0.0 109.806 179.5 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.8 136.43 3.62 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.01 72.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.304 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.0 19.89 18.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.963 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.496 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.6 m 63.54 72.74 0.47 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -107.9 -40.27 5.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.938 -179.3 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.475 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 9.1 ptp180 -118.56 168.86 10.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.986 -1.071 . . . . 0.0 110.546 -179.527 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.511 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 7.1 p -121.96 162.25 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.511 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 33.5 t0 -97.09 -74.97 0.55 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 110.246 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 147.0 48.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 -179.927 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.0 -40.49 58.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.254 -179.999 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.28 0.562 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 1' ' ' ARG . 18.2 ttmt -179.23 117.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.096 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . -121.14 -74.53 0.36 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.36 94.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -1.123 . . . . 0.0 110.157 -179.908 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.492 ' CE2' ' HA3' ' A' ' 3' ' ' GLY . 54.1 m-85 -131.31 -149.41 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.5 m -115.95 132.12 56.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -87.69 118.01 26.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 24.6 m -45.28 112.25 1.53 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 163.55 37.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.951 1.501 . . . . 0.0 110.319 179.739 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -60.32 -37.14 79.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.259 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -25.15 63.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 -179.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -110.17 -1.4 17.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.257 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -89.94 46.94 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.401 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -86.21 -12.79 48.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.047 -1.033 . . . . 0.0 109.402 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 9.1 p90 -90.3 -3.8 57.54 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.214 178.494 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.538 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.12 105.52 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.525 HG22 HD11 ' A' ' 17' ' ' ILE . 51.1 mm -70.41 -71.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.055 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HE3' ' CA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -89.69 64.0 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.488 ' O ' ' CE ' ' A' ' 13' ' ' LYS . . . -160.05 136.37 4.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 96.0 mtt180 -99.51 127.21 45.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -1.161 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 9.5 t -119.01 133.18 55.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.643 -179.664 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -102.51 123.96 47.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.853 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -105.66 116.24 31.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.458 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 53.4 t -86.56 116.88 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 110.133 179.714 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' ALA . 89.1 t -79.92 -61.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.543 -0.723 . . . . 0.0 110.549 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.0 -49.14 3.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.577 179.886 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.3 tt0 -114.5 92.83 4.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -34.47 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.262 0.553 . . . . 0.0 110.99 -179.084 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 4.4 m -149.11 86.81 5.52 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -79.23 122.5 5.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.985 1.518 . . . . 0.0 110.298 179.666 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.45 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -127.85 116.64 20.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 109.971 179.804 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.523 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.8 p -99.59 126.98 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.583 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 42.2 t -116.77 120.84 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.349 -0.844 . . . . 0.0 109.819 179.705 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.58 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 14.6 m -91.3 159.95 15.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.247 -0.908 . . . . 0.0 110.514 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -58.42 128.11 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.036 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -47.44 -49.12 25.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 45.76 3.02 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -113.04 172.85 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 110.226 179.864 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 15.2 mt -150.2 127.7 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.27 148.44 6.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.65 66.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 110.283 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' CYS . 81.0 mtt180 -89.58 13.47 13.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.507 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 3.5 m 63.36 62.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.324 -0.86 . . . . 0.0 109.762 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.521 ' CA ' ' HE3' ' A' ' 18' ' ' LYS . 10.4 tt0 -110.34 -28.82 8.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.74 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.466 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 13.2 ttm180 -111.03 109.58 19.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.017 -1.052 . . . . 0.0 110.317 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.72 159.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' HB2' HD11 ' A' ' 39' ' ' ILE . 61.4 t0 -98.57 64.72 1.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.322 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.28 174.08 10.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.297 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -48.42 -62.78 1.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.432 ' OXT' ' CG ' ' A' ' 50' ' ' TYR . 66.2 t80 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.16 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.216 0.531 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.62 116.76 8.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 110.154 179.882 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.8 70.71 0.86 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.854 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 4' ' ' HIS . 6.5 p80 -138.06 76.41 1.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 110.211 -179.793 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' CG ' HG21 ' A' ' 24' ' ' VAL . 36.2 m-85 -95.23 -144.59 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.05 162.73 18.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.347 179.942 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -106.9 154.13 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 110.171 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.423 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -83.46 127.73 67.11 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 -179.907 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.67 162.21 40.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.868 1.457 . . . . 0.0 110.383 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -61.36 -29.04 69.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -63.86 -25.61 68.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.35 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -112.12 10.55 20.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.351 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -90.0 45.45 1.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.131 179.926 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.25 -13.45 46.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.032 . . . . 0.0 109.624 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p90 -87.96 -1.76 58.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.439 -0.788 . . . . 0.0 109.197 178.607 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.78 103.2 1.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 33.2 mt -63.73 -69.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 -179.956 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.7 ptmm? -97.94 64.43 1.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.21 149.31 18.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.96 162.05 13.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 109.793 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 32' ' ' CYS . 9.2 t -151.81 156.24 39.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.02 . . . . 0.0 110.621 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -125.99 125.82 43.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.456 -0.778 . . . . 0.0 109.602 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.07 118.06 36.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.648 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 37.6 t -83.56 115.72 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.814 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 6.0 t -82.2 -63.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.52 -0.737 . . . . 0.0 110.62 -179.506 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.01 -29.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.351 -0.843 . . . . 0.0 109.787 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' THR . 97.2 mt-10 -136.93 93.46 2.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.164 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 13.1 mt-30 -34.72 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.806 -0.559 . . . . 0.0 111.146 -179.124 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 27' ' ' GLU . 3.1 m -149.18 89.57 4.84 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 110.324 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.15 117.45 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.06 1.558 . . . . 0.0 110.395 179.666 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.0 OUTLIER -118.88 110.62 17.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.132 -0.98 . . . . 0.0 109.904 179.768 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.463 ' O ' HG23 ' A' ' 33' ' ' VAL . 26.7 p -92.15 155.14 18.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.735 -179.682 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 32' ' ' CYS . 99.3 t -149.12 120.44 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.472 -0.768 . . . . 0.0 109.806 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.583 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.0 m -93.72 156.47 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -179.526 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -54.85 125.53 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.038 179.772 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.47 -39.42 15.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.826 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 40.95 2.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.84 174.24 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -1.214 . . . . 0.0 110.326 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 38' ' ' TYR . 18.0 mm -149.51 148.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.031 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.61 157.45 20.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.03 -37.71 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.164 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -93.11 9.19 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.124 179.842 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.474 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.8 m 67.41 43.72 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.402 -0.811 . . . . 0.0 110.145 179.818 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -96.29 -34.44 11.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.585 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.47 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -96.7 -178.62 4.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.476 -179.757 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.469 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.8 p -147.66 157.4 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.861 . . . . 0.0 110.391 -179.844 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -108.08 54.27 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.339 -0.851 . . . . 0.0 110.036 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.29 -167.15 1.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 110.186 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.98 -22.38 25.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.6 t80 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.225 -179.901 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 1' ' ' ARG . 7.0 ttm180 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.253 0.549 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -112.86 -0.91 14.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.907 . . . . 0.0 110.235 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 4' ' ' HIS . . . -170.48 -161.29 20.8 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 4' ' ' HIS . 44.9 p-80 -177.99 97.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -1.139 . . . . 0.0 110.286 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -107.0 -144.75 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.164 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.76 140.17 23.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.17 119.81 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.23 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -55.86 136.61 72.54 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 179.878 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.9 Cg_endo -73.35 171.71 17.12 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.91 1.479 . . . . 0.0 110.415 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -63.72 -38.62 91.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 110.234 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -63.64 -19.23 64.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.192 179.982 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.443 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.2 m-85 -107.45 -1.97 20.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.1 55.73 3.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.427 ' CE1' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -86.16 -15.5 40.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.026 -1.046 . . . . 0.0 109.303 179.923 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.509 ' OH ' ' CB ' ' A' ' 21' ' ' CYS . 3.6 p90 -90.13 3.32 53.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.493 -0.755 . . . . 0.0 109.307 178.515 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.98 106.39 1.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.154 179.85 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 9.3 mm -63.25 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.108 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -96.29 63.4 2.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.221 179.987 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.43 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -159.76 155.54 26.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -101.77 -179.06 3.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 109.832 179.832 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.509 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 8.8 t -152.63 128.05 9.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.068 -1.02 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -102.28 105.07 15.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.074 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.29 115.44 28.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 41.2 t -89.91 117.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.817 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 53.8 t -75.24 -62.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.597 -0.69 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.46 -61.23 1.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.83 . . . . 0.0 109.436 179.779 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 29' ' ' THR . 47.7 mt-10 -99.62 90.6 4.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.483 -0.761 . . . . 0.0 109.008 178.891 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.8 pm0 -34.3 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.268 0.556 . . . . 0.0 111.046 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' GLU . 43.4 m -146.03 85.36 7.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.862 . . . . 0.0 110.348 179.912 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.6 Cg_endo -76.05 99.2 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.368 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.4 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -103.35 143.01 33.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.144 179.897 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 27.5 p -123.91 118.22 26.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.767 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 t -112.44 146.82 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.6 m -117.03 161.54 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -54.19 117.41 3.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 110.219 -179.893 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -43.97 -38.1 3.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.35 46.18 3.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.07 172.49 9.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -1.183 . . . . 0.0 110.339 179.965 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 46.2 mt -150.12 143.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.13 168.79 13.37 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 -40.26 16.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -1.15 . . . . 0.0 110.119 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -96.86 13.37 28.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 0.0 110.186 179.973 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.495 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 4.3 m 67.77 51.04 0.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -101.74 -39.92 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.468 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.06 165.44 18.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.074 -1.016 . . . . 0.0 110.477 -179.798 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.516 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 8.6 p -146.09 156.12 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.05 58.35 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' CG ' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -158.77 43.34 0.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 110.197 -179.939 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.74 -76.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.965 . . . . 0.0 110.221 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.218 0.533 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.47 103.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 110.095 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 4' ' ' HIS . . . 137.44 68.94 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 4.9 t-160 -177.62 100.98 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.266 -1.137 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -91.38 -154.36 0.36 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 m -145.0 135.92 24.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.299 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 121.18 26.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.142 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -47.41 135.88 9.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.235 -179.982 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.86 173.65 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.996 1.524 . . . . 0.0 110.403 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -65.07 -31.37 72.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.89 -8.59 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -119.05 -1.26 10.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.939 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -90.12 39.39 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.263 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -85.85 -20.94 28.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 109.457 -179.832 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.21 1.1 56.82 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.009 178.124 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.45 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -160.33 92.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.884 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 75.4 mt -75.56 -55.89 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.45 42.74 1.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 110.026 179.772 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.97 -179.74 30.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.29 145.54 43.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.265 -1.138 . . . . 0.0 109.934 179.821 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 14.6 t -125.65 124.94 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.636 -179.538 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -90.2 113.15 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.789 179.602 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -95.41 116.4 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.477 -179.621 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 58.0 t -83.7 116.54 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 109.966 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 38.5 t -79.93 -59.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 0.0 110.494 -179.826 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.53 -47.92 3.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -118.08 95.17 4.78 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.755 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 56.1 tt0 -35.53 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.757 -0.589 . . . . 0.0 111.128 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.9 m -148.52 88.39 5.33 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -76.02 118.87 5.15 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.956 1.503 . . . . 0.0 110.387 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 4.3 m -122.36 115.22 21.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.894 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -98.31 154.16 18.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.72 -179.614 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 32' ' ' CYS . 41.6 t -146.94 159.34 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.883 179.68 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.494 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.4 m -121.43 157.16 31.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.031 . . . . 0.0 110.452 -179.653 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.8 m-20 -66.79 124.88 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.864 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -50.84 -40.53 56.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.31 -179.943 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.39 40.95 3.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER -117.92 176.84 5.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -1.145 . . . . 0.0 110.331 -179.879 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 39' ' ' ILE . 12.8 mt -147.0 117.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 110.245 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 150.94 5.82 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.35 -52.2 49.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -1.153 . . . . 0.0 109.959 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -92.48 17.78 9.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.827 179.691 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' ARG . 8.6 m 64.65 80.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 110.143 179.936 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -113.68 -38.4 4.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -104.8 162.19 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 47' ' ' ASP . 11.1 p -131.58 154.66 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.05 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.436 ' N ' HG22 ' A' ' 46' ' ' VAL . 38.6 t0 -134.17 44.46 2.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.509 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.5 OUTLIER -79.73 173.87 12.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 179.94 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' O ' ' C ' ' A' ' 50' ' ' TYR . 36.7 m-85 -86.72 34.81 0.66 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 110.591 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 16.0 p90 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.198 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.355 0.598 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -63.81 -27.99 69.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.151 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.19 -116.69 1.2 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.954 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.17 90.99 1.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -1.127 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CD1' HG11 ' A' ' 24' ' ' VAL . 24.8 m-85 -132.36 -158.07 0.86 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 110.064 -179.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -140.42 141.44 35.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 165.51 21.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.512 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -89.78 127.34 54.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 110.274 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 48.2 Cg_endo -73.99 166.05 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.465 . . . . 0.0 110.094 179.68 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -66.0 -36.04 82.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -12.2 16.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 110.458 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.42 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.4 m-85 -120.3 -6.0 9.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 52.08 2.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -86.28 -16.92 36.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.95 -1.094 . . . . 0.0 109.413 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.458 ' OH ' ' SG ' ' A' ' 21' ' ' CYS . 4.5 p90 -90.36 1.98 56.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 109.127 178.404 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.3 m -159.66 100.06 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 41.7 mm -72.61 -70.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.165 179.982 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -89.57 49.32 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 179.983 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -141.84 134.34 6.15 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -92.92 127.31 38.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.232 -1.157 . . . . 0.0 109.892 179.771 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.528 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 5.8 p -127.96 145.83 50.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 110.565 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.91 159.17 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.857 . . . . 0.0 109.527 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -138.51 109.14 6.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.029 . . . . 0.0 110.307 -179.751 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 7.9 t -80.46 116.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 5.8 t -78.95 -65.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.061 179.834 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.97 -42.71 3.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 109.376 179.608 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -115.95 88.95 2.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.919 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -35.06 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.235 -178.992 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.2 m -146.73 81.75 9.03 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 179.753 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.1 Cg_endo -79.12 107.67 2.25 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.061 1.558 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 136.05 53.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -120.28 129.43 54.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 t -126.34 116.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.079 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 14.9 m -89.54 150.28 22.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 -179.765 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.9 m-20 -45.62 124.26 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 110.093 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 19.2 pt-20 -51.79 -38.55 56.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -90.12 37.94 3.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -110.02 172.8 6.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 110.322 -179.932 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 39' ' ' ILE . 33.3 mm -144.98 141.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.237 179.886 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 145.97 10.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -1.188 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.1 mtm-85 -89.78 3.63 52.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 110.149 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m 67.55 51.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 109.598 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -99.42 -30.94 11.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.598 -179.565 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.475 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 82.1 mtt180 -105.6 173.76 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.402 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -146.56 146.63 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.48 38.2 2.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.0 129.27 51.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.271 -179.926 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -79.33 -44.7 21.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.086 179.959 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.192 179.97 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.264 0.554 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 -156.63 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 4' ' ' HIS . . . 152.76 -107.56 0.33 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER 66.42 98.33 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -1.162 . . . . 0.0 110.246 -179.873 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -97.99 -146.45 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 m -137.5 146.86 44.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.61 150.82 25.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.888 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -83.65 130.12 57.04 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.958 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.56 172.34 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.959 1.505 . . . . 0.0 110.396 -179.926 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -63.76 -25.18 68.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.262 179.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -62.51 -10.27 11.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 -179.885 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.585 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 8.8 m-85 -131.73 4.35 4.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -85.53 44.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.461 -179.843 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -85.2 -25.19 27.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.845 -1.16 . . . . 0.0 109.602 -179.78 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 10.9 p90 -79.16 -6.01 55.53 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.292 178.566 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 1.7 m -160.3 138.14 9.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.54 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.518 ' CD1' ' HG2' ' A' ' 44' ' ' GLU . 9.8 mt -94.68 -72.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.197 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -89.78 63.92 6.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 110.312 179.987 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.2 139.75 6.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -100.39 125.45 46.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -1.163 . . . . 0.0 109.801 179.91 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.506 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t -111.28 129.17 56.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 -179.643 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -90.89 129.17 36.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.939 179.689 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -105.62 110.48 22.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 39.4 t -80.31 114.72 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 26' ' ' ALA . 42.5 t -77.03 -65.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.593 -0.692 . . . . 0.0 110.235 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.6 -48.5 4.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.49 179.813 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -112.83 87.62 2.63 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.511 -0.743 . . . . 0.0 109.013 178.844 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -33.89 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.126 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 6.0 m -149.23 88.35 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.336 -0.852 . . . . 0.0 110.412 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.08 91.81 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.04 1.547 . . . . 0.0 110.432 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.1 p -93.34 124.98 37.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 179.784 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.506 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 6.7 t -99.97 129.56 46.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 87.4 t -117.9 109.4 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 109.584 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.2 m -79.93 153.75 28.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.835 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 5.2 m-20 -49.57 117.8 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.811 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.05 -47.08 4.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.469 -179.897 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.24 49.67 3.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -121.84 172.82 7.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.142 -1.211 . . . . 0.0 110.283 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.498 ' CD1' ' OD1' ' A' ' 47' ' ' ASP . 14.5 mt -144.09 143.8 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.193 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.09 170.36 14.97 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.2 -46.43 9.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -1.176 . . . . 0.0 110.268 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.5 mtp85 -91.41 11.96 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.152 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.484 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.7 m 67.1 64.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.436 -0.79 . . . . 0.0 110.196 179.878 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' HG2' ' CD1' ' A' ' 17' ' ' ILE . 24.1 mt-10 -116.3 -14.05 11.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.883 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 14.2 mtt180 -117.71 176.0 5.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.35 161.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.234 179.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.498 ' OD1' ' CD1' ' A' ' 39' ' ' ILE . 4.7 t70 -113.02 48.81 0.99 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 48' ' ' LEU . 3.6 mm? -118.52 -39.52 3.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.27 -59.19 2.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.278 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.168 0.509 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -130.31 67.77 1.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 179.996 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.444 ' O ' ' ND1' ' A' ' 4' ' ' HIS . . . 97.0 71.18 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -169.57 78.69 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -1.16 . . . . 0.0 110.264 -180.0 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -122.17 -138.78 0.32 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 m -127.64 120.76 28.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.869 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.03 129.69 34.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.435 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.74 132.28 72.11 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.891 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -73.72 160.24 44.12 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.519 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . 4.1 mttm -65.45 -30.66 71.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.257 179.974 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -64.03 -15.5 59.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.421 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -116.52 -1.4 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.312 -179.89 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HE3' ' HA ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.69 67.04 9.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 179.951 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -85.93 -17.64 34.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.04 -1.037 . . . . 0.0 109.37 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.423 ' C ' ' CD1' ' A' ' 15' ' ' TYR . 4.1 p90 -90.23 2.91 54.92 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.538 -0.726 . . . . 0.0 109.35 178.512 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.02 95.35 1.16 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.096 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.1 mm -55.57 -82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.364 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' NZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -89.89 66.05 6.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.017 . . . . 0.0 110.274 -179.853 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.67 154.87 25.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 10.1 ptt-85 -109.54 137.53 47.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -1.114 . . . . 0.0 109.992 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 47.6 t -124.48 123.33 39.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.41 110.45 23.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 179.764 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -95.76 110.28 22.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.355 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 9.5 t -79.89 118.89 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.109 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.2 t -79.72 -65.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.347 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.8 -46.75 3.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.86 . . . . 0.0 109.621 179.801 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 8.0 mt-10 -114.52 89.77 3.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.475 -0.765 . . . . 0.0 109.072 178.976 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.42 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.296 0.57 . . . . 0.0 111.109 -179.024 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 55.1 m -147.15 83.11 8.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.903 . . . . 0.0 110.38 179.75 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -77.63 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.515 . . . . 0.0 110.278 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -106.91 118.75 37.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.416 ' C ' HG21 ' A' ' 33' ' ' VAL . 21.9 p -98.27 148.24 23.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.973 . . . . 0.0 110.231 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG21 ' C ' ' A' ' 32' ' ' CYS . 21.4 t -145.17 150.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 33.1 m -120.93 161.68 21.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -57.62 127.66 33.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.991 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -44.0 52.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.166 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.92 43.69 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -114.84 170.66 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -1.162 . . . . 0.0 110.222 -179.963 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 21.0 mt -150.05 171.11 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.462 ' HA3' ' HD3' ' A' ' 45' ' ' ARG . . . 98.92 169.13 30.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.42 -41.75 14.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.188 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 16.6 mtt180 -96.45 21.03 9.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 -179.998 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.1 m 64.23 31.79 12.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 110.142 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.429 ' CD ' ' HB2' ' A' ' 42' ' ' ARG . 44.2 mt-10 -92.01 -18.73 23.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.551 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -97.85 163.89 12.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 7.2 p -147.91 152.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 -179.879 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' O ' HD13 ' A' ' 48' ' ' LEU . 17.0 t0 -100.41 60.75 1.02 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.108 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HB2' HG21 ' A' ' 46' ' ' VAL . 1.5 mp -135.05 145.47 48.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.96 . . . . 0.0 110.222 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' TYR . 30.5 m-85 -89.64 27.89 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.362 -0.836 . . . . 0.0 110.224 179.928 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 50' ' ' TYR . 18.9 p90 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.192 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.184 0.516 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -175.08 70.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 -179.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.9 141.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.62 54.49 1.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -1.171 . . . . 0.0 110.325 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.557 ' CD1' HG23 ' A' ' 24' ' ' VAL . 63.3 m-85 -126.45 -152.29 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.955 . . . . 0.0 110.164 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.69 134.23 42.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.987 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -84.75 150.68 24.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.349 -179.93 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.41 132.8 34.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.135 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.3 Cg_endo -73.2 161.04 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.955 1.503 . . . . 0.0 110.574 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -30.21 70.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.379 -0.826 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -9.76 42.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.451 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.0 m-85 -122.62 6.14 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 19' ' ' GLY . 50.8 mttt -89.24 56.9 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.4 -179.887 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -15.14 42.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.03 -1.044 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.471 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.23 2.04 55.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.264 178.586 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.6 m -160.51 123.42 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 95.1 mt -81.34 -64.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 110.259 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 8.6 ptmm? -106.06 61.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -150.32 155.82 26.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.884 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -106.42 136.81 45.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.114 . . . . 0.0 109.634 179.601 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 18.0 t -120.82 148.19 44.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.126 -0.984 . . . . 0.0 110.627 -179.527 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -125.35 119.08 27.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.817 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.18 116.51 32.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.947 . . . . 0.0 110.477 -179.635 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG23 ' CD1' ' A' ' 5' ' ' PHE . 21.8 t -87.19 114.45 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.018 179.704 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.0 t -75.43 -62.05 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.403 -0.811 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.14 -59.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 109.505 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 64.1 mm-40 -103.51 89.0 3.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -32.81 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.34 0.591 . . . . 0.0 111.168 -179.105 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.7 m -145.57 87.75 6.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.292 179.892 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.19 94.43 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.095 1.576 . . . . 0.0 110.452 179.833 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.453 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -95.24 141.24 29.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 179.944 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.4 p -123.48 122.14 37.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.267 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.1 143.86 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.926 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 31.6 m -115.33 164.44 14.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.471 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.508 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -45.96 122.46 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.245 179.961 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.65 -52.93 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.53 -179.877 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.44 50.61 3.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -116.3 170.94 8.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.102 -1.234 . . . . 0.0 110.343 179.783 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.1 mt -150.03 158.54 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 179.951 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 107.87 143.7 10.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.977 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.33 -29.98 68.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.264 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.07 9.26 43.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.104 179.967 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 5.3 m 65.65 49.26 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -107.81 -31.09 8.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.443 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 62.4 mtt85 -85.18 157.62 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.27 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.17 154.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.982 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -133.34 71.49 1.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.192 -179.955 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -132.31 34.73 3.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -18.69 32.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.95 . . . . 0.0 110.293 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 77.8 t80 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.225 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.411 ' HD2' HG13 ' A' ' 24' ' ' VAL . 75.3 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.052 0.454 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -133.29 125.21 28.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.473 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.58 120.98 32.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 110.05 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 33.4 m -57.19 116.0 12.27 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.62 168.38 24.91 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.9 1.474 . . . . 0.0 110.453 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -27.95 67.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -13.86 60.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -121.09 17.24 11.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 110.229 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -90.08 47.62 1.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.403 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.06 -18.5 32.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 109.135 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.9 p90 -90.64 0.52 57.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.086 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 3.1 m -160.14 91.47 0.95 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 51.7 mt -62.08 -53.31 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.123 -0.986 . . . . 0.0 110.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.17 57.39 0.62 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.14 159.78 31.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -101.85 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -1.149 . . . . 0.0 110.068 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 37.1 t -158.89 126.55 4.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 110.731 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -106.34 122.51 46.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.734 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -110.51 112.42 24.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.987 . . . . 0.0 110.577 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 27' ' ' GLU . 63.5 t -89.73 118.68 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.94 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.9 t -77.63 -64.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.744 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -46.6 4.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.345 -0.847 . . . . 0.0 109.376 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.597 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.6 tt0 -109.74 87.92 2.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.9 tt0 -34.76 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.361 0.6 . . . . 0.0 111.116 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -148.73 84.66 6.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -77.98 84.22 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.09 1.574 . . . . 0.0 110.128 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -89.88 140.36 29.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.068 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 12.0 p -129.04 110.77 12.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.415 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 20' ' ' ARG . 3.6 t -99.17 159.96 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 0.0 109.686 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.524 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 10.6 m -135.53 162.31 33.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -57.08 122.95 13.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 109.956 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.3 mt-10 -41.58 -37.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 110.168 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.68 48.17 3.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.796 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -123.26 162.17 23.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.023 -1.281 . . . . 0.0 110.38 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 38' ' ' TYR . 29.6 mm -142.29 156.03 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.212 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.55 150.96 25.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.57 80.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -1.15 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -89.65 8.06 33.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.02 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 6.9 m 64.64 58.15 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.39 -0.819 . . . . 0.0 110.153 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.76 -31.1 9.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 110.275 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.448 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 7.0 mtt180 -94.64 171.08 9.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.058 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 110.475 -179.853 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CD1' HG13 ' A' ' 24' ' ' VAL . 27.4 m-85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.318 0.58 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.05 143.2 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -80.95 127.08 32.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.309 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -59.65 130.04 87.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.2 Cg_endo -72.47 160.53 46.53 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.899 1.473 . . . . 0.0 110.356 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -61.65 -30.2 70.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.177 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -29.52 70.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.456 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -99.23 0.07 42.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.23 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.06 49.0 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.72 -20.25 29.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.021 -1.05 . . . . 0.0 109.352 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' OH ' ' SG ' ' A' ' 21' ' ' CYS . 4.4 p90 -90.35 1.24 56.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.131 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 101.46 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 38.7 mm -74.22 -69.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.85 58.61 4.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -155.16 136.0 4.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 8.6 mpt_? -93.92 128.95 40.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 110.038 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.522 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 6.4 p -126.35 147.67 49.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.61 144.94 35.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 109.808 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -121.73 108.7 13.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.511 HG13 ' CD1' ' A' ' 5' ' ' PHE . 3.9 t -83.42 120.12 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 46.2 t -81.87 -65.18 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.712 -0.617 . . . . 0.0 110.233 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.37 -34.55 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -128.14 92.04 3.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 11.1 tm0? -36.24 91.41 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.743 -0.598 . . . . 0.0 110.919 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 29' ' ' THR . 17.7 m -147.55 81.49 8.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.419 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -78.85 91.2 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.168 1.615 . . . . 0.0 110.321 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -89.26 145.38 25.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.2 p -123.98 132.09 53.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 0.0 110.591 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 66.5 t -127.25 111.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.879 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -81.94 152.34 26.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -57.39 124.96 20.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' ASP . 1.4 mm-40 -42.15 -42.73 3.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.459 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -90.4 48.02 3.1 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -119.44 169.4 10.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.268 . . . . 0.0 110.348 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 38' ' ' TYR . 44.1 mt -150.49 141.37 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.87 147.52 7.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.8 52.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.131 . . . . 0.0 110.074 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.419 ' C ' ' SG ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -94.97 20.66 8.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 110.345 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.537 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 2.4 m 63.42 67.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -102.94 -44.03 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 111.399 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 12.9 ptm180 -112.45 134.42 53.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.899 -1.126 . . . . 0.0 110.599 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.532 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.278 0.561 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -117.07 123.7 47.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -79.92 112.42 17.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -43.36 122.13 3.33 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.294 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -71.63 167.13 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.915 1.482 . . . . 0.0 110.427 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -53.57 -43.13 68.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -0.906 . . . . 0.0 110.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.87 -32.64 67.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.476 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -90.98 -12.05 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 45.57 1.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -86.16 -17.18 35.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.123 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.2 p90 -90.5 2.17 55.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.221 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -159.31 97.94 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.121 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.549 HD12 ' CG ' ' A' ' 44' ' ' GLU . 53.1 mt -63.61 -70.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.9 . . . . 0.0 110.309 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -91.86 64.31 4.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.08 153.44 24.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -114.18 140.67 48.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -1.141 . . . . 0.0 110.144 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 11.4 t -130.3 128.28 41.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.472 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -92.53 122.06 34.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 109.943 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.99 109.78 21.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 110.402 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 13.8 t -80.15 120.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 93.4 t -78.9 -64.38 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 110.344 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.28 -43.94 3.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.375 -0.828 . . . . 0.0 109.483 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.9 mt-10 -118.33 88.35 2.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.96 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.363 0.601 . . . . 0.0 111.01 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 32.9 m -143.29 85.6 9.51 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.256 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.98 87.21 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.145 1.603 . . . . 0.0 110.557 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 p -90.49 109.03 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.87 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 32.0 p -99.24 142.15 31.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.554 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.9 t -140.58 120.51 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 109.969 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 12.7 m -88.04 156.18 19.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.238 -0.914 . . . . 0.0 110.322 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -48.85 121.52 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -50.21 -43.69 52.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.302 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.59 39.1 3.12 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -113.12 178.36 4.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 110.341 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 17.7 mt -150.23 158.76 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.44 168.97 23.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.59 -44.66 11.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.338 -1.095 . . . . 0.0 110.137 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HB2' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -91.73 14.76 14.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.82 51.96 0.56 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.336 -0.852 . . . . 0.0 110.333 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.549 ' CG ' HD12 ' A' ' 17' ' ' ILE . 14.0 mt-10 -105.37 -34.96 7.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 17.2 mtp180 -85.23 160.85 19.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.516 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.469 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 4.4 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.294 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.189 0.518 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.31 134.82 48.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 110.301 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -88.21 147.53 24.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.15 143.97 43.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.22 164.84 34.25 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.04 1.547 . . . . 0.0 110.468 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -62.98 -31.58 72.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -21.46 66.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.108 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -102.61 1.38 34.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.235 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 16' ' ' CYS . 14.4 mtpt -87.41 54.38 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.325 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -18.87 31.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.941 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 1.8 p90 -90.56 -2.75 57.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.017 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 10.3 m -158.92 109.06 2.0 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.853 . . . . 0.0 110.053 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 29.6 mm -72.66 -54.87 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.019 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 7.8 ptmm? -106.41 53.02 0.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -151.5 147.09 16.58 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -101.99 141.23 35.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -1.196 . . . . 0.0 110.065 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.488 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 34.8 t -115.92 123.63 48.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 110.456 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -96.42 107.77 20.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -91.02 111.9 23.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.855 . . . . 0.0 110.443 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 27' ' ' GLU . 88.2 t -81.27 117.11 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.028 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 99.9 t -80.88 -56.61 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.657 -0.652 . . . . 0.0 110.386 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.64 -42.97 2.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.49 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.562 ' H ' HG12 ' A' ' 24' ' ' VAL . 35.3 tt0 -125.46 97.35 5.15 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -34.5 90.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.764 -0.585 . . . . 0.0 111.172 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 29' ' ' THR . 14.0 m -148.66 85.69 6.06 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.444 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.523 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -73.47 100.16 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.056 1.556 . . . . 0.0 110.412 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 t -97.16 133.77 41.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.1 p -113.98 102.27 10.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.423 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.33 122.67 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.883 . . . . 0.0 110.012 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 18.1 m -95.51 155.62 16.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.369 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 2.0 m-20 -43.84 124.27 3.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.127 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.71 -49.42 28.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.339 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 46.63 3.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.518 ' HB3' ' CB ' ' A' ' 35' ' ' ASP . 0.4 OUTLIER -111.6 171.29 7.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -1.204 . . . . 0.0 110.317 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.413 HG12 ' C ' ' A' ' 38' ' ' TYR . 25.3 mm -144.69 153.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.53 156.39 16.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.78 57.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -1.134 . . . . 0.0 110.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.2 mmm-85 -97.05 12.57 32.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.523 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.42 55.93 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 0.0 109.874 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.81 -36.73 6.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.599 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -97.08 -179.49 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.499 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.7 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.362 -0.836 . . . . 0.0 110.078 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.236 0.541 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -131.04 129.76 42.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 8' ' ' CYS . 1.9 ttm180 -88.23 111.68 21.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 46.8 m -42.93 110.73 0.92 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.255 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HG2' ' CG ' ' A' ' 11' ' ' GLN . 45.6 Cg_endo -73.59 179.25 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.927 1.488 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.98 -36.32 84.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' CG ' ' HG2' ' A' ' 9' ' ' PRO . 4.1 pt20 -59.88 -13.82 12.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.44 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.512 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.9 m-85 -120.07 -3.55 10.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.155 -0.966 . . . . 0.0 110.429 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.75 41.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.259 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -85.91 -18.41 32.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.024 -1.047 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.33 3.64 53.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.342 -0.848 . . . . 0.0 109.148 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -158.47 120.29 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.14 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.4 mm -80.46 -72.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.262 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.6 OUTLIER -95.23 65.01 2.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.028 -1.045 . . . . 0.0 110.33 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.25 171.82 33.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 11.7 mtp85 -131.99 133.43 44.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 109.807 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.9 t -121.7 137.05 54.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.75 126.28 51.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.51 112.86 26.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.546 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 58.3 t -84.18 116.59 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.059 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 26' ' ' ALA . 60.5 t -74.18 -64.55 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 110.4 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.93 -62.33 0.94 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.872 . . . . 0.0 109.34 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 21.0 mm-40 -97.82 87.77 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.88 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.742 -0.599 . . . . 0.0 111.072 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 29' ' ' THR . 10.5 m -145.0 88.1 6.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.82 91.93 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.133 1.596 . . . . 0.0 110.364 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.88 122.11 41.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.174 -0.953 . . . . 0.0 110.037 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.6 p -102.7 137.32 41.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.475 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 24.6 t -129.4 164.35 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 109.847 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.6 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 6.0 m -133.26 163.51 29.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 110.397 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.551 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-20 -55.74 121.39 9.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -46.58 -43.19 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 44.81 3.28 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.4 169.48 10.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -1.159 . . . . 0.0 110.129 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 3.3 mp -140.67 145.52 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.873 . . . . 0.0 110.217 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.37 167.3 16.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.95 -41.64 12.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 110.198 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.91 11.53 20.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.915 . . . . 0.0 110.216 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.524 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 66.9 49.59 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.304 -0.872 . . . . 0.0 109.827 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 28.8 tt0 -98.11 -34.8 10.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.9 mtt180 -94.02 157.36 16.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 110.092 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.509 ' CD1' HG13 ' A' ' 24' ' ' VAL . 64.4 m-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.255 0.55 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.2 m -124.25 131.93 53.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -91.36 145.44 24.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 110.151 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 139.31 33.17 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.9 . . . . 0.0 110.261 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.51 166.9 28.64 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.974 1.512 . . . . 0.0 110.4 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -61.63 -28.84 69.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.53 -29.45 69.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.295 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -98.03 6.75 47.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.379 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 51.82 2.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 110.357 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -21.78 28.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.5 p90 -90.49 3.91 52.59 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.072 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 119.61 2.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.189 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 18' ' ' LYS . 17.1 mm -73.37 -82.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.192 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.4 ptmm? -93.06 64.46 3.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 110.033 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -153.53 144.52 11.42 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -94.3 153.46 18.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.268 -1.137 . . . . 0.0 110.053 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 9.4 t -130.44 127.0 38.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 110.152 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.14 107.56 18.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -93.82 112.2 24.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 110.37 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.509 HG13 ' CD1' ' A' ' 5' ' ' PHE . 4.7 t -80.27 115.52 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.99 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 12.7 t -79.2 -66.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.635 -0.665 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.32 -34.2 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 109.372 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.3 mt-10 -123.66 88.9 3.0 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 15.7 tt0 -35.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.801 -0.562 . . . . 0.0 111.143 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 31.4 m -150.27 91.31 4.22 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.288 -0.883 . . . . 0.0 110.288 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 47.8 Cg_endo -75.52 108.99 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.637 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 t -111.09 141.55 44.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 10.2 p -129.4 100.28 5.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.543 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.53 124.57 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 58.9 m -93.75 159.27 15.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.7 m-20 -53.25 116.97 2.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.547 ' HG2' ' N ' ' A' ' 37' ' ' GLY . 1.4 pm0 -51.64 -29.53 18.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 110.183 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' N ' ' HG2' ' A' ' 36' ' ' GLU . . . -90.85 35.39 3.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -115.26 172.67 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -1.124 . . . . 0.0 110.54 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 24.4 mt -149.49 156.25 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.13 170.9 20.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.47 -45.78 11.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.218 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 1.6 mmp_? -89.97 12.37 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.521 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 3.8 m 69.59 47.42 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -101.0 -38.47 8.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.22 -0.925 . . . . 0.0 110.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 3.8 mtt180 -83.11 172.14 12.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.483 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.5 p . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.953 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.603 ' HD1' HG13 ' A' ' 24' ' ' VAL . 65.5 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.246 0.545 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 m -145.61 130.53 18.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.351 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -81.61 154.89 25.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.071 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -84.29 124.59 73.72 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 158.22 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.865 1.455 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -67.08 -24.46 65.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.482 ' CA ' ' HE2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -64.4 -12.08 39.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.381 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -131.92 16.01 4.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -90.29 58.61 4.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -86.1 -12.89 48.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 109.46 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 12.2 p90 -86.73 -8.95 56.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.474 -0.766 . . . . 0.0 109.038 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.38 126.4 4.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.3 mm -76.66 -55.67 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.008 . . . . 0.0 110.42 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -116.39 70.62 0.77 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.049 -1.032 . . . . 0.0 110.362 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.47 166.06 30.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 17.3 ptt180 -114.2 121.11 42.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.129 -1.218 . . . . 0.0 110.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 6.2 t -105.16 128.76 53.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 110.369 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.21 109.88 22.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 109.87 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -100.75 112.66 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.379 -179.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.603 HG13 ' HD1' ' A' ' 5' ' ' PHE . 3.4 t -87.9 118.32 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.335 -0.853 . . . . 0.0 110.02 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 26' ' ' ALA . 16.7 t -75.96 -67.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 110.44 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.4 -50.56 3.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -0.839 . . . . 0.0 109.563 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -108.44 90.32 3.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.8 mt-30 -35.55 91.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.306 0.574 . . . . 0.0 110.925 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 89.9 m -143.67 78.83 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.517 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.2 Cg_endo -75.41 81.96 2.18 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.108 1.583 . . . . 0.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -90.01 137.84 32.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 109.682 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.1 t -115.05 130.71 57.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.084 -1.01 . . . . 0.0 110.666 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 4.3 t -124.47 158.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.586 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.7 m -110.06 161.62 15.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.138 -0.976 . . . . 0.0 110.568 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.0 m-20 -61.61 120.52 10.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 37' ' ' GLY . 15.7 pt-20 -45.56 -43.63 12.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 110.183 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 36' ' ' GLU . . . -90.14 47.4 3.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.9 174.95 6.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -1.15 . . . . 0.0 110.4 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 8.5 mt -150.35 129.69 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 158.63 9.61 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.52 -46.35 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -1.151 . . . . 0.0 110.154 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.8 mtt180 -89.59 8.9 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.542 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m 67.43 61.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 109.997 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -106.25 -40.35 5.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.939 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.491 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.41 150.24 25.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.472 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.232 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.218 0.532 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.02 142.45 36.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 110.209 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 8' ' ' CYS . 10.1 mtp180 -103.9 107.5 18.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 32.0 m -42.08 121.24 2.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.901 . . . . 0.0 110.168 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.83 168.07 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.89 1.468 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -65.8 -27.96 68.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -66.53 -12.85 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -122.67 9.5 9.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HE2' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.14 51.62 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -85.74 -20.12 29.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.917 -1.115 . . . . 0.0 109.217 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.6 p90 -90.3 -1.57 57.93 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.098 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.499 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.7 m -160.59 98.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 44' ' ' GLU . 24.4 mt -77.74 -57.41 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -89.56 39.15 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.158 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -158.27 150.33 21.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.462 ' HG3' ' HE2' ' A' ' 13' ' ' LYS . 3.5 mtt180 -110.4 144.74 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -1.097 . . . . 0.0 109.781 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.49 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 17.6 t -125.94 135.91 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.99 . . . . 0.0 110.864 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.04 138.78 34.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.832 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -117.5 117.37 29.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.03 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.6 t -85.62 118.82 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.854 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 35.7 t -80.84 -65.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.627 -0.671 . . . . 0.0 110.607 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.45 -33.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 0.0 109.66 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -132.17 89.04 2.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 tt0 -34.59 90.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.763 -0.585 . . . . 0.0 111.09 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' GLU . 20.4 m -144.97 91.77 5.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.219 -0.926 . . . . 0.0 110.47 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 134.71 9.86 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.144 1.602 . . . . 0.0 110.412 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -141.15 112.09 7.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 109.915 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 29.0 p -98.53 144.43 27.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.752 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.93 127.41 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 23.8 m -102.71 164.25 11.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.3 m-20 -63.47 116.41 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.459 -0.776 . . . . 0.0 109.979 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.5 pt-20 -42.7 -31.26 0.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.486 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.84 43.26 2.97 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -125.44 170.28 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.8 mt -149.95 144.2 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.96 151.43 8.17 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.43 47.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -1.148 . . . . 0.0 110.24 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 22.8 mtt180 -89.97 12.95 16.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.926 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 5.1 m 66.64 57.23 0.69 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 109.867 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.583 ' HG2' HD12 ' A' ' 17' ' ' ILE . 8.3 mm-40 -108.09 -13.7 14.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.576 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.48 173.31 6.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.117 -0.989 . . . . 0.0 110.455 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.6 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.538 ' CD1' HG22 ' A' ' 24' ' ' VAL . 72.5 m-85 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.258 0.551 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.5 m -128.62 135.81 49.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 110.239 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -94.57 130.32 41.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.77 126.61 92.91 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.132 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.85 169.4 22.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.944 1.497 . . . . 0.0 110.306 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.5 mmtt -57.88 -24.98 60.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -33.59 75.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.575 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 26.6 m-85 -106.11 12.21 30.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -89.59 40.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 110.241 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -85.91 -18.2 33.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.02 -1.05 . . . . 0.0 109.613 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.25 3.16 54.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.4 125.8 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 10.8 mm -79.95 -72.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.135 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 6.2 ptmm? -99.27 51.56 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.096 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -140.95 141.86 11.68 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -98.15 141.44 31.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -1.073 . . . . 0.0 109.898 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 37.3 t -117.01 123.21 46.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.564 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -94.14 104.35 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.6 t80 -92.39 117.73 30.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.494 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 5' ' ' PHE . 59.1 t -84.48 118.45 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.8 t -81.72 -66.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.612 -0.68 . . . . 0.0 110.526 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.83 -36.37 0.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -124.59 90.16 3.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 27' ' ' GLU . 21.0 tt0 -35.92 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.774 -0.579 . . . . 0.0 111.052 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 16.3 m -150.15 89.48 4.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.564 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.9 Cg_endo -74.49 115.92 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.144 1.602 . . . . 0.0 110.545 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.77 123.24 46.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.7 p -103.12 135.48 44.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.3 125.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.523 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 24.3 m -92.58 163.08 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.444 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -51.74 129.56 26.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -48.75 -48.35 40.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 45.61 3.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -111.88 162.15 15.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -1.217 . . . . 0.0 110.005 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 33.4 mm -143.82 146.52 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.32 158.62 10.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.47 -43.71 38.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -1.099 . . . . 0.0 110.235 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 22.6 mtt-85 -89.89 8.73 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.0 m 68.36 48.79 0.84 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 0.0 110.011 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.8 -26.11 10.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.929 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -91.64 178.69 5.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.171 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.278 -179.965 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.702 ' CD1' HG13 ' A' ' 24' ' ' VAL . 73.8 m-85 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.102 0.477 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -130.36 118.03 20.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.033 -1.042 . . . . 0.0 110.137 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.24 121.36 26.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 110.142 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -54.76 123.31 45.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.097 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.18 162.4 41.78 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.897 1.472 . . . . 0.0 110.392 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -58.03 -25.87 61.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.61 -35.7 78.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.485 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.18 9.85 38.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -90.07 48.01 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -85.86 -17.29 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 5.2 p90 -90.45 -0.3 57.6 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.224 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 110.83 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.952 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.2 mm -81.7 -66.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 1.8 ptpp? -89.77 53.72 2.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.203 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -158.06 179.97 33.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.7 OUTLIER -133.01 171.86 13.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -1.129 . . . . 0.0 110.045 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 43.4 t -152.34 120.47 6.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.8 ttp85 -90.45 111.38 22.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.998 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.59 108.1 20.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.406 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.702 HG13 ' CD1' ' A' ' 5' ' ' PHE . 4.3 t -84.17 115.22 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.983 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ALA . 70.3 t -80.3 -60.42 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.8 -35.6 1.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.264 -0.897 . . . . 0.0 109.4 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -127.18 94.76 4.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.516 -0.74 . . . . 0.0 109.047 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -35.75 91.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.72 -0.612 . . . . 0.0 111.234 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 29' ' ' THR . 9.9 m -150.02 80.19 7.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.6 Cg_endo -77.6 89.86 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.067 1.561 . . . . 0.0 110.756 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.1 p -91.23 124.98 35.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.008 . . . . 0.0 109.811 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.7 p -114.88 110.15 19.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 0.0 110.752 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' ARG . 57.8 t -107.66 163.99 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.798 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.1 m -127.64 161.61 28.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.082 -1.011 . . . . 0.0 110.407 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.561 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.81 127.72 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 22.4 pt-20 -50.64 -43.27 57.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 110.316 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -89.17 42.09 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -113.87 171.18 7.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -1.115 . . . . 0.0 110.253 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 38' ' ' TYR . 45.9 mt -150.08 127.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.16 144.22 5.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.75 88.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -1.128 . . . . 0.0 110.315 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 20.3 mtt180 -98.74 13.67 31.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 16.4 m 60.33 58.71 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 12.5 pt-20 -108.0 -31.1 8.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.32 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 13.6 mtp-105 -99.13 160.86 13.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.235 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.153 0.501 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -134.42 124.01 24.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.249 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.06 128.78 34.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -73.3 135.03 79.54 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 159.1 47.34 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.42 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -58.52 -32.0 68.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -61.65 -33.86 74.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.73 -2.37 44.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 0.0 110.147 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -90.02 55.53 3.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 0.0 110.41 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -86.32 -16.41 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.956 -1.09 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.447 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.9 p90 -90.1 2.63 55.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.428 -0.795 . . . . 0.0 109.115 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -155.68 111.75 3.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 18.9 mm -78.05 -73.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 110.43 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -89.89 57.5 3.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.117 -0.99 . . . . 0.0 110.364 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.487 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.52 155.74 26.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -111.88 140.42 46.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 21.1 t -115.59 123.32 48.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.492 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.6 108.27 20.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.1 112.7 24.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 40.3 t -82.07 113.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.81 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 26' ' ' ALA . 43.0 t -76.04 -64.21 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.526 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.25 -51.86 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 109.666 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 tt0 -109.0 92.43 4.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 108.964 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.7 OUTLIER -35.55 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.596 . . . . 0.0 111.065 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 29' ' ' THR . 7.8 m -149.61 85.67 5.64 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.15 95.74 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.077 1.567 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.8 p -95.08 128.39 41.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 110.049 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.4 p -107.42 96.98 6.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.481 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -90.87 148.44 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.118 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 18.5 m -128.24 160.34 32.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 16.9 m-20 -57.97 120.46 8.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.92 -32.49 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.97 42.18 2.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -123.7 168.52 12.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -1.123 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.436 HG13 ' C ' ' A' ' 38' ' ' TYR . 61.6 mt -149.55 152.01 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.869 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.03 173.48 19.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -44.18 11.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -1.125 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.2 mtm180 -92.79 18.53 8.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 12.9 m 61.61 41.68 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.455 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.6 pp20? -98.72 -25.27 14.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 110.435 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -90.91 161.5 15.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.085 -1.009 . . . . 0.0 109.969 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.241 -179.938 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.799 ' HD1' HG13 ' A' ' 24' ' ' VAL . 25.3 m-85 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.268 0.556 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -138.78 131.16 28.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.857 . . . . 0.0 110.173 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 124.3 32.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 119.8 77.67 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 178.52 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.865 1.455 . . . . 0.0 110.488 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 4.3 mtpt -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.358 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -59.27 -19.41 45.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.155 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -117.81 -0.95 11.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.3 ttpt -90.05 51.79 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -86.54 -14.09 43.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.044 -1.035 . . . . 0.0 109.31 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.3 2.54 55.4 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.51 -0.744 . . . . 0.0 109.082 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -159.87 112.61 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.932 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 24.0 mt -66.03 -76.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.412 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -96.77 69.43 2.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.423 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.3 152.57 23.37 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -111.69 141.69 44.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.899 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.4 t -126.19 134.4 51.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.638 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' OG ' ' A' ' 31' ' ' SER . 10.6 mmt180 -101.96 120.12 39.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.81 116.19 32.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.267 -0.895 . . . . 0.0 110.34 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.85 ' HB ' HG22 ' A' ' 29' ' ' THR . 2.2 t -90.42 125.73 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.079 -1.013 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 39.6 t -79.54 -64.64 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 110.324 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.68 -49.84 4.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.161 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.73 ' O ' HG22 ' A' ' 29' ' ' THR . 0.5 OUTLIER -105.44 71.69 0.94 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -29.99 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.376 0.608 . . . . 0.0 111.322 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.85 HG22 ' HB ' ' A' ' 24' ' ' VAL . 9.8 t -149.94 105.77 3.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.86 91.62 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.061 1.559 . . . . 0.0 110.113 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 22' ' ' ARG . 89.0 p -90.14 101.7 14.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 110.034 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 26.3 p -90.08 131.65 35.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.445 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -130.62 135.23 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.926 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.7 m -102.2 160.94 14.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 38.0 m-20 -54.66 115.06 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.841 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.8 OUTLIER -41.59 -39.5 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.891 . . . . 0.0 110.488 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 46.95 3.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -127.36 172.83 10.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -1.155 . . . . 0.0 110.32 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.429 HG13 ' C ' ' A' ' 38' ' ' TYR . 56.8 mt -148.17 149.56 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.9 161.45 12.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -43.04 20.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.218 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mmm180 -93.04 15.32 15.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 8.7 m 64.38 39.72 6.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.338 -0.851 . . . . 0.0 110.428 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.22 -22.43 17.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.617 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -100.18 162.43 12.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.295 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.461 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 7.2 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.297 0.57 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.97 139.56 21.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.0 160.4 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 141.66 33.09 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 110.162 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.82 156.38 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.402 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -57.5 -30.28 64.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.385 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -35.32 78.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.951 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.497 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -96.11 0.29 51.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 47.63 1.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.442 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.29 -13.18 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 0.0 109.196 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.497 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.34 -0.67 57.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.514 -0.741 . . . . 0.0 109.38 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 122.16 3.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.8 mm -77.66 -78.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.999 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -89.85 52.99 2.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.057 -1.027 . . . . 0.0 110.29 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -142.26 137.72 8.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.94 134.92 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -1.169 . . . . 0.0 109.899 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.0 t -115.73 132.4 56.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.591 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -95.78 128.34 42.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.42 -0.8 . . . . 0.0 109.798 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -117.9 109.68 16.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.279 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.1 t -85.95 123.48 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.126 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.4 t -79.01 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.633 -0.667 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -50.23 3.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.397 -0.814 . . . . 0.0 109.525 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 38.0 tp10 -115.41 96.6 5.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.6 mm-40 -36.46 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 110.875 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 26.6 m -138.46 79.21 30.61 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.547 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.7 Cg_endo -78.54 80.58 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.207 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.9 p -90.22 132.45 35.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 29.7 p -106.65 128.04 53.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.8 122.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.353 -0.842 . . . . 0.0 110.199 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.7 m -89.16 159.11 17.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 7.0 m-20 -52.97 121.05 6.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -45.2 -40.85 7.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.86 3.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -122.05 170.19 10.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.17 . . . . 0.0 110.279 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' TYR . 56.6 mt -149.37 160.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.153 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.08 175.85 21.45 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.92 -44.94 10.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 3.2 ttm-85 -100.59 25.71 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.7 m 63.69 50.88 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.85 -34.68 8.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.607 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 164.46 14.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.504 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.883 . . . . 0.0 110.031 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.54 ' HD1' HG13 ' A' ' 24' ' ' VAL . 55.1 m-85 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.8 m -149.9 139.08 21.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.873 . . . . 0.0 110.232 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -93.21 147.77 22.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.309 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 56.8 m -89.93 109.36 32.13 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 47.4 Cg_endo -73.38 175.62 10.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.915 1.482 . . . . 0.0 110.46 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.1 ptmt -67.54 -26.16 66.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.03 14.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.502 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.52 13.9 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.982 . . . . 0.0 110.403 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 25.7 mtpt -90.04 47.2 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -85.61 -20.78 28.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.013 -1.055 . . . . 0.0 109.231 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 4.7 p90 -90.58 1.29 56.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.114 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -160.27 91.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 23.9 mm -54.13 -81.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.18 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -91.27 68.87 5.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.07 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.16 142.41 8.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 133.45 42.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.331 -1.1 . . . . 0.0 109.821 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.446 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 9.3 t -125.67 138.81 53.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.674 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.16 133.36 53.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.7 113.95 24.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 110.589 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.54 HG13 ' HD1' ' A' ' 5' ' ' PHE . 5.1 t -88.23 115.84 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.0 t -79.85 -59.62 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 110.349 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.84 -36.03 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 109.421 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -128.53 93.11 3.56 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.9 mt-30 -34.45 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.236 0.541 . . . . 0.0 111.239 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 53.8 m -146.8 84.28 7.65 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.368 -0.832 . . . . 0.0 110.376 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.84 96.05 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.122 1.591 . . . . 0.0 110.263 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.7 t -99.07 132.42 44.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.907 . . . . 0.0 110.259 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 30.6 p -118.75 124.41 47.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.53 117.93 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 26.0 m -92.41 163.21 13.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -49.71 126.41 13.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.35 -43.01 33.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 44.31 2.93 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -116.32 165.86 12.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -1.193 . . . . 0.0 110.249 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 39.7 mt -146.94 165.1 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.418 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 105.63 154.71 21.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.37 -13.61 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -1.208 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 29.2 mtt180 -120.9 16.65 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 8.7 m 64.16 27.8 14.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.212 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.69 -7.71 39.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.411 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.46 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -107.65 158.85 16.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.414 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.456 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 13.2 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.022 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.853 ' CD1' HG13 ' A' ' 24' ' ' VAL . 44.9 m-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.226 0.536 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.53 151.69 38.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.84 133.33 52.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.912 . . . . 0.0 110.32 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 142.88 98.41 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.3 Cg_endo -73.55 167.35 27.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.052 1.554 . . . . 0.0 110.469 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -31.82 73.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -21.96 66.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.475 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.35 6.64 35.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 52.82 2.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.445 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -86.14 -14.83 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.99 -1.069 . . . . 0.0 109.171 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.5 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.35 -2.25 57.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.293 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 4.0 m -160.18 103.63 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 62.5 mt -55.37 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 0.0 109.904 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -93.55 66.68 3.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.908 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -155.96 147.45 16.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.4 mtt85 -105.62 135.93 46.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.975 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.5 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.5 t -108.38 132.85 53.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.513 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -97.83 105.57 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -97.15 112.2 24.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.387 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.853 HG13 ' CD1' ' A' ' 5' ' ' PHE . 23.9 t -85.52 117.43 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ALA . 8.3 t -77.88 -63.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.92 -56.12 2.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.5 tp10 -103.89 91.33 3.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.017 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.1 tp-100 -34.95 91.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.766 -0.583 . . . . 0.0 111.151 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' GLU . 58.0 m -148.23 82.78 7.48 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.3 Cg_endo -76.44 93.13 1.05 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.02 1.537 . . . . 0.0 110.355 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.7 t -101.27 141.19 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.2 p -110.89 134.05 52.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.338 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.09 120.75 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 110.061 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 27.0 m -87.63 159.89 18.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.467 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -47.58 120.06 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -44.78 -44.8 9.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.456 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 47.04 3.15 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -121.75 171.03 9.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 110.252 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.506 ' CG2' ' HD2' ' A' ' 45' ' ' ARG . 27.0 mt -149.66 146.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.89 169.41 14.41 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.8 -40.72 13.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.1 mtt180 -93.49 9.69 35.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.118 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.5 m 66.84 56.75 0.68 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 0.0 110.157 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.14 -25.7 8.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.421 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.506 ' HD2' ' CG2' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -89.61 151.2 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 110.203 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 110.063 179.878 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.332 0.587 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.95 140.01 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -86.35 150.23 24.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 6.7 m -83.9 127.1 68.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 163.65 36.98 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.891 1.469 . . . . 0.0 110.53 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 1.4 pttp -63.02 -29.95 71.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.131 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.42 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -62.46 -25.9 68.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.86 . . . . 0.0 110.32 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.411 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.6 m-85 -114.03 8.31 17.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -90.32 49.75 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.091 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.28 -11.43 52.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 0.0 109.472 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 12.6 p90 -87.18 -9.56 54.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.51 127.38 4.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 110.073 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 25.6 mt -86.98 -65.0 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CG ' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -90.14 50.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 0.0 110.425 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -158.98 137.3 5.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -89.71 -179.8 5.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -1.118 . . . . 0.0 109.575 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.487 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 12.9 t -160.19 125.95 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.898 -1.126 . . . . 0.0 110.892 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.31 114.07 26.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -96.87 111.48 23.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.451 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 10.4 t -84.0 118.02 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 9.6 t -74.04 -66.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.69 -62.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.4 tp10 -98.18 88.46 4.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.336 -0.853 . . . . 0.0 108.983 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.5 mm-40 -34.64 92.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.348 0.594 . . . . 0.0 110.968 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 29' ' ' THR . 13.8 m -144.22 83.62 9.96 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 110.556 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -77.97 84.43 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.094 1.576 . . . . 0.0 110.451 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -89.92 134.42 34.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.92 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 7.7 t -114.35 119.27 36.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 110.609 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 t -103.85 115.11 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.803 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.522 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 19.3 m -88.46 158.08 18.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -53.3 125.18 16.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.891 . . . . 0.0 110.032 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' ASP . 3.0 mm-40 -42.64 -45.97 4.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.429 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -90.45 49.35 3.18 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.683 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -117.81 158.81 24.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.265 . . . . 0.0 110.518 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 38' ' ' TYR . 33.5 mm -142.47 150.46 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.16 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.36 170.35 14.87 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.56 -48.11 11.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -1.146 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mtm105 -98.18 23.69 7.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.254 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.534 ' HB3' ' CG ' ' A' ' 18' ' ' LYS . 20.2 m 61.04 76.22 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.135 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -40.16 2.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 110.379 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -97.39 179.8 4.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 110.262 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 37' ' ' GLY . 2.8 p . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 110.232 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.733 ' CD1' HG13 ' A' ' 24' ' ' VAL . 50.0 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.223 0.535 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.81 121.54 41.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 110.308 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.96 132.53 35.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.104 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 131.2 79.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.124 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.439 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 46.7 Cg_endo -73.31 173.04 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.956 1.503 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 10.0 mttm -67.63 -34.04 76.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.54 -8.68 35.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.432 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -116.1 -0.72 12.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.15 62.2 5.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -85.55 -21.05 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.089 . . . . 0.0 109.278 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 7.1 p90 -90.34 -2.18 57.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.105 178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.67 126.95 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.3 mm -89.04 -69.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.991 -1.068 . . . . 0.0 109.759 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' CD ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -93.12 63.63 3.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.158 -0.964 . . . . 0.0 110.054 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.436 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -155.32 143.67 10.15 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -101.38 124.79 47.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.206 . . . . 0.0 110.281 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.1 t -114.87 127.96 56.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 0.0 110.492 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -103.76 120.69 41.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -103.94 113.89 27.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.733 HG13 ' CD1' ' A' ' 5' ' ' PHE . 3.4 t -82.51 119.15 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.7 t -79.0 -64.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.678 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.34 -45.46 2.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -117.4 92.05 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -34.69 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.772 -0.58 . . . . 0.0 110.943 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.8 m -143.52 85.84 9.19 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.247 -0.908 . . . . 0.0 110.552 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.86 114.48 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.568 . . . . 0.0 110.533 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.448 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 17.6 m -119.03 126.38 51.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -0.91 . . . . 0.0 109.85 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 23.7 p -116.06 103.87 11.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.931 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.99 132.51 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.499 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 21.7 m -102.19 157.35 16.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -52.64 116.9 2.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 110.104 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.5 mm-40 -41.82 -48.19 4.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.373 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 50.74 3.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.545 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -121.64 171.6 8.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.098 -1.237 . . . . 0.0 110.361 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.545 HD12 ' C ' ' A' ' 38' ' ' TYR . 3.6 mp -147.19 138.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 110.135 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.14 159.17 9.45 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.69 -48.51 25.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.1 mtt180 -98.33 21.4 11.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.189 -0.944 . . . . 0.0 110.118 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.517 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 6.3 m 64.64 61.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -101.41 -31.19 11.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.134 -0.979 . . . . 0.0 110.62 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -108.37 163.54 13.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.456 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.511 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 10.2 p . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 110.057 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.857 ' CD1' HG13 ' A' ' 24' ' ' VAL . 72.7 m-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.977 0.418 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.42 129.23 26.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.986 -1.071 . . . . 0.0 110.253 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -86.09 142.12 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 110.17 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 4.0 m -78.61 126.95 81.9 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 110.074 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.6 Cg_endo -74.21 148.33 38.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.887 1.467 . . . . 0.0 110.409 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.2 ttpt -58.93 -29.93 67.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -61.44 -34.18 74.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.364 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.462 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 10.9 m-85 -101.43 7.09 42.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.31 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 2.2 mttt -86.16 60.98 6.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.082 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -85.69 -19.11 31.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.004 -1.06 . . . . 0.0 109.31 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.0 p90 -90.72 -1.95 57.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.45 -0.781 . . . . 0.0 109.187 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.3 106.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.1 mm -81.63 -64.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.219 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.82 49.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.314 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -152.58 175.85 31.01 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.1 157.18 33.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -1.05 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 43.6 t -141.41 119.51 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -95.97 109.5 21.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 109.862 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -96.82 105.53 17.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.466 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.857 HG13 ' CD1' ' A' ' 5' ' ' PHE . 57.6 t -84.49 114.6 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' ALA . 59.9 t -72.9 -59.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -65.77 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 109.415 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 tp10 -95.67 93.24 7.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 27' ' ' GLU . 4.8 mp0 -34.67 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.346 0.593 . . . . 0.0 111.151 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.702 HG22 ' O ' ' A' ' 29' ' ' THR . 4.5 m -147.0 78.98 10.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.454 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.2 Cg_endo -79.39 86.03 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.093 1.575 . . . . 0.0 110.279 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.4 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 t -90.53 133.4 35.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -129.33 101.65 6.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.31 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 34' ' ' CYS . 88.7 t -103.97 166.6 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.298 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' N ' HG12 ' A' ' 33' ' ' VAL . 34.1 m -112.88 164.33 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.306 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.531 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.9 m-20 -64.63 117.38 7.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.367 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -44.47 -41.45 6.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.12 46.07 3.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.38 175.74 7.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -1.171 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 37.5 mt -146.44 152.1 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.055 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.58 161.29 19.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.8 -49.52 12.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 21.1 mmt-85 -90.25 15.65 10.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.981 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 4.2 m 67.7 50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.801 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -101.27 0.22 36.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.493 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.28 164.05 23.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.384 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.087 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.247 0.546 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.7 m -136.61 130.43 32.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.983 . . . . 0.0 110.312 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.65 124.25 31.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -52.39 129.3 42.7 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.119 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.2 155.71 51.67 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.98 1.516 . . . . 0.0 110.388 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -59.97 -25.1 64.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -63.17 -33.08 74.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.248 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.548 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 m-85 -103.61 10.37 36.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -90.05 43.29 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -86.13 -13.71 46.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.41 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.45 2.59 55.52 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.763 . . . . 0.0 109.185 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -157.41 125.5 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.136 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 35.7 mm -83.02 -81.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.409 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.8 OUTLIER -89.69 57.47 3.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.134 -0.979 . . . . 0.0 110.268 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -149.04 160.08 28.27 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 20.9 ptt180 -116.81 139.23 50.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -1.087 . . . . 0.0 109.694 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.507 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.2 t -114.31 135.3 54.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.791 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 ttp85 -97.96 124.0 42.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.5 t80 -112.09 110.78 21.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.566 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 12.5 t -90.12 123.01 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.926 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 97.1 t -83.06 -56.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.69 -29.79 0.1 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 0.0 109.648 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.6 mt-10 -141.41 96.53 3.0 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.5 mt-30 -33.6 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.212 0.529 . . . . 0.0 111.301 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' GLU . 91.0 m -140.64 83.15 15.03 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.308 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.0 Cg_endo -82.4 83.84 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.174 1.618 . . . . 0.0 110.409 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.403 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 26.8 t -89.82 134.05 34.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.9 p -101.68 132.38 47.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 3.5 t -126.96 151.23 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.332 -0.855 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 19.5 m -123.47 162.0 23.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 110.388 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -57.66 121.05 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.206 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -44.39 -38.95 4.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.168 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 46.05 3.06 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.33 163.92 20.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -1.157 . . . . 0.0 110.187 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.9 mt -137.41 160.46 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.18 166.95 31.49 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.51 -35.88 16.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -91.55 7.2 42.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.14 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.9 m 69.25 44.68 0.94 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.404 -0.81 . . . . 0.0 110.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -100.28 -25.64 14.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.477 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 3.2 mmt180 -92.41 163.49 13.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.526 ' CD1' HG13 ' A' ' 24' ' ' VAL . 52.7 m-85 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.166 0.508 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 m -119.07 135.19 54.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.171 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.12 109.11 21.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.305 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -48.61 120.35 8.84 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 43.4 Cg_endo -70.67 175.57 8.68 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.858 1.451 . . . . 0.0 110.525 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -60.27 -41.6 93.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.551 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.98 -19.6 66.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.441 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.467 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -99.98 -9.37 22.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.193 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 2.1 ttpt -87.82 57.55 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 110.145 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -85.76 -17.4 35.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 6.3 p90 -89.98 -2.53 58.16 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.147 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.36 127.75 4.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 45.5 mt -82.23 -74.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 110.424 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -89.78 64.43 6.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 0.0 110.471 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HD2' ' A' ' 13' ' ' LYS . . . -160.15 133.19 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -95.48 132.75 40.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -1.167 . . . . 0.0 109.765 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 32.1 t -118.75 132.31 56.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.004 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -98.15 124.02 42.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -111.89 112.81 24.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 110.498 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 5' ' ' PHE . 11.6 t -84.72 117.36 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.202 -0.936 . . . . 0.0 109.975 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.4 t -80.86 -63.05 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 110.436 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.17 -39.43 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.613 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -123.0 92.37 3.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -35.04 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.21 0.529 . . . . 0.0 111.077 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 29' ' ' THR . 3.8 m -148.25 83.37 7.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.233 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.8 Cg_endo -82.79 132.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.145 1.603 . . . . 0.0 110.431 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 p -148.81 118.13 6.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.863 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 12.1 t -95.83 153.88 17.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.645 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -139.57 121.6 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.491 -0.756 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.6 m -96.94 158.22 15.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -49.51 128.47 17.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -46.5 -47.4 19.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.331 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.14 45.4 3.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.595 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -113.28 163.86 14.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -1.191 . . . . 0.0 110.1 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 31.6 mm -138.76 153.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.97 144.97 11.97 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -34.27 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -1.109 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.454 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.0 mtt180 -93.76 4.86 53.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.18 43.89 1.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.99 -13.14 15.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.465 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -109.51 166.99 10.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.864 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.542 ' HD1' HG13 ' A' ' 24' ' ' VAL . 76.1 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.223 0.535 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m -138.35 137.54 37.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -100.3 113.94 27.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 124.95 78.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.176 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.42 178.03 7.18 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.859 1.452 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -65.98 -25.65 67.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -19.91 66.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 4.3 m-85 -110.92 11.06 22.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 110.207 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 34.2 mmtm -88.93 47.6 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -85.49 -23.15 27.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.993 -1.067 . . . . 0.0 108.918 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.9 p90 -90.39 -0.76 57.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -160.68 116.19 2.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 109.901 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 32.6 mt -76.65 -63.97 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -104.36 73.8 1.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.098 -1.001 . . . . 0.0 110.417 179.764 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.31 178.27 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 1.7 mtt180 -131.15 119.89 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.164 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 15.1 t -107.09 132.3 53.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -104.64 120.8 42.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 109.993 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -104.49 106.72 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.477 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG13 ' HD1' ' A' ' 5' ' ' PHE . 24.2 t -81.58 119.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.13 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 26' ' ' ALA . 25.7 t -80.75 -62.99 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.499 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.3 -49.74 2.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.4 -0.812 . . . . 0.0 109.749 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 5.4 mt-10 -113.32 91.95 3.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.48 -0.763 . . . . 0.0 109.0 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -33.54 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.273 0.559 . . . . 0.0 111.322 -179.075 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 41.0 m -147.92 82.71 7.72 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.6 Cg_endo -77.03 86.69 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.113 1.586 . . . . 0.0 110.352 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.65 143.85 26.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 109.791 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 20.2 p -124.03 132.5 53.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 34' ' ' CYS . 58.6 t -125.45 169.68 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 109.801 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.3 m -140.67 162.32 35.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.39 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.555 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.4 m-20 -49.22 123.67 7.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -47.86 -45.79 30.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.71 3.02 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.816 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -115.44 174.0 6.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 110.217 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.816 HD12 ' C ' ' A' ' 38' ' ' TYR . 4.2 mp -150.48 147.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.141 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.99 152.97 10.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.44 -30.91 57.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -1.104 . . . . 0.0 109.975 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.16 5.33 44.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 3.9 m 68.92 66.3 0.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 -30.88 2.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.002 -1.061 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -95.97 107.07 19.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.963 -1.086 . . . . 0.0 110.506 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.524 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 12.2 p . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 110.447 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.604 ' CD1' HG13 ' A' ' 24' ' ' VAL . 25.2 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.329 0.585 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.62 134.67 47.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HG2' ' NH1' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -90.56 133.32 35.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.139 179.926 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -73.99 152.8 88.76 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -72.63 158.06 51.34 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.005 1.529 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -26.78 65.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -6.22 26.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.491 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -120.02 4.95 10.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.349 179.964 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.523 ' NZ ' ' OH ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -81.48 75.16 8.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -85.25 -25.45 27.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.018 -1.051 . . . . 0.0 109.407 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.523 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 3.3 p90 -90.45 2.97 55.15 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.95 178.065 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 1.7 m -160.81 119.77 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 43.1 mm -75.52 -71.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -99.95 68.82 1.51 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.256 179.768 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -159.97 141.25 7.32 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.9 ptp180 -96.37 143.57 27.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -1.13 . . . . 0.0 109.878 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 31' ' ' SER . 10.4 t -123.22 125.25 44.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.448 ' CZ ' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -94.5 117.75 30.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.901 179.625 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.93 112.71 25.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.322 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.604 HG13 ' CD1' ' A' ' 5' ' ' PHE . 9.0 t -85.55 119.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.134 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 58.1 t -77.41 -67.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 110.382 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.76 -45.98 3.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.423 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.8 tt0 -112.53 86.94 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.314 0.578 . . . . 0.0 110.992 -179.164 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 80.9 m -145.01 85.76 8.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.0 Cg_endo -76.39 84.44 1.85 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.033 1.544 . . . . 0.0 110.146 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 68.1 m -90.09 128.39 36.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.258 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 24.7 p -107.23 97.05 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' ARG . 98.4 t -89.63 120.78 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.023 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -86.94 157.71 19.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -48.75 118.33 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.129 179.934 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -45.93 -41.27 11.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 110.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.96 43.04 2.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -120.41 176.3 5.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 21.9 mt -150.33 136.94 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.41 166.15 12.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.77 -38.43 18.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -1.081 . . . . 0.0 110.05 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -99.34 17.55 19.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.002 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 8.2 m 63.62 43.65 5.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.1 tt0 -93.7 -32.7 13.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.492 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -95.07 158.9 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.01 . . . . 0.0 110.199 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.47 ' HB ' ' HD3' ' A' ' 18' ' ' LYS . 7.3 p . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.274 0.559 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.31 143.78 34.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 142.32 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.78 137.31 92.67 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.68 164.39 35.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.046 1.551 . . . . 0.0 110.382 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -62.61 -30.98 71.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 110.24 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -66.45 -19.96 65.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.358 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -109.94 5.64 22.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.88 50.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 110.035 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -86.15 -17.55 34.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 109.115 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -91.15 0.57 57.5 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.069 178.169 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.43 98.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.6 mt -65.69 -73.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.953 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ptpm? -89.61 52.78 2.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -0.924 . . . . 0.0 110.12 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -148.66 165.96 29.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -123.35 130.28 52.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -1.187 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.468 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.3 t -118.27 128.1 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.447 -179.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.81 139.66 30.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 110.02 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -117.56 110.87 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 27' ' ' GLU . 63.9 t -82.02 116.88 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -78.7 -63.88 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.652 -0.655 . . . . 0.0 110.221 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.26 -49.6 5.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -111.35 90.21 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.914 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.8 tt0 -35.45 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.238 0.542 . . . . 0.0 111.041 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' GLU . 18.0 m -148.36 86.96 5.79 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.892 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.02 93.47 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.093 1.575 . . . . 0.0 110.5 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 p -93.29 124.3 37.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 31.3 p -105.93 128.0 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.78 158.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 110.109 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 13.1 m -125.41 159.2 32.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 110.33 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -52.99 118.61 3.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 35' ' ' ASP . 43.3 mm-40 -42.44 -40.94 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.96 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.05 47.48 3.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -125.0 172.47 9.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -1.203 . . . . 0.0 110.281 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 41.9 mt -146.52 140.89 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.22 160.88 11.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 -40.49 22.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.117 . . . . 0.0 110.23 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 6.2 mpt_? -93.25 9.65 35.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.131 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.49 47.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -0.843 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 8.7 tt0 -104.17 -18.23 14.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -101.18 156.2 17.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.834 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.372 -179.865 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.158 0.504 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -119.91 128.46 53.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.419 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -83.37 141.78 31.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.033 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -84.08 129.97 56.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.946 . . . . 0.0 110.177 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.18 157.47 50.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.93 1.49 . . . . 0.0 110.29 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -18.33 64.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -65.18 -19.19 65.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -119.76 21.1 12.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.201 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.29 50.25 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.883 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -86.11 -16.85 36.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.053 . . . . 0.0 109.313 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 3.5 p90 -90.4 4.2 51.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.237 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -158.74 109.25 2.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.21 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.479 ' HA ' HD13 ' A' ' 17' ' ' ILE . 10.6 mm -64.3 -70.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 7.9 ptmm? -105.73 55.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -146.83 150.8 23.11 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 179.42 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 0.0 109.856 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 8.4 t -154.73 132.9 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.443 ' HD3' ' CG2' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -107.9 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 109.803 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.89 110.6 22.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.583 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.443 ' CG2' ' HD3' ' A' ' 22' ' ' ARG . 48.3 t -84.43 111.86 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 26' ' ' ALA . 37.7 t -74.09 -59.83 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.667 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.34 -59.51 1.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.466 -0.771 . . . . 0.0 109.499 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 63.1 mt-10 -104.0 92.45 4.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 108.97 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.1 tt0 -33.62 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.811 -0.556 . . . . 0.0 111.153 -179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 19.2 m -149.42 88.49 4.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.35 91.75 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.024 1.539 . . . . 0.0 110.396 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.435 ' OG ' ' HD2' ' A' ' 22' ' ' ARG . 2.3 p -90.06 148.82 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.841 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -135.13 116.43 14.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.701 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.06 157.18 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 19.3 m -122.44 161.3 23.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.357 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.2 m-20 -49.64 124.43 9.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -47.05 -41.65 17.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 110.258 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 43.29 2.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -117.04 168.27 10.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -1.19 . . . . 0.0 110.257 179.82 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 38' ' ' TYR . 48.8 mt -150.37 156.92 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.24 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.64 162.02 18.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.74 -28.77 30.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -105.69 17.57 23.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.493 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 16.7 m 61.68 35.69 16.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -100.29 -17.0 17.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.4 170.18 8.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.057 179.873 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.695 ' CD1' HG13 ' A' ' 24' ' ' VAL . 39.9 m-85 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.305 0.574 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -124.44 125.21 43.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.198 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.71 118.73 23.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 124.37 83.57 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.053 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.19 160.99 45.86 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.312 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -51.52 -24.03 4.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.35 -45.35 93.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 110.308 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.539 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.6 m-85 -94.24 10.56 33.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 37.8 mttt -84.93 46.63 1.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -86.21 -13.93 45.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.407 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 7.8 p90 -90.53 -5.13 56.35 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.089 178.29 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.03 132.58 10.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -0.918 . . . . 0.0 110.372 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 30.7 mm -80.35 -71.89 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.942 . . . . 0.0 110.141 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -101.77 69.11 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 0.0 110.303 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -155.36 159.35 29.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.427 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.39 140.68 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -1.155 . . . . 0.0 109.945 179.833 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -116.29 138.2 51.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -110.1 104.0 12.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.79 113.14 24.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.376 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.695 HG13 ' CD1' ' A' ' 5' ' ' PHE . 7.1 t -86.12 121.45 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.879 . . . . 0.0 109.933 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -74.86 -62.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.619 -0.675 . . . . 0.0 110.524 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.26 -66.98 0.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' THR . 26.3 mt-10 -97.95 92.15 5.66 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 108.893 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -33.62 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.289 0.566 . . . . 0.0 110.993 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.9 m -137.4 80.92 32.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.485 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.588 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.1 Cg_endo -74.48 83.09 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.111 1.585 . . . . 0.0 110.042 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 t -90.16 145.74 24.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.328 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.16 145.59 45.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.911 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 76.5 t -143.21 153.54 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 109.888 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 15.5 m -125.45 157.58 36.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.975 . . . . 0.0 110.353 -179.692 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 19.4 m-20 -51.92 118.65 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 3.6 tp10 -43.24 -37.2 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.962 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 45.86 3.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.86 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -125.17 160.93 27.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -1.151 . . . . 0.0 110.297 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 38' ' ' TYR . 19.3 mm -142.7 158.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 109.923 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.12 174.77 19.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.37 -47.68 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -1.145 . . . . 0.0 110.35 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -90.01 18.78 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.175 -179.894 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.6 m 62.65 38.11 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -98.46 -13.71 20.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.255 -0.903 . . . . 0.0 110.326 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -103.38 169.94 8.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 8.0 p . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 110.347 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.714 ' CD1' HG22 ' A' ' 24' ' ' VAL . 64.8 m-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.197 0.523 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.5 m -130.71 130.12 43.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 150.54 24.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 119.66 69.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.43 ' C ' ' HE3' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -72.72 173.91 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.809 1.426 . . . . 0.0 110.446 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.461 ' N ' ' HE3' ' A' ' 13' ' ' LYS . 17.0 mttm -66.52 -24.89 66.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 0.0 110.381 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.65 -10.96 30.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.295 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.526 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 12.5 m-85 -129.2 10.9 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.304 -0.873 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HE3' ' N ' ' A' ' 10' ' ' LYS . 19.0 mttt -86.21 45.96 1.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.227 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.28 -14.4 43.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.046 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.04 -1.06 57.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 178.38 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 1.8 m -160.28 129.25 4.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.035 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 5.0 mt -87.42 -63.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.074 -1.016 . . . . 0.0 110.108 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.527 ' HE3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -103.11 60.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.257 179.574 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.17 162.38 33.17 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -107.57 -178.83 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -1.19 . . . . 0.0 110.031 179.86 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -160.46 126.91 4.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -104.41 115.43 30.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -100.06 116.03 31.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.542 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.714 HG22 ' CD1' ' A' ' 5' ' ' PHE . 52.6 t -87.26 115.56 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.97 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.6 t -75.36 -61.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.19 -62.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.607 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -99.82 93.18 5.66 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 108.927 178.767 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.1 pt20 -34.92 91.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.74 -0.6 . . . . 0.0 111.143 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 9.0 m -146.19 86.22 7.12 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -76.42 98.08 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.067 1.561 . . . . 0.0 110.643 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 m -100.41 138.98 36.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.6 p -121.14 110.72 16.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.143 -0.973 . . . . 0.0 110.628 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ARG . 60.8 t -93.91 155.32 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.0 109.886 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.608 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 7.1 m -127.92 157.3 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.222 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.526 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 1.4 m-20 -48.76 125.76 10.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.55 -47.21 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 110.085 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.26 46.26 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.79 175.32 5.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -1.169 . . . . 0.0 110.328 -179.952 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 38' ' ' TYR . 3.5 mp -145.05 130.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.82 155.51 9.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.51 -41.04 40.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -1.179 . . . . 0.0 110.208 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 9.6 mtp180 -89.59 7.68 35.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.513 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 6.7 m 64.2 72.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.799 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.48 ' CA ' ' HD3' ' A' ' 18' ' ' LYS . 7.0 pt-20 -119.65 -25.09 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.658 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.438 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -112.49 95.15 5.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.787 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.527 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 14.9 p . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.813 ' CD1' HG13 ' A' ' 24' ' ' VAL . 86.8 m-85 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 120.928 0.395 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.54 146.67 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.933 -1.104 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -79.98 154.46 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -81.93 136.32 47.61 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.68 156.54 49.0 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.986 1.519 . . . . 0.0 110.426 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 13' ' ' LYS . 9.9 ttpt -63.22 -27.86 69.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -20.5 27.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 110.271 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.5 m-85 -125.4 6.38 7.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -86.5 39.62 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.054 179.759 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -86.13 -12.48 49.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.04 -1.037 . . . . 0.0 109.604 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.6 p90 -90.12 1.56 56.26 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.457 -0.777 . . . . 0.0 109.288 178.648 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -159.67 109.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 46.5 mm -70.14 -74.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -96.28 60.39 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.973 -1.079 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -148.39 141.99 9.6 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.7 45.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -1.166 . . . . 0.0 110.155 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 8.5 t -113.94 126.5 55.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.428 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.12 111.75 23.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 110.032 179.704 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -96.01 112.67 24.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.0 110.552 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.813 HG13 ' CD1' ' A' ' 5' ' ' PHE . 38.5 t -86.58 115.73 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.95 . . . . 0.0 109.976 179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 26' ' ' ALA . 62.5 t -73.08 -60.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.573 -0.704 . . . . 0.0 110.494 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.84 -66.73 0.3 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.1 tp10 -99.13 93.67 6.1 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.894 178.645 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tt0 -34.51 91.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.761 -0.587 . . . . 0.0 111.141 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' GLU . 39.6 m -143.71 84.19 10.06 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.7 Cg_endo -77.35 89.22 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.076 1.566 . . . . 0.0 110.446 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.432 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 78.4 p -89.76 131.5 35.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.069 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 23.5 p -113.91 108.5 17.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.628 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -109.66 130.39 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.969 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.1 m -94.35 162.28 13.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.185 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 18.1 m-20 -56.91 117.68 4.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.72 -38.01 2.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.55 45.7 3.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -126.49 171.06 11.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -1.14 . . . . 0.0 110.282 -179.959 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 2.3 mp -147.39 150.56 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 167.83 16.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.53 -37.41 16.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 46.5 mtt180 -96.55 18.72 13.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.038 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.498 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 12.1 m 61.42 41.1 13.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -93.98 -37.3 11.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 110.671 -179.597 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -85.44 163.99 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.256 -179.729 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.23 -179.879 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.573 ' CD1' HG13 ' A' ' 24' ' ' VAL . 81.0 m-85 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.53 133.43 22.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -96.31 152.0 18.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.877 . . . . 0.0 110.382 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' O ' ' CE ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.13 134.05 32.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.163 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.3 Cg_endo -74.12 161.53 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.866 1.456 . . . . 0.0 110.425 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -31.54 72.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -64.09 -12.22 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 110.328 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.406 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -119.68 -3.23 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.143 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.517 ' CE ' ' O ' ' A' ' 8' ' ' CYS . 18.1 mttt -84.38 62.82 7.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.322 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -85.67 -19.56 30.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.911 -1.118 . . . . 0.0 109.246 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.8 p90 -90.39 -2.9 57.99 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.046 178.253 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.68 106.72 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.607 HG22 ' HD2' ' A' ' 18' ' ' LYS . 18.2 mm -78.53 -62.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.112 -0.993 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HD2' HG22 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -90.4 57.37 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 110.374 -179.834 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' A' ' 13' ' ' LYS . . . -160.05 152.53 23.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -108.56 120.92 43.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -1.122 . . . . 0.0 109.993 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.0 t -99.97 128.71 46.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.653 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -100.5 109.73 21.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 109.718 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.96 104.75 16.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.573 HG13 ' CD1' ' A' ' 5' ' ' PHE . 21.0 t -80.66 120.93 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.071 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.3 t -76.67 -71.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 110.382 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.08 -47.36 4.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.4 tt0 -108.7 81.79 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -33.8 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.391 0.615 . . . . 0.0 111.105 -179.114 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 79.7 m -143.77 82.62 11.09 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.39 84.55 2.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.437 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 23.4 m -93.0 151.52 19.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.144 -0.972 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 31.5 p -127.44 127.88 44.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -116.76 148.54 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 70.6 m -116.41 144.52 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-20 -56.36 119.15 5.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.75 -37.98 4.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 45.02 2.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.27 172.23 9.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -1.163 . . . . 0.0 110.313 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.0 mt -150.0 157.49 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.122 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.65 154.6 20.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -42.15 55.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.031 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -90.05 8.46 32.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.886 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.465 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 4.4 m 68.73 43.41 1.28 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 109.996 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -101.84 -22.28 14.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.309 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -95.52 169.7 9.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.262 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.934 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.499 ' HD1' HG13 ' A' ' 24' ' ' VAL . 37.7 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.226 0.536 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -132.79 130.12 39.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.156 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.46 130.73 34.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 127.05 90.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.277 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.76 167.48 27.1 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.921 1.485 . . . . 0.0 110.458 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.491 ' HG2' ' HE2' ' A' ' 13' ' ' LYS . 5.4 mttt -66.16 -27.24 67.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.186 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -20.44 49.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.238 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -123.71 2.68 8.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HE2' ' HG2' ' A' ' 10' ' ' LYS . 5.1 ttpt -87.03 54.75 3.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -86.33 -15.02 41.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.097 -1.002 . . . . 0.0 109.309 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.5 p90 -90.2 1.93 55.93 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.524 -0.735 . . . . 0.0 109.128 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' HA ' ' SG ' ' A' ' 43' ' ' CYS . 1.5 m -157.42 79.12 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.834 . . . . 0.0 109.999 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 44' ' ' GLU . 83.7 mt -48.7 -55.15 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.427 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 5.9 ptmm? -112.24 60.95 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.478 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -157.49 141.24 7.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 123.51 40.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -1.113 . . . . 0.0 109.936 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 31' ' ' SER . 11.0 t -111.0 127.68 55.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.111 -0.993 . . . . 0.0 110.587 -179.595 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.61 119.39 34.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.868 . . . . 0.0 109.822 179.604 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.31 106.16 17.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 21.3 t -80.24 118.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' ALA . 73.1 t -80.28 -58.44 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.703 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.49 -50.73 3.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 mt-10 -116.06 96.6 5.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.879 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.3 tp-100 -34.84 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.78 -0.575 . . . . 0.0 111.201 -179.089 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 29' ' ' THR . 3.9 m -146.17 82.66 8.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.253 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.438 ' HD3' ' OE1' ' A' ' 28' ' ' GLN . 51.1 Cg_endo -79.56 89.06 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.108 1.583 . . . . 0.0 110.43 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -94.65 131.15 40.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.993 179.83 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 27.4 p -113.87 114.38 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.2 129.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.848 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 8.3 m -101.85 161.76 13.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.126 -0.984 . . . . 0.0 110.42 -179.388 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 63.0 m-20 -58.85 119.8 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 37' ' ' GLY . 10.3 pt-20 -43.9 -33.43 1.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' N ' ' HG3' ' A' ' 36' ' ' GLU . . . -90.28 43.83 2.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -126.24 170.65 11.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -1.2 . . . . 0.0 110.414 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 29.3 mt -150.15 151.7 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.64 169.57 17.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -40.82 13.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 110.237 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.8 mpt_? -91.02 10.9 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 6.3 m 66.54 41.45 3.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.872 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HB3' HD12 ' A' ' 17' ' ' ILE . 5.6 pt-20 -100.11 -28.29 13.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -84.88 163.24 19.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.231 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.4 p . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.27 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.102 0.477 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -147.28 134.89 20.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 110.292 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -91.0 126.69 36.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.64 133.95 95.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.8 164.97 34.06 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.943 1.497 . . . . 0.0 110.432 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -66.36 -26.65 67.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.263 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -8.65 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 7.65 5.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 0.0 110.227 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -89.94 46.27 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.32 -11.81 51.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.534 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.41 0.93 57.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.187 178.421 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.9 m -159.54 123.63 3.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 44' ' ' GLU . 57.8 mt -75.38 -76.52 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -98.72 65.06 1.53 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 0.0 110.814 -179.615 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -152.87 148.36 19.09 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -101.9 132.7 47.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.13 . . . . 0.0 110.098 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.0 t -107.63 126.63 52.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.458 ' NH1' ' CG ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -96.49 106.89 19.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.48 115.38 27.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.585 -179.601 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 17.9 t -91.64 120.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 109.944 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.7 t -79.59 -64.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 110.563 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -38.3 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.807 . . . . 0.0 109.561 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -124.51 91.49 3.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.912 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 pm0 -36.2 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 110.93 -179.078 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -146.28 83.6 8.36 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.858 . . . . 0.0 110.462 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.3 Cg_endo -78.8 88.42 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.164 1.613 . . . . 0.0 110.431 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.6 145.46 25.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.92 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 8.9 p -128.03 105.59 8.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.114 -0.991 . . . . 0.0 110.978 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.3 t -106.8 151.8 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.533 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 13.5 m -119.55 166.12 13.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.613 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.99 117.39 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.964 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -42.62 -37.25 1.63 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.213 -179.909 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 46.36 3.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -124.61 165.73 17.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -1.202 . . . . 0.0 110.38 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.4 mt -149.42 151.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.235 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.24 149.94 10.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.48 66.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.012 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -90.67 -0.39 57.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.9 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.533 ' HG ' ' HG ' ' A' ' 34' ' ' CYS . 5.2 m 69.89 38.18 1.65 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.825 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.49 ' HB2' HD12 ' A' ' 17' ' ' ILE . 6.5 tm-20 -101.39 -17.34 16.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -97.27 163.95 12.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.821 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.431 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 8.9 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.28 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.514 ' HD1' HG13 ' A' ' 24' ' ' VAL . 59.3 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.25 0.548 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -142.7 121.51 12.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.41 137.28 35.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.183 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 136.41 93.19 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -179.94 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.5 Cg_endo -72.89 161.93 42.4 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.055 1.555 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -67.46 -31.52 71.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.952 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.67 -10.83 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.7 m-85 -126.5 2.83 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.843 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -89.98 57.06 3.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.11 179.889 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -86.45 -12.68 48.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 109.422 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.3 p90 -90.17 -1.65 57.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.089 178.427 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.24 104.27 1.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 110.103 179.837 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 47.5 mm -69.29 -72.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CE ' ' HB2' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -91.16 52.8 2.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -151.42 135.9 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -99.62 125.95 45.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -1.134 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.475 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 11.0 t -105.66 125.8 51.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.251 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.03 112.16 23.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -94.77 104.7 16.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.514 HG13 ' HD1' ' A' ' 5' ' ' PHE . 21.5 t -80.52 115.13 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.266 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 27.9 t -78.13 -62.1 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.558 -0.714 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.53 -44.8 4.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.281 179.523 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -115.37 90.47 3.35 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.842 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -35.01 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.778 -0.576 . . . . 0.0 111.005 -179.133 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' GLU . 34.2 m -150.37 83.46 5.97 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 -179.882 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.493 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.5 Cg_endo -80.8 100.08 1.18 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.065 1.56 . . . . 0.0 109.953 179.419 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.438 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.3 p -112.15 132.72 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.096 -1.002 . . . . 0.0 110.454 -179.741 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 29.2 p -104.79 131.45 52.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.5 116.95 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 19.4 m -93.97 156.1 16.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 110.126 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -50.3 124.18 9.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 179.895 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -45.52 -40.78 8.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.18 46.24 3.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -120.82 166.62 13.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.339 179.899 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 9.6 mt -146.46 150.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.69 145.02 9.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.98 62.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 110.253 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.468 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.3 mmt85 -112.78 5.66 17.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m 68.34 45.22 1.22 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.131 179.704 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.48 -33.5 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 110.678 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -86.07 151.68 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.379 -179.704 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.04 179.954 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 47.4 m-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.312 0.577 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.7 128.66 35.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.164 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.91 125.66 45.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.438 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.33 127.45 92.13 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 -179.931 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.8 Cg_endo -74.2 161.27 41.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.914 1.481 . . . . 0.0 110.247 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -64.41 -32.67 74.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -65.57 -8.69 21.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.471 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -123.86 0.98 8.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 20' ' ' ARG . 27.2 mttt -87.99 73.85 9.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.372 -179.788 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -85.74 -17.82 34.79 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.207 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 14.6 p90 -82.58 -10.08 59.12 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 178.502 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.2 m -160.3 137.81 9.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.0 mm -94.37 -70.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.41 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.89 62.41 5.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.102 -0.999 . . . . 0.0 110.506 -179.925 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.35 141.96 7.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.753 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 5.3 mpt_? -95.4 150.56 20.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -1.178 . . . . 0.0 109.505 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.495 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 26.5 t -132.55 130.31 40.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.552 -179.685 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -99.49 122.18 42.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 109.994 179.619 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -111.98 103.49 11.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.211 -179.804 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.494 ' CG2' ' HB ' ' A' ' 29' ' ' THR . 22.3 t -81.42 124.67 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.1 t -79.68 -69.25 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 110.306 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.94 -44.45 3.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -112.53 93.97 4.69 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.886 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tp-100 -38.93 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.533 -0.729 . . . . 0.0 110.796 -179.148 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 7.6 m -139.18 73.15 38.25 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.218 -0.927 . . . . 0.0 110.459 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.609 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.3 Cg_endo -78.43 72.86 6.12 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.025 1.539 . . . . 0.0 110.033 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -92.56 137.91 31.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -179.695 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.7 t -114.01 107.83 16.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 20' ' ' ARG . 45.0 t -94.08 116.24 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 9.0 m -83.6 158.54 21.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.964 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -46.45 120.18 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.762 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.0 tt0 -40.83 -54.09 2.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.66 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.48 52.79 3.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -118.59 168.86 10.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -1.195 . . . . 0.0 110.655 -179.999 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.692 ' N ' HD12 ' A' ' 39' ' ' ILE . 3.3 mp -143.37 132.04 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.756 . . . . 0.0 109.806 179.5 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.8 136.43 3.62 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.01 72.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.304 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.0 19.89 18.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.963 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.6 m 63.54 72.74 0.47 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -107.9 -40.27 5.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.938 -179.3 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.481 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 9.1 ptp180 -118.56 168.86 10.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.986 -1.071 . . . . 0.0 110.546 -179.527 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 7.1 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.181 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.171 0.51 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.5 m -115.95 132.12 56.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.914 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -87.69 118.01 26.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 24.6 m -45.28 112.25 1.53 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.93 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 163.55 37.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.951 1.501 . . . . 0.0 110.319 179.739 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -60.32 -37.14 79.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.259 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.87 -25.15 63.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 -179.888 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -110.17 -1.4 17.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.257 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -89.94 46.94 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.401 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -86.21 -12.79 48.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.047 -1.033 . . . . 0.0 109.402 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 9.1 p90 -90.3 -3.8 57.54 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.214 178.494 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.12 105.52 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 51.1 mm -70.41 -71.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.055 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HE3' ' HA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -89.69 64.0 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.488 ' O ' ' CE ' ' A' ' 13' ' ' LYS . . . -160.05 136.37 4.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 96.0 mtt180 -99.51 127.21 45.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -1.161 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 9.5 t -119.01 133.18 55.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.643 -179.664 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -102.51 123.96 47.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.853 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -105.66 116.24 31.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 53.4 t -86.56 116.88 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 110.133 179.714 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' ALA . 89.1 t -79.92 -61.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.543 -0.723 . . . . 0.0 110.549 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.0 -49.14 3.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.577 179.886 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.3 tt0 -114.5 92.83 4.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.836 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -34.47 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.262 0.553 . . . . 0.0 110.99 -179.084 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 29' ' ' THR . 4.4 m -149.11 86.81 5.52 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -79.23 122.5 5.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.985 1.518 . . . . 0.0 110.298 179.666 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -127.85 116.64 20.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 109.971 179.804 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.8 p -99.59 126.98 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.583 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 42.2 t -116.77 120.84 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.349 -0.844 . . . . 0.0 109.819 179.705 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 14.6 m -91.3 159.95 15.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.247 -0.908 . . . . 0.0 110.514 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -58.42 128.11 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.036 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -47.44 -49.12 25.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 45.76 3.02 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -113.04 172.85 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 110.226 179.864 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 15.2 mt -150.2 127.7 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.27 148.44 6.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.65 66.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 110.283 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' CYS . 81.0 mtt180 -89.58 13.47 13.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.537 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 3.5 m 63.36 62.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.324 -0.86 . . . . 0.0 109.762 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 10.4 tt0 -110.34 -28.82 8.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.74 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 13.2 ttm180 -111.03 109.58 19.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.017 -1.052 . . . . 0.0 110.317 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.959 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.898 ' CG ' HG22 ' A' ' 24' ' ' VAL . 36.2 m-85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.282 0.563 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.05 162.73 18.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.347 179.942 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -106.9 154.13 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 110.171 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.429 ' CB ' ' HH ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -83.46 127.73 67.11 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 -179.907 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.67 162.21 40.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.868 1.457 . . . . 0.0 110.383 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -61.36 -29.04 69.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -63.86 -25.61 68.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.35 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -112.12 10.55 20.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.351 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -90.0 45.45 1.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.131 179.926 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.25 -13.45 46.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.032 . . . . 0.0 109.624 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p90 -87.96 -1.76 58.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.439 -0.788 . . . . 0.0 109.197 178.607 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.521 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.78 103.2 1.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 33.2 mt -63.73 -69.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 -179.956 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.7 ptmm? -97.94 64.43 1.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.21 149.31 18.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.96 162.05 13.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 109.793 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.2 t -151.81 156.24 39.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.02 . . . . 0.0 110.621 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -125.99 125.82 43.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.456 -0.778 . . . . 0.0 109.602 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.07 118.06 36.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.648 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.898 HG22 ' CG ' ' A' ' 5' ' ' PHE . 37.6 t -83.56 115.72 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.814 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 6.0 t -82.2 -63.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.52 -0.737 . . . . 0.0 110.62 -179.506 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.01 -29.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.351 -0.843 . . . . 0.0 109.787 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' THR . 97.2 mt-10 -136.93 93.46 2.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.164 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 13.1 mt-30 -34.72 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.806 -0.559 . . . . 0.0 111.146 -179.124 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 29' ' ' THR . 3.1 m -149.18 89.57 4.84 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 110.324 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.15 117.45 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.06 1.558 . . . . 0.0 110.395 179.666 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.0 OUTLIER -118.88 110.62 17.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.132 -0.98 . . . . 0.0 109.904 179.768 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.443 ' C ' HG23 ' A' ' 33' ' ' VAL . 26.7 p -92.15 155.14 18.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.735 -179.682 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.443 HG23 ' C ' ' A' ' 32' ' ' CYS . 99.3 t -149.12 120.44 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.472 -0.768 . . . . 0.0 109.806 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.0 m -93.72 156.47 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -179.526 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -54.85 125.53 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.038 179.772 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.47 -39.42 15.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.826 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 40.95 2.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.84 174.24 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -1.214 . . . . 0.0 110.326 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 38' ' ' TYR . 18.0 mm -149.51 148.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.031 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.61 157.45 20.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.03 -37.71 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.164 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -93.11 9.19 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.124 179.842 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.507 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.8 m 67.41 43.72 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.402 -0.811 . . . . 0.0 110.145 179.818 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -96.29 -34.44 11.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.585 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.485 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -96.7 -178.62 4.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.476 -179.757 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.8 p . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.861 . . . . 0.0 110.391 -179.844 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.173 0.511 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.76 140.17 23.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.17 119.81 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.23 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -55.86 136.61 72.54 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 179.878 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 46.9 Cg_endo -73.35 171.71 17.12 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.91 1.479 . . . . 0.0 110.415 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -63.72 -38.62 91.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 110.234 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -63.64 -19.23 64.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.192 179.982 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.2 m-85 -107.45 -1.97 20.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.1 55.73 3.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.427 ' CE1' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -86.16 -15.5 40.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.026 -1.046 . . . . 0.0 109.303 179.923 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.509 ' OH ' ' CB ' ' A' ' 21' ' ' CYS . 3.6 p90 -90.13 3.32 53.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.493 -0.755 . . . . 0.0 109.307 178.515 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.98 106.39 1.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.154 179.85 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 9.3 mm -63.25 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.108 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -96.29 63.4 2.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.221 179.987 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -159.76 155.54 26.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -101.77 -179.06 3.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 109.832 179.832 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.509 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 8.8 t -152.63 128.05 9.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.068 -1.02 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -102.28 105.07 15.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.074 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.29 115.44 28.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 41.2 t -89.91 117.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.817 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 53.8 t -75.24 -62.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.597 -0.69 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.46 -61.23 1.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.83 . . . . 0.0 109.436 179.779 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 29' ' ' THR . 47.7 mt-10 -99.62 90.6 4.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.483 -0.761 . . . . 0.0 109.008 178.891 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.8 pm0 -34.3 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.268 0.556 . . . . 0.0 111.046 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' GLU . 43.4 m -146.03 85.36 7.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.862 . . . . 0.0 110.348 179.912 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.6 Cg_endo -76.05 99.2 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.368 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.35 143.01 33.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.144 179.897 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 27.5 p -123.91 118.22 26.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.767 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 t -112.44 146.82 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.462 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.6 m -117.03 161.54 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -54.19 117.41 3.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 110.219 -179.893 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -43.97 -38.1 3.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.35 46.18 3.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.508 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.07 172.49 9.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -1.183 . . . . 0.0 110.339 179.965 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 46.2 mt -150.12 143.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.13 168.79 13.37 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 -40.26 16.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -1.15 . . . . 0.0 110.119 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -96.86 13.37 28.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 0.0 110.186 179.973 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.3 m 67.77 51.04 0.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -101.74 -39.92 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.06 165.44 18.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.074 -1.016 . . . . 0.0 110.477 -179.798 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.524 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 8.6 p . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.161 0.505 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 m -145.0 135.92 24.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.299 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 121.18 26.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.142 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -47.41 135.88 9.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.235 -179.982 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.86 173.65 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.996 1.524 . . . . 0.0 110.403 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -65.07 -31.37 72.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.89 -8.59 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -119.05 -1.26 10.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.939 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -90.12 39.39 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.263 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -85.85 -20.94 28.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 109.457 -179.832 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.21 1.1 56.82 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.009 178.124 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -160.33 92.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.884 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 75.4 mt -75.56 -55.89 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' CB ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.45 42.74 1.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 110.026 179.772 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.97 -179.74 30.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -137.29 145.54 43.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.265 -1.138 . . . . 0.0 109.934 179.821 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 14.6 t -125.65 124.94 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.636 -179.538 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -90.2 113.15 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.789 179.602 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -95.41 116.4 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.477 -179.621 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 27' ' ' GLU . 58.0 t -83.7 116.54 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 109.966 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 38.5 t -79.93 -59.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 0.0 110.494 -179.826 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.53 -47.92 3.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -118.08 95.17 4.78 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.755 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 56.1 tt0 -35.53 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.757 -0.589 . . . . 0.0 111.128 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.9 m -148.52 88.39 5.33 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -76.02 118.87 5.15 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.956 1.503 . . . . 0.0 110.387 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 4.3 m -122.36 115.22 21.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.894 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -98.31 154.16 18.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.72 -179.614 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.6 t -146.94 159.34 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.883 179.68 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.511 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.4 m -121.43 157.16 31.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.031 . . . . 0.0 110.452 -179.653 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.8 m-20 -66.79 124.88 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.864 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -50.84 -40.53 56.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.31 -179.943 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.39 40.95 3.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER -117.92 176.84 5.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -1.145 . . . . 0.0 110.331 -179.879 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.432 ' CG1' ' C ' ' A' ' 38' ' ' TYR . 12.8 mt -147.0 117.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 110.245 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 150.94 5.82 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.35 -52.2 49.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -1.153 . . . . 0.0 109.959 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -92.48 17.78 9.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.827 179.691 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 8.6 m 64.65 80.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 110.143 179.936 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -113.68 -38.4 4.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -104.8 162.19 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.1 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.05 -179.952 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.778 ' CD1' HG13 ' A' ' 24' ' ' VAL . 24.8 m-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.201 0.524 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -140.42 141.44 35.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 165.51 21.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.512 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -89.78 127.34 54.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 110.274 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 48.2 Cg_endo -73.99 166.05 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.465 . . . . 0.0 110.094 179.68 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -66.0 -36.04 82.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -12.2 16.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 110.458 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.418 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.4 m-85 -120.3 -6.0 9.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 52.08 2.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -86.28 -16.92 36.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.95 -1.094 . . . . 0.0 109.413 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 4.5 p90 -90.36 1.98 56.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 109.127 178.404 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.3 m -159.66 100.06 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 41.7 mm -72.61 -70.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.165 179.982 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -89.57 49.32 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 179.983 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -141.84 134.34 6.15 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -92.92 127.31 38.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.232 -1.157 . . . . 0.0 109.892 179.771 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.524 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 5.8 p -127.96 145.83 50.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 110.565 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.91 159.17 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.857 . . . . 0.0 109.527 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -138.51 109.14 6.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.029 . . . . 0.0 110.307 -179.751 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.778 HG13 ' CD1' ' A' ' 5' ' ' PHE . 7.9 t -80.46 116.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 5.8 t -78.95 -65.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.061 179.834 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.97 -42.71 3.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 109.376 179.608 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -115.95 88.95 2.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.919 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -35.06 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.235 -178.992 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.2 m -146.73 81.75 9.03 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 179.753 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.551 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.1 Cg_endo -79.12 107.67 2.25 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.061 1.558 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 136.05 53.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.524 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -120.28 129.43 54.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 t -126.34 116.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.079 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 14.9 m -89.54 150.28 22.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 -179.765 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.9 m-20 -45.62 124.26 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 110.093 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 19.2 pt-20 -51.79 -38.55 56.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -90.12 37.94 3.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -110.02 172.8 6.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 110.322 -179.932 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.409 HG12 ' C ' ' A' ' 38' ' ' TYR . 33.3 mm -144.98 141.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.237 179.886 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 145.97 10.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -1.188 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.1 mtm-85 -89.78 3.63 52.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 110.149 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m 67.55 51.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 109.598 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -99.42 -30.94 11.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.598 -179.565 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.495 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 82.1 mtt180 -105.6 173.76 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.402 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 179.964 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.454 ' CD1' HG13 ' A' ' 24' ' ' VAL . 46.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.211 0.529 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 m -137.5 146.86 44.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.61 150.82 25.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.888 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -83.65 130.12 57.04 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.958 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.56 172.34 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.959 1.505 . . . . 0.0 110.396 -179.926 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.3 pttt -63.76 -25.18 68.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -62.51 -10.27 11.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 -179.885 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.585 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 8.8 m-85 -131.73 4.35 4.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 8.9 mtpt -85.53 44.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.461 -179.843 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -85.2 -25.19 27.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.845 -1.16 . . . . 0.0 109.602 -179.78 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 10.9 p90 -79.16 -6.01 55.53 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.292 178.566 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.3 138.14 9.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.54 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 44' ' ' GLU . 9.8 mt -94.68 -72.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.197 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -89.78 63.92 6.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 110.312 179.987 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.2 139.75 6.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -100.39 125.45 46.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -1.163 . . . . 0.0 109.801 179.91 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t -111.28 129.17 56.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 -179.643 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -90.89 129.17 36.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.939 179.689 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -105.62 110.48 22.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 27' ' ' GLU . 39.4 t -80.31 114.72 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 26' ' ' ALA . 42.5 t -77.03 -65.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.593 -0.692 . . . . 0.0 110.235 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.6 -48.5 4.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.49 179.813 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -112.83 87.62 2.63 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.511 -0.743 . . . . 0.0 109.013 178.844 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -33.89 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.126 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 29' ' ' THR . 6.0 m -149.23 88.35 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.336 -0.852 . . . . 0.0 110.412 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.08 91.81 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.04 1.547 . . . . 0.0 110.432 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.1 p -93.34 124.98 37.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 179.784 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.491 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 6.7 t -99.97 129.56 46.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 87.4 t -117.9 109.4 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 109.584 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.609 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.2 m -79.93 153.75 28.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.835 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 5.2 m-20 -49.57 117.8 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.811 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.05 -47.08 4.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.469 -179.897 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.24 49.67 3.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -121.84 172.82 7.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.142 -1.211 . . . . 0.0 110.283 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 14.5 mt -144.09 143.8 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.193 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.09 170.36 14.97 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.2 -46.43 9.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -1.176 . . . . 0.0 110.268 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.5 mtp85 -91.41 11.96 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.152 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.523 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.7 m 67.1 64.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.436 -0.79 . . . . 0.0 110.196 179.878 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.698 ' HG2' HD12 ' A' ' 17' ' ' ILE . 24.1 mt-10 -116.3 -14.05 11.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.883 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 14.2 mtt180 -117.71 176.0 5.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 13.9 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.234 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.804 ' CD1' HG13 ' A' ' 24' ' ' VAL . 77.8 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.082 0.468 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 m -127.64 120.76 28.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.869 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.03 129.69 34.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.74 132.28 72.11 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.891 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -73.72 160.24 44.12 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.519 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 4.1 mttm -65.45 -30.66 71.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.257 179.974 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -64.03 -15.5 59.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.876 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.435 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -116.52 -1.4 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.312 -179.89 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.69 67.04 9.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 179.951 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -85.93 -17.64 34.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.04 -1.037 . . . . 0.0 109.37 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.1 p90 -90.23 2.91 54.92 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.538 -0.726 . . . . 0.0 109.35 178.512 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.02 95.35 1.16 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.096 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.1 mm -55.57 -82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.364 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.523 ' NZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -89.89 66.05 6.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.017 . . . . 0.0 110.274 -179.853 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -152.67 154.87 25.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.511 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 10.1 ptt-85 -109.54 137.53 47.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -1.114 . . . . 0.0 109.992 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 47.6 t -124.48 123.33 39.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.41 110.45 23.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 179.764 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -95.76 110.28 22.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.355 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.804 HG13 ' CD1' ' A' ' 5' ' ' PHE . 9.5 t -79.89 118.89 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.109 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.2 t -79.72 -65.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.347 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.8 -46.75 3.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.86 . . . . 0.0 109.621 179.801 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 8.0 mt-10 -114.52 89.77 3.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.475 -0.765 . . . . 0.0 109.072 178.976 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.42 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.296 0.57 . . . . 0.0 111.109 -179.024 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 55.1 m -147.15 83.11 8.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.903 . . . . 0.0 110.38 179.75 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -77.63 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.515 . . . . 0.0 110.278 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -106.91 118.75 37.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.402 ' C ' HG23 ' A' ' 33' ' ' VAL . 21.9 p -98.27 148.24 23.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.973 . . . . 0.0 110.231 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.402 HG23 ' C ' ' A' ' 32' ' ' CYS . 21.4 t -145.17 150.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 33.1 m -120.93 161.68 21.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -57.62 127.66 33.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.991 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -44.0 52.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.166 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.92 43.69 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.99 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -114.84 170.66 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -1.162 . . . . 0.0 110.222 -179.963 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 40' ' ' GLY . 21.0 mt -150.05 171.11 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 98.92 169.13 30.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.42 -41.75 14.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.188 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.45 ' HB2' ' CD ' ' A' ' 44' ' ' GLU . 16.6 mtt180 -96.45 21.03 9.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 -179.998 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.509 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.1 m 64.23 31.79 12.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 110.142 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' CD ' ' HB2' ' A' ' 42' ' ' ARG . 44.2 mt-10 -92.01 -18.73 23.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.551 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -97.85 163.89 12.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 7.2 p . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 -179.879 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.563 ' CD1' HG22 ' A' ' 24' ' ' VAL . 63.3 m-85 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.206 0.526 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.69 134.23 42.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.987 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -84.75 150.68 24.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.349 -179.93 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.41 132.8 34.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.135 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.3 Cg_endo -73.2 161.04 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.955 1.503 . . . . 0.0 110.574 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -30.21 70.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.379 -0.826 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -9.76 42.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.455 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.0 m-85 -122.62 6.14 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 19' ' ' GLY . 50.8 mttt -89.24 56.9 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.4 -179.887 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -15.14 42.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.03 -1.044 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.23 2.04 55.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.264 178.586 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.6 m -160.51 123.42 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 95.1 mt -81.34 -64.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 110.259 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 8.6 ptmm? -106.06 61.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.32 155.82 26.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.884 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -106.42 136.81 45.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.114 . . . . 0.0 109.634 179.601 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 18.0 t -120.82 148.19 44.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.126 -0.984 . . . . 0.0 110.627 -179.527 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -125.35 119.08 27.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.817 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -101.18 116.51 32.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.947 . . . . 0.0 110.477 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.563 HG22 ' CD1' ' A' ' 5' ' ' PHE . 21.8 t -87.19 114.45 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.018 179.704 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.0 t -75.43 -62.05 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.403 -0.811 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.14 -59.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 109.505 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 64.1 mm-40 -103.51 89.0 3.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -32.81 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.34 0.591 . . . . 0.0 111.168 -179.105 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.7 m -145.57 87.75 6.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.292 179.892 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.9 Cg_endo -78.19 94.43 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.095 1.576 . . . . 0.0 110.452 179.833 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.24 141.24 29.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 179.944 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.4 p -123.48 122.14 37.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.267 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.1 143.86 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.926 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 31.6 m -115.33 164.44 14.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.471 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.526 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -45.96 122.46 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.245 179.961 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.65 -52.93 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.53 -179.877 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.44 50.61 3.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -116.3 170.94 8.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.102 -1.234 . . . . 0.0 110.343 179.783 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.1 mt -150.03 158.54 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 179.951 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.87 143.7 10.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.33 -29.98 68.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.264 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.07 9.26 43.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.104 179.967 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 5.3 m 65.65 49.26 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -107.81 -31.09 8.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.443 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 62.4 mtt85 -85.18 157.62 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.27 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.216 0.531 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.95 149.88 43.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.57 110.37 0.32 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -171.59 93.09 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -1.128 . . . . 0.0 110.255 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' HD2' HG13 ' A' ' 24' ' ' VAL . 75.3 m-85 -119.9 -152.05 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 110.035 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -133.29 125.21 28.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.473 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.58 120.98 32.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 110.05 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 33.4 m -57.19 116.0 12.27 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.62 168.38 24.91 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.9 1.474 . . . . 0.0 110.453 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -27.95 67.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -13.86 60.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -121.09 17.24 11.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 110.229 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -90.08 47.62 1.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.403 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.06 -18.5 32.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 109.135 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.9 p90 -90.64 0.52 57.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.086 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 3.1 m -160.14 91.47 0.95 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 51.7 mt -62.08 -53.31 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.123 -0.986 . . . . 0.0 110.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.17 57.39 0.62 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.14 159.78 31.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -101.85 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -1.149 . . . . 0.0 110.068 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 37.1 t -158.89 126.55 4.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 110.731 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -106.34 122.51 46.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.734 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -110.51 112.42 24.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.987 . . . . 0.0 110.577 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 27' ' ' GLU . 63.5 t -89.73 118.68 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.94 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.9 t -77.63 -64.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.744 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -46.6 4.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.345 -0.847 . . . . 0.0 109.376 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.597 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.6 tt0 -109.74 87.92 2.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.9 tt0 -34.76 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.361 0.6 . . . . 0.0 111.116 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -148.73 84.66 6.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -77.98 84.22 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.09 1.574 . . . . 0.0 110.128 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -89.88 140.36 29.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.068 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 12.0 p -129.04 110.77 12.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.415 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 20' ' ' ARG . 3.6 t -99.17 159.96 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 0.0 109.686 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.524 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 10.6 m -135.53 162.31 33.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -57.08 122.95 13.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 109.956 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.3 mt-10 -41.58 -37.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 110.168 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.68 48.17 3.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.796 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -123.26 162.17 23.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.023 -1.281 . . . . 0.0 110.38 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 38' ' ' TYR . 29.6 mm -142.29 156.03 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.212 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.55 150.96 25.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.57 80.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -1.15 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -89.65 8.06 33.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.02 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 6.9 m 64.64 58.15 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.39 -0.819 . . . . 0.0 110.153 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.76 -31.1 9.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 110.275 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.448 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 7.0 mtt180 -94.64 171.08 9.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.058 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.51 141.36 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 110.475 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.49 ' HB2' HG13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -142.85 62.87 1.4 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.425 -0.797 . . . . 0.0 110.198 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.1 tt -101.6 37.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -0.99 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER -44.54 -37.63 3.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 0.0 110.2 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 49' ' ' PHE . 5.7 m-85 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 1' ' ' ARG . 12.3 ptp180 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.214 0.53 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.95 -47.11 3.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.257 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 4' ' ' HIS . . . 140.17 162.19 9.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 4' ' ' HIS . 0.0 OUTLIER 176.05 89.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 0.0 110.153 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CD1' HG13 ' A' ' 24' ' ' VAL . 27.4 m-85 -113.78 -155.37 0.57 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.208 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.05 143.2 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -80.95 127.08 32.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.309 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -59.65 130.04 87.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.2 Cg_endo -72.47 160.53 46.53 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.899 1.473 . . . . 0.0 110.356 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -61.65 -30.2 70.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.177 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -29.52 70.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.456 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -99.23 0.07 42.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.23 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.06 49.0 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.72 -20.25 29.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.021 -1.05 . . . . 0.0 109.352 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' OH ' ' SG ' ' A' ' 21' ' ' CYS . 4.4 p90 -90.35 1.24 56.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.131 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 101.46 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 38.7 mm -74.22 -69.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.85 58.61 4.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -155.16 136.0 4.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 8.6 mpt_? -93.92 128.95 40.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 110.038 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.522 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 6.4 p -126.35 147.67 49.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.61 144.94 35.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 109.808 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -121.73 108.7 13.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.511 HG13 ' CD1' ' A' ' 5' ' ' PHE . 3.9 t -83.42 120.12 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 46.2 t -81.87 -65.18 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.712 -0.617 . . . . 0.0 110.233 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.37 -34.55 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -128.14 92.04 3.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 11.1 tm0? -36.24 91.41 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.743 -0.598 . . . . 0.0 110.919 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 29' ' ' THR . 17.7 m -147.55 81.49 8.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.419 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -78.85 91.2 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.168 1.615 . . . . 0.0 110.321 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -89.26 145.38 25.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.2 p -123.98 132.09 53.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 0.0 110.591 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 66.5 t -127.25 111.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.879 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -81.94 152.34 26.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -57.39 124.96 20.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' ASP . 1.4 mm-40 -42.15 -42.73 3.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.459 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -90.4 48.02 3.1 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -119.44 169.4 10.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.268 . . . . 0.0 110.348 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.476 HD11 ' CG ' ' A' ' 47' ' ' ASP . 44.1 mt -150.49 141.37 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.87 147.52 7.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.8 52.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.131 . . . . 0.0 110.074 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.419 ' C ' ' SG ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -94.97 20.66 8.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 110.345 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.537 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 2.4 m 63.42 67.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -102.94 -44.03 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 111.399 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 12.9 ptm180 -112.45 134.42 53.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.899 -1.126 . . . . 0.0 110.599 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.532 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.4 p -91.45 159.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.476 ' CG ' HD11 ' A' ' 39' ' ' ILE . 12.0 t0 -97.96 70.33 2.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.232 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.13 138.65 26.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 0.0 110.271 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.31 -48.87 65.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.282 -0.886 . . . . 0.0 110.207 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.232 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.266 0.555 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -119.61 119.4 33.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.16 166.07 12.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.11 59.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -1.119 . . . . 0.0 110.268 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -90.09 -154.42 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -117.07 123.7 47.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -79.92 112.42 17.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -43.36 122.13 3.33 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.294 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -71.63 167.13 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.915 1.482 . . . . 0.0 110.427 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -53.57 -43.13 68.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -0.906 . . . . 0.0 110.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.87 -32.64 67.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.476 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -90.98 -12.05 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 45.57 1.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -86.16 -17.18 35.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.123 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.2 p90 -90.5 2.17 55.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.221 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -159.31 97.94 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.121 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.549 HD12 ' CG ' ' A' ' 44' ' ' GLU . 53.1 mt -63.61 -70.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.9 . . . . 0.0 110.309 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -91.86 64.31 4.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.08 153.44 24.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -114.18 140.67 48.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -1.141 . . . . 0.0 110.144 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 11.4 t -130.3 128.28 41.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.472 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -92.53 122.06 34.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 109.943 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.99 109.78 21.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 110.402 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 13.8 t -80.15 120.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 93.4 t -78.9 -64.38 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 110.344 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.28 -43.94 3.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.375 -0.828 . . . . 0.0 109.483 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.9 mt-10 -118.33 88.35 2.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.96 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.363 0.601 . . . . 0.0 111.01 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 32.9 m -143.29 85.6 9.51 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.256 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.98 87.21 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.145 1.603 . . . . 0.0 110.557 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 p -90.49 109.03 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.87 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 32.0 p -99.24 142.15 31.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.554 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.9 t -140.58 120.51 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 109.969 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 12.7 m -88.04 156.18 19.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.238 -0.914 . . . . 0.0 110.322 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -48.85 121.52 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -50.21 -43.69 52.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.302 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.59 39.1 3.12 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -113.12 178.36 4.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 110.341 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 17.7 mt -150.23 158.76 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.44 168.97 23.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.59 -44.66 11.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.338 -1.095 . . . . 0.0 110.137 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HB2' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -91.73 14.76 14.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.82 51.96 0.56 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.336 -0.852 . . . . 0.0 110.333 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.549 ' CG ' HD12 ' A' ' 17' ' ' ILE . 14.0 mt-10 -105.37 -34.96 7.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 17.2 mtp180 -85.23 160.85 19.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.516 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.469 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 4.4 p -134.5 148.15 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.294 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -100.79 46.55 0.94 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -148.54 179.93 7.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -81.57 3.79 23.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.123 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.547 ' CE2' HD22 ' A' ' 48' ' ' LEU . 26.0 m-85 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.174 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' LYS . 4.8 tpp180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.22 0.533 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' ARG . 1.3 tttp 44.25 61.27 2.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.157 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.39 -151.55 6.18 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 51.46 87.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -1.157 . . . . 0.0 110.167 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -94.94 -146.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.237 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.31 134.82 48.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 110.301 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -88.21 147.53 24.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.15 143.97 43.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.22 164.84 34.25 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.04 1.547 . . . . 0.0 110.468 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -62.98 -31.58 72.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -21.46 66.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.108 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -102.61 1.38 34.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.235 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 16' ' ' CYS . 14.4 mtpt -87.41 54.38 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.325 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -18.87 31.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.941 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 1.8 p90 -90.56 -2.75 57.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.017 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 10.3 m -158.92 109.06 2.0 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.853 . . . . 0.0 110.053 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 29.6 mm -72.66 -54.87 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.019 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 7.8 ptmm? -106.41 53.02 0.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -151.5 147.09 16.58 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -101.99 141.23 35.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -1.196 . . . . 0.0 110.065 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.488 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 34.8 t -115.92 123.63 48.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 110.456 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -96.42 107.77 20.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -91.02 111.9 23.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.855 . . . . 0.0 110.443 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 27' ' ' GLU . 88.2 t -81.27 117.11 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.028 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 99.9 t -80.88 -56.61 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.657 -0.652 . . . . 0.0 110.386 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.64 -42.97 2.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.49 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.562 ' H ' HG12 ' A' ' 24' ' ' VAL . 35.3 tt0 -125.46 97.35 5.15 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -34.5 90.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.764 -0.585 . . . . 0.0 111.172 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 29' ' ' THR . 14.0 m -148.66 85.69 6.06 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.444 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.523 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -73.47 100.16 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.056 1.556 . . . . 0.0 110.412 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 t -97.16 133.77 41.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.1 p -113.98 102.27 10.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.423 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.33 122.67 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.883 . . . . 0.0 110.012 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 18.1 m -95.51 155.62 16.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.369 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 2.0 m-20 -43.84 124.27 3.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.127 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.71 -49.42 28.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.339 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 46.63 3.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.518 ' HB3' ' CB ' ' A' ' 35' ' ' ASP . 0.4 OUTLIER -111.6 171.29 7.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -1.204 . . . . 0.0 110.317 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 47' ' ' ASP . 25.3 mm -144.69 153.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.53 156.39 16.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.78 57.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -1.134 . . . . 0.0 110.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.2 mmm-85 -97.05 12.57 32.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.523 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.42 55.93 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 0.0 109.874 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.81 -36.73 6.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.599 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -97.08 -179.49 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.499 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.444 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.7 p -149.19 150.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -0.836 . . . . 0.0 110.078 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.513 ' HB2' ' CG1' ' A' ' 39' ' ' ILE . 48.3 t0 -114.36 83.05 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.321 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.795 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.4 pt? -112.85 2.92 16.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 0.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -66.21 0.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.4 t80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.25 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.436 ' NH2' ' HG2' ' A' ' 1' ' ' ARG . 11.4 mtp85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.18 0.514 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 155.03 17.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.06 42.62 0.77 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -125.22 75.07 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -1.131 . . . . 0.0 110.216 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -132.66 -141.46 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 110.021 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -131.04 129.76 42.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 8' ' ' CYS . 1.9 ttm180 -88.23 111.68 21.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 46.8 m -42.93 110.73 0.92 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.255 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HG2' ' CG ' ' A' ' 11' ' ' GLN . 45.6 Cg_endo -73.59 179.25 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.927 1.488 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.98 -36.32 84.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' CG ' ' HG2' ' A' ' 9' ' ' PRO . 4.1 pt20 -59.88 -13.82 12.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.44 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.512 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.9 m-85 -120.07 -3.55 10.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.155 -0.966 . . . . 0.0 110.429 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.75 41.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.259 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -85.91 -18.41 32.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.024 -1.047 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.33 3.64 53.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.342 -0.848 . . . . 0.0 109.148 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -158.47 120.29 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.14 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.4 mm -80.46 -72.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.262 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.6 OUTLIER -95.23 65.01 2.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.028 -1.045 . . . . 0.0 110.33 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.25 171.82 33.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 11.7 mtp85 -131.99 133.43 44.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 109.807 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.9 t -121.7 137.05 54.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.75 126.28 51.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.51 112.86 26.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.546 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 58.3 t -84.18 116.59 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.059 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 26' ' ' ALA . 60.5 t -74.18 -64.55 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 110.4 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.93 -62.33 0.94 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.872 . . . . 0.0 109.34 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 21.0 mm-40 -97.82 87.77 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.88 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.742 -0.599 . . . . 0.0 111.072 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 29' ' ' THR . 10.5 m -145.0 88.1 6.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.82 91.93 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.133 1.596 . . . . 0.0 110.364 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.88 122.11 41.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.174 -0.953 . . . . 0.0 110.037 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.6 p -102.7 137.32 41.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.475 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 24.6 t -129.4 164.35 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 109.847 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.6 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 6.0 m -133.26 163.51 29.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 110.397 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.551 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-20 -55.74 121.39 9.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -46.58 -43.19 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 44.81 3.28 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.4 169.48 10.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -1.159 . . . . 0.0 110.129 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.757 HD11 ' HB2' ' A' ' 47' ' ' ASP . 3.3 mp -140.67 145.52 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.873 . . . . 0.0 110.217 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.37 167.3 16.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.95 -41.64 12.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 110.198 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.91 11.53 20.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.915 . . . . 0.0 110.216 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.524 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 66.9 49.59 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.304 -0.872 . . . . 0.0 109.827 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 28.8 tt0 -98.11 -34.8 10.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.9 mtt180 -94.02 157.36 16.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 110.092 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.74 153.82 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.757 ' HB2' HD11 ' A' ' 39' ' ' ILE . 4.4 t0 -125.02 53.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.283 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.52 -42.38 2.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.944 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 50' ' ' TYR . 96.3 m-85 -89.99 25.8 2.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.845 . . . . 0.0 109.967 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' PHE . 2.8 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.302 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.321 0.581 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -153.08 115.96 4.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -0.932 . . . . 0.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.11 174.33 42.54 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.415 ' O ' ' CG ' ' A' ' 4' ' ' HIS . 0.0 OUTLIER -163.94 74.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -1.153 . . . . 0.0 110.283 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.509 ' CD1' HG13 ' A' ' 24' ' ' VAL . 64.4 m-85 -108.23 -154.22 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.197 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.2 m -124.25 131.93 53.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -91.36 145.44 24.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 110.151 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 139.31 33.17 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.9 . . . . 0.0 110.261 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.51 166.9 28.64 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.974 1.512 . . . . 0.0 110.4 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -61.63 -28.84 69.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.53 -29.45 69.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.295 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -98.03 6.75 47.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.379 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 51.82 2.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 110.357 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -21.78 28.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.5 p90 -90.49 3.91 52.59 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.072 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 119.61 2.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.189 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 18' ' ' LYS . 17.1 mm -73.37 -82.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.192 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.4 ptmm? -93.06 64.46 3.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 110.033 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -153.53 144.52 11.42 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -94.3 153.46 18.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.268 -1.137 . . . . 0.0 110.053 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 9.4 t -130.44 127.0 38.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 110.152 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.14 107.56 18.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -93.82 112.2 24.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 110.37 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.509 HG13 ' CD1' ' A' ' 5' ' ' PHE . 4.7 t -80.27 115.52 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.99 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 12.7 t -79.2 -66.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.635 -0.665 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.32 -34.2 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 109.372 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.3 mt-10 -123.66 88.9 3.0 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 15.7 tt0 -35.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.801 -0.562 . . . . 0.0 111.143 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 31.4 m -150.27 91.31 4.22 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.288 -0.883 . . . . 0.0 110.288 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 47.8 Cg_endo -75.52 108.99 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.637 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 t -111.09 141.55 44.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 10.2 p -129.4 100.28 5.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.543 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.53 124.57 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 58.9 m -93.75 159.27 15.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.7 m-20 -53.25 116.97 2.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.547 ' HG2' ' N ' ' A' ' 37' ' ' GLY . 1.4 pm0 -51.64 -29.53 18.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 110.183 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' N ' ' HG2' ' A' ' 36' ' ' GLU . . . -90.85 35.39 3.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -115.26 172.67 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -1.124 . . . . 0.0 110.54 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.497 HD11 ' CG ' ' A' ' 47' ' ' ASP . 24.4 mt -149.49 156.25 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.13 170.9 20.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.47 -45.78 11.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.218 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 1.6 mmp_? -89.97 12.37 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.521 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 3.8 m 69.59 47.42 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -101.0 -38.47 8.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.22 -0.925 . . . . 0.0 110.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 3.8 mtt180 -83.11 172.14 12.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.483 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.5 p -145.87 152.61 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.953 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.497 ' CG ' HD11 ' A' ' 39' ' ' ILE . 1.6 t0 -129.3 47.33 2.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.487 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.78 -50.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.405 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.472 ' O ' ' OXT' ' A' ' 50' ' ' TYR . 3.3 m-85 -68.33 -36.26 79.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.388 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' OXT' ' O ' ' A' ' 49' ' ' PHE . 12.9 m-85 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.268 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.482 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 42.6 ptt85 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.212 0.53 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 1' ' ' ARG . 0.5 OUTLIER 175.21 -81.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.78 77.26 0.16 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -167.02 86.56 0.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -1.171 . . . . 0.0 110.232 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.603 ' HD1' HG13 ' A' ' 24' ' ' VAL . 65.5 m-85 -111.4 -153.05 0.51 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 m -145.61 130.53 18.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.351 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -81.61 154.89 25.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.071 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -84.29 124.59 73.72 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 158.22 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.865 1.455 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -67.08 -24.46 65.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.482 ' CA ' ' HE2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -64.4 -12.08 39.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.381 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -131.92 16.01 4.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -90.29 58.61 4.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -86.1 -12.89 48.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 109.46 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 12.2 p90 -86.73 -8.95 56.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.474 -0.766 . . . . 0.0 109.038 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.38 126.4 4.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.3 mm -76.66 -55.67 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.008 . . . . 0.0 110.42 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -116.39 70.62 0.77 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.049 -1.032 . . . . 0.0 110.362 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.47 166.06 30.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 17.3 ptt180 -114.2 121.11 42.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.129 -1.218 . . . . 0.0 110.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 6.2 t -105.16 128.76 53.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 110.369 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.21 109.88 22.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 109.87 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -100.75 112.66 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.379 -179.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.603 HG13 ' HD1' ' A' ' 5' ' ' PHE . 3.4 t -87.9 118.32 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.335 -0.853 . . . . 0.0 110.02 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 26' ' ' ALA . 16.7 t -75.96 -67.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 110.44 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.4 -50.56 3.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -0.839 . . . . 0.0 109.563 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -108.44 90.32 3.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.8 mt-30 -35.55 91.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.306 0.574 . . . . 0.0 110.925 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 89.9 m -143.67 78.83 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.517 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.2 Cg_endo -75.41 81.96 2.18 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.108 1.583 . . . . 0.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -90.01 137.84 32.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 109.682 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.1 t -115.05 130.71 57.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.084 -1.01 . . . . 0.0 110.666 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 4.3 t -124.47 158.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.586 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.7 m -110.06 161.62 15.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.138 -0.976 . . . . 0.0 110.568 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.0 m-20 -61.61 120.52 10.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 37' ' ' GLY . 15.7 pt-20 -45.56 -43.63 12.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 110.183 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 36' ' ' GLU . . . -90.14 47.4 3.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.9 174.95 6.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -1.15 . . . . 0.0 110.4 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 8.5 mt -150.35 129.69 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 158.63 9.61 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.52 -46.35 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -1.151 . . . . 0.0 110.154 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.8 mtt180 -89.59 8.9 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.542 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m 67.43 61.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 109.997 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -106.25 -40.35 5.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.939 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.491 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.41 150.24 25.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.472 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 48' ' ' LEU . 2.5 p -122.91 147.25 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.232 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -120.49 39.01 3.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' H ' HG22 ' A' ' 46' ' ' VAL . 12.6 mt -105.87 172.0 7.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.253 -0.904 . . . . 0.0 110.368 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -58.12 3.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.302 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.24 -179.902 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 4' ' ' HIS . 2.0 mmt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.206 0.527 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -55.85 110.78 0.78 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.52 56.61 3.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 1' ' ' ARG . 1.4 m80 -162.68 73.21 0.36 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -1.138 . . . . 0.0 110.199 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -123.93 -141.47 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.139 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.02 142.45 36.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 110.209 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 8' ' ' CYS . 10.1 mtp180 -103.9 107.5 18.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 32.0 m -42.08 121.24 2.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.901 . . . . 0.0 110.168 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.83 168.07 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.89 1.468 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -65.8 -27.96 68.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -66.53 -12.85 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -122.67 9.5 9.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HE2' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.14 51.62 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -85.74 -20.12 29.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.917 -1.115 . . . . 0.0 109.217 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.6 p90 -90.3 -1.57 57.93 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.098 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.499 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.7 m -160.59 98.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 44' ' ' GLU . 24.4 mt -77.74 -57.41 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -89.56 39.15 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.158 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -158.27 150.33 21.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.462 ' HG3' ' HE2' ' A' ' 13' ' ' LYS . 3.5 mtt180 -110.4 144.74 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -1.097 . . . . 0.0 109.781 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.49 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 17.6 t -125.94 135.91 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.99 . . . . 0.0 110.864 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.04 138.78 34.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.832 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -117.5 117.37 29.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.03 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.6 t -85.62 118.82 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.854 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 35.7 t -80.84 -65.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.627 -0.671 . . . . 0.0 110.607 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.45 -33.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 0.0 109.66 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -132.17 89.04 2.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 tt0 -34.59 90.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.763 -0.585 . . . . 0.0 111.09 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' GLU . 20.4 m -144.97 91.77 5.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.219 -0.926 . . . . 0.0 110.47 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 134.71 9.86 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.144 1.602 . . . . 0.0 110.412 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -141.15 112.09 7.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 109.915 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 29.0 p -98.53 144.43 27.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.752 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.93 127.41 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 23.8 m -102.71 164.25 11.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.3 m-20 -63.47 116.41 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.459 -0.776 . . . . 0.0 109.979 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.5 pt-20 -42.7 -31.26 0.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.486 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.84 43.26 2.97 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -125.44 170.28 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 30.8 mt -149.95 144.2 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.96 151.43 8.17 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.43 47.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -1.148 . . . . 0.0 110.24 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 22.8 mtt180 -89.97 12.95 16.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.926 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 5.1 m 66.64 57.23 0.69 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 109.867 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.583 ' HG2' HD12 ' A' ' 17' ' ' ILE . 8.3 mm-40 -108.09 -13.7 14.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.576 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.48 173.31 6.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.117 -0.989 . . . . 0.0 110.455 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.6 p -144.46 155.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.487 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 22.1 t0 -130.3 81.15 1.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.903 . . . . 0.0 110.328 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.08 -156.18 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 110.247 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.94 2.52 17.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.192 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 3' ' ' GLY . 6.2 mpt_? . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.328 0.585 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 mttp 51.42 -89.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.917 . . . . 0.0 110.246 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 1' ' ' ARG . . . 168.56 160.2 15.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -130.47 77.26 1.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -1.178 . . . . 0.0 110.312 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.538 ' CD1' HG22 ' A' ' 24' ' ' VAL . 72.5 m-85 -102.65 -153.21 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.002 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.5 m -128.62 135.81 49.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 110.239 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -94.57 130.32 41.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.77 126.61 92.91 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.132 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.85 169.4 22.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.944 1.497 . . . . 0.0 110.306 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.5 mmtt -57.88 -24.98 60.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -33.59 75.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.575 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 26.6 m-85 -106.11 12.21 30.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -89.59 40.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 110.241 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -85.91 -18.2 33.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.02 -1.05 . . . . 0.0 109.613 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.25 3.16 54.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.4 125.8 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 10.8 mm -79.95 -72.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.135 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 6.2 ptmm? -99.27 51.56 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.096 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -140.95 141.86 11.68 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -98.15 141.44 31.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -1.073 . . . . 0.0 109.898 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 37.3 t -117.01 123.21 46.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.564 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -94.14 104.35 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.6 t80 -92.39 117.73 30.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.494 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 5' ' ' PHE . 59.1 t -84.48 118.45 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.8 t -81.72 -66.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.612 -0.68 . . . . 0.0 110.526 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.83 -36.37 0.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -124.59 90.16 3.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 27' ' ' GLU . 21.0 tt0 -35.92 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.774 -0.579 . . . . 0.0 111.052 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 16.3 m -150.15 89.48 4.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.564 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.9 Cg_endo -74.49 115.92 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.144 1.602 . . . . 0.0 110.545 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.77 123.24 46.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.7 p -103.12 135.48 44.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.3 125.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.523 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 24.3 m -92.58 163.08 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.444 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -51.74 129.56 26.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -48.75 -48.35 40.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 45.61 3.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -111.88 162.15 15.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -1.217 . . . . 0.0 110.005 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 33.4 mm -143.82 146.52 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.32 158.62 10.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.47 -43.71 38.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -1.099 . . . . 0.0 110.235 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 22.6 mtt-85 -89.89 8.73 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.0 m 68.36 48.79 0.84 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 0.0 110.011 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.8 -26.11 10.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.929 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -91.64 178.69 5.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.171 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.3 p -144.31 150.94 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.278 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -98.41 67.7 1.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.871 . . . . 0.0 110.192 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -110.14 47.02 0.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.147 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -71.3 -8.37 53.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.888 . . . . 0.0 110.135 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.116 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.96 -176.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.91 165.56 43.85 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.41 ' O ' ' CG ' ' A' ' 4' ' ' HIS . 0.0 OUTLIER -156.63 74.1 0.8 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -1.187 . . . . 0.0 110.341 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.702 ' CD1' HG13 ' A' ' 24' ' ' VAL . 73.8 m-85 -109.23 -139.27 0.38 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 109.954 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -130.36 118.03 20.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.033 -1.042 . . . . 0.0 110.137 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.24 121.36 26.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 110.142 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -54.76 123.31 45.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.097 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.18 162.4 41.78 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.897 1.472 . . . . 0.0 110.392 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -58.03 -25.87 61.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.61 -35.7 78.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.485 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.18 9.85 38.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -90.07 48.01 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -85.86 -17.29 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 5.2 p90 -90.45 -0.3 57.6 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.224 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 110.83 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.952 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.2 mm -81.7 -66.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 1.8 ptpp? -89.77 53.72 2.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.203 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -158.06 179.97 33.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.7 OUTLIER -133.01 171.86 13.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -1.129 . . . . 0.0 110.045 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 43.4 t -152.34 120.47 6.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.8 ttp85 -90.45 111.38 22.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.998 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.59 108.1 20.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.406 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.702 HG13 ' CD1' ' A' ' 5' ' ' PHE . 4.3 t -84.17 115.22 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.983 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ALA . 70.3 t -80.3 -60.42 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.8 -35.6 1.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.264 -0.897 . . . . 0.0 109.4 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -127.18 94.76 4.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.516 -0.74 . . . . 0.0 109.047 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -35.75 91.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.72 -0.612 . . . . 0.0 111.234 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 29' ' ' THR . 9.9 m -150.02 80.19 7.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.6 Cg_endo -77.6 89.86 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.067 1.561 . . . . 0.0 110.756 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.1 p -91.23 124.98 35.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.008 . . . . 0.0 109.811 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.7 p -114.88 110.15 19.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 0.0 110.752 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' ARG . 57.8 t -107.66 163.99 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.798 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.1 m -127.64 161.61 28.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.082 -1.011 . . . . 0.0 110.407 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.561 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.81 127.72 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 22.4 pt-20 -50.64 -43.27 57.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 110.316 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -89.17 42.09 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -113.87 171.18 7.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -1.115 . . . . 0.0 110.253 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 38' ' ' TYR . 45.9 mt -150.08 127.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.16 144.22 5.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.75 88.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -1.128 . . . . 0.0 110.315 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 20.3 mtt180 -98.74 13.67 31.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 16.4 m 60.33 58.71 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 12.5 pt-20 -108.0 -31.1 8.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.32 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 13.6 mtp-105 -99.13 160.86 13.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.235 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.86 146.74 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -90.78 -67.56 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.253 -0.904 . . . . 0.0 110.227 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.3 mt -114.49 97.81 6.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -42.29 -27.94 0.17 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 48' ' ' LEU . 84.9 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.152 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.209 0.528 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.62 -174.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.152 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.79 108.24 0.98 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -137.14 65.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.11 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -113.08 -151.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.237 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -134.42 124.01 24.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.249 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.06 128.78 34.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -73.3 135.03 79.54 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 159.1 47.34 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.42 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -58.52 -32.0 68.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -61.65 -33.86 74.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.73 -2.37 44.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 0.0 110.147 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -90.02 55.53 3.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 0.0 110.41 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -86.32 -16.41 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.956 -1.09 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.447 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.9 p90 -90.1 2.63 55.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.428 -0.795 . . . . 0.0 109.115 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -155.68 111.75 3.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 18.9 mm -78.05 -73.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 110.43 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -89.89 57.5 3.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.117 -0.99 . . . . 0.0 110.364 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.487 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.52 155.74 26.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -111.88 140.42 46.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 21.1 t -115.59 123.32 48.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.492 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.6 108.27 20.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.1 112.7 24.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 40.3 t -82.07 113.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.81 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 26' ' ' ALA . 43.0 t -76.04 -64.21 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.526 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.25 -51.86 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 109.666 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 tt0 -109.0 92.43 4.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 108.964 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.7 OUTLIER -35.55 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.596 . . . . 0.0 111.065 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 29' ' ' THR . 7.8 m -149.61 85.67 5.64 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.15 95.74 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.077 1.567 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.8 p -95.08 128.39 41.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 110.049 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.4 p -107.42 96.98 6.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.481 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -90.87 148.44 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.118 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 18.5 m -128.24 160.34 32.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 16.9 m-20 -57.97 120.46 8.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.92 -32.49 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.97 42.18 2.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -123.7 168.52 12.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -1.123 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.436 HG13 ' C ' ' A' ' 38' ' ' TYR . 61.6 mt -149.55 152.01 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.869 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.03 173.48 19.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -44.18 11.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -1.125 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.2 mtm180 -92.79 18.53 8.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 12.9 m 61.61 41.68 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.455 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.6 pp20? -98.72 -25.27 14.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 110.435 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -90.91 161.5 15.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.085 -1.009 . . . . 0.0 109.969 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 49' ' ' PHE . 7.2 p -118.69 161.33 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.241 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.645 ' O ' HD22 ' A' ' 48' ' ' LEU . 23.9 t0 -98.1 -91.1 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.231 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 47' ' ' ASP . 1.5 mm? -123.93 60.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.307 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.49 ' HB2' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -64.28 -43.63 94.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.186 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.19 -179.899 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.24 0.543 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.4 -9.62 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 110.168 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.8 148.58 13.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.481 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 30.2 p-80 -158.73 86.34 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -1.155 . . . . 0.0 110.23 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.799 ' HD1' HG13 ' A' ' 24' ' ' VAL . 25.3 m-85 -104.18 -157.1 0.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.272 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -138.78 131.16 28.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.857 . . . . 0.0 110.173 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 124.3 32.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 119.8 77.67 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 178.52 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.865 1.455 . . . . 0.0 110.488 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 4.3 mtpt -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.358 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -59.27 -19.41 45.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.155 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -117.81 -0.95 11.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.3 ttpt -90.05 51.79 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -86.54 -14.09 43.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.044 -1.035 . . . . 0.0 109.31 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.3 2.54 55.4 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.51 -0.744 . . . . 0.0 109.082 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -159.87 112.61 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.932 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 24.0 mt -66.03 -76.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.412 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -96.77 69.43 2.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.423 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.3 152.57 23.37 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -111.69 141.69 44.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.899 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.4 t -126.19 134.4 51.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.638 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' OG ' ' A' ' 31' ' ' SER . 10.6 mmt180 -101.96 120.12 39.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.81 116.19 32.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.267 -0.895 . . . . 0.0 110.34 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.85 ' HB ' HG22 ' A' ' 29' ' ' THR . 2.2 t -90.42 125.73 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.079 -1.013 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 39.6 t -79.54 -64.64 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 110.324 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.68 -49.84 4.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.161 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.73 ' O ' HG22 ' A' ' 29' ' ' THR . 0.5 OUTLIER -105.44 71.69 0.94 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -29.99 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.376 0.608 . . . . 0.0 111.322 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.85 HG22 ' HB ' ' A' ' 24' ' ' VAL . 9.8 t -149.94 105.77 3.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.86 91.62 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.061 1.559 . . . . 0.0 110.113 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 22' ' ' ARG . 89.0 p -90.14 101.7 14.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 110.034 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 26.3 p -90.08 131.65 35.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.445 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -130.62 135.23 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.926 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.7 m -102.2 160.94 14.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 38.0 m-20 -54.66 115.06 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.841 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.8 OUTLIER -41.59 -39.5 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.891 . . . . 0.0 110.488 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 46.95 3.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -127.36 172.83 10.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -1.155 . . . . 0.0 110.32 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.429 HG13 ' C ' ' A' ' 38' ' ' TYR . 56.8 mt -148.17 149.56 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.9 161.45 12.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -43.04 20.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.218 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mmm180 -93.04 15.32 15.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 8.7 m 64.38 39.72 6.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.338 -0.851 . . . . 0.0 110.428 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.22 -22.43 17.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.617 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -100.18 162.43 12.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.295 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.461 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 7.2 p -133.33 151.05 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -93.02 33.81 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mt -138.65 168.36 19.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.221 -0.924 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.06 -62.95 1.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.135 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.224 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.271 0.558 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -69.08 -71.13 0.23 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.575 ' HA3' ' CZ ' ' A' ' 5' ' ' PHE . . . -45.89 -31.06 3.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.468 ' HB3' ' O ' ' A' ' 3' ' ' GLY . 5.9 t60 63.12 76.08 0.38 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -1.111 . . . . 0.0 110.36 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.575 ' CZ ' ' HA3' ' A' ' 3' ' ' GLY . 52.7 m-85 -109.51 -153.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.97 139.56 21.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.0 160.4 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 141.66 33.09 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 110.162 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.82 156.38 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.402 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -57.5 -30.28 64.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.385 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -35.32 78.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.951 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.497 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -96.11 0.29 51.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 47.63 1.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.442 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.29 -13.18 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 0.0 109.196 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.497 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.34 -0.67 57.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.514 -0.741 . . . . 0.0 109.38 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 122.16 3.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.8 mm -77.66 -78.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.999 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -89.85 52.99 2.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.057 -1.027 . . . . 0.0 110.29 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -142.26 137.72 8.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.94 134.92 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -1.169 . . . . 0.0 109.899 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.0 t -115.73 132.4 56.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.591 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -95.78 128.34 42.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.42 -0.8 . . . . 0.0 109.798 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -117.9 109.68 16.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.279 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.1 t -85.95 123.48 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.126 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.4 t -79.01 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.633 -0.667 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -50.23 3.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.397 -0.814 . . . . 0.0 109.525 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 38.0 tp10 -115.41 96.6 5.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.6 mm-40 -36.46 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 110.875 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 26.6 m -138.46 79.21 30.61 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.547 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.7 Cg_endo -78.54 80.58 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.207 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.9 p -90.22 132.45 35.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 29.7 p -106.65 128.04 53.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.8 122.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.353 -0.842 . . . . 0.0 110.199 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.7 m -89.16 159.11 17.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 7.0 m-20 -52.97 121.05 6.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -45.2 -40.85 7.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.86 3.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -122.05 170.19 10.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.17 . . . . 0.0 110.279 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' TYR . 56.6 mt -149.37 160.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.153 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.08 175.85 21.45 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.92 -44.94 10.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 3.2 ttm-85 -100.59 25.71 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.7 m 63.69 50.88 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.85 -34.68 8.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.607 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 164.46 14.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.504 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 p -117.29 161.69 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.883 . . . . 0.0 110.031 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.574 ' CG ' HD23 ' A' ' 48' ' ' LEU . 45.7 t0 -111.27 -71.25 0.77 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.92 . . . . 0.0 110.355 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.574 HD23 ' CG ' ' A' ' 47' ' ' ASP . 1.1 pt? -159.99 51.37 0.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 110.228 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.61 -40.95 40.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 0.0 110.215 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.132 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.539 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.84 -152.38 0.37 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.27 -174.46 1.0 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -123.97 46.1 2.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -1.133 . . . . 0.0 110.258 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.54 ' HD1' HG13 ' A' ' 24' ' ' VAL . 55.1 m-85 -114.51 -153.18 0.52 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.8 m -149.9 139.08 21.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.873 . . . . 0.0 110.232 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -93.21 147.77 22.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.309 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 56.8 m -89.93 109.36 32.13 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 47.4 Cg_endo -73.38 175.62 10.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.915 1.482 . . . . 0.0 110.46 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.1 ptmt -67.54 -26.16 66.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.03 14.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.502 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.52 13.9 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.982 . . . . 0.0 110.403 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 25.7 mtpt -90.04 47.2 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -85.61 -20.78 28.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.013 -1.055 . . . . 0.0 109.231 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 4.7 p90 -90.58 1.29 56.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.114 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -160.27 91.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 23.9 mm -54.13 -81.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.18 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -91.27 68.87 5.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.07 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.16 142.41 8.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 133.45 42.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.331 -1.1 . . . . 0.0 109.821 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.446 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 9.3 t -125.67 138.81 53.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.674 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.16 133.36 53.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.7 113.95 24.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 110.589 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.54 HG13 ' HD1' ' A' ' 5' ' ' PHE . 5.1 t -88.23 115.84 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.0 t -79.85 -59.62 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 110.349 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.84 -36.03 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 109.421 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -128.53 93.11 3.56 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.9 mt-30 -34.45 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.236 0.541 . . . . 0.0 111.239 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 53.8 m -146.8 84.28 7.65 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.368 -0.832 . . . . 0.0 110.376 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.84 96.05 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.122 1.591 . . . . 0.0 110.263 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.7 t -99.07 132.42 44.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.907 . . . . 0.0 110.259 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 30.6 p -118.75 124.41 47.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.53 117.93 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 26.0 m -92.41 163.21 13.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -49.71 126.41 13.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.35 -43.01 33.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 44.31 2.93 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -116.32 165.86 12.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -1.193 . . . . 0.0 110.249 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 39.7 mt -146.94 165.1 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.418 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 105.63 154.71 21.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.37 -13.61 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -1.208 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 29.2 mtt180 -120.9 16.65 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 8.7 m 64.16 27.8 14.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.212 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.69 -7.71 39.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.411 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.46 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -107.65 158.85 16.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.414 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.456 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 13.2 p -127.29 154.24 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.022 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 33.7 t70 -117.07 61.53 0.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.374 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HG ' ' N ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -93.64 -25.48 17.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.477 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 92.4 m-85 -81.52 9.04 8.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.41 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 33.9 p90 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 110.168 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.051 0.453 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 1' ' ' ARG . 14.2 ptpt 38.44 -153.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.597 -0.689 . . . . 0.0 110.511 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.443 ' N ' ' HG3' ' A' ' 2' ' ' LYS . . . -135.07 -115.77 1.55 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 1.4 m170 58.09 75.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -1.201 . . . . 0.0 110.267 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.853 ' CD1' HG13 ' A' ' 24' ' ' VAL . 44.9 m-85 -98.22 -142.42 0.31 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 110.163 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.53 151.69 38.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.84 133.33 52.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.912 . . . . 0.0 110.32 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 142.88 98.41 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.3 Cg_endo -73.55 167.35 27.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.052 1.554 . . . . 0.0 110.469 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -31.82 73.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -21.96 66.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.475 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.35 6.64 35.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 52.82 2.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.445 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -86.14 -14.83 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.99 -1.069 . . . . 0.0 109.171 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.5 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.35 -2.25 57.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.293 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 4.0 m -160.18 103.63 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 62.5 mt -55.37 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 0.0 109.904 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -93.55 66.68 3.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.908 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -155.96 147.45 16.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.4 mtt85 -105.62 135.93 46.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.975 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.5 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.5 t -108.38 132.85 53.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.513 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -97.83 105.57 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -97.15 112.2 24.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.387 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.853 HG13 ' CD1' ' A' ' 5' ' ' PHE . 23.9 t -85.52 117.43 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ALA . 8.3 t -77.88 -63.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.92 -56.12 2.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.5 tp10 -103.89 91.33 3.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.017 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.1 tp-100 -34.95 91.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.766 -0.583 . . . . 0.0 111.151 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' GLU . 58.0 m -148.23 82.78 7.48 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.3 Cg_endo -76.44 93.13 1.05 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.02 1.537 . . . . 0.0 110.355 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.7 t -101.27 141.19 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.2 p -110.89 134.05 52.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.338 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.09 120.75 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 110.061 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 27.0 m -87.63 159.89 18.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.467 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -47.58 120.06 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -44.78 -44.8 9.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.456 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 47.04 3.15 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -121.75 171.03 9.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 110.252 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.506 ' CG2' ' HD2' ' A' ' 45' ' ' ARG . 27.0 mt -149.66 146.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.89 169.41 14.41 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.8 -40.72 13.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.1 mtt180 -93.49 9.69 35.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.118 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.5 m 66.84 56.75 0.68 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 0.0 110.157 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.14 -25.7 8.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.421 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.506 ' HD2' ' CG2' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -89.61 151.2 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 110.203 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p -127.18 140.41 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 110.063 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.51 65.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.363 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.6 -9.19 10.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.192 -0.943 . . . . 0.0 110.254 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -74.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.167 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.234 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.211 0.529 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -107.32 13.65 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.918 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 120.86 149.69 8.25 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -168.82 60.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -1.132 . . . . 0.0 110.232 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -103.15 -155.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.171 -0.956 . . . . 0.0 110.168 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.95 140.01 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -86.35 150.23 24.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 6.7 m -83.9 127.1 68.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 163.65 36.98 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.891 1.469 . . . . 0.0 110.53 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 1.4 pttp -63.02 -29.95 71.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.131 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.42 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -62.46 -25.9 68.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.86 . . . . 0.0 110.32 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.411 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.6 m-85 -114.03 8.31 17.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -90.32 49.75 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.091 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.28 -11.43 52.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 0.0 109.472 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 12.6 p90 -87.18 -9.56 54.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.51 127.38 4.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 110.073 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 25.6 mt -86.98 -65.0 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CG ' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -90.14 50.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 0.0 110.425 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -158.98 137.3 5.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -89.71 -179.8 5.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -1.118 . . . . 0.0 109.575 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.487 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 12.9 t -160.19 125.95 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.898 -1.126 . . . . 0.0 110.892 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.31 114.07 26.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -96.87 111.48 23.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.451 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 10.4 t -84.0 118.02 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 9.6 t -74.04 -66.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.69 -62.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.4 tp10 -98.18 88.46 4.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.336 -0.853 . . . . 0.0 108.983 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.5 mm-40 -34.64 92.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.348 0.594 . . . . 0.0 110.968 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 29' ' ' THR . 13.8 m -144.22 83.62 9.96 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 110.556 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -77.97 84.43 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.094 1.576 . . . . 0.0 110.451 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -89.92 134.42 34.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.92 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 7.7 t -114.35 119.27 36.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 110.609 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 t -103.85 115.11 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.803 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.522 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 19.3 m -88.46 158.08 18.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -53.3 125.18 16.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.891 . . . . 0.0 110.032 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' ASP . 3.0 mm-40 -42.64 -45.97 4.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.429 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -90.45 49.35 3.18 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.683 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -117.81 158.81 24.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.265 . . . . 0.0 110.518 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 38' ' ' TYR . 33.5 mm -142.47 150.46 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.16 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.36 170.35 14.87 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.56 -48.11 11.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -1.146 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mtm105 -98.18 23.69 7.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.254 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.534 ' HB3' ' CG ' ' A' ' 18' ' ' LYS . 20.2 m 61.04 76.22 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.135 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -40.16 2.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 110.379 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -97.39 179.8 4.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 110.262 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 37' ' ' GLY . 2.8 p -142.62 144.29 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 110.232 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.533 ' HB2' ' CG1' ' A' ' 39' ' ' ILE . 13.4 t0 -97.21 -94.57 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -0.874 . . . . 0.0 110.111 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.48 174.62 13.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 109.988 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.2 -39.07 13.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 110.377 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.243 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.3 ptt-85 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.253 0.549 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -115.05 -179.73 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.214 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.15 119.69 0.52 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -136.35 72.22 1.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -1.145 . . . . 0.0 110.064 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.733 ' CD1' HG13 ' A' ' 24' ' ' VAL . 50.0 m-85 -102.89 -145.83 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.81 121.54 41.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 110.308 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.96 132.53 35.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.104 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 131.2 79.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.124 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 46.7 Cg_endo -73.31 173.04 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.956 1.503 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 10.0 mttm -67.63 -34.04 76.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.54 -8.68 35.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.432 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -116.1 -0.72 12.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.15 62.2 5.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -85.55 -21.05 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.089 . . . . 0.0 109.278 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 7.1 p90 -90.34 -2.18 57.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.105 178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.67 126.95 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.3 mm -89.04 -69.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.991 -1.068 . . . . 0.0 109.759 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' CD ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -93.12 63.63 3.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.158 -0.964 . . . . 0.0 110.054 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.436 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -155.32 143.67 10.15 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -101.38 124.79 47.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.206 . . . . 0.0 110.281 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.1 t -114.87 127.96 56.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 0.0 110.492 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -103.76 120.69 41.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -103.94 113.89 27.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.733 HG13 ' CD1' ' A' ' 5' ' ' PHE . 3.4 t -82.51 119.15 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.7 t -79.0 -64.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.678 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.34 -45.46 2.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -117.4 92.05 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -34.69 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.772 -0.58 . . . . 0.0 110.943 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.8 m -143.52 85.84 9.19 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.247 -0.908 . . . . 0.0 110.552 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.86 114.48 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.568 . . . . 0.0 110.533 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.448 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 17.6 m -119.03 126.38 51.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -0.91 . . . . 0.0 109.85 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 23.7 p -116.06 103.87 11.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.931 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.99 132.51 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.499 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 21.7 m -102.19 157.35 16.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -52.64 116.9 2.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 110.104 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.5 mm-40 -41.82 -48.19 4.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.373 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 50.74 3.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.545 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -121.64 171.6 8.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.098 -1.237 . . . . 0.0 110.361 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.545 HD12 ' C ' ' A' ' 38' ' ' TYR . 3.6 mp -147.19 138.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 110.135 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.14 159.17 9.45 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.69 -48.51 25.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.1 mtt180 -98.33 21.4 11.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.189 -0.944 . . . . 0.0 110.118 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.517 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 6.3 m 64.64 61.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -101.41 -31.19 11.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.134 -0.979 . . . . 0.0 110.62 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -108.37 163.54 13.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.456 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.511 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 10.2 p -149.22 161.94 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 110.057 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.93 43.58 2.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.365 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.41 -168.54 1.4 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 110.089 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -7.88 51.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.157 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.302 0.573 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.59 113.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 110.148 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.7 124.1 0.08 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.8 68.46 1.45 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 110.285 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.857 ' CD1' HG13 ' A' ' 24' ' ' VAL . 72.7 m-85 -142.95 -136.05 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.94 . . . . 0.0 110.022 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.42 129.23 26.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.986 -1.071 . . . . 0.0 110.253 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -86.09 142.12 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 110.17 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 4.0 m -78.61 126.95 81.9 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 110.074 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.6 Cg_endo -74.21 148.33 38.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.887 1.467 . . . . 0.0 110.409 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.2 ttpt -58.93 -29.93 67.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -61.44 -34.18 74.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.364 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.462 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 10.9 m-85 -101.43 7.09 42.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.31 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 2.2 mttt -86.16 60.98 6.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.082 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -85.69 -19.11 31.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.004 -1.06 . . . . 0.0 109.31 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.0 p90 -90.72 -1.95 57.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.45 -0.781 . . . . 0.0 109.187 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.3 106.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.1 mm -81.63 -64.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.219 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.82 49.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.314 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -152.58 175.85 31.01 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.1 157.18 33.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -1.05 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 43.6 t -141.41 119.51 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -95.97 109.5 21.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 109.862 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -96.82 105.53 17.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.466 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.857 HG13 ' CD1' ' A' ' 5' ' ' PHE . 57.6 t -84.49 114.6 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' ALA . 59.9 t -72.9 -59.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -65.77 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 109.415 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 tp10 -95.67 93.24 7.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 27' ' ' GLU . 4.8 mp0 -34.67 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.346 0.593 . . . . 0.0 111.151 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.702 HG22 ' O ' ' A' ' 29' ' ' THR . 4.5 m -147.0 78.98 10.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.454 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.2 Cg_endo -79.39 86.03 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.093 1.575 . . . . 0.0 110.279 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.4 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 t -90.53 133.4 35.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -129.33 101.65 6.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.31 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 34' ' ' CYS . 88.7 t -103.97 166.6 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.298 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' N ' HG12 ' A' ' 33' ' ' VAL . 34.1 m -112.88 164.33 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.306 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.531 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.9 m-20 -64.63 117.38 7.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.367 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -44.47 -41.45 6.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.12 46.07 3.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.38 175.74 7.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -1.171 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 37.5 mt -146.44 152.1 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.055 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.58 161.29 19.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.8 -49.52 12.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 21.1 mmt-85 -90.25 15.65 10.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.981 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 4.2 m 67.7 50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.801 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -101.27 0.22 36.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.493 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.28 164.05 23.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.384 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p -130.81 157.62 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.087 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -102.26 50.7 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -141.03 -38.54 0.42 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.102 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.32 -30.81 71.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 110.231 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.16 179.954 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.19 0.519 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.45 116.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.878 . . . . 0.0 110.216 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.19 -179.09 20.35 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -169.06 95.46 0.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -1.148 . . . . 0.0 110.307 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -117.42 -150.58 0.46 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.107 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.7 m -136.61 130.43 32.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.983 . . . . 0.0 110.312 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.65 124.25 31.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -52.39 129.3 42.7 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.119 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.2 155.71 51.67 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.98 1.516 . . . . 0.0 110.388 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -59.97 -25.1 64.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -63.17 -33.08 74.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.248 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.548 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 m-85 -103.61 10.37 36.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -90.05 43.29 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -86.13 -13.71 46.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.41 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.45 2.59 55.52 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.763 . . . . 0.0 109.185 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -157.41 125.5 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.136 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 35.7 mm -83.02 -81.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.409 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.8 OUTLIER -89.69 57.47 3.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.134 -0.979 . . . . 0.0 110.268 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -149.04 160.08 28.27 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 20.9 ptt180 -116.81 139.23 50.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -1.087 . . . . 0.0 109.694 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.507 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.2 t -114.31 135.3 54.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.791 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 ttp85 -97.96 124.0 42.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.5 t80 -112.09 110.78 21.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.566 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 12.5 t -90.12 123.01 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.926 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 97.1 t -83.06 -56.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.69 -29.79 0.1 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 0.0 109.648 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.6 mt-10 -141.41 96.53 3.0 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.5 mt-30 -33.6 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.212 0.529 . . . . 0.0 111.301 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' GLU . 91.0 m -140.64 83.15 15.03 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.308 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.0 Cg_endo -82.4 83.84 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.174 1.618 . . . . 0.0 110.409 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.403 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 26.8 t -89.82 134.05 34.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.9 p -101.68 132.38 47.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 3.5 t -126.96 151.23 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.332 -0.855 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 19.5 m -123.47 162.0 23.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 110.388 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -57.66 121.05 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.206 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -44.39 -38.95 4.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.168 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 46.05 3.06 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.33 163.92 20.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -1.157 . . . . 0.0 110.187 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.9 mt -137.41 160.46 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.18 166.95 31.49 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.51 -35.88 16.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -91.55 7.2 42.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.14 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.9 m 69.25 44.68 0.94 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.404 -0.81 . . . . 0.0 110.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -100.28 -25.64 14.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.477 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 3.2 mmt180 -92.41 163.49 13.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -141.49 146.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -111.89 49.89 0.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.95 . . . . 0.0 110.329 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.35 -54.57 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.208 -0.932 . . . . 0.0 110.131 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.427 ' O ' ' OXT' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -57.93 -65.66 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.427 ' OXT' ' O ' ' A' ' 49' ' ' PHE . 16.4 m-85 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.234 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 2' ' ' LYS . 3.5 mtt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.265 0.555 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 1' ' ' ARG . 15.7 mmmt 55.56 163.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.329 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.92 134.54 12.3 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.43 ' O ' ' CG ' ' A' ' 4' ' ' HIS . 46.7 t-80 -146.13 49.01 1.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.141 . . . . 0.0 110.217 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.526 ' CD1' HG13 ' A' ' 24' ' ' VAL . 52.7 m-85 -120.01 -146.2 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.268 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 m -119.07 135.19 54.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.171 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.12 109.11 21.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.305 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -48.61 120.35 8.84 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 43.4 Cg_endo -70.67 175.57 8.68 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.858 1.451 . . . . 0.0 110.525 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -60.27 -41.6 93.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.551 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.98 -19.6 66.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.441 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.467 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -99.98 -9.37 22.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.193 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 2.1 ttpt -87.82 57.55 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 110.145 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -85.76 -17.4 35.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 6.3 p90 -89.98 -2.53 58.16 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.147 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.36 127.75 4.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 45.5 mt -82.23 -74.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 110.424 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -89.78 64.43 6.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 0.0 110.471 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HD2' ' A' ' 13' ' ' LYS . . . -160.15 133.19 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -95.48 132.75 40.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -1.167 . . . . 0.0 109.765 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 32.1 t -118.75 132.31 56.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.004 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -98.15 124.02 42.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -111.89 112.81 24.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 110.498 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 5' ' ' PHE . 11.6 t -84.72 117.36 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.202 -0.936 . . . . 0.0 109.975 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.4 t -80.86 -63.05 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 110.436 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.17 -39.43 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.613 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -123.0 92.37 3.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -35.04 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.21 0.529 . . . . 0.0 111.077 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 29' ' ' THR . 3.8 m -148.25 83.37 7.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.233 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.8 Cg_endo -82.79 132.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.145 1.603 . . . . 0.0 110.431 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 p -148.81 118.13 6.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.863 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 12.1 t -95.83 153.88 17.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.645 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -139.57 121.6 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.491 -0.756 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.6 m -96.94 158.22 15.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -49.51 128.47 17.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -46.5 -47.4 19.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.331 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.14 45.4 3.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.595 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -113.28 163.86 14.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -1.191 . . . . 0.0 110.1 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 47' ' ' ASP . 31.6 mm -138.76 153.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.97 144.97 11.97 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -34.27 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -1.109 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.454 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.0 mtt180 -93.76 4.86 53.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.18 43.89 1.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.99 -13.14 15.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.465 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -109.51 166.99 10.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.28 149.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.476 ' HB2' HG12 ' A' ' 39' ' ' ILE . 14.5 t0 -107.81 57.27 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 110.356 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.64 168.61 18.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.923 . . . . 0.0 110.272 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -85.67 -1.39 57.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.422 ' OXT' ' CD1' ' A' ' 50' ' ' TYR . 6.2 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.252 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.246 0.546 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.39 -84.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.167 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.15 116.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -150.95 70.36 0.99 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -1.149 . . . . 0.0 110.25 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.542 ' HD1' HG13 ' A' ' 24' ' ' VAL . 76.1 m-85 -92.19 -153.45 0.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.905 . . . . 0.0 110.166 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m -138.35 137.54 37.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -100.3 113.94 27.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 124.95 78.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.176 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.42 178.03 7.18 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.859 1.452 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -65.98 -25.65 67.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -19.91 66.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 4.3 m-85 -110.92 11.06 22.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 110.207 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 34.2 mmtm -88.93 47.6 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -85.49 -23.15 27.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.993 -1.067 . . . . 0.0 108.918 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.9 p90 -90.39 -0.76 57.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -160.68 116.19 2.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 109.901 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 32.6 mt -76.65 -63.97 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -104.36 73.8 1.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.098 -1.001 . . . . 0.0 110.417 179.764 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.31 178.27 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 1.7 mtt180 -131.15 119.89 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.164 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 15.1 t -107.09 132.3 53.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -104.64 120.8 42.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 109.993 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -104.49 106.72 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.477 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG13 ' HD1' ' A' ' 5' ' ' PHE . 24.2 t -81.58 119.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.13 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 26' ' ' ALA . 25.7 t -80.75 -62.99 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.499 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.3 -49.74 2.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.4 -0.812 . . . . 0.0 109.749 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 5.4 mt-10 -113.32 91.95 3.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.48 -0.763 . . . . 0.0 109.0 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -33.54 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.273 0.559 . . . . 0.0 111.322 -179.075 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 41.0 m -147.92 82.71 7.72 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.6 Cg_endo -77.03 86.69 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.113 1.586 . . . . 0.0 110.352 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.65 143.85 26.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 109.791 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 20.2 p -124.03 132.5 53.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 34' ' ' CYS . 58.6 t -125.45 169.68 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 109.801 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.3 m -140.67 162.32 35.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.39 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.555 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.4 m-20 -49.22 123.67 7.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -47.86 -45.79 30.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.71 3.02 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.816 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -115.44 174.0 6.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 110.217 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.816 HD12 ' C ' ' A' ' 38' ' ' TYR . 4.2 mp -150.48 147.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.141 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.99 152.97 10.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.44 -30.91 57.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -1.104 . . . . 0.0 109.975 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.16 5.33 44.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 3.9 m 68.92 66.3 0.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 -30.88 2.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.002 -1.061 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -95.97 107.07 19.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.963 -1.086 . . . . 0.0 110.506 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.763 HG12 ' CD2' ' A' ' 49' ' ' PHE . 12.2 p -89.35 154.7 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 110.447 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' HB2' HD11 ' A' ' 39' ' ' ILE . 15.7 t70 -90.97 18.62 6.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 110.235 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.408 ' H ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -157.51 64.66 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.251 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.763 ' CD2' HG12 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -87.58 -54.24 4.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.243 -179.996 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.263 179.93 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.212 0.53 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -54.94 136.91 46.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 67.1 -133.82 31.35 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.5 t60 57.63 85.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.604 ' CD1' HG13 ' A' ' 24' ' ' VAL . 25.2 m-85 -90.81 -156.75 0.45 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.89 . . . . 0.0 110.171 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.62 134.67 47.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HG2' ' NH1' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -90.56 133.32 35.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.139 179.926 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -73.99 152.8 88.76 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -72.63 158.06 51.34 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.005 1.529 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -26.78 65.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -6.22 26.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.491 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -120.02 4.95 10.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.349 179.964 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.523 ' NZ ' ' OH ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -81.48 75.16 8.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -85.25 -25.45 27.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.018 -1.051 . . . . 0.0 109.407 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.523 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 3.3 p90 -90.45 2.97 55.15 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.95 178.065 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 1.7 m -160.81 119.77 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 43.1 mm -75.52 -71.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -99.95 68.82 1.51 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.256 179.768 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -159.97 141.25 7.32 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.9 ptp180 -96.37 143.57 27.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -1.13 . . . . 0.0 109.878 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 31' ' ' SER . 10.4 t -123.22 125.25 44.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' CZ ' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -94.5 117.75 30.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.901 179.625 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.93 112.71 25.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.322 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.604 HG13 ' CD1' ' A' ' 5' ' ' PHE . 9.0 t -85.55 119.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.134 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 58.1 t -77.41 -67.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 110.382 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.76 -45.98 3.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.423 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.8 tt0 -112.53 86.94 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.314 0.578 . . . . 0.0 110.992 -179.164 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 80.9 m -145.01 85.76 8.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.0 Cg_endo -76.39 84.44 1.85 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.033 1.544 . . . . 0.0 110.146 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 68.1 m -90.09 128.39 36.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.258 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 24.7 p -107.23 97.05 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' ARG . 98.4 t -89.63 120.78 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.023 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -86.94 157.71 19.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -48.75 118.33 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.129 179.934 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -45.93 -41.27 11.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 110.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.96 43.04 2.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -120.41 176.3 5.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 21.9 mt -150.33 136.94 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.41 166.15 12.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.77 -38.43 18.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -1.081 . . . . 0.0 110.05 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -99.34 17.55 19.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.002 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 8.2 m 63.62 43.65 5.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.1 tt0 -93.7 -32.7 13.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.492 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -95.07 158.9 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.01 . . . . 0.0 110.199 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.47 ' HB ' ' HD3' ' A' ' 18' ' ' LYS . 7.3 p -147.39 149.58 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.09 47.99 1.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.78 -71.71 0.72 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 110.187 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -75.24 -47.0 30.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 33.0 t80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.263 179.938 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.274 0.559 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -164.08 -50.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.461 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . 116.57 -88.1 0.45 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.425 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 1.8 t-80 65.2 68.11 0.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -1.16 . . . . 0.0 110.186 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CE2' ' HA3' ' A' ' 3' ' ' GLY . 30.5 m-85 -103.06 -143.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 110.268 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.31 143.78 34.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 142.32 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.78 137.31 92.67 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.68 164.39 35.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.046 1.551 . . . . 0.0 110.382 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -62.61 -30.98 71.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 110.24 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -66.45 -19.96 65.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.358 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -109.94 5.64 22.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.88 50.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 110.035 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -86.15 -17.55 34.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 109.115 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -91.15 0.57 57.5 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.069 178.169 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.43 98.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.6 mt -65.69 -73.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.953 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ptpm? -89.61 52.78 2.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -0.924 . . . . 0.0 110.12 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -148.66 165.96 29.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -123.35 130.28 52.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -1.187 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.468 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.3 t -118.27 128.1 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.447 -179.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.81 139.66 30.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 110.02 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -117.56 110.87 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 27' ' ' GLU . 63.9 t -82.02 116.88 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -78.7 -63.88 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.652 -0.655 . . . . 0.0 110.221 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.26 -49.6 5.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -111.35 90.21 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.914 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.8 tt0 -35.45 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.238 0.542 . . . . 0.0 111.041 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' GLU . 18.0 m -148.36 86.96 5.79 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.892 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.02 93.47 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.093 1.575 . . . . 0.0 110.5 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 p -93.29 124.3 37.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 31.3 p -105.93 128.0 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.78 158.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 110.109 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 13.1 m -125.41 159.2 32.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 110.33 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -52.99 118.61 3.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 35' ' ' ASP . 43.3 mm-40 -42.44 -40.94 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.96 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . -90.05 47.48 3.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -125.0 172.47 9.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -1.203 . . . . 0.0 110.281 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 41.9 mt -146.52 140.89 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.22 160.88 11.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 -40.49 22.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.117 . . . . 0.0 110.23 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 6.2 mpt_? -93.25 9.65 35.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.131 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.49 47.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -0.843 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 8.7 tt0 -104.17 -18.23 14.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -101.18 156.2 17.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.834 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.26 149.12 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.372 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 9.4 t70 -93.07 -65.24 1.01 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.43 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 170.61 7.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.16 -0.962 . . . . 0.0 110.273 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.68 -57.24 3.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.342 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 18.2 t80 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.25 -179.948 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 2' ' ' LYS . 18.7 mtm-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.316 0.579 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 1' ' ' ARG . 0.1 OUTLIER 44.13 80.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.54 ' HA2' ' CZ ' ' A' ' 5' ' ' PHE . . . 54.69 -114.88 4.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.448 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER 66.73 75.13 0.33 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.279 -1.13 . . . . 0.0 110.271 -179.975 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.54 ' CZ ' ' HA2' ' A' ' 3' ' ' GLY . 58.6 m-85 -116.03 -154.26 0.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.061 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -119.91 128.46 53.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.419 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -83.37 141.78 31.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.033 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -84.08 129.97 56.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.946 . . . . 0.0 110.177 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.18 157.47 50.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.93 1.49 . . . . 0.0 110.29 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -18.33 64.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -65.18 -19.19 65.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -119.76 21.1 12.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.201 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.29 50.25 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.883 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -86.11 -16.85 36.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.053 . . . . 0.0 109.313 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 3.5 p90 -90.4 4.2 51.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.237 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -158.74 109.25 2.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.21 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.479 ' HA ' HD13 ' A' ' 17' ' ' ILE . 10.6 mm -64.3 -70.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 7.9 ptmm? -105.73 55.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -146.83 150.8 23.11 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 179.42 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 0.0 109.856 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 8.4 t -154.73 132.9 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.443 ' HD3' ' CG2' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -107.9 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 109.803 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.89 110.6 22.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.583 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.443 ' CG2' ' HD3' ' A' ' 22' ' ' ARG . 48.3 t -84.43 111.86 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 26' ' ' ALA . 37.7 t -74.09 -59.83 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.667 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.34 -59.51 1.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.466 -0.771 . . . . 0.0 109.499 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 63.1 mt-10 -104.0 92.45 4.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 108.97 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.1 tt0 -33.62 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.811 -0.556 . . . . 0.0 111.153 -179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 19.2 m -149.42 88.49 4.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.35 91.75 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.024 1.539 . . . . 0.0 110.396 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.435 ' OG ' ' HD2' ' A' ' 22' ' ' ARG . 2.3 p -90.06 148.82 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.841 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -135.13 116.43 14.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.701 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.06 157.18 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 19.3 m -122.44 161.3 23.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.357 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.2 m-20 -49.64 124.43 9.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -47.05 -41.65 17.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 110.258 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 43.29 2.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -117.04 168.27 10.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -1.19 . . . . 0.0 110.257 179.82 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 38' ' ' TYR . 48.8 mt -150.37 156.92 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.24 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.64 162.02 18.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.74 -28.77 30.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -105.69 17.57 23.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.493 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 16.7 m 61.68 35.69 16.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -100.29 -17.0 17.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.4 170.18 8.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.03 155.01 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.057 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -92.05 -76.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.357 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.583 ' C ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -160.32 -33.0 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.195 -0.941 . . . . 0.0 110.669 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.493 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -51.66 -73.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.046 -1.034 . . . . 0.0 110.269 -179.951 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.089 179.945 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.23 0.538 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -50.26 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.281 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.1 -95.56 2.04 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.95 93.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.695 ' CD1' HG13 ' A' ' 24' ' ' VAL . 39.9 m-85 -115.9 -151.6 0.49 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -124.44 125.21 43.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.198 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.71 118.73 23.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 124.37 83.57 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.053 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.19 160.99 45.86 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.312 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -51.52 -24.03 4.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.35 -45.35 93.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 110.308 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.539 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.6 m-85 -94.24 10.56 33.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 37.8 mttt -84.93 46.63 1.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -86.21 -13.93 45.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.407 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 7.8 p90 -90.53 -5.13 56.35 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.089 178.29 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.03 132.58 10.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -0.918 . . . . 0.0 110.372 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 30.7 mm -80.35 -71.89 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.942 . . . . 0.0 110.141 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -101.77 69.11 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 0.0 110.303 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -155.36 159.35 29.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.427 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.39 140.68 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -1.155 . . . . 0.0 109.945 179.833 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -116.29 138.2 51.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -110.1 104.0 12.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.79 113.14 24.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.376 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.695 HG13 ' CD1' ' A' ' 5' ' ' PHE . 7.1 t -86.12 121.45 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.879 . . . . 0.0 109.933 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -74.86 -62.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.619 -0.675 . . . . 0.0 110.524 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.26 -66.98 0.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' THR . 26.3 mt-10 -97.95 92.15 5.66 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 108.893 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -33.62 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.289 0.566 . . . . 0.0 110.993 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.9 m -137.4 80.92 32.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.485 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.588 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.1 Cg_endo -74.48 83.09 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.111 1.585 . . . . 0.0 110.042 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 t -90.16 145.74 24.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.328 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.16 145.59 45.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.911 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 76.5 t -143.21 153.54 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 109.888 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 15.5 m -125.45 157.58 36.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.975 . . . . 0.0 110.353 -179.692 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 19.4 m-20 -51.92 118.65 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 3.6 tp10 -43.24 -37.2 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.962 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 45.86 3.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.86 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -125.17 160.93 27.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -1.151 . . . . 0.0 110.297 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 38' ' ' TYR . 19.3 mm -142.7 158.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 109.923 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.12 174.77 19.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.37 -47.68 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -1.145 . . . . 0.0 110.35 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -90.01 18.78 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.175 -179.894 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.6 m 62.65 38.11 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -98.46 -13.71 20.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.255 -0.903 . . . . 0.0 110.326 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -103.38 169.94 8.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 8.0 p -148.36 151.58 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 110.347 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.75 71.35 0.77 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.53 110.48 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.329 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.61 -17.54 8.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.255 -0.903 . . . . 0.0 110.027 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.224 -180.0 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.206 0.526 . . . . 0.0 110.187 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.52 -89.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 110.195 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 1' ' ' ARG . . . 102.45 138.68 10.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -92.72 44.27 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.353 -1.087 . . . . 0.0 110.178 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.714 ' CD1' HG22 ' A' ' 24' ' ' VAL . 64.8 m-85 -109.69 -152.31 0.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.858 . . . . 0.0 110.203 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.5 m -130.71 130.12 43.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 150.54 24.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 119.66 69.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' C ' ' HE3' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -72.72 173.91 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.809 1.426 . . . . 0.0 110.446 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.461 ' N ' ' HE3' ' A' ' 13' ' ' LYS . 17.0 mttm -66.52 -24.89 66.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 0.0 110.381 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.65 -10.96 30.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.295 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.526 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 12.5 m-85 -129.2 10.9 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.304 -0.873 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HE3' ' N ' ' A' ' 10' ' ' LYS . 19.0 mttt -86.21 45.96 1.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.227 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.28 -14.4 43.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.046 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.04 -1.06 57.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 178.38 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 1.8 m -160.28 129.25 4.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.035 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 5.0 mt -87.42 -63.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.074 -1.016 . . . . 0.0 110.108 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.527 ' HE3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -103.11 60.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.257 179.574 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.17 162.38 33.17 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -107.57 -178.83 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -1.19 . . . . 0.0 110.031 179.86 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -160.46 126.91 4.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -104.41 115.43 30.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -100.06 116.03 31.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.542 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.714 HG22 ' CD1' ' A' ' 5' ' ' PHE . 52.6 t -87.26 115.56 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.97 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.6 t -75.36 -61.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.19 -62.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.607 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -99.82 93.18 5.66 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 108.927 178.767 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.1 pt20 -34.92 91.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.74 -0.6 . . . . 0.0 111.143 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 9.0 m -146.19 86.22 7.12 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -76.42 98.08 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.067 1.561 . . . . 0.0 110.643 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 m -100.41 138.98 36.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.6 p -121.14 110.72 16.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.143 -0.973 . . . . 0.0 110.628 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ARG . 60.8 t -93.91 155.32 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.0 109.886 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.608 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 7.1 m -127.92 157.3 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.222 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.526 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 1.4 m-20 -48.76 125.76 10.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.55 -47.21 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 110.085 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.26 46.26 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.79 175.32 5.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -1.169 . . . . 0.0 110.328 -179.952 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 38' ' ' TYR . 3.5 mp -145.05 130.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.82 155.51 9.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.51 -41.04 40.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -1.179 . . . . 0.0 110.208 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 9.6 mtp180 -89.59 7.68 35.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.513 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 6.7 m 64.2 72.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.799 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.48 ' CA ' ' HD3' ' A' ' 18' ' ' LYS . 7.0 pt-20 -119.65 -25.09 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.658 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.438 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -112.49 95.15 5.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.787 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.527 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 14.9 p -89.98 154.75 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.27 47.89 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.56 41.45 0.87 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -55.47 20.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.199 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.225 179.912 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.25 0.548 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.7 146.85 36.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.232 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.44 111.22 3.76 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -119.46 -119.02 0.31 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.235 -1.156 . . . . 0.0 109.78 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.813 ' CD1' HG13 ' A' ' 24' ' ' VAL . 86.8 m-85 -97.85 -131.74 0.21 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 110.104 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.54 146.67 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.933 -1.104 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -79.98 154.46 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -81.93 136.32 47.61 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.68 156.54 49.0 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.986 1.519 . . . . 0.0 110.426 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 13' ' ' LYS . 9.9 ttpt -63.22 -27.86 69.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -20.5 27.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 110.271 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.5 m-85 -125.4 6.38 7.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -86.5 39.62 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.054 179.759 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -86.13 -12.48 49.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.04 -1.037 . . . . 0.0 109.604 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.6 p90 -90.12 1.56 56.26 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.457 -0.777 . . . . 0.0 109.288 178.648 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -159.67 109.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 46.5 mm -70.14 -74.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -96.28 60.39 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.973 -1.079 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -148.39 141.99 9.6 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.7 45.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -1.166 . . . . 0.0 110.155 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 8.5 t -113.94 126.5 55.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.428 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.12 111.75 23.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 110.032 179.704 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -96.01 112.67 24.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.0 110.552 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.813 HG13 ' CD1' ' A' ' 5' ' ' PHE . 38.5 t -86.58 115.73 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.95 . . . . 0.0 109.976 179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 26' ' ' ALA . 62.5 t -73.08 -60.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.573 -0.704 . . . . 0.0 110.494 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.84 -66.73 0.3 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.1 tp10 -99.13 93.67 6.1 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.894 178.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tt0 -34.51 91.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.761 -0.587 . . . . 0.0 111.141 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' GLU . 39.6 m -143.71 84.19 10.06 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.7 Cg_endo -77.35 89.22 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.076 1.566 . . . . 0.0 110.446 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.432 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 78.4 p -89.76 131.5 35.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.069 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 23.5 p -113.91 108.5 17.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.628 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -109.66 130.39 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.969 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.1 m -94.35 162.28 13.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.185 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 18.1 m-20 -56.91 117.68 4.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.72 -38.01 2.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.55 45.7 3.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -126.49 171.06 11.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -1.14 . . . . 0.0 110.282 -179.959 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 2.3 mp -147.39 150.56 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 167.83 16.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.53 -37.41 16.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 46.5 mtt180 -96.55 18.72 13.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.038 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.498 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 12.1 m 61.42 41.1 13.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -93.98 -37.3 11.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 110.671 -179.597 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -85.44 163.99 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.256 -179.729 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.02 157.53 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.23 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' OD1' HD11 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -97.13 32.9 2.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.945 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.88 118.16 9.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.234 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -69.6 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.382 -0.824 . . . . 0.0 110.164 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.1 t80 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.182 179.956 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.239 0.542 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -157.39 133.91 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.591 ' O ' ' CE2' ' A' ' 5' ' ' PHE . . . -49.68 -70.68 0.75 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER 73.53 47.96 0.16 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.378 -1.072 . . . . 0.0 110.484 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.591 ' CE2' ' O ' ' A' ' 3' ' ' GLY . 81.0 m-85 -142.24 -148.6 0.24 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.357 -0.839 . . . . 0.0 109.567 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.53 133.43 22.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -96.31 152.0 18.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.877 . . . . 0.0 110.382 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' O ' ' CE ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.13 134.05 32.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.163 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.3 Cg_endo -74.12 161.53 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.866 1.456 . . . . 0.0 110.425 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -31.54 72.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -64.09 -12.22 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 110.328 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.406 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -119.68 -3.23 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.143 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.517 ' CE ' ' O ' ' A' ' 8' ' ' CYS . 18.1 mttt -84.38 62.82 7.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.322 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -85.67 -19.56 30.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.911 -1.118 . . . . 0.0 109.246 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.8 p90 -90.39 -2.9 57.99 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.046 178.253 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.68 106.72 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.607 HG22 ' HD2' ' A' ' 18' ' ' LYS . 18.2 mm -78.53 -62.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.112 -0.993 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HD2' HG22 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -90.4 57.37 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 110.374 -179.834 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' A' ' 13' ' ' LYS . . . -160.05 152.53 23.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -108.56 120.92 43.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -1.122 . . . . 0.0 109.993 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.0 t -99.97 128.71 46.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.653 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -100.5 109.73 21.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 109.718 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.96 104.75 16.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.573 HG13 ' CD1' ' A' ' 5' ' ' PHE . 21.0 t -80.66 120.93 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.071 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.3 t -76.67 -71.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 110.382 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.08 -47.36 4.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.4 tt0 -108.7 81.79 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -33.8 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.391 0.615 . . . . 0.0 111.105 -179.114 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 79.7 m -143.77 82.62 11.09 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.39 84.55 2.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.437 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 23.4 m -93.0 151.52 19.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.144 -0.972 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 31.5 p -127.44 127.88 44.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -116.76 148.54 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 70.6 m -116.41 144.52 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-20 -56.36 119.15 5.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.75 -37.98 4.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 45.02 2.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.27 172.23 9.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -1.163 . . . . 0.0 110.313 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.48 HG13 ' HB2' ' A' ' 47' ' ' ASP . 18.0 mt -150.0 157.49 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.122 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.65 154.6 20.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -42.15 55.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.031 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -90.05 8.46 32.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.886 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.465 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 4.4 m 68.73 43.41 1.28 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 109.996 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -101.84 -22.28 14.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.309 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -95.52 169.7 9.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.262 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.06 153.81 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.48 ' HB2' HG13 ' A' ' 39' ' ' ILE . 27.0 t0 -102.61 -86.87 0.42 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.277 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -95.33 -4.1 46.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.277 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.459 ' O ' ' OXT' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -82.73 6.88 16.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.137 179.916 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.459 ' OXT' ' O ' ' A' ' 49' ' ' PHE . 34.8 t80 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.18 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.259 0.552 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -175.21 -143.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 179.967 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.503 ' N ' ' HG3' ' A' ' 2' ' ' LYS . . . -68.49 97.09 0.45 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.69 78.23 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -1.172 . . . . 0.0 110.174 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.499 ' HD1' HG13 ' A' ' 24' ' ' VAL . 37.7 m-85 -118.81 -157.29 0.68 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.89 . . . . 0.0 110.227 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -132.79 130.12 39.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.156 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.46 130.73 34.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 127.05 90.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.277 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.76 167.48 27.1 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.921 1.485 . . . . 0.0 110.458 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.491 ' HG2' ' HE2' ' A' ' 13' ' ' LYS . 5.4 mttt -66.16 -27.24 67.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.186 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -20.44 49.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.238 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -123.71 2.68 8.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HE2' ' HG2' ' A' ' 10' ' ' LYS . 5.1 ttpt -87.03 54.75 3.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -86.33 -15.02 41.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.097 -1.002 . . . . 0.0 109.309 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.5 p90 -90.2 1.93 55.93 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.524 -0.735 . . . . 0.0 109.128 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' HA ' ' SG ' ' A' ' 43' ' ' CYS . 1.5 m -157.42 79.12 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.834 . . . . 0.0 109.999 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 44' ' ' GLU . 83.7 mt -48.7 -55.15 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.427 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 5.9 ptmm? -112.24 60.95 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.478 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -157.49 141.24 7.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 123.51 40.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -1.113 . . . . 0.0 109.936 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 31' ' ' SER . 11.0 t -111.0 127.68 55.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.111 -0.993 . . . . 0.0 110.587 -179.595 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.61 119.39 34.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.868 . . . . 0.0 109.822 179.604 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.31 106.16 17.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 21.3 t -80.24 118.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' ALA . 73.1 t -80.28 -58.44 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.703 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.49 -50.73 3.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 mt-10 -116.06 96.6 5.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.879 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.3 tp-100 -34.84 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.78 -0.575 . . . . 0.0 111.201 -179.089 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 29' ' ' THR . 3.9 m -146.17 82.66 8.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.253 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.438 ' HD3' ' OE1' ' A' ' 28' ' ' GLN . 51.1 Cg_endo -79.56 89.06 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.108 1.583 . . . . 0.0 110.43 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -94.65 131.15 40.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.993 179.83 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 27.4 p -113.87 114.38 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.2 129.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.848 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 8.3 m -101.85 161.76 13.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.126 -0.984 . . . . 0.0 110.42 -179.388 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 63.0 m-20 -58.85 119.8 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 37' ' ' GLY . 10.3 pt-20 -43.9 -33.43 1.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' N ' ' HG3' ' A' ' 36' ' ' GLU . . . -90.28 43.83 2.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -126.24 170.65 11.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -1.2 . . . . 0.0 110.414 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 29.3 mt -150.15 151.7 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.64 169.57 17.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -40.82 13.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 110.237 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.8 mpt_? -91.02 10.9 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 6.3 m 66.54 41.45 3.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.872 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HB3' HD12 ' A' ' 17' ' ' ILE . 5.6 pt-20 -100.11 -28.29 13.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -84.88 163.24 19.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.231 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.4 p -139.81 157.17 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.27 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -123.98 36.36 4.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.88 . . . . 0.0 110.119 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.75 71.61 0.8 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -88.88 -72.1 0.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.172 -179.837 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.234 0.54 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.65 88.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.899 . . . . 0.0 110.248 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.4 101.49 0.2 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -150.28 58.48 0.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -1.133 . . . . 0.0 110.36 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -112.52 -139.85 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.952 . . . . 0.0 110.062 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -147.28 134.89 20.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 110.292 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -91.0 126.69 36.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.64 133.95 95.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.8 164.97 34.06 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.943 1.497 . . . . 0.0 110.432 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -66.36 -26.65 67.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.263 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -8.65 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 7.65 5.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 0.0 110.227 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -89.94 46.27 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.32 -11.81 51.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.534 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.41 0.93 57.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.187 178.421 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.9 m -159.54 123.63 3.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 44' ' ' GLU . 57.8 mt -75.38 -76.52 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -98.72 65.06 1.53 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 0.0 110.814 -179.615 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -152.87 148.36 19.09 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -101.9 132.7 47.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.13 . . . . 0.0 110.098 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.0 t -107.63 126.63 52.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' NH1' ' CG ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -96.49 106.89 19.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.48 115.38 27.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.585 -179.601 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 17.9 t -91.64 120.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 109.944 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.7 t -79.59 -64.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 110.563 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -38.3 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.807 . . . . 0.0 109.561 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -124.51 91.49 3.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.912 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 pm0 -36.2 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 110.93 -179.078 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -146.28 83.6 8.36 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.858 . . . . 0.0 110.462 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.3 Cg_endo -78.8 88.42 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.164 1.613 . . . . 0.0 110.431 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.6 145.46 25.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.92 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 8.9 p -128.03 105.59 8.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.114 -0.991 . . . . 0.0 110.978 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.3 t -106.8 151.8 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.533 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 13.5 m -119.55 166.12 13.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.613 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.99 117.39 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.964 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -42.62 -37.25 1.63 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.213 -179.909 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 46.36 3.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -124.61 165.73 17.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -1.202 . . . . 0.0 110.38 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 47' ' ' ASP . 16.4 mt -149.42 151.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.235 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.24 149.94 10.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.48 66.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.012 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -90.67 -0.39 57.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.9 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.533 ' HG ' ' HG ' ' A' ' 34' ' ' CYS . 5.2 m 69.89 38.18 1.65 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.825 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.49 ' HB2' HD12 ' A' ' 17' ' ' ILE . 6.5 tm-20 -101.39 -17.34 16.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -97.27 163.95 12.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.821 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.431 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 8.9 p -150.11 155.13 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB2' HD11 ' A' ' 39' ' ' ILE . 1.7 t70 -121.46 80.36 1.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.242 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -148.42 71.96 1.18 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 110.197 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.17 -45.1 64.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 0.0 110.233 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 6.4 p90 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.107 -179.939 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.255 0.55 . . . . 0.0 110.2 . . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 1' ' ' ARG . 13.4 tttt 64.72 123.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.46 74.55 0.2 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.475 ' O ' ' CD1' ' A' ' 5' ' ' PHE . 13.8 t-80 -87.07 55.04 3.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.18 . . . . 0.0 110.368 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.514 ' HD1' HG13 ' A' ' 24' ' ' VAL . 59.3 m-85 -149.68 -155.38 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.965 . . . . 0.0 110.275 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -142.7 121.51 12.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.41 137.28 35.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.183 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 136.41 93.19 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -179.94 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.5 Cg_endo -72.89 161.93 42.4 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.055 1.555 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -67.46 -31.52 71.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.952 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.67 -10.83 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.7 m-85 -126.5 2.83 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.843 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -89.98 57.06 3.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.11 179.889 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -86.45 -12.68 48.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 109.422 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.3 p90 -90.17 -1.65 57.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.089 178.427 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.24 104.27 1.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 110.103 179.837 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 47.5 mm -69.29 -72.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CE ' ' HB2' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -91.16 52.8 2.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -151.42 135.9 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -99.62 125.95 45.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -1.134 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.475 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 11.0 t -105.66 125.8 51.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.251 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.03 112.16 23.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -94.77 104.7 16.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.514 HG13 ' HD1' ' A' ' 5' ' ' PHE . 21.5 t -80.52 115.13 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.266 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 27.9 t -78.13 -62.1 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.558 -0.714 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.53 -44.8 4.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.281 179.523 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -115.37 90.47 3.35 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.842 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -35.01 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.778 -0.576 . . . . 0.0 111.005 -179.133 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' GLU . 34.2 m -150.37 83.46 5.97 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 -179.882 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.493 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.5 Cg_endo -80.8 100.08 1.18 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.065 1.56 . . . . 0.0 109.953 179.419 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.438 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.3 p -112.15 132.72 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.096 -1.002 . . . . 0.0 110.454 -179.741 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 29.2 p -104.79 131.45 52.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.5 116.95 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 19.4 m -93.97 156.1 16.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 110.126 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -50.3 124.18 9.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 179.895 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -45.52 -40.78 8.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.18 46.24 3.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -120.82 166.62 13.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.339 179.899 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.515 HD11 ' OD2' ' A' ' 47' ' ' ASP . 9.6 mt -146.46 150.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.69 145.02 9.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.98 62.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 110.253 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.3 mmt85 -112.78 5.66 17.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m 68.34 45.22 1.22 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.131 179.704 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.48 -33.5 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 110.678 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -86.07 151.68 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.379 -179.704 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.49 144.54 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.04 179.954 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.515 ' OD2' HD11 ' A' ' 39' ' ' ILE . 1.5 t0 -130.7 55.2 1.84 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -0.907 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.4 mt -134.19 136.16 43.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 110.209 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -89.48 30.39 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.175 -179.987 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 19.8 p90 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.193 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.271 0.557 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -87.27 54.17 3.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.32 -0.863 . . . . 0.0 110.195 -179.905 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.89 59.52 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.89 31.05 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -1.134 . . . . 0.0 110.256 179.931 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 47.4 m-85 -138.13 -152.93 0.45 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.7 128.66 35.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.164 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.91 125.66 45.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.438 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.33 127.45 92.13 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 -179.931 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.8 Cg_endo -74.2 161.27 41.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.914 1.481 . . . . 0.0 110.247 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -64.41 -32.67 74.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -65.57 -8.69 21.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.471 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -123.86 0.98 8.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 20' ' ' ARG . 27.2 mttt -87.99 73.85 9.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.372 -179.788 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -85.74 -17.82 34.79 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.207 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 14.6 p90 -82.58 -10.08 59.12 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 178.502 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.2 m -160.3 137.81 9.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.0 mm -94.37 -70.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.41 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.89 62.41 5.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.102 -0.999 . . . . 0.0 110.506 -179.925 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.35 141.96 7.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.753 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 5.3 mpt_? -95.4 150.56 20.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -1.178 . . . . 0.0 109.505 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.495 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 26.5 t -132.55 130.31 40.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.552 -179.685 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -99.49 122.18 42.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 109.994 179.619 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -111.98 103.49 11.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.211 -179.804 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.494 ' CG2' ' HB ' ' A' ' 29' ' ' THR . 22.3 t -81.42 124.67 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.1 t -79.68 -69.25 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 110.306 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.94 -44.45 3.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -112.53 93.97 4.69 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.886 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tp-100 -38.93 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.533 -0.729 . . . . 0.0 110.796 -179.148 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 7.6 m -139.18 73.15 38.25 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.218 -0.927 . . . . 0.0 110.459 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.609 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.3 Cg_endo -78.43 72.86 6.12 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.025 1.539 . . . . 0.0 110.033 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -92.56 137.91 31.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -179.695 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.7 t -114.01 107.83 16.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 20' ' ' ARG . 45.0 t -94.08 116.24 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 9.0 m -83.6 158.54 21.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.964 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -46.45 120.18 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.762 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.0 tt0 -40.83 -54.09 2.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.66 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.48 52.79 3.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -118.59 168.86 10.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -1.195 . . . . 0.0 110.655 -179.999 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.956 HD11 ' HB2' ' A' ' 47' ' ' ASP . 3.3 mp -143.37 132.04 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.756 . . . . 0.0 109.806 179.5 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.8 136.43 3.62 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.01 72.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.304 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.0 19.89 18.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.963 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.6 m 63.54 72.74 0.47 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -107.9 -40.27 5.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.938 -179.3 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.481 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 9.1 ptp180 -118.56 168.86 10.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.986 -1.071 . . . . 0.0 110.546 -179.527 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 7.1 p -121.96 162.25 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.956 ' HB2' HD11 ' A' ' 39' ' ' ILE . 33.5 t0 -97.09 -74.97 0.55 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 110.246 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -135.38 147.0 48.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 -179.927 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.0 -40.49 58.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' HB2' HD23 ' A' ' 48' ' ' LEU . 55.4 m-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.254 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.28 0.562 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 1' ' ' ARG . 18.2 ttmt -179.23 117.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.096 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . -121.14 -74.53 0.36 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.36 94.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -1.123 . . . . 0.0 110.157 -179.908 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CE2' ' HA3' ' A' ' 3' ' ' GLY . 54.1 m-85 -131.31 -149.41 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.5 m -115.95 132.12 56.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.914 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -87.69 118.01 26.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 24.6 m -45.28 112.25 1.53 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.93 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 163.55 37.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.951 1.501 . . . . 0.0 110.319 179.739 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -60.32 -37.14 79.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.259 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.87 -25.15 63.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 -179.888 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -110.17 -1.4 17.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.257 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -89.94 46.94 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.401 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -86.21 -12.79 48.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.047 -1.033 . . . . 0.0 109.402 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 9.1 p90 -90.3 -3.8 57.54 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.214 178.494 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.12 105.52 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 51.1 mm -70.41 -71.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.055 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HE3' ' HA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -89.69 64.0 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.488 ' O ' ' CE ' ' A' ' 13' ' ' LYS . . . -160.05 136.37 4.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 96.0 mtt180 -99.51 127.21 45.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -1.161 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 9.5 t -119.01 133.18 55.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.643 -179.664 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -102.51 123.96 47.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.853 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -105.66 116.24 31.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 53.4 t -86.56 116.88 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 110.133 179.714 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' ALA . 89.1 t -79.92 -61.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.543 -0.723 . . . . 0.0 110.549 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.0 -49.14 3.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.577 179.886 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.3 tt0 -114.5 92.83 4.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.836 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -34.47 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.262 0.553 . . . . 0.0 110.99 -179.084 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 29' ' ' THR . 4.4 m -149.11 86.81 5.52 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -79.23 122.5 5.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.985 1.518 . . . . 0.0 110.298 179.666 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -127.85 116.64 20.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 109.971 179.804 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.8 p -99.59 126.98 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.583 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 42.2 t -116.77 120.84 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.349 -0.844 . . . . 0.0 109.819 179.705 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 14.6 m -91.3 159.95 15.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.247 -0.908 . . . . 0.0 110.514 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -58.42 128.11 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.036 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -47.44 -49.12 25.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 45.76 3.02 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -113.04 172.85 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 110.226 179.864 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 15.2 mt -150.2 127.7 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.27 148.44 6.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.65 66.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 110.283 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' CYS . 81.0 mtt180 -89.58 13.47 13.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.537 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 3.5 m 63.36 62.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.324 -0.86 . . . . 0.0 109.762 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 10.4 tt0 -110.34 -28.82 8.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.74 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 13.2 ttm180 -111.03 109.58 19.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.017 -1.052 . . . . 0.0 110.317 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.72 159.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -98.57 64.72 1.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.322 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.28 174.08 10.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.297 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -48.42 -62.78 1.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.432 ' OXT' ' CG ' ' A' ' 50' ' ' TYR . 66.2 t80 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.16 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.216 0.531 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.62 116.76 8.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 110.154 179.882 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.8 70.71 0.86 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.854 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -138.06 76.41 1.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 110.211 -179.793 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.898 ' CG ' HG22 ' A' ' 24' ' ' VAL . 36.2 m-85 -95.23 -144.59 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.05 162.73 18.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.347 179.942 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -106.9 154.13 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 110.171 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.429 ' CB ' ' HH ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -83.46 127.73 67.11 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 -179.907 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.67 162.21 40.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.868 1.457 . . . . 0.0 110.383 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -61.36 -29.04 69.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -63.86 -25.61 68.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.35 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -112.12 10.55 20.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.351 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -90.0 45.45 1.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.131 179.926 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.25 -13.45 46.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.032 . . . . 0.0 109.624 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p90 -87.96 -1.76 58.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.439 -0.788 . . . . 0.0 109.197 178.607 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.521 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.78 103.2 1.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 33.2 mt -63.73 -69.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 -179.956 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.7 ptmm? -97.94 64.43 1.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.21 149.31 18.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.96 162.05 13.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 109.793 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.2 t -151.81 156.24 39.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.02 . . . . 0.0 110.621 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -125.99 125.82 43.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.456 -0.778 . . . . 0.0 109.602 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.07 118.06 36.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.648 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.898 HG22 ' CG ' ' A' ' 5' ' ' PHE . 37.6 t -83.56 115.72 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.814 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 6.0 t -82.2 -63.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.52 -0.737 . . . . 0.0 110.62 -179.506 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.01 -29.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.351 -0.843 . . . . 0.0 109.787 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' THR . 97.2 mt-10 -136.93 93.46 2.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.164 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 13.1 mt-30 -34.72 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.806 -0.559 . . . . 0.0 111.146 -179.124 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 29' ' ' THR . 3.1 m -149.18 89.57 4.84 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 110.324 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.15 117.45 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.06 1.558 . . . . 0.0 110.395 179.666 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.0 OUTLIER -118.88 110.62 17.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.132 -0.98 . . . . 0.0 109.904 179.768 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.443 ' C ' HG23 ' A' ' 33' ' ' VAL . 26.7 p -92.15 155.14 18.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.735 -179.682 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.443 HG23 ' C ' ' A' ' 32' ' ' CYS . 99.3 t -149.12 120.44 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.472 -0.768 . . . . 0.0 109.806 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.0 m -93.72 156.47 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -179.526 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -54.85 125.53 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.038 179.772 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.47 -39.42 15.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.826 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 40.95 2.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.84 174.24 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -1.214 . . . . 0.0 110.326 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 38' ' ' TYR . 18.0 mm -149.51 148.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.031 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.61 157.45 20.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.03 -37.71 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.164 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -93.11 9.19 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.124 179.842 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.507 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.8 m 67.41 43.72 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.402 -0.811 . . . . 0.0 110.145 179.818 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -96.29 -34.44 11.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.585 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.485 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -96.7 -178.62 4.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.476 -179.757 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.8 p -147.66 157.4 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.861 . . . . 0.0 110.391 -179.844 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -108.08 54.27 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.339 -0.851 . . . . 0.0 110.036 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.29 -167.15 1.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 110.186 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.98 -22.38 25.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.6 t80 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.225 -179.901 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 1' ' ' ARG . 7.0 ttm180 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.253 0.549 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -112.86 -0.91 14.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.907 . . . . 0.0 110.235 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 4' ' ' HIS . . . -170.48 -161.29 20.8 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 44.9 p-80 -177.99 97.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -1.139 . . . . 0.0 110.286 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -107.0 -144.75 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.164 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.76 140.17 23.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.17 119.81 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.23 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -55.86 136.61 72.54 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 179.878 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 46.9 Cg_endo -73.35 171.71 17.12 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.91 1.479 . . . . 0.0 110.415 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -63.72 -38.62 91.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 110.234 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -63.64 -19.23 64.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.192 179.982 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.2 m-85 -107.45 -1.97 20.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.1 55.73 3.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.427 ' CE1' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -86.16 -15.5 40.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.026 -1.046 . . . . 0.0 109.303 179.923 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.509 ' OH ' ' CB ' ' A' ' 21' ' ' CYS . 3.6 p90 -90.13 3.32 53.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.493 -0.755 . . . . 0.0 109.307 178.515 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.98 106.39 1.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.154 179.85 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 9.3 mm -63.25 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.108 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -96.29 63.4 2.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.221 179.987 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -159.76 155.54 26.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -101.77 -179.06 3.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 109.832 179.832 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.509 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 8.8 t -152.63 128.05 9.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.068 -1.02 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -102.28 105.07 15.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.074 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.29 115.44 28.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 41.2 t -89.91 117.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.817 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 53.8 t -75.24 -62.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.597 -0.69 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.46 -61.23 1.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.83 . . . . 0.0 109.436 179.779 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 29' ' ' THR . 47.7 mt-10 -99.62 90.6 4.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.483 -0.761 . . . . 0.0 109.008 178.891 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.8 pm0 -34.3 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.268 0.556 . . . . 0.0 111.046 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' GLU . 43.4 m -146.03 85.36 7.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.862 . . . . 0.0 110.348 179.912 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.6 Cg_endo -76.05 99.2 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.368 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.35 143.01 33.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.144 179.897 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 27.5 p -123.91 118.22 26.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.767 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 t -112.44 146.82 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.462 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.6 m -117.03 161.54 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -54.19 117.41 3.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 110.219 -179.893 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -43.97 -38.1 3.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.35 46.18 3.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.508 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.07 172.49 9.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -1.183 . . . . 0.0 110.339 179.965 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 46.2 mt -150.12 143.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.13 168.79 13.37 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 -40.26 16.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -1.15 . . . . 0.0 110.119 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -96.86 13.37 28.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 0.0 110.186 179.973 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.3 m 67.77 51.04 0.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -101.74 -39.92 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.06 165.44 18.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.074 -1.016 . . . . 0.0 110.477 -179.798 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.524 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 8.6 p -146.09 156.12 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.05 58.35 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' CG ' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -158.77 43.34 0.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 110.197 -179.939 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.74 -76.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.965 . . . . 0.0 110.221 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.218 0.533 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.47 103.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 110.095 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 4' ' ' HIS . . . 137.44 68.94 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 1.6 t-80 -177.62 100.98 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.266 -1.137 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -91.38 -154.36 0.36 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 m -145.0 135.92 24.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.299 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 121.18 26.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.142 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -47.41 135.88 9.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.235 -179.982 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.86 173.65 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.996 1.524 . . . . 0.0 110.403 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -65.07 -31.37 72.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.89 -8.59 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -119.05 -1.26 10.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.939 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -90.12 39.39 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.263 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -85.85 -20.94 28.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 109.457 -179.832 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.21 1.1 56.82 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.009 178.124 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -160.33 92.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.884 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 75.4 mt -75.56 -55.89 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' CB ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.45 42.74 1.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 110.026 179.772 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.97 -179.74 30.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -137.29 145.54 43.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.265 -1.138 . . . . 0.0 109.934 179.821 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 14.6 t -125.65 124.94 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.636 -179.538 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -90.2 113.15 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.789 179.602 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -95.41 116.4 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.477 -179.621 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 27' ' ' GLU . 58.0 t -83.7 116.54 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 109.966 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 38.5 t -79.93 -59.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 0.0 110.494 -179.826 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.53 -47.92 3.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -118.08 95.17 4.78 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.755 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 56.1 tt0 -35.53 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.757 -0.589 . . . . 0.0 111.128 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.9 m -148.52 88.39 5.33 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -76.02 118.87 5.15 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.956 1.503 . . . . 0.0 110.387 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 4.3 m -122.36 115.22 21.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.894 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -98.31 154.16 18.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.72 -179.614 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.6 t -146.94 159.34 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.883 179.68 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.511 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.4 m -121.43 157.16 31.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.031 . . . . 0.0 110.452 -179.653 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.8 m-20 -66.79 124.88 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.864 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -50.84 -40.53 56.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.31 -179.943 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.39 40.95 3.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER -117.92 176.84 5.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -1.145 . . . . 0.0 110.331 -179.879 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' A' ' 47' ' ' ASP . 12.8 mt -147.0 117.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 110.245 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 150.94 5.82 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.35 -52.2 49.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -1.153 . . . . 0.0 109.959 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -92.48 17.78 9.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.827 179.691 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 8.6 m 64.65 80.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 110.143 179.936 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -113.68 -38.4 4.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -104.8 162.19 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.1 p -131.58 154.66 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.05 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.63 ' HB2' HD11 ' A' ' 39' ' ' ILE . 38.6 t0 -134.17 44.46 2.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.509 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.5 OUTLIER -79.73 173.87 12.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 179.94 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' O ' ' C ' ' A' ' 50' ' ' TYR . 36.7 m-85 -86.72 34.81 0.66 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 110.591 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 16.0 p90 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.198 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.355 0.598 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -63.81 -27.99 69.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.151 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.19 -116.69 1.2 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.954 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.17 90.99 1.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -1.127 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.778 ' CD1' HG13 ' A' ' 24' ' ' VAL . 24.8 m-85 -132.36 -158.07 0.86 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 110.064 -179.953 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -140.42 141.44 35.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 165.51 21.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.512 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -89.78 127.34 54.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 110.274 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 48.2 Cg_endo -73.99 166.05 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.465 . . . . 0.0 110.094 179.68 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -66.0 -36.04 82.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -12.2 16.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 110.458 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.418 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.4 m-85 -120.3 -6.0 9.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 52.08 2.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -86.28 -16.92 36.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.95 -1.094 . . . . 0.0 109.413 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 4.5 p90 -90.36 1.98 56.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 109.127 178.404 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.3 m -159.66 100.06 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 41.7 mm -72.61 -70.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.165 179.982 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -89.57 49.32 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 179.983 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -141.84 134.34 6.15 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -92.92 127.31 38.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.232 -1.157 . . . . 0.0 109.892 179.771 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.524 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 5.8 p -127.96 145.83 50.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 110.565 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.91 159.17 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.857 . . . . 0.0 109.527 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -138.51 109.14 6.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.029 . . . . 0.0 110.307 -179.751 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.778 HG13 ' CD1' ' A' ' 5' ' ' PHE . 7.9 t -80.46 116.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 5.8 t -78.95 -65.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.061 179.834 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.97 -42.71 3.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 109.376 179.608 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -115.95 88.95 2.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.919 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -35.06 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.235 -178.992 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.2 m -146.73 81.75 9.03 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 179.753 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.551 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.1 Cg_endo -79.12 107.67 2.25 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.061 1.558 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 136.05 53.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.524 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -120.28 129.43 54.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 t -126.34 116.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.079 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 14.9 m -89.54 150.28 22.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 -179.765 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.9 m-20 -45.62 124.26 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 110.093 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 19.2 pt-20 -51.79 -38.55 56.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -90.12 37.94 3.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -110.02 172.8 6.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 110.322 -179.932 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.409 HG12 ' C ' ' A' ' 38' ' ' TYR . 33.3 mm -144.98 141.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.237 179.886 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 145.97 10.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -1.188 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.1 mtm-85 -89.78 3.63 52.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 110.149 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m 67.55 51.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 109.598 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -99.42 -30.94 11.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.598 -179.565 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.495 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 82.1 mtt180 -105.6 173.76 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.402 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.592 HG22 ' H ' ' A' ' 48' ' ' LEU . 5.7 p -146.56 146.63 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.48 38.2 2.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' H ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -104.0 129.27 51.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.271 -179.926 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -79.33 -44.7 21.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.086 179.959 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.192 179.97 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.264 0.554 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 -156.63 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 4' ' ' HIS . . . 152.76 -107.56 0.33 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER 66.42 98.33 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -1.162 . . . . 0.0 110.246 -179.873 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.454 ' CD1' HG13 ' A' ' 24' ' ' VAL . 46.2 m-85 -97.99 -146.45 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 m -137.5 146.86 44.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.61 150.82 25.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.888 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -83.65 130.12 57.04 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.958 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.56 172.34 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.959 1.505 . . . . 0.0 110.396 -179.926 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.3 pttt -63.76 -25.18 68.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -62.51 -10.27 11.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 -179.885 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.585 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 8.8 m-85 -131.73 4.35 4.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 8.9 mtpt -85.53 44.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.461 -179.843 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -85.2 -25.19 27.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.845 -1.16 . . . . 0.0 109.602 -179.78 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 10.9 p90 -79.16 -6.01 55.53 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.292 178.566 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.3 138.14 9.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.54 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 44' ' ' GLU . 9.8 mt -94.68 -72.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.197 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -89.78 63.92 6.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 110.312 179.987 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.2 139.75 6.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -100.39 125.45 46.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -1.163 . . . . 0.0 109.801 179.91 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t -111.28 129.17 56.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 -179.643 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -90.89 129.17 36.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.939 179.689 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -105.62 110.48 22.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 27' ' ' GLU . 39.4 t -80.31 114.72 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 26' ' ' ALA . 42.5 t -77.03 -65.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.593 -0.692 . . . . 0.0 110.235 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.6 -48.5 4.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.49 179.813 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -112.83 87.62 2.63 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.511 -0.743 . . . . 0.0 109.013 178.844 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -33.89 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.126 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 29' ' ' THR . 6.0 m -149.23 88.35 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.336 -0.852 . . . . 0.0 110.412 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.08 91.81 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.04 1.547 . . . . 0.0 110.432 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.1 p -93.34 124.98 37.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 179.784 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.491 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 6.7 t -99.97 129.56 46.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 87.4 t -117.9 109.4 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 109.584 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.609 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.2 m -79.93 153.75 28.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.835 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 5.2 m-20 -49.57 117.8 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.811 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.05 -47.08 4.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.469 -179.897 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.24 49.67 3.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -121.84 172.82 7.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.142 -1.211 . . . . 0.0 110.283 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.959 HD11 ' OD1' ' A' ' 47' ' ' ASP . 14.5 mt -144.09 143.8 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.193 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.09 170.36 14.97 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.2 -46.43 9.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -1.176 . . . . 0.0 110.268 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.5 mtp85 -91.41 11.96 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.152 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.523 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.7 m 67.1 64.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.436 -0.79 . . . . 0.0 110.196 179.878 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.698 ' HG2' HD12 ' A' ' 17' ' ' ILE . 24.1 mt-10 -116.3 -14.05 11.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.883 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 14.2 mtt180 -117.71 176.0 5.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 13.9 p -141.35 161.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.234 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.959 ' OD1' HD11 ' A' ' 39' ' ' ILE . 4.7 t70 -113.02 48.81 0.99 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.61 HD22 ' O ' ' A' ' 47' ' ' ASP . 3.6 mm? -118.52 -39.52 3.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.27 -59.19 2.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.278 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.168 0.509 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -130.31 67.77 1.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 179.996 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.444 ' O ' ' ND1' ' A' ' 4' ' ' HIS . . . 97.0 71.18 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -169.57 78.69 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -1.16 . . . . 0.0 110.264 -180.0 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.804 ' CD1' HG13 ' A' ' 24' ' ' VAL . 77.8 m-85 -122.17 -138.78 0.32 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.969 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 m -127.64 120.76 28.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.869 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.03 129.69 34.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.74 132.28 72.11 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.891 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -73.72 160.24 44.12 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.519 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 4.1 mttm -65.45 -30.66 71.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.257 179.974 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -64.03 -15.5 59.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.876 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.435 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -116.52 -1.4 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.312 -179.89 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.69 67.04 9.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 179.951 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -85.93 -17.64 34.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.04 -1.037 . . . . 0.0 109.37 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.1 p90 -90.23 2.91 54.92 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.538 -0.726 . . . . 0.0 109.35 178.512 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.02 95.35 1.16 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.096 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.1 mm -55.57 -82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.364 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' NZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -89.89 66.05 6.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.017 . . . . 0.0 110.274 -179.853 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -152.67 154.87 25.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.511 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 10.1 ptt-85 -109.54 137.53 47.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -1.114 . . . . 0.0 109.992 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 47.6 t -124.48 123.33 39.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.41 110.45 23.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 179.764 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -95.76 110.28 22.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.355 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.804 HG13 ' CD1' ' A' ' 5' ' ' PHE . 9.5 t -79.89 118.89 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.109 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.2 t -79.72 -65.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.347 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.8 -46.75 3.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.86 . . . . 0.0 109.621 179.801 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 8.0 mt-10 -114.52 89.77 3.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.475 -0.765 . . . . 0.0 109.072 178.976 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.42 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.296 0.57 . . . . 0.0 111.109 -179.024 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 55.1 m -147.15 83.11 8.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.903 . . . . 0.0 110.38 179.75 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -77.63 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.515 . . . . 0.0 110.278 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -106.91 118.75 37.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.402 ' C ' HG23 ' A' ' 33' ' ' VAL . 21.9 p -98.27 148.24 23.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.973 . . . . 0.0 110.231 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.402 HG23 ' C ' ' A' ' 32' ' ' CYS . 21.4 t -145.17 150.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 33.1 m -120.93 161.68 21.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -57.62 127.66 33.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.991 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -44.0 52.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.166 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.92 43.69 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.99 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -114.84 170.66 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -1.162 . . . . 0.0 110.222 -179.963 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 40' ' ' GLY . 21.0 mt -150.05 171.11 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 98.92 169.13 30.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.42 -41.75 14.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.188 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.45 ' HB2' ' CD ' ' A' ' 44' ' ' GLU . 16.6 mtt180 -96.45 21.03 9.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 -179.998 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.509 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.1 m 64.23 31.79 12.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 110.142 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' CD ' ' HB2' ' A' ' 42' ' ' ARG . 44.2 mt-10 -92.01 -18.73 23.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.551 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -97.85 163.89 12.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 7.2 p -147.91 152.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 -179.879 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.479 ' O ' HD12 ' A' ' 48' ' ' LEU . 17.0 t0 -100.41 60.75 1.02 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.108 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 47' ' ' ASP . 1.5 mp -135.05 145.47 48.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.96 . . . . 0.0 110.222 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' TYR . 30.5 m-85 -89.64 27.89 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.362 -0.836 . . . . 0.0 110.224 179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.486 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 18.9 p90 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.192 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.184 0.516 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -175.08 70.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 -179.967 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.9 141.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.62 54.49 1.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -1.171 . . . . 0.0 110.325 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.563 ' CD1' HG22 ' A' ' 24' ' ' VAL . 63.3 m-85 -126.45 -152.29 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.955 . . . . 0.0 110.164 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.69 134.23 42.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.987 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -84.75 150.68 24.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.349 -179.93 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.41 132.8 34.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.135 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.3 Cg_endo -73.2 161.04 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.955 1.503 . . . . 0.0 110.574 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -30.21 70.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.379 -0.826 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -9.76 42.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.455 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.0 m-85 -122.62 6.14 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 19' ' ' GLY . 50.8 mttt -89.24 56.9 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.4 -179.887 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -15.14 42.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.03 -1.044 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.23 2.04 55.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.264 178.586 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.6 m -160.51 123.42 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 95.1 mt -81.34 -64.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 110.259 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 8.6 ptmm? -106.06 61.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.32 155.82 26.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.884 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -106.42 136.81 45.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.114 . . . . 0.0 109.634 179.601 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 18.0 t -120.82 148.19 44.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.126 -0.984 . . . . 0.0 110.627 -179.527 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -125.35 119.08 27.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.817 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -101.18 116.51 32.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.947 . . . . 0.0 110.477 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.563 HG22 ' CD1' ' A' ' 5' ' ' PHE . 21.8 t -87.19 114.45 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.018 179.704 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.0 t -75.43 -62.05 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.403 -0.811 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.14 -59.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 109.505 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 64.1 mm-40 -103.51 89.0 3.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -32.81 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.34 0.591 . . . . 0.0 111.168 -179.105 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.7 m -145.57 87.75 6.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.292 179.892 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.9 Cg_endo -78.19 94.43 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.095 1.576 . . . . 0.0 110.452 179.833 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.24 141.24 29.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 179.944 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.4 p -123.48 122.14 37.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.267 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.1 143.86 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.926 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 31.6 m -115.33 164.44 14.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.471 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.526 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -45.96 122.46 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.245 179.961 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.65 -52.93 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.53 -179.877 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.44 50.61 3.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -116.3 170.94 8.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.102 -1.234 . . . . 0.0 110.343 179.783 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.1 mt -150.03 158.54 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 179.951 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.87 143.7 10.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.33 -29.98 68.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.264 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.07 9.26 43.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.104 179.967 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 5.3 m 65.65 49.26 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -107.81 -31.09 8.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.443 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 62.4 mtt85 -85.18 157.62 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.27 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.17 154.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.982 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -133.34 71.49 1.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.192 -179.955 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -132.31 34.73 3.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -18.69 32.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.95 . . . . 0.0 110.293 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 77.8 t80 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.225 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.411 ' HD2' HG13 ' A' ' 24' ' ' VAL . 75.3 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.052 0.454 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -133.29 125.21 28.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.473 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.58 120.98 32.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 110.05 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 33.4 m -57.19 116.0 12.27 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.62 168.38 24.91 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.9 1.474 . . . . 0.0 110.453 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -27.95 67.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -13.86 60.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -121.09 17.24 11.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 110.229 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -90.08 47.62 1.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.403 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.06 -18.5 32.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 109.135 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.9 p90 -90.64 0.52 57.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.086 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 3.1 m -160.14 91.47 0.95 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 51.7 mt -62.08 -53.31 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.123 -0.986 . . . . 0.0 110.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.17 57.39 0.62 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.14 159.78 31.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -101.85 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -1.149 . . . . 0.0 110.068 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 37.1 t -158.89 126.55 4.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 110.731 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -106.34 122.51 46.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.734 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -110.51 112.42 24.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.987 . . . . 0.0 110.577 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 27' ' ' GLU . 63.5 t -89.73 118.68 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.94 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.9 t -77.63 -64.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.744 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -46.6 4.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.345 -0.847 . . . . 0.0 109.376 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.597 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.6 tt0 -109.74 87.92 2.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.9 tt0 -34.76 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.361 0.6 . . . . 0.0 111.116 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -148.73 84.66 6.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -77.98 84.22 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.09 1.574 . . . . 0.0 110.128 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -89.88 140.36 29.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.068 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 12.0 p -129.04 110.77 12.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.415 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 20' ' ' ARG . 3.6 t -99.17 159.96 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 0.0 109.686 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.524 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 10.6 m -135.53 162.31 33.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -57.08 122.95 13.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 109.956 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.3 mt-10 -41.58 -37.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 110.168 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.68 48.17 3.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.796 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -123.26 162.17 23.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.023 -1.281 . . . . 0.0 110.38 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 38' ' ' TYR . 29.6 mm -142.29 156.03 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.212 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.55 150.96 25.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.57 80.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -1.15 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -89.65 8.06 33.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.02 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 6.9 m 64.64 58.15 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.39 -0.819 . . . . 0.0 110.153 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.76 -31.1 9.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 110.275 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.448 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 7.0 mtt180 -94.64 171.08 9.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.058 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 110.475 -179.853 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CD1' HG13 ' A' ' 24' ' ' VAL . 27.4 m-85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.318 0.58 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.05 143.2 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -80.95 127.08 32.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.309 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -59.65 130.04 87.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.2 Cg_endo -72.47 160.53 46.53 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.899 1.473 . . . . 0.0 110.356 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -61.65 -30.2 70.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.177 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -29.52 70.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.456 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -99.23 0.07 42.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.23 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.06 49.0 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.72 -20.25 29.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.021 -1.05 . . . . 0.0 109.352 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' OH ' ' SG ' ' A' ' 21' ' ' CYS . 4.4 p90 -90.35 1.24 56.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.131 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 101.46 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 38.7 mm -74.22 -69.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.85 58.61 4.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -155.16 136.0 4.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 8.6 mpt_? -93.92 128.95 40.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 110.038 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.522 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 6.4 p -126.35 147.67 49.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.61 144.94 35.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 109.808 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -121.73 108.7 13.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.511 HG13 ' CD1' ' A' ' 5' ' ' PHE . 3.9 t -83.42 120.12 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 46.2 t -81.87 -65.18 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.712 -0.617 . . . . 0.0 110.233 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.37 -34.55 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -128.14 92.04 3.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 11.1 tm0? -36.24 91.41 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.743 -0.598 . . . . 0.0 110.919 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 29' ' ' THR . 17.7 m -147.55 81.49 8.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.419 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -78.85 91.2 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.168 1.615 . . . . 0.0 110.321 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -89.26 145.38 25.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.2 p -123.98 132.09 53.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 0.0 110.591 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 66.5 t -127.25 111.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.879 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -81.94 152.34 26.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -57.39 124.96 20.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' ASP . 1.4 mm-40 -42.15 -42.73 3.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.459 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -90.4 48.02 3.1 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -119.44 169.4 10.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.268 . . . . 0.0 110.348 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 38' ' ' TYR . 44.1 mt -150.49 141.37 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.87 147.52 7.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.8 52.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.131 . . . . 0.0 110.074 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.419 ' C ' ' SG ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -94.97 20.66 8.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 110.345 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.537 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 2.4 m 63.42 67.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -102.94 -44.03 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 111.399 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 12.9 ptm180 -112.45 134.42 53.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.899 -1.126 . . . . 0.0 110.599 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.532 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.278 0.561 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -117.07 123.7 47.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -79.92 112.42 17.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -43.36 122.13 3.33 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.294 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -71.63 167.13 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.915 1.482 . . . . 0.0 110.427 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -53.57 -43.13 68.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -0.906 . . . . 0.0 110.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.87 -32.64 67.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.476 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -90.98 -12.05 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 45.57 1.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -86.16 -17.18 35.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.123 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.2 p90 -90.5 2.17 55.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.221 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -159.31 97.94 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.121 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.549 HD12 ' CG ' ' A' ' 44' ' ' GLU . 53.1 mt -63.61 -70.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.9 . . . . 0.0 110.309 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -91.86 64.31 4.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.08 153.44 24.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -114.18 140.67 48.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -1.141 . . . . 0.0 110.144 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 11.4 t -130.3 128.28 41.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.472 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -92.53 122.06 34.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 109.943 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.99 109.78 21.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 110.402 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 13.8 t -80.15 120.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 93.4 t -78.9 -64.38 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 110.344 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.28 -43.94 3.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.375 -0.828 . . . . 0.0 109.483 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.9 mt-10 -118.33 88.35 2.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.96 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.363 0.601 . . . . 0.0 111.01 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 32.9 m -143.29 85.6 9.51 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.256 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.98 87.21 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.145 1.603 . . . . 0.0 110.557 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 p -90.49 109.03 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.87 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 32.0 p -99.24 142.15 31.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.554 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.9 t -140.58 120.51 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 109.969 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 12.7 m -88.04 156.18 19.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.238 -0.914 . . . . 0.0 110.322 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -48.85 121.52 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -50.21 -43.69 52.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.302 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.59 39.1 3.12 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -113.12 178.36 4.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 110.341 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 17.7 mt -150.23 158.76 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.44 168.97 23.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.59 -44.66 11.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.338 -1.095 . . . . 0.0 110.137 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HB2' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -91.73 14.76 14.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.82 51.96 0.56 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.336 -0.852 . . . . 0.0 110.333 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.549 ' CG ' HD12 ' A' ' 17' ' ' ILE . 14.0 mt-10 -105.37 -34.96 7.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 17.2 mtp180 -85.23 160.85 19.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.516 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.469 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 4.4 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.294 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.189 0.518 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.31 134.82 48.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 110.301 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -88.21 147.53 24.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.15 143.97 43.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.22 164.84 34.25 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.04 1.547 . . . . 0.0 110.468 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -62.98 -31.58 72.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -21.46 66.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.108 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -102.61 1.38 34.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.235 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 16' ' ' CYS . 14.4 mtpt -87.41 54.38 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.325 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -18.87 31.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.941 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 1.8 p90 -90.56 -2.75 57.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.017 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 10.3 m -158.92 109.06 2.0 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.853 . . . . 0.0 110.053 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 29.6 mm -72.66 -54.87 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.019 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 7.8 ptmm? -106.41 53.02 0.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -151.5 147.09 16.58 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -101.99 141.23 35.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -1.196 . . . . 0.0 110.065 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.488 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 34.8 t -115.92 123.63 48.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 110.456 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -96.42 107.77 20.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -91.02 111.9 23.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.855 . . . . 0.0 110.443 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 27' ' ' GLU . 88.2 t -81.27 117.11 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.028 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 99.9 t -80.88 -56.61 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.657 -0.652 . . . . 0.0 110.386 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.64 -42.97 2.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.49 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.562 ' H ' HG12 ' A' ' 24' ' ' VAL . 35.3 tt0 -125.46 97.35 5.15 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -34.5 90.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.764 -0.585 . . . . 0.0 111.172 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 29' ' ' THR . 14.0 m -148.66 85.69 6.06 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.444 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.523 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -73.47 100.16 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.056 1.556 . . . . 0.0 110.412 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 t -97.16 133.77 41.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.1 p -113.98 102.27 10.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.423 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.33 122.67 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.883 . . . . 0.0 110.012 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 18.1 m -95.51 155.62 16.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.369 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 2.0 m-20 -43.84 124.27 3.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.127 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.71 -49.42 28.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.339 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 46.63 3.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.518 ' HB3' ' CB ' ' A' ' 35' ' ' ASP . 0.4 OUTLIER -111.6 171.29 7.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -1.204 . . . . 0.0 110.317 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.413 HG12 ' C ' ' A' ' 38' ' ' TYR . 25.3 mm -144.69 153.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.53 156.39 16.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.78 57.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -1.134 . . . . 0.0 110.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.2 mmm-85 -97.05 12.57 32.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.523 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.42 55.93 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 0.0 109.874 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.81 -36.73 6.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.599 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -97.08 -179.49 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.499 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.7 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.362 -0.836 . . . . 0.0 110.078 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.236 0.541 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -131.04 129.76 42.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 8' ' ' CYS . 1.9 ttm180 -88.23 111.68 21.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 46.8 m -42.93 110.73 0.92 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.255 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HG2' ' CG ' ' A' ' 11' ' ' GLN . 45.6 Cg_endo -73.59 179.25 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.927 1.488 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.98 -36.32 84.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' CG ' ' HG2' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -59.88 -13.82 12.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.44 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.512 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.9 m-85 -120.07 -3.55 10.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.155 -0.966 . . . . 0.0 110.429 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.75 41.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.259 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -85.91 -18.41 32.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.024 -1.047 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.33 3.64 53.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.342 -0.848 . . . . 0.0 109.148 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -158.47 120.29 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.14 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.4 mm -80.46 -72.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.262 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.6 OUTLIER -95.23 65.01 2.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.028 -1.045 . . . . 0.0 110.33 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.25 171.82 33.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 11.7 mtp85 -131.99 133.43 44.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 109.807 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.9 t -121.7 137.05 54.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.75 126.28 51.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.51 112.86 26.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.546 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 58.3 t -84.18 116.59 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.059 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 26' ' ' ALA . 60.5 t -74.18 -64.55 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 110.4 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.93 -62.33 0.94 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.872 . . . . 0.0 109.34 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 21.0 mm-40 -97.82 87.77 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.88 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.742 -0.599 . . . . 0.0 111.072 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 29' ' ' THR . 10.5 m -145.0 88.1 6.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.82 91.93 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.133 1.596 . . . . 0.0 110.364 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.88 122.11 41.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.174 -0.953 . . . . 0.0 110.037 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.6 p -102.7 137.32 41.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.475 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 24.6 t -129.4 164.35 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 109.847 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.6 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 6.0 m -133.26 163.51 29.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 110.397 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.551 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-20 -55.74 121.39 9.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -46.58 -43.19 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 44.81 3.28 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.4 169.48 10.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -1.159 . . . . 0.0 110.129 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 3.3 mp -140.67 145.52 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.873 . . . . 0.0 110.217 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.37 167.3 16.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.95 -41.64 12.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 110.198 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.91 11.53 20.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.915 . . . . 0.0 110.216 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.524 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 66.9 49.59 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.304 -0.872 . . . . 0.0 109.827 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 28.8 tt0 -98.11 -34.8 10.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.9 mtt180 -94.02 157.36 16.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 110.092 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.509 ' CD1' HG13 ' A' ' 24' ' ' VAL . 64.4 m-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.255 0.55 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.2 m -124.25 131.93 53.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -91.36 145.44 24.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 110.151 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 139.31 33.17 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.9 . . . . 0.0 110.261 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.51 166.9 28.64 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.974 1.512 . . . . 0.0 110.4 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -61.63 -28.84 69.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.53 -29.45 69.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.295 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -98.03 6.75 47.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.379 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 51.82 2.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 110.357 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -21.78 28.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.5 p90 -90.49 3.91 52.59 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.072 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 119.61 2.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.189 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 18' ' ' LYS . 17.1 mm -73.37 -82.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.192 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.4 ptmm? -93.06 64.46 3.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 110.033 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -153.53 144.52 11.42 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -94.3 153.46 18.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.268 -1.137 . . . . 0.0 110.053 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 9.4 t -130.44 127.0 38.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 110.152 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.14 107.56 18.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -93.82 112.2 24.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 110.37 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.509 HG13 ' CD1' ' A' ' 5' ' ' PHE . 4.7 t -80.27 115.52 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.99 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 12.7 t -79.2 -66.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.635 -0.665 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.32 -34.2 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 109.372 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.3 mt-10 -123.66 88.9 3.0 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 15.7 tt0 -35.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.801 -0.562 . . . . 0.0 111.143 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 31.4 m -150.27 91.31 4.22 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.288 -0.883 . . . . 0.0 110.288 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 47.8 Cg_endo -75.52 108.99 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.637 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 t -111.09 141.55 44.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 10.2 p -129.4 100.28 5.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.543 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.53 124.57 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 58.9 m -93.75 159.27 15.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.7 m-20 -53.25 116.97 2.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.547 ' HG2' ' N ' ' A' ' 37' ' ' GLY . 1.4 pm0 -51.64 -29.53 18.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 110.183 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' N ' ' HG2' ' A' ' 36' ' ' GLU . . . -90.85 35.39 3.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -115.26 172.67 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -1.124 . . . . 0.0 110.54 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 24.4 mt -149.49 156.25 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.13 170.9 20.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.47 -45.78 11.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.218 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 1.6 mmp_? -89.97 12.37 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.521 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 3.8 m 69.59 47.42 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -101.0 -38.47 8.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.22 -0.925 . . . . 0.0 110.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 3.8 mtt180 -83.11 172.14 12.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.483 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.5 p . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.953 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.603 ' HD1' HG13 ' A' ' 24' ' ' VAL . 65.5 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.246 0.545 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 m -145.61 130.53 18.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.351 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -81.61 154.89 25.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.071 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -84.29 124.59 73.72 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 158.22 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.865 1.455 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -67.08 -24.46 65.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.482 ' CA ' ' HE2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -64.4 -12.08 39.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.381 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -131.92 16.01 4.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -90.29 58.61 4.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -86.1 -12.89 48.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 109.46 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 12.2 p90 -86.73 -8.95 56.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.474 -0.766 . . . . 0.0 109.038 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.38 126.4 4.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.3 mm -76.66 -55.67 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.008 . . . . 0.0 110.42 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -116.39 70.62 0.77 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.049 -1.032 . . . . 0.0 110.362 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.47 166.06 30.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 17.3 ptt180 -114.2 121.11 42.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.129 -1.218 . . . . 0.0 110.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 6.2 t -105.16 128.76 53.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 110.369 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.21 109.88 22.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 109.87 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -100.75 112.66 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.379 -179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.603 HG13 ' HD1' ' A' ' 5' ' ' PHE . 3.4 t -87.9 118.32 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.335 -0.853 . . . . 0.0 110.02 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 26' ' ' ALA . 16.7 t -75.96 -67.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 110.44 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.4 -50.56 3.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -0.839 . . . . 0.0 109.563 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -108.44 90.32 3.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.8 mt-30 -35.55 91.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.306 0.574 . . . . 0.0 110.925 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 89.9 m -143.67 78.83 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.517 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.2 Cg_endo -75.41 81.96 2.18 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.108 1.583 . . . . 0.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -90.01 137.84 32.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 109.682 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.1 t -115.05 130.71 57.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.084 -1.01 . . . . 0.0 110.666 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 4.3 t -124.47 158.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.586 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.7 m -110.06 161.62 15.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.138 -0.976 . . . . 0.0 110.568 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.0 m-20 -61.61 120.52 10.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 37' ' ' GLY . 15.7 pt-20 -45.56 -43.63 12.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 110.183 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 36' ' ' GLU . . . -90.14 47.4 3.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.9 174.95 6.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -1.15 . . . . 0.0 110.4 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 8.5 mt -150.35 129.69 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 158.63 9.61 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.52 -46.35 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -1.151 . . . . 0.0 110.154 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.8 mtt180 -89.59 8.9 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.542 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m 67.43 61.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 109.997 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -106.25 -40.35 5.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.939 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.491 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.41 150.24 25.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.472 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.232 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.218 0.532 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.02 142.45 36.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 110.209 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 8' ' ' CYS . 10.1 mtp180 -103.9 107.5 18.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 32.0 m -42.08 121.24 2.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.901 . . . . 0.0 110.168 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.83 168.07 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.89 1.468 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -65.8 -27.96 68.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -66.53 -12.85 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -122.67 9.5 9.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HE2' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.14 51.62 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -85.74 -20.12 29.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.917 -1.115 . . . . 0.0 109.217 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.6 p90 -90.3 -1.57 57.93 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.098 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.499 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.7 m -160.59 98.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 44' ' ' GLU . 24.4 mt -77.74 -57.41 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -89.56 39.15 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.158 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -158.27 150.33 21.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.462 ' HG3' ' HE2' ' A' ' 13' ' ' LYS . 3.5 mtt180 -110.4 144.74 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -1.097 . . . . 0.0 109.781 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.49 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 17.6 t -125.94 135.91 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.99 . . . . 0.0 110.864 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.04 138.78 34.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.832 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -117.5 117.37 29.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.03 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.6 t -85.62 118.82 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.854 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 35.7 t -80.84 -65.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.627 -0.671 . . . . 0.0 110.607 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.45 -33.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 0.0 109.66 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -132.17 89.04 2.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 tt0 -34.59 90.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.763 -0.585 . . . . 0.0 111.09 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' GLU . 20.4 m -144.97 91.77 5.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.219 -0.926 . . . . 0.0 110.47 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 134.71 9.86 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.144 1.602 . . . . 0.0 110.412 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -141.15 112.09 7.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 109.915 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 29.0 p -98.53 144.43 27.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.752 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.93 127.41 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 23.8 m -102.71 164.25 11.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.3 m-20 -63.47 116.41 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.459 -0.776 . . . . 0.0 109.979 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.5 pt-20 -42.7 -31.26 0.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.486 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.84 43.26 2.97 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -125.44 170.28 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.8 mt -149.95 144.2 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.96 151.43 8.17 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.43 47.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -1.148 . . . . 0.0 110.24 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 22.8 mtt180 -89.97 12.95 16.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.926 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 5.1 m 66.64 57.23 0.69 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 109.867 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.583 ' HG2' HD12 ' A' ' 17' ' ' ILE . 8.3 mm-40 -108.09 -13.7 14.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.576 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.48 173.31 6.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.117 -0.989 . . . . 0.0 110.455 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.6 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.538 ' CD1' HG22 ' A' ' 24' ' ' VAL . 72.5 m-85 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.258 0.551 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.5 m -128.62 135.81 49.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 110.239 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -94.57 130.32 41.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.77 126.61 92.91 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.132 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.85 169.4 22.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.944 1.497 . . . . 0.0 110.306 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.5 mmtt -57.88 -24.98 60.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -33.59 75.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.575 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 26.6 m-85 -106.11 12.21 30.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -89.59 40.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 110.241 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -85.91 -18.2 33.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.02 -1.05 . . . . 0.0 109.613 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.25 3.16 54.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.4 125.8 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 10.8 mm -79.95 -72.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.135 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 6.2 ptmm? -99.27 51.56 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.096 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -140.95 141.86 11.68 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -98.15 141.44 31.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -1.073 . . . . 0.0 109.898 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 37.3 t -117.01 123.21 46.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.564 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -94.14 104.35 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.6 t80 -92.39 117.73 30.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.494 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 5' ' ' PHE . 59.1 t -84.48 118.45 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.8 t -81.72 -66.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.612 -0.68 . . . . 0.0 110.526 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.83 -36.37 0.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -124.59 90.16 3.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 27' ' ' GLU . 21.0 tt0 -35.92 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.774 -0.579 . . . . 0.0 111.052 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 16.3 m -150.15 89.48 4.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.564 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.9 Cg_endo -74.49 115.92 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.144 1.602 . . . . 0.0 110.545 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.77 123.24 46.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.7 p -103.12 135.48 44.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.3 125.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.523 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 24.3 m -92.58 163.08 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.444 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -51.74 129.56 26.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -48.75 -48.35 40.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 45.61 3.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -111.88 162.15 15.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -1.217 . . . . 0.0 110.005 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 33.4 mm -143.82 146.52 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.32 158.62 10.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.47 -43.71 38.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -1.099 . . . . 0.0 110.235 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 22.6 mtt-85 -89.89 8.73 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.0 m 68.36 48.79 0.84 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 0.0 110.011 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.8 -26.11 10.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.929 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -91.64 178.69 5.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.171 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.278 -179.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.702 ' CD1' HG13 ' A' ' 24' ' ' VAL . 73.8 m-85 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.102 0.477 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -130.36 118.03 20.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.033 -1.042 . . . . 0.0 110.137 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.24 121.36 26.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 110.142 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -54.76 123.31 45.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.097 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.18 162.4 41.78 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.897 1.472 . . . . 0.0 110.392 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -58.03 -25.87 61.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.61 -35.7 78.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.485 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.18 9.85 38.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -90.07 48.01 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -85.86 -17.29 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 5.2 p90 -90.45 -0.3 57.6 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.224 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 110.83 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.952 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.2 mm -81.7 -66.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 1.8 ptpp? -89.77 53.72 2.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.203 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -158.06 179.97 33.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.7 OUTLIER -133.01 171.86 13.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -1.129 . . . . 0.0 110.045 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 43.4 t -152.34 120.47 6.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.8 ttp85 -90.45 111.38 22.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.998 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.59 108.1 20.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.406 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.702 HG13 ' CD1' ' A' ' 5' ' ' PHE . 4.3 t -84.17 115.22 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.983 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ALA . 70.3 t -80.3 -60.42 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.8 -35.6 1.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.264 -0.897 . . . . 0.0 109.4 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -127.18 94.76 4.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.516 -0.74 . . . . 0.0 109.047 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -35.75 91.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.72 -0.612 . . . . 0.0 111.234 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 29' ' ' THR . 9.9 m -150.02 80.19 7.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.6 Cg_endo -77.6 89.86 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.067 1.561 . . . . 0.0 110.756 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.1 p -91.23 124.98 35.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.008 . . . . 0.0 109.811 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.7 p -114.88 110.15 19.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 0.0 110.752 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' ARG . 57.8 t -107.66 163.99 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.798 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.1 m -127.64 161.61 28.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.082 -1.011 . . . . 0.0 110.407 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.561 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.81 127.72 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 22.4 pt-20 -50.64 -43.27 57.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 110.316 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -89.17 42.09 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -113.87 171.18 7.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -1.115 . . . . 0.0 110.253 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 38' ' ' TYR . 45.9 mt -150.08 127.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.16 144.22 5.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.75 88.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -1.128 . . . . 0.0 110.315 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 20.3 mtt180 -98.74 13.67 31.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 16.4 m 60.33 58.71 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 12.5 pt-20 -108.0 -31.1 8.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.32 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 13.6 mtp-105 -99.13 160.86 13.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.235 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.153 0.501 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -134.42 124.01 24.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.249 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.06 128.78 34.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -73.3 135.03 79.54 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 159.1 47.34 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.42 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -58.52 -32.0 68.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -61.65 -33.86 74.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.73 -2.37 44.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 0.0 110.147 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -90.02 55.53 3.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 0.0 110.41 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -86.32 -16.41 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.956 -1.09 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.447 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.9 p90 -90.1 2.63 55.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.428 -0.795 . . . . 0.0 109.115 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -155.68 111.75 3.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 18.9 mm -78.05 -73.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 110.43 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -89.89 57.5 3.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.117 -0.99 . . . . 0.0 110.364 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.487 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.52 155.74 26.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -111.88 140.42 46.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 21.1 t -115.59 123.32 48.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.492 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.6 108.27 20.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.1 112.7 24.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 40.3 t -82.07 113.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.81 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 26' ' ' ALA . 43.0 t -76.04 -64.21 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.526 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.25 -51.86 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 109.666 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 tt0 -109.0 92.43 4.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 108.964 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.7 OUTLIER -35.55 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.596 . . . . 0.0 111.065 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 29' ' ' THR . 7.8 m -149.61 85.67 5.64 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.15 95.74 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.077 1.567 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.8 p -95.08 128.39 41.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 110.049 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.4 p -107.42 96.98 6.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.481 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -90.87 148.44 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.118 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 18.5 m -128.24 160.34 32.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 16.9 m-20 -57.97 120.46 8.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.92 -32.49 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.97 42.18 2.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -123.7 168.52 12.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -1.123 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.436 HG13 ' C ' ' A' ' 38' ' ' TYR . 61.6 mt -149.55 152.01 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.869 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.03 173.48 19.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -44.18 11.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -1.125 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.2 mtm180 -92.79 18.53 8.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 12.9 m 61.61 41.68 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.455 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.6 pp20? -98.72 -25.27 14.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 110.435 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -90.91 161.5 15.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.085 -1.009 . . . . 0.0 109.969 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.241 -179.938 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.799 ' HD1' HG13 ' A' ' 24' ' ' VAL . 25.3 m-85 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.268 0.556 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -138.78 131.16 28.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.857 . . . . 0.0 110.173 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 124.3 32.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 119.8 77.67 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 178.52 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.865 1.455 . . . . 0.0 110.488 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 4.3 mtpt -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.358 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -59.27 -19.41 45.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.155 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -117.81 -0.95 11.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.3 ttpt -90.05 51.79 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -86.54 -14.09 43.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.044 -1.035 . . . . 0.0 109.31 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.3 2.54 55.4 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.51 -0.744 . . . . 0.0 109.082 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -159.87 112.61 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.932 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 24.0 mt -66.03 -76.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.412 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -96.77 69.43 2.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.423 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.3 152.57 23.37 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -111.69 141.69 44.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.899 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.4 t -126.19 134.4 51.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.638 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' OG ' ' A' ' 31' ' ' SER . 10.6 mmt180 -101.96 120.12 39.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.81 116.19 32.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.267 -0.895 . . . . 0.0 110.34 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.85 ' HB ' HG22 ' A' ' 29' ' ' THR . 2.2 t -90.42 125.73 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.079 -1.013 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 39.6 t -79.54 -64.64 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 110.324 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.68 -49.84 4.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.161 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.73 ' O ' HG22 ' A' ' 29' ' ' THR . 0.5 OUTLIER -105.44 71.69 0.94 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -29.99 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.376 0.608 . . . . 0.0 111.322 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.85 HG22 ' HB ' ' A' ' 24' ' ' VAL . 9.8 t -149.94 105.77 3.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.86 91.62 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.061 1.559 . . . . 0.0 110.113 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 22' ' ' ARG . 89.0 p -90.14 101.7 14.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 110.034 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 26.3 p -90.08 131.65 35.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.445 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -130.62 135.23 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.926 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.7 m -102.2 160.94 14.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 38.0 m-20 -54.66 115.06 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.841 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.8 OUTLIER -41.59 -39.5 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.891 . . . . 0.0 110.488 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 46.95 3.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -127.36 172.83 10.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -1.155 . . . . 0.0 110.32 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.429 HG13 ' C ' ' A' ' 38' ' ' TYR . 56.8 mt -148.17 149.56 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.9 161.45 12.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -43.04 20.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.218 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mmm180 -93.04 15.32 15.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 8.7 m 64.38 39.72 6.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.338 -0.851 . . . . 0.0 110.428 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.22 -22.43 17.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.617 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -100.18 162.43 12.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.295 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.461 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 7.2 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.297 0.57 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.97 139.56 21.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.0 160.4 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 141.66 33.09 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 110.162 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.82 156.38 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.402 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -57.5 -30.28 64.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.385 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -35.32 78.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.951 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.497 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -96.11 0.29 51.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 47.63 1.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.442 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.29 -13.18 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 0.0 109.196 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.497 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.34 -0.67 57.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.514 -0.741 . . . . 0.0 109.38 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 122.16 3.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.8 mm -77.66 -78.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.999 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -89.85 52.99 2.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.057 -1.027 . . . . 0.0 110.29 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -142.26 137.72 8.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.94 134.92 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -1.169 . . . . 0.0 109.899 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.0 t -115.73 132.4 56.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.591 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -95.78 128.34 42.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.42 -0.8 . . . . 0.0 109.798 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -117.9 109.68 16.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.279 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.1 t -85.95 123.48 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.126 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.4 t -79.01 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.633 -0.667 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -50.23 3.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.397 -0.814 . . . . 0.0 109.525 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 38.0 tp10 -115.41 96.6 5.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -36.46 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 110.875 -179.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 26.6 m -138.46 79.21 30.61 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.547 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.7 Cg_endo -78.54 80.58 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.207 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.9 p -90.22 132.45 35.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 29.7 p -106.65 128.04 53.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.8 122.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.353 -0.842 . . . . 0.0 110.199 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.7 m -89.16 159.11 17.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 7.0 m-20 -52.97 121.05 6.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -45.2 -40.85 7.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.86 3.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -122.05 170.19 10.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.17 . . . . 0.0 110.279 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' TYR . 56.6 mt -149.37 160.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.153 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.08 175.85 21.45 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.92 -44.94 10.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 3.2 ttm-85 -100.59 25.71 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.7 m 63.69 50.88 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.85 -34.68 8.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.607 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 164.46 14.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.504 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.883 . . . . 0.0 110.031 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.54 ' HD1' HG13 ' A' ' 24' ' ' VAL . 55.1 m-85 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.8 m -149.9 139.08 21.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.873 . . . . 0.0 110.232 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -93.21 147.77 22.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.309 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 56.8 m -89.93 109.36 32.13 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 47.4 Cg_endo -73.38 175.62 10.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.915 1.482 . . . . 0.0 110.46 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.1 ptmt -67.54 -26.16 66.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.03 14.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.502 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.52 13.9 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.982 . . . . 0.0 110.403 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 25.7 mtpt -90.04 47.2 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -85.61 -20.78 28.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.013 -1.055 . . . . 0.0 109.231 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 4.7 p90 -90.58 1.29 56.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.114 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -160.27 91.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 23.9 mm -54.13 -81.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.18 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -91.27 68.87 5.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.07 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.16 142.41 8.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 133.45 42.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.331 -1.1 . . . . 0.0 109.821 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.446 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 9.3 t -125.67 138.81 53.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.674 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.16 133.36 53.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.7 113.95 24.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 110.589 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.54 HG13 ' HD1' ' A' ' 5' ' ' PHE . 5.1 t -88.23 115.84 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.0 t -79.85 -59.62 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 110.349 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.84 -36.03 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 109.421 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -128.53 93.11 3.56 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.9 mt-30 -34.45 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.236 0.541 . . . . 0.0 111.239 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 53.8 m -146.8 84.28 7.65 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.368 -0.832 . . . . 0.0 110.376 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.84 96.05 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.122 1.591 . . . . 0.0 110.263 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.7 t -99.07 132.42 44.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.907 . . . . 0.0 110.259 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 30.6 p -118.75 124.41 47.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.53 117.93 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 26.0 m -92.41 163.21 13.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -49.71 126.41 13.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.35 -43.01 33.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 44.31 2.93 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -116.32 165.86 12.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -1.193 . . . . 0.0 110.249 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 39.7 mt -146.94 165.1 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.418 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 105.63 154.71 21.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.37 -13.61 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -1.208 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 29.2 mtt180 -120.9 16.65 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 8.7 m 64.16 27.8 14.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.212 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.69 -7.71 39.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.411 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.46 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -107.65 158.85 16.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.414 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.456 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 13.2 p . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.022 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.853 ' CD1' HG13 ' A' ' 24' ' ' VAL . 44.9 m-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.226 0.536 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.53 151.69 38.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.84 133.33 52.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.912 . . . . 0.0 110.32 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 142.88 98.41 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.3 Cg_endo -73.55 167.35 27.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.052 1.554 . . . . 0.0 110.469 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -31.82 73.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -21.96 66.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.475 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.35 6.64 35.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 52.82 2.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.445 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -86.14 -14.83 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.99 -1.069 . . . . 0.0 109.171 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.5 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.35 -2.25 57.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.293 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 4.0 m -160.18 103.63 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 62.5 mt -55.37 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 0.0 109.904 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -93.55 66.68 3.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.908 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -155.96 147.45 16.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.4 mtt85 -105.62 135.93 46.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.975 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.5 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.5 t -108.38 132.85 53.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.513 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -97.83 105.57 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -97.15 112.2 24.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.387 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.853 HG13 ' CD1' ' A' ' 5' ' ' PHE . 23.9 t -85.52 117.43 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ALA . 8.3 t -77.88 -63.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.92 -56.12 2.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.5 tp10 -103.89 91.33 3.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.017 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.1 tp-100 -34.95 91.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.766 -0.583 . . . . 0.0 111.151 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' GLU . 58.0 m -148.23 82.78 7.48 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.3 Cg_endo -76.44 93.13 1.05 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.02 1.537 . . . . 0.0 110.355 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.7 t -101.27 141.19 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.2 p -110.89 134.05 52.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.338 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.09 120.75 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 110.061 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 27.0 m -87.63 159.89 18.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.467 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -47.58 120.06 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -44.78 -44.8 9.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.456 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 47.04 3.15 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -121.75 171.03 9.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 110.252 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.506 ' CG2' ' HD2' ' A' ' 45' ' ' ARG . 27.0 mt -149.66 146.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.89 169.41 14.41 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.8 -40.72 13.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.1 mtt180 -93.49 9.69 35.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.118 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.5 m 66.84 56.75 0.68 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 0.0 110.157 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.14 -25.7 8.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.421 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.506 ' HD2' ' CG2' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -89.61 151.2 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 110.203 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 110.063 179.878 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.332 0.587 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.95 140.01 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -86.35 150.23 24.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 6.7 m -83.9 127.1 68.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 163.65 36.98 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.891 1.469 . . . . 0.0 110.53 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 1.4 pttp -63.02 -29.95 71.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.131 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.42 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -62.46 -25.9 68.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.86 . . . . 0.0 110.32 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.411 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.6 m-85 -114.03 8.31 17.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -90.32 49.75 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.091 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.28 -11.43 52.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 0.0 109.472 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 12.6 p90 -87.18 -9.56 54.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.51 127.38 4.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 110.073 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 25.6 mt -86.98 -65.0 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CG ' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -90.14 50.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 0.0 110.425 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -158.98 137.3 5.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -89.71 -179.8 5.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -1.118 . . . . 0.0 109.575 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.487 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 12.9 t -160.19 125.95 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.898 -1.126 . . . . 0.0 110.892 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.31 114.07 26.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -96.87 111.48 23.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.451 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 10.4 t -84.0 118.02 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 9.6 t -74.04 -66.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.69 -62.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.4 tp10 -98.18 88.46 4.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.336 -0.853 . . . . 0.0 108.983 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.5 mm-40 -34.64 92.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.348 0.594 . . . . 0.0 110.968 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 29' ' ' THR . 13.8 m -144.22 83.62 9.96 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 110.556 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -77.97 84.43 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.094 1.576 . . . . 0.0 110.451 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -89.92 134.42 34.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.92 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 7.7 t -114.35 119.27 36.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 110.609 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 t -103.85 115.11 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.803 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.522 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 19.3 m -88.46 158.08 18.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -53.3 125.18 16.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.891 . . . . 0.0 110.032 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' ASP . 3.0 mm-40 -42.64 -45.97 4.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.429 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -90.45 49.35 3.18 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.683 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -117.81 158.81 24.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.265 . . . . 0.0 110.518 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 38' ' ' TYR . 33.5 mm -142.47 150.46 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.16 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.36 170.35 14.87 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.56 -48.11 11.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -1.146 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mtm105 -98.18 23.69 7.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.254 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.534 ' HB3' ' CG ' ' A' ' 18' ' ' LYS . 20.2 m 61.04 76.22 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.135 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -40.16 2.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 110.379 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -97.39 179.8 4.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 110.262 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 37' ' ' GLY . 2.8 p . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 110.232 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.733 ' CD1' HG13 ' A' ' 24' ' ' VAL . 50.0 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.223 0.535 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.81 121.54 41.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 110.308 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.96 132.53 35.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.104 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 131.2 79.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.124 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.439 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 46.7 Cg_endo -73.31 173.04 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.956 1.503 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 10.0 mttm -67.63 -34.04 76.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.54 -8.68 35.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.432 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -116.1 -0.72 12.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.15 62.2 5.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -85.55 -21.05 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.089 . . . . 0.0 109.278 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 7.1 p90 -90.34 -2.18 57.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.105 178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.67 126.95 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.3 mm -89.04 -69.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.991 -1.068 . . . . 0.0 109.759 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' CD ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -93.12 63.63 3.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.158 -0.964 . . . . 0.0 110.054 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.436 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -155.32 143.67 10.15 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -101.38 124.79 47.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.206 . . . . 0.0 110.281 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.1 t -114.87 127.96 56.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 0.0 110.492 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -103.76 120.69 41.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -103.94 113.89 27.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.733 HG13 ' CD1' ' A' ' 5' ' ' PHE . 3.4 t -82.51 119.15 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.7 t -79.0 -64.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.678 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.34 -45.46 2.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -117.4 92.05 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -34.69 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.772 -0.58 . . . . 0.0 110.943 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.8 m -143.52 85.84 9.19 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.247 -0.908 . . . . 0.0 110.552 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.86 114.48 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.568 . . . . 0.0 110.533 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.448 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 17.6 m -119.03 126.38 51.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -0.91 . . . . 0.0 109.85 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 23.7 p -116.06 103.87 11.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.931 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.99 132.51 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.499 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 21.7 m -102.19 157.35 16.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -52.64 116.9 2.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 110.104 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.5 mm-40 -41.82 -48.19 4.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.373 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 50.74 3.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.545 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -121.64 171.6 8.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.098 -1.237 . . . . 0.0 110.361 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.545 HD12 ' C ' ' A' ' 38' ' ' TYR . 3.6 mp -147.19 138.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 110.135 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.14 159.17 9.45 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.69 -48.51 25.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.1 mtt180 -98.33 21.4 11.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.189 -0.944 . . . . 0.0 110.118 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.517 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 6.3 m 64.64 61.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -101.41 -31.19 11.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.134 -0.979 . . . . 0.0 110.62 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -108.37 163.54 13.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.456 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.511 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 10.2 p . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 110.057 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.857 ' CD1' HG13 ' A' ' 24' ' ' VAL . 72.7 m-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.977 0.418 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.42 129.23 26.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.986 -1.071 . . . . 0.0 110.253 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -86.09 142.12 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 110.17 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 4.0 m -78.61 126.95 81.9 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 110.074 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.6 Cg_endo -74.21 148.33 38.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.887 1.467 . . . . 0.0 110.409 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.2 ttpt -58.93 -29.93 67.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -61.44 -34.18 74.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.364 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.462 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 10.9 m-85 -101.43 7.09 42.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.31 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 2.2 mttt -86.16 60.98 6.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.082 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -85.69 -19.11 31.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.004 -1.06 . . . . 0.0 109.31 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.0 p90 -90.72 -1.95 57.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.45 -0.781 . . . . 0.0 109.187 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.3 106.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.1 mm -81.63 -64.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.219 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.82 49.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.314 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -152.58 175.85 31.01 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.1 157.18 33.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -1.05 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 43.6 t -141.41 119.51 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -95.97 109.5 21.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 109.862 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -96.82 105.53 17.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.466 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.857 HG13 ' CD1' ' A' ' 5' ' ' PHE . 57.6 t -84.49 114.6 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' ALA . 59.9 t -72.9 -59.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -65.77 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 109.415 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 tp10 -95.67 93.24 7.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 27' ' ' GLU . 4.8 mp0 -34.67 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.346 0.593 . . . . 0.0 111.151 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.702 HG22 ' O ' ' A' ' 29' ' ' THR . 4.5 m -147.0 78.98 10.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.454 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.2 Cg_endo -79.39 86.03 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.093 1.575 . . . . 0.0 110.279 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.4 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 t -90.53 133.4 35.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -129.33 101.65 6.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.31 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 34' ' ' CYS . 88.7 t -103.97 166.6 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.298 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' N ' HG12 ' A' ' 33' ' ' VAL . 34.1 m -112.88 164.33 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.306 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.531 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.9 m-20 -64.63 117.38 7.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.367 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -44.47 -41.45 6.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.12 46.07 3.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.38 175.74 7.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -1.171 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 37.5 mt -146.44 152.1 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.055 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.58 161.29 19.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.8 -49.52 12.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 21.1 mmt-85 -90.25 15.65 10.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.981 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 4.2 m 67.7 50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.801 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -101.27 0.22 36.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.493 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.28 164.05 23.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.384 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.087 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.247 0.546 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.7 m -136.61 130.43 32.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.983 . . . . 0.0 110.312 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.65 124.25 31.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -52.39 129.3 42.7 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.119 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.2 155.71 51.67 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.98 1.516 . . . . 0.0 110.388 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -59.97 -25.1 64.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -63.17 -33.08 74.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.248 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.548 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 m-85 -103.61 10.37 36.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -90.05 43.29 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -86.13 -13.71 46.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.41 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.45 2.59 55.52 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.763 . . . . 0.0 109.185 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -157.41 125.5 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.136 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 35.7 mm -83.02 -81.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.409 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.8 OUTLIER -89.69 57.47 3.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.134 -0.979 . . . . 0.0 110.268 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -149.04 160.08 28.27 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 20.9 ptt180 -116.81 139.23 50.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -1.087 . . . . 0.0 109.694 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.507 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.2 t -114.31 135.3 54.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.791 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 ttp85 -97.96 124.0 42.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.5 t80 -112.09 110.78 21.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.566 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 12.5 t -90.12 123.01 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.926 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 97.1 t -83.06 -56.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.69 -29.79 0.1 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 0.0 109.648 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.6 mt-10 -141.41 96.53 3.0 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.5 mt-30 -33.6 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.212 0.529 . . . . 0.0 111.301 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' GLU . 91.0 m -140.64 83.15 15.03 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.308 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.0 Cg_endo -82.4 83.84 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.174 1.618 . . . . 0.0 110.409 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.403 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 26.8 t -89.82 134.05 34.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.9 p -101.68 132.38 47.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 3.5 t -126.96 151.23 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.332 -0.855 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 19.5 m -123.47 162.0 23.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 110.388 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -57.66 121.05 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.206 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -44.39 -38.95 4.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.168 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 46.05 3.06 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.33 163.92 20.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -1.157 . . . . 0.0 110.187 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.9 mt -137.41 160.46 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.18 166.95 31.49 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.51 -35.88 16.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -91.55 7.2 42.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.14 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.9 m 69.25 44.68 0.94 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.404 -0.81 . . . . 0.0 110.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -100.28 -25.64 14.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.477 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 3.2 mmt180 -92.41 163.49 13.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.526 ' CD1' HG13 ' A' ' 24' ' ' VAL . 52.7 m-85 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.166 0.508 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 m -119.07 135.19 54.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.171 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.12 109.11 21.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.305 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -48.61 120.35 8.84 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 43.4 Cg_endo -70.67 175.57 8.68 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.858 1.451 . . . . 0.0 110.525 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -60.27 -41.6 93.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.551 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.98 -19.6 66.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.441 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.467 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -99.98 -9.37 22.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.193 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 2.1 ttpt -87.82 57.55 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 110.145 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -85.76 -17.4 35.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 6.3 p90 -89.98 -2.53 58.16 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.147 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.36 127.75 4.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 45.5 mt -82.23 -74.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 110.424 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -89.78 64.43 6.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 0.0 110.471 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HD2' ' A' ' 13' ' ' LYS . . . -160.15 133.19 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -95.48 132.75 40.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -1.167 . . . . 0.0 109.765 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 32.1 t -118.75 132.31 56.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.004 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -98.15 124.02 42.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -111.89 112.81 24.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 110.498 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 5' ' ' PHE . 11.6 t -84.72 117.36 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.202 -0.936 . . . . 0.0 109.975 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.4 t -80.86 -63.05 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 110.436 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.17 -39.43 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.613 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -123.0 92.37 3.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -35.04 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.21 0.529 . . . . 0.0 111.077 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 29' ' ' THR . 3.8 m -148.25 83.37 7.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.233 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.8 Cg_endo -82.79 132.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.145 1.603 . . . . 0.0 110.431 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 p -148.81 118.13 6.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.863 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 12.1 t -95.83 153.88 17.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.645 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -139.57 121.6 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.491 -0.756 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.6 m -96.94 158.22 15.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -49.51 128.47 17.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -46.5 -47.4 19.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.331 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.14 45.4 3.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.595 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -113.28 163.86 14.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -1.191 . . . . 0.0 110.1 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 31.6 mm -138.76 153.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.97 144.97 11.97 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -34.27 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -1.109 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.454 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.0 mtt180 -93.76 4.86 53.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.18 43.89 1.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.99 -13.14 15.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.465 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -109.51 166.99 10.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.864 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.542 ' HD1' HG13 ' A' ' 24' ' ' VAL . 76.1 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.223 0.535 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m -138.35 137.54 37.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -100.3 113.94 27.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 124.95 78.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.176 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.42 178.03 7.18 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.859 1.452 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -65.98 -25.65 67.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -19.91 66.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 4.3 m-85 -110.92 11.06 22.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 110.207 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 34.2 mmtm -88.93 47.6 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -85.49 -23.15 27.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.993 -1.067 . . . . 0.0 108.918 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.9 p90 -90.39 -0.76 57.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -160.68 116.19 2.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 109.901 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 32.6 mt -76.65 -63.97 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -104.36 73.8 1.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.098 -1.001 . . . . 0.0 110.417 179.764 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.31 178.27 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 1.7 mtt180 -131.15 119.89 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.164 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 15.1 t -107.09 132.3 53.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -104.64 120.8 42.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 109.993 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -104.49 106.72 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.477 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG13 ' HD1' ' A' ' 5' ' ' PHE . 24.2 t -81.58 119.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.13 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 26' ' ' ALA . 25.7 t -80.75 -62.99 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.499 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.3 -49.74 2.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.4 -0.812 . . . . 0.0 109.749 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 5.4 mt-10 -113.32 91.95 3.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.48 -0.763 . . . . 0.0 109.0 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -33.54 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.273 0.559 . . . . 0.0 111.322 -179.075 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 41.0 m -147.92 82.71 7.72 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.6 Cg_endo -77.03 86.69 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.113 1.586 . . . . 0.0 110.352 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.65 143.85 26.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 109.791 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 20.2 p -124.03 132.5 53.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 34' ' ' CYS . 58.6 t -125.45 169.68 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 109.801 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.3 m -140.67 162.32 35.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.39 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.555 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.4 m-20 -49.22 123.67 7.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -47.86 -45.79 30.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.71 3.02 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.816 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -115.44 174.0 6.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 110.217 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.816 HD12 ' C ' ' A' ' 38' ' ' TYR . 4.2 mp -150.48 147.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.141 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.99 152.97 10.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.44 -30.91 57.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -1.104 . . . . 0.0 109.975 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.16 5.33 44.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 3.9 m 68.92 66.3 0.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 -30.88 2.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.002 -1.061 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -95.97 107.07 19.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.963 -1.086 . . . . 0.0 110.506 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.524 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 12.2 p . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 110.447 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.604 ' CD1' HG13 ' A' ' 24' ' ' VAL . 25.2 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.329 0.585 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.62 134.67 47.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HG2' ' NH1' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -90.56 133.32 35.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.139 179.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -73.99 152.8 88.76 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -72.63 158.06 51.34 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.005 1.529 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -26.78 65.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -6.22 26.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.491 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -120.02 4.95 10.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.349 179.964 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.523 ' NZ ' ' OH ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -81.48 75.16 8.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -85.25 -25.45 27.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.018 -1.051 . . . . 0.0 109.407 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.523 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 3.3 p90 -90.45 2.97 55.15 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.95 178.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 1.7 m -160.81 119.77 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 43.1 mm -75.52 -71.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -99.95 68.82 1.51 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.256 179.768 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -159.97 141.25 7.32 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.9 ptp180 -96.37 143.57 27.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -1.13 . . . . 0.0 109.878 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 31' ' ' SER . 10.4 t -123.22 125.25 44.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.448 ' CZ ' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -94.5 117.75 30.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.901 179.625 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.93 112.71 25.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.322 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.604 HG13 ' CD1' ' A' ' 5' ' ' PHE . 9.0 t -85.55 119.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.134 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 58.1 t -77.41 -67.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 110.382 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.76 -45.98 3.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.423 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.8 tt0 -112.53 86.94 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.314 0.578 . . . . 0.0 110.992 -179.164 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 80.9 m -145.01 85.76 8.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.0 Cg_endo -76.39 84.44 1.85 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.033 1.544 . . . . 0.0 110.146 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 68.1 m -90.09 128.39 36.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.258 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 24.7 p -107.23 97.05 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' ARG . 98.4 t -89.63 120.78 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.023 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -86.94 157.71 19.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -48.75 118.33 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.129 179.934 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -45.93 -41.27 11.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 110.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.96 43.04 2.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -120.41 176.3 5.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 21.9 mt -150.33 136.94 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.41 166.15 12.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.77 -38.43 18.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -1.081 . . . . 0.0 110.05 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -99.34 17.55 19.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.002 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 8.2 m 63.62 43.65 5.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.1 tt0 -93.7 -32.7 13.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.492 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -95.07 158.9 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.01 . . . . 0.0 110.199 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.47 ' HB ' ' HD3' ' A' ' 18' ' ' LYS . 7.3 p . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.274 0.559 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.31 143.78 34.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 142.32 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.78 137.31 92.67 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.479 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 46.3 Cg_endo -72.68 164.39 35.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.046 1.551 . . . . 0.0 110.382 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -62.61 -30.98 71.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 110.24 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.479 ' NE2' ' HB2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -66.45 -19.96 65.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.358 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -109.94 5.64 22.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.88 50.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 110.035 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -86.15 -17.55 34.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 109.115 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -91.15 0.57 57.5 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.069 178.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.43 98.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.6 mt -65.69 -73.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.953 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ptpm? -89.61 52.78 2.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -0.924 . . . . 0.0 110.12 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -148.66 165.96 29.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -123.35 130.28 52.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -1.187 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.468 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.3 t -118.27 128.1 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.447 -179.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.81 139.66 30.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 110.02 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -117.56 110.87 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 27' ' ' GLU . 63.9 t -82.02 116.88 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -78.7 -63.88 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.652 -0.655 . . . . 0.0 110.221 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.26 -49.6 5.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -111.35 90.21 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.914 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.8 tt0 -35.45 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.238 0.542 . . . . 0.0 111.041 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' GLU . 18.0 m -148.36 86.96 5.79 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.892 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.02 93.47 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.093 1.575 . . . . 0.0 110.5 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 p -93.29 124.3 37.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 31.3 p -105.93 128.0 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.78 158.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 110.109 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 13.1 m -125.41 159.2 32.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 110.33 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -52.99 118.61 3.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 35' ' ' ASP . 43.3 mm-40 -42.44 -40.94 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.96 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.05 47.48 3.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -125.0 172.47 9.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -1.203 . . . . 0.0 110.281 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 41.9 mt -146.52 140.89 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.22 160.88 11.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 -40.49 22.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.117 . . . . 0.0 110.23 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 6.2 mpt_? -93.25 9.65 35.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.131 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.49 47.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -0.843 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 8.7 tt0 -104.17 -18.23 14.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -101.18 156.2 17.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.834 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.372 -179.865 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.158 0.504 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -119.91 128.46 53.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.419 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -83.37 141.78 31.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.033 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -84.08 129.97 56.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.946 . . . . 0.0 110.177 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.18 157.47 50.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.93 1.49 . . . . 0.0 110.29 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -18.33 64.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -65.18 -19.19 65.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -119.76 21.1 12.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.201 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.29 50.25 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.883 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -86.11 -16.85 36.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.053 . . . . 0.0 109.313 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 3.5 p90 -90.4 4.2 51.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.237 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -158.74 109.25 2.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.21 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.479 ' HA ' HD13 ' A' ' 17' ' ' ILE . 10.6 mm -64.3 -70.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 7.9 ptmm? -105.73 55.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -146.83 150.8 23.11 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 179.42 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 0.0 109.856 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 8.4 t -154.73 132.9 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.443 ' HD3' ' CG2' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -107.9 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 109.803 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.89 110.6 22.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.583 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.443 ' CG2' ' HD3' ' A' ' 22' ' ' ARG . 48.3 t -84.43 111.86 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 26' ' ' ALA . 37.7 t -74.09 -59.83 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.667 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.34 -59.51 1.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.466 -0.771 . . . . 0.0 109.499 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 63.1 mt-10 -104.0 92.45 4.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 108.97 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.1 tt0 -33.62 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.811 -0.556 . . . . 0.0 111.153 -179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 19.2 m -149.42 88.49 4.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.35 91.75 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.024 1.539 . . . . 0.0 110.396 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.435 ' OG ' ' HD2' ' A' ' 22' ' ' ARG . 2.3 p -90.06 148.82 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.841 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -135.13 116.43 14.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.701 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.06 157.18 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 19.3 m -122.44 161.3 23.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.357 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.2 m-20 -49.64 124.43 9.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -47.05 -41.65 17.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 110.258 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 43.29 2.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -117.04 168.27 10.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -1.19 . . . . 0.0 110.257 179.82 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 38' ' ' TYR . 48.8 mt -150.37 156.92 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.24 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.64 162.02 18.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.74 -28.77 30.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -105.69 17.57 23.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.493 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 16.7 m 61.68 35.69 16.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -100.29 -17.0 17.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.4 170.18 8.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.057 179.873 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.695 ' CD1' HG13 ' A' ' 24' ' ' VAL . 39.9 m-85 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.305 0.574 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -124.44 125.21 43.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.198 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.71 118.73 23.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 124.37 83.57 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.053 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.19 160.99 45.86 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.312 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -51.52 -24.03 4.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.35 -45.35 93.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 110.308 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.539 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.6 m-85 -94.24 10.56 33.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 37.8 mttt -84.93 46.63 1.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -86.21 -13.93 45.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.407 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 7.8 p90 -90.53 -5.13 56.35 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.089 178.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.03 132.58 10.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -0.918 . . . . 0.0 110.372 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 30.7 mm -80.35 -71.89 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.942 . . . . 0.0 110.141 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -101.77 69.11 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 0.0 110.303 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -155.36 159.35 29.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.427 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.39 140.68 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -1.155 . . . . 0.0 109.945 179.833 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -116.29 138.2 51.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -110.1 104.0 12.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.79 113.14 24.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.376 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.695 HG13 ' CD1' ' A' ' 5' ' ' PHE . 7.1 t -86.12 121.45 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.879 . . . . 0.0 109.933 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -74.86 -62.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.619 -0.675 . . . . 0.0 110.524 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.26 -66.98 0.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' THR . 26.3 mt-10 -97.95 92.15 5.66 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 108.893 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -33.62 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.289 0.566 . . . . 0.0 110.993 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.9 m -137.4 80.92 32.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.485 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.588 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.1 Cg_endo -74.48 83.09 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.111 1.585 . . . . 0.0 110.042 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 t -90.16 145.74 24.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.328 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.16 145.59 45.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.911 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 76.5 t -143.21 153.54 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 109.888 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 15.5 m -125.45 157.58 36.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.975 . . . . 0.0 110.353 -179.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 19.4 m-20 -51.92 118.65 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 3.6 tp10 -43.24 -37.2 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.962 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 45.86 3.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.86 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -125.17 160.93 27.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -1.151 . . . . 0.0 110.297 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 38' ' ' TYR . 19.3 mm -142.7 158.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 109.923 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.12 174.77 19.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.37 -47.68 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -1.145 . . . . 0.0 110.35 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -90.01 18.78 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.175 -179.894 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.6 m 62.65 38.11 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -98.46 -13.71 20.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.255 -0.903 . . . . 0.0 110.326 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -103.38 169.94 8.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 8.0 p . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 110.347 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.714 ' CD1' HG22 ' A' ' 24' ' ' VAL . 64.8 m-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.197 0.523 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.5 m -130.71 130.12 43.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 150.54 24.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 119.66 69.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.43 ' C ' ' HE3' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -72.72 173.91 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.809 1.426 . . . . 0.0 110.446 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.461 ' N ' ' HE3' ' A' ' 13' ' ' LYS . 17.0 mttm -66.52 -24.89 66.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 0.0 110.381 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.65 -10.96 30.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.295 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.526 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 12.5 m-85 -129.2 10.9 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.304 -0.873 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HE3' ' N ' ' A' ' 10' ' ' LYS . 19.0 mttt -86.21 45.96 1.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.227 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.28 -14.4 43.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.046 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.04 -1.06 57.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 178.38 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 1.8 m -160.28 129.25 4.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.035 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 5.0 mt -87.42 -63.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.074 -1.016 . . . . 0.0 110.108 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.527 ' HE3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -103.11 60.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.257 179.574 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.17 162.38 33.17 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -107.57 -178.83 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -1.19 . . . . 0.0 110.031 179.86 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -160.46 126.91 4.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -104.41 115.43 30.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -100.06 116.03 31.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.542 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.714 HG22 ' CD1' ' A' ' 5' ' ' PHE . 52.6 t -87.26 115.56 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.97 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.6 t -75.36 -61.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.19 -62.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.607 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -99.82 93.18 5.66 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 108.927 178.767 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.1 pt20 -34.92 91.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.74 -0.6 . . . . 0.0 111.143 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 9.0 m -146.19 86.22 7.12 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -76.42 98.08 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.067 1.561 . . . . 0.0 110.643 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 m -100.41 138.98 36.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.6 p -121.14 110.72 16.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.143 -0.973 . . . . 0.0 110.628 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ARG . 60.8 t -93.91 155.32 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.0 109.886 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.608 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 7.1 m -127.92 157.3 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.222 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.526 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 1.4 m-20 -48.76 125.76 10.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.55 -47.21 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 110.085 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.26 46.26 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.79 175.32 5.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -1.169 . . . . 0.0 110.328 -179.952 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 38' ' ' TYR . 3.5 mp -145.05 130.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.82 155.51 9.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.51 -41.04 40.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -1.179 . . . . 0.0 110.208 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 9.6 mtp180 -89.59 7.68 35.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.513 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 6.7 m 64.2 72.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.799 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.48 ' CA ' ' HD3' ' A' ' 18' ' ' LYS . 7.0 pt-20 -119.65 -25.09 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.658 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.438 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -112.49 95.15 5.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.787 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.527 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 14.9 p . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.813 ' CD1' HG13 ' A' ' 24' ' ' VAL . 86.8 m-85 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 120.928 0.395 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.54 146.67 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.933 -1.104 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -79.98 154.46 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -81.93 136.32 47.61 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.68 156.54 49.0 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.986 1.519 . . . . 0.0 110.426 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 13' ' ' LYS . 9.9 ttpt -63.22 -27.86 69.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -20.5 27.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 110.271 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.5 m-85 -125.4 6.38 7.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -86.5 39.62 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.054 179.759 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -86.13 -12.48 49.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.04 -1.037 . . . . 0.0 109.604 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.6 p90 -90.12 1.56 56.26 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.457 -0.777 . . . . 0.0 109.288 178.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -159.67 109.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 46.5 mm -70.14 -74.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -96.28 60.39 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.973 -1.079 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -148.39 141.99 9.6 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.7 45.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -1.166 . . . . 0.0 110.155 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 8.5 t -113.94 126.5 55.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.428 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.12 111.75 23.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 110.032 179.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -96.01 112.67 24.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.0 110.552 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.813 HG13 ' CD1' ' A' ' 5' ' ' PHE . 38.5 t -86.58 115.73 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.95 . . . . 0.0 109.976 179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 26' ' ' ALA . 62.5 t -73.08 -60.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.573 -0.704 . . . . 0.0 110.494 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.84 -66.73 0.3 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.1 tp10 -99.13 93.67 6.1 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.894 178.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tt0 -34.51 91.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.761 -0.587 . . . . 0.0 111.141 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' GLU . 39.6 m -143.71 84.19 10.06 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.7 Cg_endo -77.35 89.22 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.076 1.566 . . . . 0.0 110.446 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.432 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 78.4 p -89.76 131.5 35.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.069 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 23.5 p -113.91 108.5 17.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.628 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -109.66 130.39 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.969 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.1 m -94.35 162.28 13.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.185 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 18.1 m-20 -56.91 117.68 4.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.72 -38.01 2.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.55 45.7 3.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -126.49 171.06 11.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -1.14 . . . . 0.0 110.282 -179.959 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 2.3 mp -147.39 150.56 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 167.83 16.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.53 -37.41 16.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 46.5 mtt180 -96.55 18.72 13.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.038 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.498 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 12.1 m 61.42 41.1 13.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -93.98 -37.3 11.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 110.671 -179.597 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -85.44 163.99 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.256 -179.729 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.23 -179.879 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.573 ' CD1' HG13 ' A' ' 24' ' ' VAL . 81.0 m-85 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.53 133.43 22.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -96.31 152.0 18.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.877 . . . . 0.0 110.382 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' O ' ' CE ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.13 134.05 32.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.163 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.3 Cg_endo -74.12 161.53 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.866 1.456 . . . . 0.0 110.425 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -31.54 72.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -64.09 -12.22 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 110.328 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.406 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -119.68 -3.23 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.143 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.517 ' CE ' ' O ' ' A' ' 8' ' ' CYS . 18.1 mttt -84.38 62.82 7.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.322 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -85.67 -19.56 30.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.911 -1.118 . . . . 0.0 109.246 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.8 p90 -90.39 -2.9 57.99 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.046 178.253 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.68 106.72 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.607 HG22 ' HD2' ' A' ' 18' ' ' LYS . 18.2 mm -78.53 -62.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.112 -0.993 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HD2' HG22 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -90.4 57.37 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 110.374 -179.834 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' A' ' 13' ' ' LYS . . . -160.05 152.53 23.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -108.56 120.92 43.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -1.122 . . . . 0.0 109.993 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.0 t -99.97 128.71 46.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.653 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -100.5 109.73 21.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 109.718 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.96 104.75 16.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.573 HG13 ' CD1' ' A' ' 5' ' ' PHE . 21.0 t -80.66 120.93 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.071 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.3 t -76.67 -71.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 110.382 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.08 -47.36 4.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.4 tt0 -108.7 81.79 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -33.8 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.391 0.615 . . . . 0.0 111.105 -179.114 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 79.7 m -143.77 82.62 11.09 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.39 84.55 2.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.437 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 23.4 m -93.0 151.52 19.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.144 -0.972 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 31.5 p -127.44 127.88 44.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -116.76 148.54 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 70.6 m -116.41 144.52 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-20 -56.36 119.15 5.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.75 -37.98 4.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 45.02 2.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.27 172.23 9.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -1.163 . . . . 0.0 110.313 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.0 mt -150.0 157.49 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.122 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.65 154.6 20.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -42.15 55.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.031 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -90.05 8.46 32.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.886 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.465 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 4.4 m 68.73 43.41 1.28 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 109.996 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -101.84 -22.28 14.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.309 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -95.52 169.7 9.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.262 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.934 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.499 ' HD1' HG13 ' A' ' 24' ' ' VAL . 37.7 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.226 0.536 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -132.79 130.12 39.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.156 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.46 130.73 34.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 127.05 90.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.277 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.76 167.48 27.1 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.921 1.485 . . . . 0.0 110.458 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.491 ' HG2' ' HE2' ' A' ' 13' ' ' LYS . 5.4 mttt -66.16 -27.24 67.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.186 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -20.44 49.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.238 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -123.71 2.68 8.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HE2' ' HG2' ' A' ' 10' ' ' LYS . 5.1 ttpt -87.03 54.75 3.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -86.33 -15.02 41.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.097 -1.002 . . . . 0.0 109.309 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.5 p90 -90.2 1.93 55.93 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.524 -0.735 . . . . 0.0 109.128 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.454 ' HA ' ' SG ' ' A' ' 43' ' ' CYS . 1.5 m -157.42 79.12 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.834 . . . . 0.0 109.999 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 44' ' ' GLU . 83.7 mt -48.7 -55.15 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.427 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 5.9 ptmm? -112.24 60.95 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.478 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -157.49 141.24 7.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 123.51 40.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -1.113 . . . . 0.0 109.936 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 31' ' ' SER . 11.0 t -111.0 127.68 55.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.111 -0.993 . . . . 0.0 110.587 -179.595 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.61 119.39 34.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.868 . . . . 0.0 109.822 179.604 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.31 106.16 17.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 21.3 t -80.24 118.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' ALA . 73.1 t -80.28 -58.44 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.703 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.49 -50.73 3.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 mt-10 -116.06 96.6 5.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.3 tp-100 -34.84 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.78 -0.575 . . . . 0.0 111.201 -179.089 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 29' ' ' THR . 3.9 m -146.17 82.66 8.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.253 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.438 ' HD3' ' OE1' ' A' ' 28' ' ' GLN . 51.1 Cg_endo -79.56 89.06 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.108 1.583 . . . . 0.0 110.43 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -94.65 131.15 40.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.993 179.83 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 27.4 p -113.87 114.38 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.2 129.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.848 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 8.3 m -101.85 161.76 13.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.126 -0.984 . . . . 0.0 110.42 -179.388 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 63.0 m-20 -58.85 119.8 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 37' ' ' GLY . 10.3 pt-20 -43.9 -33.43 1.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' N ' ' HG3' ' A' ' 36' ' ' GLU . . . -90.28 43.83 2.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -126.24 170.65 11.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -1.2 . . . . 0.0 110.414 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 29.3 mt -150.15 151.7 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.64 169.57 17.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -40.82 13.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 110.237 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.8 mpt_? -91.02 10.9 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 6.3 m 66.54 41.45 3.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.872 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HB3' HD12 ' A' ' 17' ' ' ILE . 5.6 pt-20 -100.11 -28.29 13.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -84.88 163.24 19.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.231 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.4 p . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.27 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.102 0.477 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -147.28 134.89 20.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 110.292 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -91.0 126.69 36.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.64 133.95 95.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.8 164.97 34.06 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.943 1.497 . . . . 0.0 110.432 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -66.36 -26.65 67.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.263 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -8.65 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 7.65 5.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 0.0 110.227 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -89.94 46.27 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.32 -11.81 51.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.534 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.41 0.93 57.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.187 178.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.9 m -159.54 123.63 3.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 44' ' ' GLU . 57.8 mt -75.38 -76.52 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -98.72 65.06 1.53 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 0.0 110.814 -179.615 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -152.87 148.36 19.09 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -101.9 132.7 47.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.13 . . . . 0.0 110.098 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.0 t -107.63 126.63 52.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.458 ' NH1' ' CG ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -96.49 106.89 19.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.48 115.38 27.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.585 -179.601 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 17.9 t -91.64 120.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 109.944 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.7 t -79.59 -64.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 110.563 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -38.3 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.807 . . . . 0.0 109.561 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -124.51 91.49 3.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 pm0 -36.2 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 110.93 -179.078 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -146.28 83.6 8.36 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.858 . . . . 0.0 110.462 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.3 Cg_endo -78.8 88.42 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.164 1.613 . . . . 0.0 110.431 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.6 145.46 25.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.92 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 8.9 p -128.03 105.59 8.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.114 -0.991 . . . . 0.0 110.978 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.3 t -106.8 151.8 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.533 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 13.5 m -119.55 166.12 13.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.613 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.99 117.39 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.964 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -42.62 -37.25 1.63 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.213 -179.909 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 46.36 3.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -124.61 165.73 17.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -1.202 . . . . 0.0 110.38 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.4 mt -149.42 151.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.235 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.24 149.94 10.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.48 66.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.012 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -90.67 -0.39 57.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.9 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.533 ' HG ' ' HG ' ' A' ' 34' ' ' CYS . 5.2 m 69.89 38.18 1.65 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.825 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.49 ' HB2' HD12 ' A' ' 17' ' ' ILE . 6.5 tm-20 -101.39 -17.34 16.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -97.27 163.95 12.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.821 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.431 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 8.9 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.28 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.514 ' HD1' HG13 ' A' ' 24' ' ' VAL . 59.3 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.25 0.548 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -142.7 121.51 12.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.41 137.28 35.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.183 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 136.41 93.19 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -179.94 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.5 Cg_endo -72.89 161.93 42.4 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.055 1.555 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -67.46 -31.52 71.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.952 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.67 -10.83 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.7 m-85 -126.5 2.83 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.843 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -89.98 57.06 3.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.11 179.889 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -86.45 -12.68 48.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 109.422 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.3 p90 -90.17 -1.65 57.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.089 178.427 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.24 104.27 1.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 110.103 179.837 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 47.5 mm -69.29 -72.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CE ' ' HB2' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -91.16 52.8 2.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -151.42 135.9 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -99.62 125.95 45.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -1.134 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.475 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 11.0 t -105.66 125.8 51.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.251 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.03 112.16 23.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -94.77 104.7 16.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.514 HG13 ' HD1' ' A' ' 5' ' ' PHE . 21.5 t -80.52 115.13 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.266 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 27.9 t -78.13 -62.1 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.558 -0.714 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.53 -44.8 4.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.281 179.523 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -115.37 90.47 3.35 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.842 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -35.01 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.778 -0.576 . . . . 0.0 111.005 -179.133 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' GLU . 34.2 m -150.37 83.46 5.97 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 -179.882 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.493 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.5 Cg_endo -80.8 100.08 1.18 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.065 1.56 . . . . 0.0 109.953 179.419 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.438 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.3 p -112.15 132.72 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.096 -1.002 . . . . 0.0 110.454 -179.741 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 29.2 p -104.79 131.45 52.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.5 116.95 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 19.4 m -93.97 156.1 16.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 110.126 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -50.3 124.18 9.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 179.895 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -45.52 -40.78 8.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.18 46.24 3.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -120.82 166.62 13.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.339 179.899 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 9.6 mt -146.46 150.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.69 145.02 9.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.98 62.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 110.253 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.468 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.3 mmt85 -112.78 5.66 17.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m 68.34 45.22 1.22 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.131 179.704 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.48 -33.5 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 110.678 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -86.07 151.68 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.379 -179.704 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.04 179.954 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 47.4 m-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.312 0.577 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.7 128.66 35.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.164 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.91 125.66 45.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.438 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.33 127.45 92.13 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 -179.931 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.8 Cg_endo -74.2 161.27 41.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.914 1.481 . . . . 0.0 110.247 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -64.41 -32.67 74.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -65.57 -8.69 21.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.471 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -123.86 0.98 8.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 20' ' ' ARG . 27.2 mttt -87.99 73.85 9.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.372 -179.788 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -85.74 -17.82 34.79 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.207 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 14.6 p90 -82.58 -10.08 59.12 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 178.502 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.2 m -160.3 137.81 9.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.0 mm -94.37 -70.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.41 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.89 62.41 5.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.102 -0.999 . . . . 0.0 110.506 -179.925 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.35 141.96 7.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.753 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 5.3 mpt_? -95.4 150.56 20.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -1.178 . . . . 0.0 109.505 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.495 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 26.5 t -132.55 130.31 40.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.552 -179.685 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -99.49 122.18 42.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 109.994 179.619 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -111.98 103.49 11.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.211 -179.804 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.494 ' CG2' ' HB ' ' A' ' 29' ' ' THR . 22.3 t -81.42 124.67 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.1 t -79.68 -69.25 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 110.306 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.94 -44.45 3.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -112.53 93.97 4.69 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.886 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tp-100 -38.93 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.533 -0.729 . . . . 0.0 110.796 -179.148 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 7.6 m -139.18 73.15 38.25 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.218 -0.927 . . . . 0.0 110.459 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.609 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.3 Cg_endo -78.43 72.86 6.12 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.025 1.539 . . . . 0.0 110.033 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -92.56 137.91 31.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -179.695 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.7 t -114.01 107.83 16.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 20' ' ' ARG . 45.0 t -94.08 116.24 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 9.0 m -83.6 158.54 21.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.964 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -46.45 120.18 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.762 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.0 tt0 -40.83 -54.09 2.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.66 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.48 52.79 3.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -118.59 168.86 10.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -1.195 . . . . 0.0 110.655 -179.999 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.692 ' N ' HD12 ' A' ' 39' ' ' ILE . 3.3 mp -143.37 132.04 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.756 . . . . 0.0 109.806 179.5 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.8 136.43 3.62 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.01 72.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.304 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.0 19.89 18.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.963 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.6 m 63.54 72.74 0.47 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -107.9 -40.27 5.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.938 -179.3 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.481 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 9.1 ptp180 -118.56 168.86 10.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.986 -1.071 . . . . 0.0 110.546 -179.527 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 7.1 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.181 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.171 0.51 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.5 m -115.95 132.12 56.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -87.69 118.01 26.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 24.6 m -45.28 112.25 1.53 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 163.55 37.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.951 1.501 . . . . 0.0 110.319 179.739 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -60.32 -37.14 79.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.259 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -25.15 63.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 -179.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -110.17 -1.4 17.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.257 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -89.94 46.94 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.401 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -86.21 -12.79 48.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.047 -1.033 . . . . 0.0 109.402 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 9.1 p90 -90.3 -3.8 57.54 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.214 178.494 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.12 105.52 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 51.1 mm -70.41 -71.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.055 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HE3' ' HA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -89.69 64.0 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.488 ' O ' ' CE ' ' A' ' 13' ' ' LYS . . . -160.05 136.37 4.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 96.0 mtt180 -99.51 127.21 45.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -1.161 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 9.5 t -119.01 133.18 55.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.643 -179.664 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -102.51 123.96 47.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.853 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -105.66 116.24 31.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 53.4 t -86.56 116.88 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 110.133 179.714 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' ALA . 89.1 t -79.92 -61.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.543 -0.723 . . . . 0.0 110.549 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.0 -49.14 3.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.577 179.886 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.3 tt0 -114.5 92.83 4.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -34.47 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.262 0.553 . . . . 0.0 110.99 -179.084 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 29' ' ' THR . 4.4 m -149.11 86.81 5.52 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -79.23 122.5 5.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.985 1.518 . . . . 0.0 110.298 179.666 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -127.85 116.64 20.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 109.971 179.804 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.8 p -99.59 126.98 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.583 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 42.2 t -116.77 120.84 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.349 -0.844 . . . . 0.0 109.819 179.705 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 14.6 m -91.3 159.95 15.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.247 -0.908 . . . . 0.0 110.514 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -58.42 128.11 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.036 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -47.44 -49.12 25.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 45.76 3.02 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -113.04 172.85 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 110.226 179.864 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 15.2 mt -150.2 127.7 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.27 148.44 6.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.65 66.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 110.283 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' CYS . 81.0 mtt180 -89.58 13.47 13.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.537 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 3.5 m 63.36 62.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.324 -0.86 . . . . 0.0 109.762 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 10.4 tt0 -110.34 -28.82 8.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.74 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 13.2 ttm180 -111.03 109.58 19.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.017 -1.052 . . . . 0.0 110.317 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.959 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.898 ' CG ' HG22 ' A' ' 24' ' ' VAL . 36.2 m-85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.282 0.563 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.05 162.73 18.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.347 179.942 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -106.9 154.13 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 110.171 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.429 ' CB ' ' HH ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -83.46 127.73 67.11 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 -179.907 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.67 162.21 40.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.868 1.457 . . . . 0.0 110.383 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -61.36 -29.04 69.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -63.86 -25.61 68.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.35 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -112.12 10.55 20.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.351 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -90.0 45.45 1.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.131 179.926 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.25 -13.45 46.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.032 . . . . 0.0 109.624 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p90 -87.96 -1.76 58.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.439 -0.788 . . . . 0.0 109.197 178.607 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.521 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.78 103.2 1.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 33.2 mt -63.73 -69.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 -179.956 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.7 ptmm? -97.94 64.43 1.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.21 149.31 18.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.96 162.05 13.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 109.793 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.2 t -151.81 156.24 39.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.02 . . . . 0.0 110.621 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -125.99 125.82 43.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.456 -0.778 . . . . 0.0 109.602 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.07 118.06 36.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.648 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.898 HG22 ' CG ' ' A' ' 5' ' ' PHE . 37.6 t -83.56 115.72 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.814 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 6.0 t -82.2 -63.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.52 -0.737 . . . . 0.0 110.62 -179.506 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.01 -29.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.351 -0.843 . . . . 0.0 109.787 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' THR . 97.2 mt-10 -136.93 93.46 2.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.164 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 13.1 mt-30 -34.72 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.806 -0.559 . . . . 0.0 111.146 -179.124 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 29' ' ' THR . 3.1 m -149.18 89.57 4.84 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 110.324 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.15 117.45 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.06 1.558 . . . . 0.0 110.395 179.666 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.0 OUTLIER -118.88 110.62 17.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.132 -0.98 . . . . 0.0 109.904 179.768 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.443 ' C ' HG23 ' A' ' 33' ' ' VAL . 26.7 p -92.15 155.14 18.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.735 -179.682 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.443 HG23 ' C ' ' A' ' 32' ' ' CYS . 99.3 t -149.12 120.44 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.472 -0.768 . . . . 0.0 109.806 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.0 m -93.72 156.47 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -179.526 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -54.85 125.53 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.038 179.772 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.47 -39.42 15.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.826 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 40.95 2.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.84 174.24 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -1.214 . . . . 0.0 110.326 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 38' ' ' TYR . 18.0 mm -149.51 148.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.031 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.61 157.45 20.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.03 -37.71 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.164 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -93.11 9.19 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.124 179.842 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.507 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.8 m 67.41 43.72 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.402 -0.811 . . . . 0.0 110.145 179.818 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -96.29 -34.44 11.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.585 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.485 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -96.7 -178.62 4.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.476 -179.757 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.8 p . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.861 . . . . 0.0 110.391 -179.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.173 0.511 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.76 140.17 23.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.17 119.81 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.23 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -55.86 136.61 72.54 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 179.878 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 46.9 Cg_endo -73.35 171.71 17.12 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.91 1.479 . . . . 0.0 110.415 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -63.72 -38.62 91.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 110.234 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -63.64 -19.23 64.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.192 179.982 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.2 m-85 -107.45 -1.97 20.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.1 55.73 3.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.427 ' CE1' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -86.16 -15.5 40.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.026 -1.046 . . . . 0.0 109.303 179.923 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.509 ' OH ' ' CB ' ' A' ' 21' ' ' CYS . 3.6 p90 -90.13 3.32 53.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.493 -0.755 . . . . 0.0 109.307 178.515 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.98 106.39 1.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.154 179.85 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 9.3 mm -63.25 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.108 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -96.29 63.4 2.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.221 179.987 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -159.76 155.54 26.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -101.77 -179.06 3.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 109.832 179.832 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.509 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 8.8 t -152.63 128.05 9.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.068 -1.02 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -102.28 105.07 15.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.074 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.29 115.44 28.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 41.2 t -89.91 117.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.817 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 53.8 t -75.24 -62.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.597 -0.69 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.46 -61.23 1.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.83 . . . . 0.0 109.436 179.779 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 29' ' ' THR . 47.7 mt-10 -99.62 90.6 4.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.483 -0.761 . . . . 0.0 109.008 178.891 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.8 pm0 -34.3 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.268 0.556 . . . . 0.0 111.046 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' GLU . 43.4 m -146.03 85.36 7.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.862 . . . . 0.0 110.348 179.912 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.6 Cg_endo -76.05 99.2 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.368 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.35 143.01 33.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.144 179.897 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 27.5 p -123.91 118.22 26.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.767 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 t -112.44 146.82 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.462 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.6 m -117.03 161.54 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -54.19 117.41 3.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 110.219 -179.893 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -43.97 -38.1 3.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.35 46.18 3.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.508 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.07 172.49 9.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -1.183 . . . . 0.0 110.339 179.965 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 46.2 mt -150.12 143.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.13 168.79 13.37 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 -40.26 16.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -1.15 . . . . 0.0 110.119 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -96.86 13.37 28.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 0.0 110.186 179.973 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.3 m 67.77 51.04 0.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -101.74 -39.92 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.06 165.44 18.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.074 -1.016 . . . . 0.0 110.477 -179.798 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.524 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 8.6 p . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.161 0.505 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 m -145.0 135.92 24.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.299 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 121.18 26.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.142 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -47.41 135.88 9.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.235 -179.982 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.86 173.65 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.996 1.524 . . . . 0.0 110.403 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -65.07 -31.37 72.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.89 -8.59 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -119.05 -1.26 10.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.939 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -90.12 39.39 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.263 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -85.85 -20.94 28.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 109.457 -179.832 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.21 1.1 56.82 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.009 178.124 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -160.33 92.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.884 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 75.4 mt -75.56 -55.89 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' CB ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.45 42.74 1.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 110.026 179.772 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.97 -179.74 30.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -137.29 145.54 43.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.265 -1.138 . . . . 0.0 109.934 179.821 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 14.6 t -125.65 124.94 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.636 -179.538 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -90.2 113.15 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.789 179.602 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -95.41 116.4 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.477 -179.621 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 27' ' ' GLU . 58.0 t -83.7 116.54 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 109.966 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 38.5 t -79.93 -59.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 0.0 110.494 -179.826 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.53 -47.92 3.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -118.08 95.17 4.78 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.755 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 56.1 tt0 -35.53 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.757 -0.589 . . . . 0.0 111.128 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.9 m -148.52 88.39 5.33 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -76.02 118.87 5.15 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.956 1.503 . . . . 0.0 110.387 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 4.3 m -122.36 115.22 21.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.894 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -98.31 154.16 18.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.72 -179.614 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.6 t -146.94 159.34 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.883 179.68 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.511 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.4 m -121.43 157.16 31.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.031 . . . . 0.0 110.452 -179.653 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.8 m-20 -66.79 124.88 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.864 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -50.84 -40.53 56.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.31 -179.943 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.39 40.95 3.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER -117.92 176.84 5.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -1.145 . . . . 0.0 110.331 -179.879 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.432 ' CG1' ' C ' ' A' ' 38' ' ' TYR . 12.8 mt -147.0 117.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 110.245 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 150.94 5.82 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.35 -52.2 49.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -1.153 . . . . 0.0 109.959 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -92.48 17.78 9.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.827 179.691 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 8.6 m 64.65 80.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 110.143 179.936 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -113.68 -38.4 4.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -104.8 162.19 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.1 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.05 -179.952 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.778 ' CD1' HG13 ' A' ' 24' ' ' VAL . 24.8 m-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.201 0.524 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -140.42 141.44 35.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 165.51 21.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.512 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -89.78 127.34 54.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 110.274 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 48.2 Cg_endo -73.99 166.05 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.465 . . . . 0.0 110.094 179.68 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -66.0 -36.04 82.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -12.2 16.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 110.458 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.418 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.4 m-85 -120.3 -6.0 9.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 52.08 2.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -86.28 -16.92 36.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.95 -1.094 . . . . 0.0 109.413 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 4.5 p90 -90.36 1.98 56.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 109.127 178.404 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.3 m -159.66 100.06 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 41.7 mm -72.61 -70.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.165 179.982 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -89.57 49.32 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 179.983 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -141.84 134.34 6.15 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -92.92 127.31 38.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.232 -1.157 . . . . 0.0 109.892 179.771 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.524 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 5.8 p -127.96 145.83 50.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 110.565 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.91 159.17 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.857 . . . . 0.0 109.527 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -138.51 109.14 6.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.029 . . . . 0.0 110.307 -179.751 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.778 HG13 ' CD1' ' A' ' 5' ' ' PHE . 7.9 t -80.46 116.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 5.8 t -78.95 -65.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.061 179.834 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.97 -42.71 3.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 109.376 179.608 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -115.95 88.95 2.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.919 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -35.06 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.235 -178.992 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.2 m -146.73 81.75 9.03 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 179.753 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.551 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.1 Cg_endo -79.12 107.67 2.25 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.061 1.558 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 136.05 53.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.524 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -120.28 129.43 54.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 t -126.34 116.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.079 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 14.9 m -89.54 150.28 22.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 -179.765 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.9 m-20 -45.62 124.26 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 110.093 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 19.2 pt-20 -51.79 -38.55 56.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -90.12 37.94 3.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -110.02 172.8 6.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 110.322 -179.932 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.409 HG12 ' C ' ' A' ' 38' ' ' TYR . 33.3 mm -144.98 141.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.237 179.886 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 145.97 10.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -1.188 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.1 mtm-85 -89.78 3.63 52.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 110.149 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m 67.55 51.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 109.598 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -99.42 -30.94 11.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.598 -179.565 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.495 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 82.1 mtt180 -105.6 173.76 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.402 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 179.964 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.454 ' CD1' HG13 ' A' ' 24' ' ' VAL . 46.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.211 0.529 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 m -137.5 146.86 44.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.61 150.82 25.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.888 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -83.65 130.12 57.04 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.958 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.56 172.34 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.959 1.505 . . . . 0.0 110.396 -179.926 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.3 pttt -63.76 -25.18 68.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -62.51 -10.27 11.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 -179.885 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.585 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 8.8 m-85 -131.73 4.35 4.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 8.9 mtpt -85.53 44.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.461 -179.843 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -85.2 -25.19 27.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.845 -1.16 . . . . 0.0 109.602 -179.78 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 10.9 p90 -79.16 -6.01 55.53 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.292 178.566 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.3 138.14 9.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.54 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 44' ' ' GLU . 9.8 mt -94.68 -72.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.197 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -89.78 63.92 6.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 110.312 179.987 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.2 139.75 6.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -100.39 125.45 46.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -1.163 . . . . 0.0 109.801 179.91 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t -111.28 129.17 56.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 -179.643 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -90.89 129.17 36.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.939 179.689 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -105.62 110.48 22.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 27' ' ' GLU . 39.4 t -80.31 114.72 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 26' ' ' ALA . 42.5 t -77.03 -65.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.593 -0.692 . . . . 0.0 110.235 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.6 -48.5 4.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.49 179.813 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -112.83 87.62 2.63 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.511 -0.743 . . . . 0.0 109.013 178.844 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -33.89 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.126 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 29' ' ' THR . 6.0 m -149.23 88.35 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.336 -0.852 . . . . 0.0 110.412 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.08 91.81 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.04 1.547 . . . . 0.0 110.432 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.1 p -93.34 124.98 37.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 179.784 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.491 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 6.7 t -99.97 129.56 46.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 87.4 t -117.9 109.4 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 109.584 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.609 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.2 m -79.93 153.75 28.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.835 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 5.2 m-20 -49.57 117.8 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.811 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.05 -47.08 4.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.469 -179.897 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.24 49.67 3.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -121.84 172.82 7.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.142 -1.211 . . . . 0.0 110.283 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 14.5 mt -144.09 143.8 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.193 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.09 170.36 14.97 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.2 -46.43 9.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -1.176 . . . . 0.0 110.268 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.5 mtp85 -91.41 11.96 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.152 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.523 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.7 m 67.1 64.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.436 -0.79 . . . . 0.0 110.196 179.878 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.698 ' HG2' HD12 ' A' ' 17' ' ' ILE . 24.1 mt-10 -116.3 -14.05 11.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.883 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 14.2 mtt180 -117.71 176.0 5.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 13.9 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.234 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.804 ' CD1' HG13 ' A' ' 24' ' ' VAL . 77.8 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.082 0.468 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 m -127.64 120.76 28.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.869 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.03 129.69 34.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.74 132.28 72.11 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.891 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -73.72 160.24 44.12 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.519 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 4.1 mttm -65.45 -30.66 71.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.257 179.974 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -64.03 -15.5 59.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.876 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.435 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -116.52 -1.4 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.312 -179.89 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.69 67.04 9.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 179.951 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -85.93 -17.64 34.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.04 -1.037 . . . . 0.0 109.37 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.1 p90 -90.23 2.91 54.92 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.538 -0.726 . . . . 0.0 109.35 178.512 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.02 95.35 1.16 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.096 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.1 mm -55.57 -82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.364 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.523 ' NZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -89.89 66.05 6.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.017 . . . . 0.0 110.274 -179.853 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -152.67 154.87 25.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.511 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 10.1 ptt-85 -109.54 137.53 47.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -1.114 . . . . 0.0 109.992 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 47.6 t -124.48 123.33 39.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.41 110.45 23.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 179.764 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -95.76 110.28 22.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.355 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.804 HG13 ' CD1' ' A' ' 5' ' ' PHE . 9.5 t -79.89 118.89 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.109 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.2 t -79.72 -65.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.347 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.8 -46.75 3.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.86 . . . . 0.0 109.621 179.801 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 8.0 mt-10 -114.52 89.77 3.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.475 -0.765 . . . . 0.0 109.072 178.976 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.42 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.296 0.57 . . . . 0.0 111.109 -179.024 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 55.1 m -147.15 83.11 8.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.903 . . . . 0.0 110.38 179.75 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -77.63 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.515 . . . . 0.0 110.278 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -106.91 118.75 37.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.402 ' C ' HG23 ' A' ' 33' ' ' VAL . 21.9 p -98.27 148.24 23.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.973 . . . . 0.0 110.231 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.402 HG23 ' C ' ' A' ' 32' ' ' CYS . 21.4 t -145.17 150.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 33.1 m -120.93 161.68 21.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -57.62 127.66 33.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.991 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -44.0 52.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.166 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.92 43.69 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.99 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -114.84 170.66 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -1.162 . . . . 0.0 110.222 -179.963 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 40' ' ' GLY . 21.0 mt -150.05 171.11 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 98.92 169.13 30.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.42 -41.75 14.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.188 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.45 ' HB2' ' CD ' ' A' ' 44' ' ' GLU . 16.6 mtt180 -96.45 21.03 9.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 -179.998 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.509 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.1 m 64.23 31.79 12.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 110.142 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' CD ' ' HB2' ' A' ' 42' ' ' ARG . 44.2 mt-10 -92.01 -18.73 23.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.551 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -97.85 163.89 12.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 7.2 p . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 -179.879 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.563 ' CD1' HG22 ' A' ' 24' ' ' VAL . 63.3 m-85 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.206 0.526 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.69 134.23 42.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.987 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -84.75 150.68 24.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.349 -179.93 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.41 132.8 34.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.135 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.3 Cg_endo -73.2 161.04 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.955 1.503 . . . . 0.0 110.574 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -30.21 70.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.379 -0.826 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -9.76 42.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.455 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.0 m-85 -122.62 6.14 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 19' ' ' GLY . 50.8 mttt -89.24 56.9 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.4 -179.887 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -15.14 42.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.03 -1.044 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.23 2.04 55.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.264 178.586 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.6 m -160.51 123.42 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 95.1 mt -81.34 -64.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 110.259 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 8.6 ptmm? -106.06 61.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.32 155.82 26.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.884 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -106.42 136.81 45.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.114 . . . . 0.0 109.634 179.601 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 18.0 t -120.82 148.19 44.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.126 -0.984 . . . . 0.0 110.627 -179.527 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -125.35 119.08 27.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.817 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -101.18 116.51 32.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.947 . . . . 0.0 110.477 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.563 HG22 ' CD1' ' A' ' 5' ' ' PHE . 21.8 t -87.19 114.45 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.018 179.704 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.0 t -75.43 -62.05 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.403 -0.811 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.14 -59.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 109.505 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 64.1 mm-40 -103.51 89.0 3.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -32.81 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.34 0.591 . . . . 0.0 111.168 -179.105 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.7 m -145.57 87.75 6.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.292 179.892 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.9 Cg_endo -78.19 94.43 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.095 1.576 . . . . 0.0 110.452 179.833 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.24 141.24 29.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 179.944 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.4 p -123.48 122.14 37.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.267 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.1 143.86 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.926 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 31.6 m -115.33 164.44 14.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.471 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.526 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -45.96 122.46 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.245 179.961 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.65 -52.93 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.53 -179.877 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.44 50.61 3.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -116.3 170.94 8.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.102 -1.234 . . . . 0.0 110.343 179.783 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.1 mt -150.03 158.54 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 179.951 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.87 143.7 10.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.33 -29.98 68.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.264 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.07 9.26 43.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.104 179.967 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 5.3 m 65.65 49.26 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -107.81 -31.09 8.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.443 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 62.4 mtt85 -85.18 157.62 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.27 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.216 0.531 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -122.95 149.88 43.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.57 110.37 0.32 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -171.59 93.09 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -1.128 . . . . 0.0 110.255 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' HD2' HG13 ' A' ' 24' ' ' VAL . 75.3 m-85 -119.9 -152.05 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 110.035 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -133.29 125.21 28.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.473 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.58 120.98 32.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.353 -0.842 . . . . 0.0 110.05 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 33.4 m -57.19 116.0 12.27 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.62 168.38 24.91 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.9 1.474 . . . . 0.0 110.453 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -27.95 67.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -13.86 60.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.235 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -121.09 17.24 11.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.13 -0.981 . . . . 0.0 110.229 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -90.08 47.62 1.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.403 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.06 -18.5 32.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 109.135 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.9 p90 -90.64 0.52 57.36 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.086 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 3.1 m -160.14 91.47 0.95 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 51.7 mt -62.08 -53.31 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.123 -0.986 . . . . 0.0 110.16 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.17 57.39 0.62 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.14 159.78 31.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -101.85 176.58 5.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -1.149 . . . . 0.0 110.068 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 37.1 t -158.89 126.55 4.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 110.731 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -106.34 122.51 46.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.734 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -110.51 112.42 24.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.987 . . . . 0.0 110.577 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 27' ' ' GLU . 63.5 t -89.73 118.68 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.94 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.9 t -77.63 -64.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.744 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -46.6 4.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.345 -0.847 . . . . 0.0 109.376 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.597 ' H ' HG12 ' A' ' 24' ' ' VAL . 2.6 tt0 -109.74 87.92 2.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.9 tt0 -34.76 91.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.361 0.6 . . . . 0.0 111.116 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -148.73 84.66 6.39 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.451 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -77.98 84.22 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.09 1.574 . . . . 0.0 110.128 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -89.88 140.36 29.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 0.0 110.068 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 12.0 p -129.04 110.77 12.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -0.934 . . . . 0.0 110.415 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 20' ' ' ARG . 3.6 t -99.17 159.96 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 0.0 109.686 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.524 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 10.6 m -135.53 162.31 33.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.054 -1.029 . . . . 0.0 110.165 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -57.08 122.95 13.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 109.956 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.3 mt-10 -41.58 -37.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 110.168 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.68 48.17 3.05 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.796 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -123.26 162.17 23.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.023 -1.281 . . . . 0.0 110.38 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 38' ' ' TYR . 29.6 mm -142.29 156.03 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.212 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.55 150.96 25.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.57 80.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -1.15 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -89.65 8.06 33.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.02 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 6.9 m 64.64 58.15 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.39 -0.819 . . . . 0.0 110.153 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.76 -31.1 9.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 110.275 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.448 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 7.0 mtt180 -94.64 171.08 9.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.058 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.51 141.36 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 110.475 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.49 ' HB2' HG13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -142.85 62.87 1.4 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.425 -0.797 . . . . 0.0 110.198 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.1 tt -101.6 37.92 1.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -0.99 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER -44.54 -37.63 3.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 0.0 110.2 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 49' ' ' PHE . 5.7 m-85 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 1' ' ' ARG . 12.3 ptp180 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.214 0.53 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.95 -47.11 3.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.257 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 4' ' ' HIS . . . 140.17 162.19 9.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 4' ' ' HIS . 0.0 OUTLIER 176.05 89.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 0.0 110.153 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CD1' HG13 ' A' ' 24' ' ' VAL . 27.4 m-85 -113.78 -155.37 0.57 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.208 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.05 143.2 49.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -80.95 127.08 32.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.0 110.309 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -59.65 130.04 87.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.2 Cg_endo -72.47 160.53 46.53 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.899 1.473 . . . . 0.0 110.356 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -61.65 -30.2 70.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 110.177 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -29.52 70.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.456 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -99.23 0.07 42.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.23 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.06 49.0 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.72 -20.25 29.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.021 -1.05 . . . . 0.0 109.352 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' OH ' ' SG ' ' A' ' 21' ' ' CYS . 4.4 p90 -90.35 1.24 56.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.131 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 101.46 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 38.7 mm -74.22 -69.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.85 58.61 4.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 0.0 110.124 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -155.16 136.0 4.92 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 8.6 mpt_? -93.92 128.95 40.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -1.157 . . . . 0.0 110.038 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.522 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 6.4 p -126.35 147.67 49.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 110.446 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.61 144.94 35.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 109.808 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -121.73 108.7 13.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 110.154 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.511 HG13 ' CD1' ' A' ' 5' ' ' PHE . 3.9 t -83.42 120.12 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 46.2 t -81.87 -65.18 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.712 -0.617 . . . . 0.0 110.233 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.37 -34.55 0.53 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 0.0 109.496 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -128.14 92.04 3.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 11.1 tm0? -36.24 91.41 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.743 -0.598 . . . . 0.0 110.919 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 29' ' ' THR . 17.7 m -147.55 81.49 8.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.419 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -78.85 91.2 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.168 1.615 . . . . 0.0 110.321 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -89.26 145.38 25.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.062 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.2 p -123.98 132.09 53.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 0.0 110.591 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 66.5 t -127.25 111.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.879 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -81.94 152.34 26.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.315 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -57.39 124.96 20.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' ASP . 1.4 mm-40 -42.15 -42.73 3.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 110.459 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -90.4 48.02 3.1 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -119.44 169.4 10.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.045 -1.268 . . . . 0.0 110.348 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.476 HD11 ' CG ' ' A' ' 47' ' ' ASP . 44.1 mt -150.49 141.37 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.87 147.52 7.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.8 52.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.131 . . . . 0.0 110.074 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.419 ' C ' ' SG ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -94.97 20.66 8.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 110.345 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.537 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 2.4 m 63.42 67.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -102.94 -44.03 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 111.399 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 12.9 ptm180 -112.45 134.42 53.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.899 -1.126 . . . . 0.0 110.599 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.532 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.4 p -91.45 159.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.476 ' CG ' HD11 ' A' ' 39' ' ' ILE . 12.0 t0 -97.96 70.33 2.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 110.232 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.13 138.65 26.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 0.0 110.271 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.31 -48.87 65.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.282 -0.886 . . . . 0.0 110.207 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.232 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.266 0.555 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -119.61 119.4 33.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.16 166.07 12.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.11 59.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -1.119 . . . . 0.0 110.268 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -90.09 -154.42 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.6 m -117.07 123.7 47.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -79.92 112.42 17.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 110.256 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -43.36 122.13 3.33 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.294 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -71.63 167.13 27.33 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.915 1.482 . . . . 0.0 110.427 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -53.57 -43.13 68.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.25 -0.906 . . . . 0.0 110.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.87 -32.64 67.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.476 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -90.98 -12.05 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 45.57 1.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -86.16 -17.18 35.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.123 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.2 p90 -90.5 2.17 55.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.221 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -159.31 97.94 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.121 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.549 HD12 ' CG ' ' A' ' 44' ' ' GLU . 53.1 mt -63.61 -70.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.9 . . . . 0.0 110.309 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -91.86 64.31 4.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.08 153.44 24.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -114.18 140.67 48.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.26 -1.141 . . . . 0.0 110.144 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 11.4 t -130.3 128.28 41.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 110.472 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -92.53 122.06 34.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 109.943 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -103.99 109.78 21.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 110.402 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 13.8 t -80.15 120.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 93.4 t -78.9 -64.38 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 110.344 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.28 -43.94 3.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.375 -0.828 . . . . 0.0 109.483 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.9 mt-10 -118.33 88.35 2.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.96 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.363 0.601 . . . . 0.0 111.01 -178.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 32.9 m -143.29 85.6 9.51 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.256 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.98 87.21 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.145 1.603 . . . . 0.0 110.557 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 p -90.49 109.03 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.87 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 32.0 p -99.24 142.15 31.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.554 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.9 t -140.58 120.51 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 109.969 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 12.7 m -88.04 156.18 19.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.238 -0.914 . . . . 0.0 110.322 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -48.85 121.52 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -50.21 -43.69 52.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.302 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.59 39.1 3.12 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -113.12 178.36 4.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 110.341 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 17.7 mt -150.23 158.76 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 0.0 110.221 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.44 168.97 23.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.59 -44.66 11.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.338 -1.095 . . . . 0.0 110.137 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HB2' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -91.73 14.76 14.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.82 51.96 0.56 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.336 -0.852 . . . . 0.0 110.333 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.549 ' CG ' HD12 ' A' ' 17' ' ' ILE . 14.0 mt-10 -105.37 -34.96 7.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 17.2 mtp180 -85.23 160.85 19.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.516 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.469 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 4.4 p -134.5 148.15 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.294 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -100.79 46.55 0.94 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -148.54 179.93 7.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -81.57 3.79 23.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.123 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.547 ' CE2' HD22 ' A' ' 48' ' ' LEU . 26.0 m-85 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.174 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' LYS . 4.8 tpp180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.22 0.533 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' ARG . 1.3 tttp 44.25 61.27 2.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.157 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.39 -151.55 6.18 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 t60 51.46 87.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -1.157 . . . . 0.0 110.167 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -94.94 -146.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.237 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.31 134.82 48.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 110.301 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -88.21 147.53 24.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 110.224 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.15 143.97 43.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.22 164.84 34.25 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.04 1.547 . . . . 0.0 110.468 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -62.98 -31.58 72.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -21.46 66.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.108 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -102.61 1.38 34.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.235 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 16' ' ' CYS . 14.4 mtpt -87.41 54.38 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.325 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -18.87 31.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 108.941 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 1.8 p90 -90.56 -2.75 57.89 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.017 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 10.3 m -158.92 109.06 2.0 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.336 -0.853 . . . . 0.0 110.053 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 29.6 mm -72.66 -54.87 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.019 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 7.8 ptmm? -106.41 53.02 0.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -151.5 147.09 16.58 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -101.99 141.23 35.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -1.196 . . . . 0.0 110.065 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.488 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 34.8 t -115.92 123.63 48.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 110.456 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -96.42 107.77 20.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -91.02 111.9 23.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.855 . . . . 0.0 110.443 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 27' ' ' GLU . 88.2 t -81.27 117.11 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.028 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 99.9 t -80.88 -56.61 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.657 -0.652 . . . . 0.0 110.386 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.64 -42.97 2.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.49 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.562 ' H ' HG12 ' A' ' 24' ' ' VAL . 35.3 tt0 -125.46 97.35 5.15 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -34.5 90.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.764 -0.585 . . . . 0.0 111.172 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 29' ' ' THR . 14.0 m -148.66 85.69 6.06 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.444 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.523 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -73.47 100.16 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.056 1.556 . . . . 0.0 110.412 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 t -97.16 133.77 41.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.1 p -113.98 102.27 10.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.423 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.33 122.67 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.883 . . . . 0.0 110.012 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 18.1 m -95.51 155.62 16.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.369 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 2.0 m-20 -43.84 124.27 3.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.127 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.71 -49.42 28.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 110.339 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 46.63 3.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.518 ' HB3' ' CB ' ' A' ' 35' ' ' ASP . 0.4 OUTLIER -111.6 171.29 7.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -1.204 . . . . 0.0 110.317 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 47' ' ' ASP . 25.3 mm -144.69 153.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.53 156.39 16.65 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.65 -39.78 57.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -1.134 . . . . 0.0 110.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.2 mmm-85 -97.05 12.57 32.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.523 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.42 55.93 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 0.0 109.874 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.81 -36.73 6.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.599 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -97.08 -179.49 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.499 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.444 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.7 p -149.19 150.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -0.836 . . . . 0.0 110.078 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.513 ' HB2' ' CG1' ' A' ' 39' ' ' ILE . 48.3 t0 -114.36 83.05 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.321 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.795 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.4 pt? -112.85 2.92 16.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 0.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -66.21 0.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.4 t80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.25 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.436 ' NH2' ' HG2' ' A' ' 1' ' ' ARG . 11.4 mtp85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.18 0.514 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 155.03 17.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.06 42.62 0.77 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -125.22 75.07 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -1.131 . . . . 0.0 110.216 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -132.66 -141.46 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 110.021 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -131.04 129.76 42.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 110.201 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 8' ' ' CYS . 1.9 ttm180 -88.23 111.68 21.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 46.8 m -42.93 110.73 0.92 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.255 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HG2' ' CG ' ' A' ' 11' ' ' GLN . 45.6 Cg_endo -73.59 179.25 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.927 1.488 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.98 -36.32 84.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' CG ' ' HG2' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -59.88 -13.82 12.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.44 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.512 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.9 m-85 -120.07 -3.55 10.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.155 -0.966 . . . . 0.0 110.429 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.75 41.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.259 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -85.91 -18.41 32.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.024 -1.047 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.33 3.64 53.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.342 -0.848 . . . . 0.0 109.148 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -158.47 120.29 3.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 110.14 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.4 mm -80.46 -72.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.262 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.6 OUTLIER -95.23 65.01 2.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.028 -1.045 . . . . 0.0 110.33 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.25 171.82 33.45 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 11.7 mtp85 -131.99 133.43 44.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 109.807 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.9 t -121.7 137.05 54.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 110.422 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.75 126.28 51.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 109.649 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.51 112.86 26.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.546 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 58.3 t -84.18 116.59 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.059 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 26' ' ' ALA . 60.5 t -74.18 -64.55 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 110.4 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.93 -62.33 0.94 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.872 . . . . 0.0 109.34 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 21.0 mm-40 -97.82 87.77 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.88 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.742 -0.599 . . . . 0.0 111.072 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 29' ' ' THR . 10.5 m -145.0 88.1 6.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.91 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.82 91.93 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.133 1.596 . . . . 0.0 110.364 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.88 122.11 41.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.174 -0.953 . . . . 0.0 110.037 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 19.6 p -102.7 137.32 41.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.475 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 24.6 t -129.4 164.35 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 109.847 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.6 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 6.0 m -133.26 163.51 29.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 110.397 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.551 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.7 m-20 -55.74 121.39 9.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -46.58 -43.19 17.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.72 44.81 3.28 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.4 169.48 10.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -1.159 . . . . 0.0 110.129 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.757 HD11 ' HB2' ' A' ' 47' ' ' ASP . 3.3 mp -140.67 145.52 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.873 . . . . 0.0 110.217 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.37 167.3 16.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.95 -41.64 12.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 110.198 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.91 11.53 20.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.915 . . . . 0.0 110.216 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.524 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 66.9 49.59 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.304 -0.872 . . . . 0.0 109.827 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 28.8 tt0 -98.11 -34.8 10.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 1.9 mtt180 -94.02 157.36 16.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 110.092 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.74 153.82 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.757 ' HB2' HD11 ' A' ' 39' ' ' ILE . 4.4 t0 -125.02 53.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.283 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.52 -42.38 2.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.944 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 50' ' ' TYR . 96.3 m-85 -89.99 25.8 2.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.845 . . . . 0.0 109.967 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' PHE . 2.8 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.302 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.321 0.581 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -153.08 115.96 4.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -0.932 . . . . 0.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.11 174.33 42.54 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.495 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 0.6 OUTLIER -163.94 74.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -1.153 . . . . 0.0 110.283 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.509 ' CD1' HG13 ' A' ' 24' ' ' VAL . 64.4 m-85 -108.23 -154.22 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.197 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.2 m -124.25 131.93 53.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -91.36 145.44 24.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 110.151 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 139.31 33.17 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.9 . . . . 0.0 110.261 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.51 166.9 28.64 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.974 1.512 . . . . 0.0 110.4 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -61.63 -28.84 69.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.973 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.53 -29.45 69.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.295 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -98.03 6.75 47.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 110.379 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.08 51.82 2.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 110.357 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 -21.78 28.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.999 -1.063 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 2.5 p90 -90.49 3.91 52.59 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.072 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.57 119.61 2.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.189 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 18' ' ' LYS . 17.1 mm -73.37 -82.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.192 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.4 ptmm? -93.06 64.46 3.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.0 110.033 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -153.53 144.52 11.42 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -94.3 153.46 18.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.268 -1.137 . . . . 0.0 110.053 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 9.4 t -130.44 127.0 38.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 110.152 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.14 107.56 18.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.07 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -93.82 112.2 24.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 110.37 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.509 HG13 ' CD1' ' A' ' 5' ' ' PHE . 4.7 t -80.27 115.52 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.99 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 12.7 t -79.2 -66.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.635 -0.665 . . . . 0.0 110.18 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.32 -34.2 0.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 109.372 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.3 mt-10 -123.66 88.9 3.0 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 15.7 tt0 -35.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.801 -0.562 . . . . 0.0 111.143 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 31.4 m -150.27 91.31 4.22 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.288 -0.883 . . . . 0.0 110.288 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 47.8 Cg_endo -75.52 108.99 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.994 1.523 . . . . 0.0 110.637 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 t -111.09 141.55 44.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 10.2 p -129.4 100.28 5.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.958 . . . . 0.0 110.543 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.53 124.57 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 58.9 m -93.75 159.27 15.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.7 m-20 -53.25 116.97 2.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.041 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.547 ' HG2' ' N ' ' A' ' 37' ' ' GLY . 1.4 pm0 -51.64 -29.53 18.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 110.183 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' N ' ' HG2' ' A' ' 36' ' ' GLU . . . -90.85 35.39 3.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -115.26 172.67 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -1.124 . . . . 0.0 110.54 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.497 HD11 ' CG ' ' A' ' 47' ' ' ASP . 24.4 mt -149.49 156.25 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.13 170.9 20.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.47 -45.78 11.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.218 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 1.6 mmp_? -89.97 12.37 17.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.521 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 3.8 m 69.59 47.42 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -101.0 -38.47 8.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.22 -0.925 . . . . 0.0 110.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 3.8 mtt180 -83.11 172.14 12.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.483 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 7.5 p -145.87 152.61 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.953 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.497 ' CG ' HD11 ' A' ' 39' ' ' ILE . 1.6 t0 -129.3 47.33 2.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.487 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.78 -50.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.405 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.472 ' O ' ' OXT' ' A' ' 50' ' ' TYR . 3.3 m-85 -68.33 -36.26 79.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.388 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' OXT' ' O ' ' A' ' 49' ' ' PHE . 12.9 m-85 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.268 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.482 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 42.6 ptt85 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.212 0.53 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 1' ' ' ARG . 0.5 OUTLIER 175.21 -81.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.78 77.26 0.16 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -167.02 86.56 0.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -1.171 . . . . 0.0 110.232 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.603 ' HD1' HG13 ' A' ' 24' ' ' VAL . 65.5 m-85 -111.4 -153.05 0.51 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 m -145.61 130.53 18.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.351 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -81.61 154.89 25.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.071 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -84.29 124.59 73.72 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 158.22 48.71 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.865 1.455 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -67.08 -24.46 65.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.482 ' CA ' ' HE2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -64.4 -12.08 39.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.381 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -131.92 16.01 4.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -90.29 58.61 4.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -86.1 -12.89 48.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 109.46 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 12.2 p90 -86.73 -8.95 56.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.474 -0.766 . . . . 0.0 109.038 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.38 126.4 4.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.804 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.3 mm -76.66 -55.67 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.008 . . . . 0.0 110.42 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -116.39 70.62 0.77 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.049 -1.032 . . . . 0.0 110.362 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.47 166.06 30.09 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 17.3 ptt180 -114.2 121.11 42.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.129 -1.218 . . . . 0.0 110.17 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 6.2 t -105.16 128.76 53.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 110.369 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.21 109.88 22.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 109.87 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -100.75 112.66 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.379 -179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.603 HG13 ' HD1' ' A' ' 5' ' ' PHE . 3.4 t -87.9 118.32 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.335 -0.853 . . . . 0.0 110.02 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 26' ' ' ALA . 16.7 t -75.96 -67.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 110.44 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.4 -50.56 3.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -0.839 . . . . 0.0 109.563 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -108.44 90.32 3.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.8 mt-30 -35.55 91.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.306 0.574 . . . . 0.0 110.925 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 89.9 m -143.67 78.83 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.517 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.2 Cg_endo -75.41 81.96 2.18 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.108 1.583 . . . . 0.0 110.423 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -90.01 137.84 32.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 109.682 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.1 t -115.05 130.71 57.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.084 -1.01 . . . . 0.0 110.666 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 4.3 t -124.47 158.55 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.586 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.7 m -110.06 161.62 15.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.138 -0.976 . . . . 0.0 110.568 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.0 m-20 -61.61 120.52 10.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 37' ' ' GLY . 15.7 pt-20 -45.56 -43.63 12.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.103 -0.998 . . . . 0.0 110.183 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 36' ' ' GLU . . . -90.14 47.4 3.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -122.9 174.95 6.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -1.15 . . . . 0.0 110.4 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 8.5 mt -150.35 129.69 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.28 158.63 9.61 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.52 -46.35 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -1.151 . . . . 0.0 110.154 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.8 mtt180 -89.59 8.9 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.542 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m 67.43 61.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 109.997 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -106.25 -40.35 5.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 110.939 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.491 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.41 150.24 25.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.472 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 48' ' ' LEU . 2.5 p -122.91 147.25 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.232 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -120.49 39.01 3.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.225 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' H ' HG22 ' A' ' 46' ' ' VAL . 12.6 mt -105.87 172.0 7.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.253 -0.904 . . . . 0.0 110.368 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -58.12 3.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.302 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.24 -179.902 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 4' ' ' HIS . 2.0 mmt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.206 0.527 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -55.85 110.78 0.78 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.52 56.61 3.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 1' ' ' ARG . 1.4 m80 -162.68 73.21 0.36 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -1.138 . . . . 0.0 110.199 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -123.93 -141.47 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.139 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.02 142.45 36.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 110.209 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 8' ' ' CYS . 10.1 mtp180 -103.9 107.5 18.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 32.0 m -42.08 121.24 2.44 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.901 . . . . 0.0 110.168 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.83 168.07 25.58 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.89 1.468 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -65.8 -27.96 68.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -66.53 -12.85 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -122.67 9.5 9.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.228 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HE2' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -90.14 51.62 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -85.74 -20.12 29.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.917 -1.115 . . . . 0.0 109.217 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.6 p90 -90.3 -1.57 57.93 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.098 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.499 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.7 m -160.59 98.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 44' ' ' GLU . 24.4 mt -77.74 -57.41 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -89.56 39.15 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.158 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -158.27 150.33 21.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.462 ' HG3' ' HE2' ' A' ' 13' ' ' LYS . 3.5 mtt180 -110.4 144.74 38.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -1.097 . . . . 0.0 109.781 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.49 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 17.6 t -125.94 135.91 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.99 . . . . 0.0 110.864 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.04 138.78 34.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.832 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -117.5 117.37 29.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.03 . . . . 0.0 110.624 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.6 t -85.62 118.82 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.854 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 35.7 t -80.84 -65.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.627 -0.671 . . . . 0.0 110.607 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.45 -33.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 0.0 109.66 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -132.17 89.04 2.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 tt0 -34.59 90.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.763 -0.585 . . . . 0.0 111.09 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' GLU . 20.4 m -144.97 91.77 5.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.219 -0.926 . . . . 0.0 110.47 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 134.71 9.86 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.144 1.602 . . . . 0.0 110.412 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -141.15 112.09 7.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 109.915 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 29.0 p -98.53 144.43 27.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.752 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.93 127.41 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 23.8 m -102.71 164.25 11.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.3 m-20 -63.47 116.41 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.459 -0.776 . . . . 0.0 109.979 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.5 pt-20 -42.7 -31.26 0.45 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.486 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.84 43.26 2.97 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -125.44 170.28 11.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.296 -1.12 . . . . 0.0 110.427 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 30.8 mt -149.95 144.2 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.96 151.43 8.17 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.21 -50.43 47.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -1.148 . . . . 0.0 110.24 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 22.8 mtt180 -89.97 12.95 16.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.926 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 5.1 m 66.64 57.23 0.69 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 109.867 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.583 ' HG2' HD12 ' A' ' 17' ' ' ILE . 8.3 mm-40 -108.09 -13.7 14.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.576 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.48 173.31 6.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.117 -0.989 . . . . 0.0 110.455 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.6 p -144.46 155.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.487 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 22.1 t0 -130.3 81.15 1.99 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.903 . . . . 0.0 110.328 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.08 -156.18 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 110.247 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.94 2.52 17.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.192 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 3' ' ' GLY . 6.2 mpt_? . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.328 0.585 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 mttp 51.42 -89.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.917 . . . . 0.0 110.246 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 1' ' ' ARG . . . 168.56 160.2 15.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -130.47 77.26 1.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -1.178 . . . . 0.0 110.312 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.538 ' CD1' HG22 ' A' ' 24' ' ' VAL . 72.5 m-85 -102.65 -153.21 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.002 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.5 m -128.62 135.81 49.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 110.239 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -94.57 130.32 41.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.195 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.77 126.61 92.91 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.132 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.85 169.4 22.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.944 1.497 . . . . 0.0 110.306 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.5 mmtt -57.88 -24.98 60.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -33.59 75.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.575 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 26.6 m-85 -106.11 12.21 30.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -89.59 40.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 110.241 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -85.91 -18.2 33.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.02 -1.05 . . . . 0.0 109.613 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 3.7 p90 -90.25 3.16 54.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.4 125.8 3.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 10.8 mm -79.95 -72.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 110.135 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 6.2 ptmm? -99.27 51.56 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.143 -0.973 . . . . 0.0 110.096 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -140.95 141.86 11.68 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -98.15 141.44 31.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -1.073 . . . . 0.0 109.898 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 37.3 t -117.01 123.21 46.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.564 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -94.14 104.35 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.6 t80 -92.39 117.73 30.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 110.494 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 5' ' ' PHE . 59.1 t -84.48 118.45 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.8 t -81.72 -66.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.612 -0.68 . . . . 0.0 110.526 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.83 -36.37 0.62 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -124.59 90.16 3.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.066 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 27' ' ' GLU . 21.0 tt0 -35.92 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.774 -0.579 . . . . 0.0 111.052 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 16.3 m -150.15 89.48 4.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.564 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 46.9 Cg_endo -74.49 115.92 4.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.144 1.602 . . . . 0.0 110.545 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.77 123.24 46.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.7 p -103.12 135.48 44.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.3 125.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.89 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.523 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 24.3 m -92.58 163.08 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 110.444 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -51.74 129.56 26.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 110.329 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -48.75 -48.35 40.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.0 110.261 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 45.61 3.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -111.88 162.15 15.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -1.217 . . . . 0.0 110.005 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 33.4 mm -143.82 146.52 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.32 158.62 10.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.47 -43.71 38.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -1.099 . . . . 0.0 110.235 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 22.6 mtt-85 -89.89 8.73 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.0 m 68.36 48.79 0.84 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 0.0 110.011 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -108.8 -26.11 10.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.929 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -91.64 178.69 5.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.171 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.3 p -144.31 150.94 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.278 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -98.41 67.7 1.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.871 . . . . 0.0 110.192 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -110.14 47.02 0.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.147 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -71.3 -8.37 53.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.888 . . . . 0.0 110.135 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.116 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.96 -176.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.91 165.56 43.85 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.55 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 0.7 OUTLIER -156.63 74.1 0.8 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -1.187 . . . . 0.0 110.341 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.702 ' CD1' HG13 ' A' ' 24' ' ' VAL . 73.8 m-85 -109.23 -139.27 0.38 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 109.954 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -130.36 118.03 20.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.033 -1.042 . . . . 0.0 110.137 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.24 121.36 26.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 110.142 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' ' OH ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -54.76 123.31 45.08 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 110.097 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.18 162.4 41.78 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.897 1.472 . . . . 0.0 110.392 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -58.03 -25.87 61.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.29 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.61 -35.7 78.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.485 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.18 9.85 38.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -90.07 48.01 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -85.86 -17.29 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 5.2 p90 -90.45 -0.3 57.6 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.224 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 110.83 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.952 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.2 mm -81.7 -66.25 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 1.8 ptpp? -89.77 53.72 2.65 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.203 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -158.06 179.97 33.37 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.7 OUTLIER -133.01 171.86 13.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -1.129 . . . . 0.0 110.045 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 43.4 t -152.34 120.47 6.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.186 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.8 ttp85 -90.45 111.38 22.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.998 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.59 108.1 20.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 110.406 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.702 HG13 ' CD1' ' A' ' 5' ' ' PHE . 4.3 t -84.17 115.22 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.983 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ALA . 70.3 t -80.3 -60.42 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 110.162 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.8 -35.6 1.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.264 -0.897 . . . . 0.0 109.4 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -127.18 94.76 4.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.516 -0.74 . . . . 0.0 109.047 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -35.75 91.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.72 -0.612 . . . . 0.0 111.234 -179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 29' ' ' THR . 9.9 m -150.02 80.19 7.37 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.6 Cg_endo -77.6 89.86 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.067 1.561 . . . . 0.0 110.756 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 8.1 p -91.23 124.98 35.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.088 -1.008 . . . . 0.0 109.811 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.7 p -114.88 110.15 19.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 0.0 110.752 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 20' ' ' ARG . 57.8 t -107.66 163.99 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.798 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.1 m -127.64 161.61 28.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.082 -1.011 . . . . 0.0 110.407 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.561 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.81 127.72 24.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.099 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 22.4 pt-20 -50.64 -43.27 57.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 110.316 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -89.17 42.09 3.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -113.87 171.18 7.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -1.115 . . . . 0.0 110.253 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 38' ' ' TYR . 45.9 mt -150.08 127.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.16 144.22 5.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.75 88.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -1.128 . . . . 0.0 110.315 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 20.3 mtt180 -98.74 13.67 31.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 110.249 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 16.4 m 60.33 58.71 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.229 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 12.5 pt-20 -108.0 -31.1 8.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.32 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 13.6 mtp-105 -99.13 160.86 13.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.235 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -122.86 146.74 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.188 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -90.78 -67.56 0.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.253 -0.904 . . . . 0.0 110.227 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.3 mt -114.49 97.81 6.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -42.29 -27.94 0.17 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.278 -0.889 . . . . 0.0 110.233 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 48' ' ' LEU . 84.9 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.152 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.209 0.528 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.62 -174.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.152 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.79 108.24 0.98 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -137.14 65.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.11 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -113.08 -151.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.237 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -134.42 124.01 24.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.249 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.06 128.78 34.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -73.3 135.03 79.54 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 159.1 47.34 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.963 1.507 . . . . 0.0 110.42 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -58.52 -32.0 68.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -61.65 -33.86 74.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.148 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -96.73 -2.37 44.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 0.0 110.147 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -90.02 55.53 3.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 0.0 110.41 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -86.32 -16.41 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.956 -1.09 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.447 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.9 p90 -90.1 2.63 55.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.428 -0.795 . . . . 0.0 109.115 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -155.68 111.75 3.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 18.9 mm -78.05 -73.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.94 . . . . 0.0 110.43 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -89.89 57.5 3.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.117 -0.99 . . . . 0.0 110.364 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.487 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.52 155.74 26.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -111.88 140.42 46.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 21.1 t -115.59 123.32 48.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.492 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.6 108.27 20.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.837 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.1 112.7 24.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 40.3 t -82.07 113.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.81 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 26' ' ' ALA . 43.0 t -76.04 -64.21 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.526 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.25 -51.86 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.336 -0.852 . . . . 0.0 109.666 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 tt0 -109.0 92.43 4.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 108.964 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.7 OUTLIER -35.55 91.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.596 . . . . 0.0 111.065 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 29' ' ' THR . 7.8 m -149.61 85.67 5.64 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.15 95.74 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.077 1.567 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.8 p -95.08 128.39 41.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 110.049 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 25.4 p -107.42 96.98 6.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.481 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -90.87 148.44 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.118 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 18.5 m -128.24 160.34 32.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 16.9 m-20 -57.97 120.46 8.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 110.215 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.92 -32.49 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.97 42.18 2.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -123.7 168.52 12.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -1.123 . . . . 0.0 110.354 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.436 HG13 ' C ' ' A' ' 38' ' ' TYR . 61.6 mt -149.55 152.01 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.869 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.03 173.48 19.34 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -44.18 11.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -1.125 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.2 mtm180 -92.79 18.53 8.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.096 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 12.9 m 61.61 41.68 12.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.455 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.6 pp20? -98.72 -25.27 14.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 110.435 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -90.91 161.5 15.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.085 -1.009 . . . . 0.0 109.969 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 49' ' ' PHE . 7.2 p -118.69 161.33 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.241 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.645 ' O ' HD22 ' A' ' 48' ' ' LEU . 23.9 t0 -98.1 -91.1 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.231 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 47' ' ' ASP . 1.5 mm? -123.93 60.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.307 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.49 ' HB2' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -64.28 -43.63 94.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.186 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.19 -179.899 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.24 0.543 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.4 -9.62 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 110.168 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.8 148.58 13.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.481 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 30.2 p-80 -158.73 86.34 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -1.155 . . . . 0.0 110.23 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.799 ' HD1' HG13 ' A' ' 24' ' ' VAL . 25.3 m-85 -104.18 -157.1 0.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.272 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -138.78 131.16 28.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.857 . . . . 0.0 110.173 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.82 124.3 32.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 119.8 77.67 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.15 178.52 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.865 1.455 . . . . 0.0 110.488 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 4.3 mtpt -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.358 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -59.27 -19.41 45.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.155 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -117.81 -0.95 11.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 7.3 ttpt -90.05 51.79 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -86.54 -14.09 43.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.044 -1.035 . . . . 0.0 109.31 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.3 2.54 55.4 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.51 -0.744 . . . . 0.0 109.082 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -159.87 112.61 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.932 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 24.0 mt -66.03 -76.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.412 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -96.77 69.43 2.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.423 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.3 152.57 23.37 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -111.69 141.69 44.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.899 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.4 t -126.19 134.4 51.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.638 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' OG ' ' A' ' 31' ' ' SER . 10.6 mmt180 -101.96 120.12 39.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.81 116.19 32.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.267 -0.895 . . . . 0.0 110.34 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.85 ' HB ' HG22 ' A' ' 29' ' ' THR . 2.2 t -90.42 125.73 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.079 -1.013 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 39.6 t -79.54 -64.64 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 110.324 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.68 -49.84 4.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.852 . . . . 0.0 109.161 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.73 ' O ' HG22 ' A' ' 29' ' ' THR . 0.5 OUTLIER -105.44 71.69 0.94 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -29.99 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.376 0.608 . . . . 0.0 111.322 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.85 HG22 ' HB ' ' A' ' 24' ' ' VAL . 9.8 t -149.94 105.77 3.21 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.86 91.62 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.061 1.559 . . . . 0.0 110.113 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 22' ' ' ARG . 89.0 p -90.14 101.7 14.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 110.034 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 26.3 p -90.08 131.65 35.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.445 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.3 t -130.62 135.23 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.926 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.7 m -102.2 160.94 14.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 38.0 m-20 -54.66 115.06 1.95 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.841 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.8 OUTLIER -41.59 -39.5 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.891 . . . . 0.0 110.488 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.07 46.95 3.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -127.36 172.83 10.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -1.155 . . . . 0.0 110.32 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.429 HG13 ' C ' ' A' ' 38' ' ' TYR . 56.8 mt -148.17 149.56 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.9 161.45 12.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -43.04 20.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.218 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mmm180 -93.04 15.32 15.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.176 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 8.7 m 64.38 39.72 6.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.338 -0.851 . . . . 0.0 110.428 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.22 -22.43 17.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.617 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -100.18 162.43 12.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.295 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.461 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 7.2 p -133.33 151.05 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -93.02 33.81 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mt -138.65 168.36 19.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.221 -0.924 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.06 -62.95 1.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.135 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.224 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.271 0.558 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -69.08 -71.13 0.23 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.575 ' HA3' ' CZ ' ' A' ' 5' ' ' PHE . . . -45.89 -31.06 3.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.468 ' HB3' ' O ' ' A' ' 3' ' ' GLY . 5.9 t60 63.12 76.08 0.38 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -1.111 . . . . 0.0 110.36 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.575 ' CZ ' ' HA3' ' A' ' 3' ' ' GLY . 52.7 m-85 -109.51 -153.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.97 139.56 21.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.201 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.0 160.4 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 141.66 33.09 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 110.162 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.82 156.38 52.88 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.402 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -57.5 -30.28 64.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.945 . . . . 0.0 110.385 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -35.32 78.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.951 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.497 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -96.11 0.29 51.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 47.63 1.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.442 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.29 -13.18 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 0.0 109.196 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.497 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.34 -0.67 57.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.514 -0.741 . . . . 0.0 109.38 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.26 122.16 3.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 19.8 mm -77.66 -78.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.999 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -89.85 52.99 2.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.057 -1.027 . . . . 0.0 110.29 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -142.26 137.72 8.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.94 134.92 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -1.169 . . . . 0.0 109.899 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.0 t -115.73 132.4 56.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.591 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -95.78 128.34 42.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.42 -0.8 . . . . 0.0 109.798 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -117.9 109.68 16.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.279 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.1 t -85.95 123.48 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.126 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.4 t -79.01 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.633 -0.667 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -50.23 3.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.397 -0.814 . . . . 0.0 109.525 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 38.0 tp10 -115.41 96.6 5.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -36.46 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 110.875 -179.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 26.6 m -138.46 79.21 30.61 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.547 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.7 Cg_endo -78.54 80.58 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.121 1.59 . . . . 0.0 110.207 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.9 p -90.22 132.45 35.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.139 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 29.7 p -106.65 128.04 53.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.0 t -127.8 122.71 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.353 -0.842 . . . . 0.0 110.199 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.7 m -89.16 159.11 17.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 7.0 m-20 -52.97 121.05 6.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -45.2 -40.85 7.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.86 3.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -122.05 170.19 10.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -1.17 . . . . 0.0 110.279 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' TYR . 56.6 mt -149.37 160.77 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.153 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.08 175.85 21.45 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.92 -44.94 10.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 3.2 ttm-85 -100.59 25.71 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.7 m 63.69 50.88 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.85 -34.68 8.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 0.0 110.607 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 164.46 14.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.504 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 p -117.29 161.69 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.883 . . . . 0.0 110.031 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.574 ' CG ' HD23 ' A' ' 48' ' ' LEU . 45.7 t0 -111.27 -71.25 0.77 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.92 . . . . 0.0 110.355 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.574 HD23 ' CG ' ' A' ' 47' ' ' ASP . 1.1 pt? -159.99 51.37 0.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 110.228 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.61 -40.95 40.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 0.0 110.215 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.132 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.539 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.84 -152.38 0.37 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.27 -174.46 1.0 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -123.97 46.1 2.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -1.133 . . . . 0.0 110.258 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.54 ' HD1' HG13 ' A' ' 24' ' ' VAL . 55.1 m-85 -114.51 -153.18 0.52 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.8 m -149.9 139.08 21.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.873 . . . . 0.0 110.232 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -93.21 147.77 22.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.309 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 21' ' ' CYS . 56.8 m -89.93 109.36 32.13 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 47.4 Cg_endo -73.38 175.62 10.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.915 1.482 . . . . 0.0 110.46 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.1 ptmt -67.54 -26.16 66.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -11.03 14.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.502 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.52 13.9 3.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.982 . . . . 0.0 110.403 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 25.7 mtpt -90.04 47.2 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -85.61 -20.78 28.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.013 -1.055 . . . . 0.0 109.231 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 4.7 p90 -90.58 1.29 56.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.437 -0.789 . . . . 0.0 109.114 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -160.27 91.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 23.9 mm -54.13 -81.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.18 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -91.27 68.87 5.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.07 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -159.16 142.41 8.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.69 133.45 42.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.331 -1.1 . . . . 0.0 109.821 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.446 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 9.3 t -125.67 138.81 53.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.674 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.16 133.36 53.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.733 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.7 113.95 24.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 110.589 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.54 HG13 ' HD1' ' A' ' 5' ' ' PHE . 5.1 t -88.23 115.84 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 26' ' ' ALA . 17.0 t -79.85 -59.62 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 110.349 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.84 -36.03 0.95 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 109.421 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -128.53 93.11 3.56 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.9 mt-30 -34.45 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.236 0.541 . . . . 0.0 111.239 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' GLU . 53.8 m -146.8 84.28 7.65 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.368 -0.832 . . . . 0.0 110.376 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.84 96.05 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.122 1.591 . . . . 0.0 110.263 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.7 t -99.07 132.42 44.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.907 . . . . 0.0 110.259 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 30.6 p -118.75 124.41 47.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.53 117.93 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 26.0 m -92.41 163.21 13.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -49.71 126.41 13.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.35 -43.01 33.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.415 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.34 44.31 2.93 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -116.32 165.86 12.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -1.193 . . . . 0.0 110.249 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 39.7 mt -146.94 165.1 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.185 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.418 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 105.63 154.71 21.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.37 -13.61 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.146 -1.208 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 29.2 mtt180 -120.9 16.65 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 8.7 m 64.16 27.8 14.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 110.212 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.69 -7.71 39.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.411 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.46 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -107.65 158.85 16.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.414 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.456 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 13.2 p -127.29 154.24 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.022 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 33.7 t70 -117.07 61.53 0.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.374 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HG ' ' N ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -93.64 -25.48 17.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.904 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.477 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 92.4 m-85 -81.52 9.04 8.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.41 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 33.9 p90 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 110.168 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.051 0.453 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 1' ' ' ARG . 14.2 ptpt 38.44 -153.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.597 -0.689 . . . . 0.0 110.511 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.443 ' N ' ' HG3' ' A' ' 2' ' ' LYS . . . -135.07 -115.77 1.55 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 1.4 m170 58.09 75.23 0.39 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -1.201 . . . . 0.0 110.267 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.853 ' CD1' HG13 ' A' ' 24' ' ' VAL . 44.9 m-85 -98.22 -142.42 0.31 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 110.163 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.53 151.69 38.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.84 133.33 52.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.912 . . . . 0.0 110.32 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 142.88 98.41 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.3 Cg_endo -73.55 167.35 27.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.052 1.554 . . . . 0.0 110.469 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -31.82 73.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.82 -21.96 66.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 110.317 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.475 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -104.35 6.64 35.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.924 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 52.82 2.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.445 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -86.14 -14.83 42.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.99 -1.069 . . . . 0.0 109.171 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.5 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.35 -2.25 57.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.293 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 4.0 m -160.18 103.63 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 62.5 mt -55.37 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 0.0 109.904 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -93.55 66.68 3.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.156 -0.965 . . . . 0.0 109.908 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -155.96 147.45 16.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.4 mtt85 -105.62 135.93 46.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -1.094 . . . . 0.0 109.975 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.5 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.5 t -108.38 132.85 53.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.513 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -97.83 105.57 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -97.15 112.2 24.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.387 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.853 HG13 ' CD1' ' A' ' 5' ' ' PHE . 23.9 t -85.52 117.43 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ALA . 8.3 t -77.88 -63.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.551 -0.718 . . . . 0.0 110.148 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.92 -56.12 2.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.5 tp10 -103.89 91.33 3.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.017 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.1 tp-100 -34.95 91.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.766 -0.583 . . . . 0.0 111.151 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 27' ' ' GLU . 58.0 m -148.23 82.78 7.48 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.3 Cg_endo -76.44 93.13 1.05 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.02 1.537 . . . . 0.0 110.355 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.7 t -101.27 141.19 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.2 p -110.89 134.05 52.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.338 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.09 120.75 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 110.061 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 27.0 m -87.63 159.89 18.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.467 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -47.58 120.06 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -44.78 -44.8 9.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.456 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 47.04 3.15 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -121.75 171.03 9.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 110.252 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.506 ' CG2' ' HD2' ' A' ' 45' ' ' ARG . 27.0 mt -149.66 146.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.89 169.41 14.41 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.8 -40.72 13.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.1 mtt180 -93.49 9.69 35.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.118 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.5 m 66.84 56.75 0.68 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 0.0 110.157 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.14 -25.7 8.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 110.421 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.506 ' HD2' ' CG2' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -89.61 151.2 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 110.203 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 p -127.18 140.41 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 110.063 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.51 65.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.363 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.6 -9.19 10.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.192 -0.943 . . . . 0.0 110.254 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -74.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.167 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.234 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.211 0.529 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -107.32 13.65 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.918 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 120.86 149.69 8.25 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 4' ' ' HIS . 3.7 p80 -168.82 60.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -1.132 . . . . 0.0 110.232 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -103.15 -155.05 0.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.171 -0.956 . . . . 0.0 110.168 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.95 140.01 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.249 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -86.35 150.23 24.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.286 -0.884 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 6.7 m -83.9 127.1 68.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.124 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.54 163.65 36.98 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.891 1.469 . . . . 0.0 110.53 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 1.4 pttp -63.02 -29.95 71.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.131 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.42 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -62.46 -25.9 68.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.86 . . . . 0.0 110.32 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.411 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.6 m-85 -114.03 8.31 17.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.342 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -90.32 49.75 1.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.091 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -86.28 -11.43 52.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.097 -1.002 . . . . 0.0 109.472 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 12.6 p90 -87.18 -9.56 54.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.8 m -160.51 127.38 4.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 110.073 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 25.6 mt -86.98 -65.0 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CG ' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -90.14 50.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 0.0 110.425 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -158.98 137.3 5.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -89.71 -179.8 5.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -1.118 . . . . 0.0 109.575 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.487 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 12.9 t -160.19 125.95 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.898 -1.126 . . . . 0.0 110.892 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.31 114.07 26.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -96.87 111.48 23.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.451 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 10.4 t -84.0 118.02 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 9.6 t -74.04 -66.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.69 -62.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.4 tp10 -98.18 88.46 4.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.336 -0.853 . . . . 0.0 108.983 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.5 mm-40 -34.64 92.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.348 0.594 . . . . 0.0 110.968 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 29' ' ' THR . 13.8 m -144.22 83.62 9.96 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.943 . . . . 0.0 110.556 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -77.97 84.43 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.094 1.576 . . . . 0.0 110.451 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -89.92 134.42 34.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.92 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 7.7 t -114.35 119.27 36.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 110.609 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 t -103.85 115.11 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.803 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.522 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 19.3 m -88.46 158.08 18.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -53.3 125.18 16.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.891 . . . . 0.0 110.032 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 35' ' ' ASP . 3.0 mm-40 -42.64 -45.97 4.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -0.986 . . . . 0.0 110.429 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -90.45 49.35 3.18 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.683 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -117.81 158.81 24.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.265 . . . . 0.0 110.518 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 38' ' ' TYR . 33.5 mm -142.47 150.46 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.16 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.36 170.35 14.87 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.56 -48.11 11.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -1.146 . . . . 0.0 110.341 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.0 mtm105 -98.18 23.69 7.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 110.254 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.534 ' HB3' ' CG ' ' A' ' 18' ' ' LYS . 20.2 m 61.04 76.22 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.135 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 -40.16 2.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 110.379 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -97.39 179.8 4.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 110.262 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 37' ' ' GLY . 2.8 p -142.62 144.29 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 110.232 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.533 ' HB2' ' CG1' ' A' ' 39' ' ' ILE . 13.4 t0 -97.21 -94.57 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -0.874 . . . . 0.0 110.111 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.48 174.62 13.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 109.988 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.2 -39.07 13.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.983 . . . . 0.0 110.377 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.243 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.3 ptt-85 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.253 0.549 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -115.05 -179.73 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.214 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.15 119.69 0.52 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -136.35 72.22 1.43 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -1.145 . . . . 0.0 110.064 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.733 ' CD1' HG13 ' A' ' 24' ' ' VAL . 50.0 m-85 -102.89 -145.83 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.81 121.54 41.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 110.308 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.96 132.53 35.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.104 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 131.2 79.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.124 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 46.7 Cg_endo -73.31 173.04 14.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.956 1.503 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HA ' ' HZ2' ' A' ' 13' ' ' LYS . 10.0 mttm -67.63 -34.04 76.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.54 -8.68 35.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.292 -0.88 . . . . 0.0 110.285 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.432 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -116.1 -0.72 12.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.15 62.2 5.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.203 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -85.55 -21.05 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.089 . . . . 0.0 109.278 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 7.1 p90 -90.34 -2.18 57.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.105 178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.67 126.95 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.3 mm -89.04 -69.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.991 -1.068 . . . . 0.0 109.759 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' CD ' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -93.12 63.63 3.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.158 -0.964 . . . . 0.0 110.054 179.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.436 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -155.32 143.67 10.15 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -101.38 124.79 47.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.206 . . . . 0.0 110.281 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 7.1 t -114.87 127.96 56.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 0.0 110.492 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -103.76 120.69 41.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.893 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -103.94 113.89 27.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 110.618 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.733 HG13 ' CD1' ' A' ' 5' ' ' PHE . 3.4 t -82.51 119.15 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.7 t -79.0 -64.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.678 . . . . 0.0 110.494 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.34 -45.46 2.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -117.4 92.05 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -34.69 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.772 -0.58 . . . . 0.0 110.943 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.8 m -143.52 85.84 9.19 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.247 -0.908 . . . . 0.0 110.552 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.86 114.48 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.568 . . . . 0.0 110.533 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.448 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 17.6 m -119.03 126.38 51.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -0.91 . . . . 0.0 109.85 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 23.7 p -116.06 103.87 11.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.931 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.3 t -96.99 132.51 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.499 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 21.7 m -102.19 157.35 16.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -52.64 116.9 2.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 110.104 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 35' ' ' ASP . 4.5 mm-40 -41.82 -48.19 4.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.181 -0.949 . . . . 0.0 110.373 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 50.74 3.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.545 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -121.64 171.6 8.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.098 -1.237 . . . . 0.0 110.361 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.545 HD12 ' C ' ' A' ' 38' ' ' TYR . 3.6 mp -147.19 138.12 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 110.135 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.14 159.17 9.45 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.69 -48.51 25.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -1.163 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.1 mtt180 -98.33 21.4 11.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.189 -0.944 . . . . 0.0 110.118 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.517 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 6.3 m 64.64 61.19 0.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.292 -0.88 . . . . 0.0 109.817 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -101.41 -31.19 11.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.134 -0.979 . . . . 0.0 110.62 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -108.37 163.54 13.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.456 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.511 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 10.2 p -149.22 161.94 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 110.057 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.93 43.58 2.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.365 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.41 -168.54 1.4 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 110.089 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -7.88 51.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.157 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.302 0.573 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.59 113.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 110.148 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.7 124.1 0.08 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.8 68.46 1.45 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 110.285 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.857 ' CD1' HG13 ' A' ' 24' ' ' VAL . 72.7 m-85 -142.95 -136.05 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.94 . . . . 0.0 110.022 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.42 129.23 26.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.986 -1.071 . . . . 0.0 110.253 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -86.09 142.12 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 110.17 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 4.0 m -78.61 126.95 81.9 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 110.074 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.6 Cg_endo -74.21 148.33 38.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.887 1.467 . . . . 0.0 110.409 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.2 ttpt -58.93 -29.93 67.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -61.44 -34.18 74.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.364 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.462 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 10.9 m-85 -101.43 7.09 42.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.31 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 2.2 mttt -86.16 60.98 6.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.082 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -85.69 -19.11 31.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.004 -1.06 . . . . 0.0 109.31 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.0 p90 -90.72 -1.95 57.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.45 -0.781 . . . . 0.0 109.187 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.9 m -160.3 106.39 1.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 28.1 mm -81.63 -64.18 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.219 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.82 49.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.314 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -152.58 175.85 31.01 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.1 157.18 33.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -1.05 . . . . 0.0 109.969 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 43.6 t -141.41 119.51 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -95.97 109.5 21.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 0.0 109.862 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -96.82 105.53 17.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.466 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.857 HG13 ' CD1' ' A' ' 5' ' ' PHE . 57.6 t -84.49 114.6 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' ALA . 59.9 t -72.9 -59.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.41 -65.77 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 109.415 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 tp10 -95.67 93.24 7.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 108.94 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 27' ' ' GLU . 4.8 mp0 -34.67 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.346 0.593 . . . . 0.0 111.151 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.702 HG22 ' O ' ' A' ' 29' ' ' THR . 4.5 m -147.0 78.98 10.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.454 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.2 Cg_endo -79.39 86.03 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.093 1.575 . . . . 0.0 110.279 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.4 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 22.5 t -90.53 133.4 35.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -129.33 101.65 6.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.31 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 34' ' ' CYS . 88.7 t -103.97 166.6 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.298 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' N ' HG12 ' A' ' 33' ' ' VAL . 34.1 m -112.88 164.33 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.306 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.531 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.9 m-20 -64.63 117.38 7.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.367 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -44.47 -41.45 6.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.364 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.12 46.07 3.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.38 175.74 7.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -1.171 . . . . 0.0 110.225 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 37.5 mt -146.44 152.1 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 110.055 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.58 161.29 19.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.8 -49.52 12.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 21.1 mmt-85 -90.25 15.65 10.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.981 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 4.2 m 67.7 50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.801 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -101.27 0.22 36.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 110.499 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.493 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -128.28 164.05 23.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.384 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p -130.81 157.62 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.087 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -102.26 50.7 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -141.03 -38.54 0.42 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.277 -0.889 . . . . 0.0 110.102 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.32 -30.81 71.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 110.231 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.16 179.954 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.19 0.519 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.45 116.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.878 . . . . 0.0 110.216 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.19 -179.09 20.35 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -169.06 95.46 0.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -1.148 . . . . 0.0 110.307 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -117.42 -150.58 0.46 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.107 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.7 m -136.61 130.43 32.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.128 -0.983 . . . . 0.0 110.312 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.65 124.25 31.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -52.39 129.3 42.7 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.119 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.2 155.71 51.67 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.98 1.516 . . . . 0.0 110.388 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -59.97 -25.1 64.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -63.17 -33.08 74.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.248 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.548 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 m-85 -103.61 10.37 36.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -90.05 43.29 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.271 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -86.13 -13.71 46.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.41 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.548 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.45 2.59 55.52 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.48 -0.763 . . . . 0.0 109.185 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -157.41 125.5 5.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.136 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 35.7 mm -83.02 -81.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.409 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.8 OUTLIER -89.69 57.47 3.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.134 -0.979 . . . . 0.0 110.268 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -149.04 160.08 28.27 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 20.9 ptt180 -116.81 139.23 50.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -1.087 . . . . 0.0 109.694 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.507 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.2 t -114.31 135.3 54.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.791 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.2 ttp85 -97.96 124.0 42.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.765 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.5 t80 -112.09 110.78 21.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.566 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 12.5 t -90.12 123.01 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.926 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 97.1 t -83.06 -56.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.571 -0.706 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.69 -29.79 0.1 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.335 -0.853 . . . . 0.0 109.648 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.6 mt-10 -141.41 96.53 3.0 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.5 mt-30 -33.6 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.212 0.529 . . . . 0.0 111.301 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' GLU . 91.0 m -140.64 83.15 15.03 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.308 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.0 Cg_endo -82.4 83.84 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.174 1.618 . . . . 0.0 110.409 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.403 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 26.8 t -89.82 134.05 34.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.9 p -101.68 132.38 47.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 3.5 t -126.96 151.23 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.332 -0.855 . . . . 0.0 109.785 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 19.5 m -123.47 162.0 23.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 110.388 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -57.66 121.05 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.206 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -44.39 -38.95 4.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.168 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 46.05 3.06 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.33 163.92 20.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -1.157 . . . . 0.0 110.187 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.9 mt -137.41 160.46 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.18 166.95 31.49 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.51 -35.88 16.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -91.55 7.2 42.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.14 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.9 m 69.25 44.68 0.94 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.404 -0.81 . . . . 0.0 110.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -100.28 -25.64 14.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.477 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 3.2 mmt180 -92.41 163.49 13.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -141.49 146.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -0.884 . . . . 0.0 110.286 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -111.89 49.89 0.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.95 . . . . 0.0 110.329 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.35 -54.57 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.208 -0.932 . . . . 0.0 110.131 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.427 ' O ' ' OXT' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -57.93 -65.66 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.427 ' OXT' ' O ' ' A' ' 49' ' ' PHE . 16.4 m-85 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.234 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 2' ' ' LYS . 3.5 mtt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.265 0.555 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 1' ' ' ARG . 15.7 mmmt 55.56 163.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.329 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.92 134.54 12.3 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.43 ' O ' ' CG ' ' A' ' 4' ' ' HIS . 46.7 t-80 -146.13 49.01 1.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.141 . . . . 0.0 110.217 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.526 ' CD1' HG13 ' A' ' 24' ' ' VAL . 52.7 m-85 -120.01 -146.2 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.268 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.8 m -119.07 135.19 54.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.171 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.12 109.11 21.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.305 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -48.61 120.35 8.84 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 12' ' ' TYR . 43.4 Cg_endo -70.67 175.57 8.68 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.858 1.451 . . . . 0.0 110.525 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -60.27 -41.6 93.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.551 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.98 -19.6 66.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.441 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.467 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -99.98 -9.37 22.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.193 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 19' ' ' GLY . 2.1 ttpt -87.82 57.55 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 110.145 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -85.76 -17.4 35.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.991 . . . . 0.0 109.316 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 6.3 p90 -89.98 -2.53 58.16 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.147 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.36 127.75 4.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 45.5 mt -82.23 -74.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 110.424 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -89.78 64.43 6.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 0.0 110.471 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HD2' ' A' ' 13' ' ' LYS . . . -160.15 133.19 3.19 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -95.48 132.75 40.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -1.167 . . . . 0.0 109.765 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 32.1 t -118.75 132.31 56.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.004 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -98.15 124.02 42.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -111.89 112.81 24.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 110.498 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 5' ' ' PHE . 11.6 t -84.72 117.36 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.202 -0.936 . . . . 0.0 109.975 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.4 t -80.86 -63.05 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.568 -0.708 . . . . 0.0 110.436 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.17 -39.43 1.3 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 109.613 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.2 tt0 -123.0 92.37 3.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -35.04 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.21 0.529 . . . . 0.0 111.077 -179.04 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 29' ' ' THR . 3.8 m -148.25 83.37 7.21 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.233 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.8 Cg_endo -82.79 132.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.145 1.603 . . . . 0.0 110.431 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 p -148.81 118.13 6.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.863 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 12.1 t -95.83 153.88 17.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.645 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -139.57 121.6 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.491 -0.756 . . . . 0.0 109.661 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.595 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.6 m -96.94 158.22 15.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -49.51 128.47 17.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.077 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -46.5 -47.4 19.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.331 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.14 45.4 3.0 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.595 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -113.28 163.86 14.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -1.191 . . . . 0.0 110.1 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 47' ' ' ASP . 31.6 mm -138.76 153.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.97 144.97 11.97 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -34.27 70.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -1.109 . . . . 0.0 110.117 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.454 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 2.0 mtt180 -93.76 4.86 53.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.18 43.89 1.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.99 -13.14 15.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.465 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -109.51 166.99 10.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.28 149.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.476 ' HB2' HG12 ' A' ' 39' ' ' ILE . 14.5 t0 -107.81 57.27 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 110.356 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.64 168.61 18.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.923 . . . . 0.0 110.272 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -85.67 -1.39 57.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.422 ' OXT' ' CD1' ' A' ' 50' ' ' TYR . 6.2 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.252 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.246 0.546 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.39 -84.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.167 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.15 116.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -150.95 70.36 0.99 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -1.149 . . . . 0.0 110.25 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.542 ' HD1' HG13 ' A' ' 24' ' ' VAL . 76.1 m-85 -92.19 -153.45 0.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.905 . . . . 0.0 110.166 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m -138.35 137.54 37.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -100.3 113.94 27.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 124.95 78.04 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.176 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.42 178.03 7.18 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.859 1.452 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -65.98 -25.65 67.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -19.91 66.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 4.3 m-85 -110.92 11.06 22.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 110.207 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 34.2 mmtm -88.93 47.6 1.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -85.49 -23.15 27.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.993 -1.067 . . . . 0.0 108.918 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.9 p90 -90.39 -0.76 57.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -160.68 116.19 2.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 109.901 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 32.6 mt -76.65 -63.97 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -104.36 73.8 1.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.098 -1.001 . . . . 0.0 110.417 179.764 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -160.31 178.27 36.41 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 1.7 mtt180 -131.15 119.89 22.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.164 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 15.1 t -107.09 132.3 53.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -104.64 120.8 42.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 109.993 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -104.49 106.72 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.477 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG13 ' HD1' ' A' ' 5' ' ' PHE . 24.2 t -81.58 119.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.13 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 26' ' ' ALA . 25.7 t -80.75 -62.99 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.499 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.3 -49.74 2.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.4 -0.812 . . . . 0.0 109.749 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 5.4 mt-10 -113.32 91.95 3.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.48 -0.763 . . . . 0.0 109.0 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -33.54 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.273 0.559 . . . . 0.0 111.322 -179.075 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 41.0 m -147.92 82.71 7.72 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.6 Cg_endo -77.03 86.69 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.113 1.586 . . . . 0.0 110.352 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.65 143.85 26.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 109.791 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 20.2 p -124.03 132.5 53.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 34' ' ' CYS . 58.6 t -125.45 169.68 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 109.801 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.3 m -140.67 162.32 35.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.39 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.555 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.4 m-20 -49.22 123.67 7.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 110.081 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -47.86 -45.79 30.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.28 42.71 3.02 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.816 ' C ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -115.44 174.0 6.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 110.217 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.816 HD12 ' C ' ' A' ' 38' ' ' TYR . 4.2 mp -150.48 147.93 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.141 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.99 152.97 10.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.44 -30.91 57.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -1.104 . . . . 0.0 109.975 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.16 5.33 44.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 3.9 m 68.92 66.3 0.29 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 109.972 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 -30.88 2.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.002 -1.061 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -95.97 107.07 19.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.963 -1.086 . . . . 0.0 110.506 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.763 HG12 ' CD2' ' A' ' 49' ' ' PHE . 12.2 p -89.35 154.7 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 0.0 110.447 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' HB2' HD11 ' A' ' 39' ' ' ILE . 15.7 t70 -90.97 18.62 6.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 110.235 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.408 ' H ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -157.51 64.66 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.251 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.763 ' CD2' HG12 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -87.58 -54.24 4.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.243 -179.996 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.263 179.93 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.212 0.53 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -54.94 136.91 46.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 67.1 -133.82 31.35 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.5 t60 57.63 85.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.604 ' CD1' HG13 ' A' ' 24' ' ' VAL . 25.2 m-85 -90.81 -156.75 0.45 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.89 . . . . 0.0 110.171 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.62 134.67 47.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HG2' ' NH1' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -90.56 133.32 35.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.139 179.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -73.99 152.8 88.76 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -72.63 158.06 51.34 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.005 1.529 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.5 -26.78 65.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -6.22 26.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.491 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -120.02 4.95 10.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.349 179.964 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.523 ' NZ ' ' OH ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -81.48 75.16 8.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -85.25 -25.45 27.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.018 -1.051 . . . . 0.0 109.407 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.523 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 3.3 p90 -90.45 2.97 55.15 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.95 178.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 1.7 m -160.81 119.77 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 43.1 mm -75.52 -71.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -99.95 68.82 1.51 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.205 -0.935 . . . . 0.0 110.256 179.768 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -159.97 141.25 7.32 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' VAL . 10.9 ptp180 -96.37 143.57 27.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -1.13 . . . . 0.0 109.878 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 31' ' ' SER . 10.4 t -123.22 125.25 44.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' CZ ' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -94.5 117.75 30.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.901 179.625 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.93 112.71 25.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.322 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.604 HG13 ' CD1' ' A' ' 5' ' ' PHE . 9.0 t -85.55 119.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.134 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 58.1 t -77.41 -67.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.629 -0.67 . . . . 0.0 110.382 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.76 -45.98 3.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.423 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 3.8 tt0 -112.53 86.94 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.86 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.314 0.578 . . . . 0.0 110.992 -179.164 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 80.9 m -145.01 85.76 8.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.0 Cg_endo -76.39 84.44 1.85 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.033 1.544 . . . . 0.0 110.146 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 68.1 m -90.09 128.39 36.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.258 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 24.7 p -107.23 97.05 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 20' ' ' ARG . 98.4 t -89.63 120.78 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.023 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 8.7 m -86.94 157.71 19.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.278 -0.889 . . . . 0.0 110.339 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -48.75 118.33 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.129 179.934 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -45.93 -41.27 11.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 110.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.96 43.04 2.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -120.41 176.3 5.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.144 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 21.9 mt -150.33 136.94 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.41 166.15 12.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.77 -38.43 18.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -1.081 . . . . 0.0 110.05 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -99.34 17.55 19.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.002 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 8.2 m 63.62 43.65 5.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.13 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 1.1 tt0 -93.7 -32.7 13.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.843 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.492 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -95.07 158.9 15.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.01 . . . . 0.0 110.199 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.47 ' HB ' ' HD3' ' A' ' 18' ' ' LYS . 7.3 p -147.39 149.58 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.284 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.09 47.99 1.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.78 -71.71 0.72 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 110.187 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -75.24 -47.0 30.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 33.0 t80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.263 179.938 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.274 0.559 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -164.08 -50.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.461 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . 116.57 -88.1 0.45 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.425 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 1.8 t-80 65.2 68.11 0.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -1.16 . . . . 0.0 110.186 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CE2' ' HA3' ' A' ' 3' ' ' GLY . 30.5 m-85 -103.06 -143.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 110.268 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.31 143.78 34.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 110.292 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 142.32 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.78 137.31 92.67 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.479 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 46.3 Cg_endo -72.68 164.39 35.74 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.046 1.551 . . . . 0.0 110.382 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -62.61 -30.98 71.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 110.24 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.479 ' NE2' ' HB2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -66.45 -19.96 65.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.358 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -109.94 5.64 22.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.88 50.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 110.035 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -86.15 -17.55 34.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.112 -0.992 . . . . 0.0 109.115 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -91.15 0.57 57.5 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.069 178.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.0 m -160.43 98.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 11.6 mt -65.69 -73.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.953 . . . . 0.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ptpm? -89.61 52.78 2.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -0.924 . . . . 0.0 110.12 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -148.66 165.96 29.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -123.35 130.28 52.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -1.187 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.468 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.3 t -118.27 128.1 54.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.447 -179.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.81 139.66 30.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 110.02 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -117.56 110.87 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 27' ' ' GLU . 63.9 t -82.02 116.88 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -78.7 -63.88 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.652 -0.655 . . . . 0.0 110.221 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.26 -49.6 5.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -111.35 90.21 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.914 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.8 tt0 -35.45 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.238 0.542 . . . . 0.0 111.041 -179.135 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' GLU . 18.0 m -148.36 86.96 5.79 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.892 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.02 93.47 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.093 1.575 . . . . 0.0 110.5 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 p -93.29 124.3 37.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 31.3 p -105.93 128.0 53.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.78 158.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 110.109 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 13.1 m -125.41 159.2 32.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 110.33 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -52.99 118.61 3.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 110.257 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 35' ' ' ASP . 43.3 mm-40 -42.44 -40.94 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.96 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' ' 47' ' ' ASP . . . -90.05 47.48 3.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -125.0 172.47 9.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -1.203 . . . . 0.0 110.281 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 41.9 mt -146.52 140.89 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.221 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.22 160.88 11.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.66 -40.49 22.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.117 . . . . 0.0 110.23 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 6.2 mpt_? -93.25 9.65 35.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.131 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m 68.49 47.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -0.843 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' C ' ' HE3' ' A' ' 18' ' ' LYS . 8.7 tt0 -104.17 -18.23 14.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -101.18 156.2 17.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.834 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.26 149.12 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.372 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 37' ' ' GLY . 9.4 t70 -93.07 -65.24 1.01 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.43 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 170.61 7.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.16 -0.962 . . . . 0.0 110.273 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.68 -57.24 3.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.342 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 18.2 t80 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.25 -179.948 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 2' ' ' LYS . 18.7 mtm-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.316 0.579 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 1' ' ' ARG . 0.1 OUTLIER 44.13 80.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.54 ' HA2' ' CZ ' ' A' ' 5' ' ' PHE . . . 54.69 -114.88 4.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.448 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER 66.73 75.13 0.33 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.279 -1.13 . . . . 0.0 110.271 -179.975 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.54 ' CZ ' ' HA2' ' A' ' 3' ' ' GLY . 58.6 m-85 -116.03 -154.26 0.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.061 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -119.91 128.46 53.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.419 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -83.37 141.78 31.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.033 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -84.08 129.97 56.54 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.946 . . . . 0.0 110.177 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.18 157.47 50.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.93 1.49 . . . . 0.0 110.29 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -18.33 64.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -65.18 -19.19 65.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -119.76 21.1 12.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.201 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.29 50.25 1.82 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.883 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -86.11 -16.85 36.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.053 . . . . 0.0 109.313 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 3.5 p90 -90.4 4.2 51.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 109.237 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -158.74 109.25 2.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.21 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.479 ' HA ' HD13 ' A' ' 17' ' ' ILE . 10.6 mm -64.3 -70.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.155 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 7.9 ptmm? -105.73 55.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -146.83 150.8 23.11 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 179.42 5.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 0.0 109.856 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 8.4 t -154.73 132.9 11.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.443 ' HD3' ' CG2' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -107.9 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 109.803 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.89 110.6 22.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.583 -179.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.443 ' CG2' ' HD3' ' A' ' 22' ' ' ARG . 48.3 t -84.43 111.86 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 109.871 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 26' ' ' ALA . 37.7 t -74.09 -59.83 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.667 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.34 -59.51 1.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.466 -0.771 . . . . 0.0 109.499 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 63.1 mt-10 -104.0 92.45 4.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 108.97 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.1 tt0 -33.62 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.811 -0.556 . . . . 0.0 111.153 -179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' GLU . 19.2 m -149.42 88.49 4.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.35 91.75 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.024 1.539 . . . . 0.0 110.396 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.435 ' OG ' ' HD2' ' A' ' 22' ' ' ARG . 2.3 p -90.06 148.82 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.841 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 20.4 p -135.13 116.43 14.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 110.701 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.06 157.18 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 19.3 m -122.44 161.3 23.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.357 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 1.2 m-20 -49.64 124.43 9.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -47.05 -41.65 17.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 110.258 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 43.29 2.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -117.04 168.27 10.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -1.19 . . . . 0.0 110.257 179.82 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 38' ' ' TYR . 48.8 mt -150.37 156.92 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.24 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.64 162.02 18.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.74 -28.77 30.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -105.69 17.57 23.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.493 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 16.7 m 61.68 35.69 16.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -100.29 -17.0 17.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.4 170.18 8.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.288 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.03 155.01 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.057 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -92.05 -76.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.357 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.583 ' C ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -160.32 -33.0 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.195 -0.941 . . . . 0.0 110.669 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.493 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -51.66 -73.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.046 -1.034 . . . . 0.0 110.269 -179.951 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.089 179.945 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.23 0.538 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -50.26 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.281 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.1 -95.56 2.04 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.95 93.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.695 ' CD1' HG13 ' A' ' 24' ' ' VAL . 39.9 m-85 -115.9 -151.6 0.49 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -124.44 125.21 43.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.198 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.71 118.73 23.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.244 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 124.37 83.57 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 110.053 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.19 160.99 45.86 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.312 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -51.52 -24.03 4.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.926 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.35 -45.35 93.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 110.308 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.539 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.6 m-85 -94.24 10.56 33.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 37.8 mttt -84.93 46.63 1.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.0 110.126 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -86.21 -13.93 45.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.047 -1.033 . . . . 0.0 109.407 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 7.8 p90 -90.53 -5.13 56.35 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.089 178.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.03 132.58 10.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -0.918 . . . . 0.0 110.372 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 30.7 mm -80.35 -71.89 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.942 . . . . 0.0 110.141 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -101.77 69.11 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 0.0 110.303 -179.996 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -155.36 159.35 29.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.427 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.39 140.68 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -1.155 . . . . 0.0 109.945 179.833 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -116.29 138.2 51.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -110.1 104.0 12.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.79 113.14 24.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.376 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.695 HG13 ' CD1' ' A' ' 5' ' ' PHE . 7.1 t -86.12 121.45 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.879 . . . . 0.0 109.933 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' ALA . 19.9 t -74.86 -62.49 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.619 -0.675 . . . . 0.0 110.524 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.26 -66.98 0.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' THR . 26.3 mt-10 -97.95 92.15 5.66 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.371 -0.83 . . . . 0.0 108.893 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -33.62 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.289 0.566 . . . . 0.0 110.993 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.9 m -137.4 80.92 32.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.485 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.588 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.1 Cg_endo -74.48 83.09 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.111 1.585 . . . . 0.0 110.042 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 t -90.16 145.74 24.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.914 . . . . 0.0 110.328 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.16 145.59 45.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.911 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 76.5 t -143.21 153.54 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 109.888 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 15.5 m -125.45 157.58 36.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.975 . . . . 0.0 110.353 -179.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 19.4 m-20 -51.92 118.65 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.265 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 3.6 tp10 -43.24 -37.2 2.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.962 . . . . 0.0 110.283 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.03 45.86 3.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.86 ' O ' HD13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -125.17 160.93 27.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -1.151 . . . . 0.0 110.297 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 38' ' ' TYR . 19.3 mm -142.7 158.5 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 109.923 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.12 174.77 19.65 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.37 -47.68 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -1.145 . . . . 0.0 110.35 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -90.01 18.78 5.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.175 -179.894 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.6 m 62.65 38.11 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -98.46 -13.71 20.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.255 -0.903 . . . . 0.0 110.326 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -103.38 169.94 8.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 8.0 p -148.36 151.58 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 110.347 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.75 71.35 0.77 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.179 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.53 110.48 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 110.329 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.61 -17.54 8.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.255 -0.903 . . . . 0.0 110.027 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.224 -180.0 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.206 0.526 . . . . 0.0 110.187 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.52 -89.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 110.195 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 1' ' ' ARG . . . 102.45 138.68 10.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -92.72 44.27 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.353 -1.087 . . . . 0.0 110.178 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.714 ' CD1' HG22 ' A' ' 24' ' ' VAL . 64.8 m-85 -109.69 -152.31 0.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.858 . . . . 0.0 110.203 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.5 m -130.71 130.12 43.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 150.54 24.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.197 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 119.66 69.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' C ' ' HE3' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -72.72 173.91 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.809 1.426 . . . . 0.0 110.446 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.461 ' N ' ' HE3' ' A' ' 13' ' ' LYS . 17.0 mttm -66.52 -24.89 66.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 0.0 110.381 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.65 -10.96 30.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.295 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.526 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 12.5 m-85 -129.2 10.9 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.304 -0.873 . . . . 0.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HE3' ' N ' ' A' ' 10' ' ' LYS . 19.0 mttt -86.21 45.96 1.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 110.227 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.28 -14.4 43.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.046 . . . . 0.0 109.411 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 5.4 p90 -90.04 -1.06 57.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 178.38 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 1.8 m -160.28 129.25 4.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.035 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 5.0 mt -87.42 -63.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.074 -1.016 . . . . 0.0 110.108 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.527 ' HE3' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -103.11 60.83 0.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.257 179.574 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.17 162.38 33.17 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -107.57 -178.83 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -1.19 . . . . 0.0 110.031 179.86 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 8.7 t -160.46 126.91 4.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -104.41 115.43 30.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -100.06 116.03 31.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.542 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.714 HG22 ' CD1' ' A' ' 5' ' ' PHE . 52.6 t -87.26 115.56 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.97 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.6 t -75.36 -61.43 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 110.493 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.19 -62.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.607 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -99.82 93.18 5.66 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 108.927 178.767 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' C ' ' O ' ' A' ' 27' ' ' GLU . 2.1 pt20 -34.92 91.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.74 -0.6 . . . . 0.0 111.143 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 9.0 m -146.19 86.22 7.12 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.845 . . . . 0.0 110.268 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.0 Cg_endo -76.42 98.08 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.067 1.561 . . . . 0.0 110.643 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 m -100.41 138.98 36.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.6 p -121.14 110.72 16.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.143 -0.973 . . . . 0.0 110.628 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ARG . 60.8 t -93.91 155.32 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.0 109.886 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.608 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 7.1 m -127.92 157.3 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.222 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.526 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 1.4 m-20 -48.76 125.76 10.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 110.043 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.55 -47.21 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 110.085 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.26 46.26 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.79 175.32 5.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -1.169 . . . . 0.0 110.328 -179.952 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 38' ' ' TYR . 3.5 mp -145.05 130.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.82 155.51 9.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.51 -41.04 40.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -1.179 . . . . 0.0 110.208 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 9.6 mtp180 -89.59 7.68 35.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.513 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 6.7 m 64.2 72.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.799 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.48 ' CA ' ' HD3' ' A' ' 18' ' ' LYS . 7.0 pt-20 -119.65 -25.09 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 110.658 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.438 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -112.49 95.15 5.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.787 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.527 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 14.9 p -89.98 154.75 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 110.285 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.27 47.89 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.56 41.45 0.87 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -55.47 20.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.199 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.225 179.912 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.25 0.548 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 4' ' ' HIS . 0.0 OUTLIER -141.7 146.85 36.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.232 179.949 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.44 111.22 3.76 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.584 ' CE1' ' HB3' ' A' ' 2' ' ' LYS . 32.2 m80 -119.46 -119.02 0.31 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.235 -1.156 . . . . 0.0 109.78 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.813 ' CD1' HG13 ' A' ' 24' ' ' VAL . 86.8 m-85 -97.85 -131.74 0.21 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 110.104 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.54 146.67 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.933 -1.104 . . . . 0.0 110.395 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -79.98 154.46 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -81.93 136.32 47.61 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.68 156.54 49.0 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.986 1.519 . . . . 0.0 110.426 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 13' ' ' LYS . 9.9 ttpt -63.22 -27.86 69.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -20.5 27.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 110.271 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.5 m-85 -125.4 6.38 7.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -86.5 39.62 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.054 179.759 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -86.13 -12.48 49.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.04 -1.037 . . . . 0.0 109.604 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.6 p90 -90.12 1.56 56.26 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.457 -0.777 . . . . 0.0 109.288 178.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.5 m -159.67 109.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 46.5 mm -70.14 -74.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -96.28 60.39 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.973 -1.079 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -148.39 141.99 9.6 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.7 45.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -1.166 . . . . 0.0 110.155 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 8.5 t -113.94 126.5 55.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.428 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.12 111.75 23.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 110.032 179.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -96.01 112.67 24.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.0 110.552 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.813 HG13 ' CD1' ' A' ' 5' ' ' PHE . 38.5 t -86.58 115.73 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.95 . . . . 0.0 109.976 179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 26' ' ' ALA . 62.5 t -73.08 -60.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.573 -0.704 . . . . 0.0 110.494 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.84 -66.73 0.3 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 29' ' ' THR . 9.1 tp10 -99.13 93.67 6.1 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.894 178.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tt0 -34.51 91.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.761 -0.587 . . . . 0.0 111.141 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' GLU . 39.6 m -143.71 84.19 10.06 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.7 Cg_endo -77.35 89.22 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.076 1.566 . . . . 0.0 110.446 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.432 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 78.4 p -89.76 131.5 35.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.105 -0.997 . . . . 0.0 110.069 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 23.5 p -113.91 108.5 17.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.628 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.0 t -109.66 130.39 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.969 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 16.1 m -94.35 162.28 13.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.185 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 18.1 m-20 -56.91 117.68 4.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.72 -38.01 2.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.55 45.7 3.12 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -126.49 171.06 11.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -1.14 . . . . 0.0 110.282 -179.959 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 2.3 mp -147.39 150.56 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 167.83 16.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.53 -37.41 16.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 109.986 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 46.5 mtt180 -96.55 18.72 13.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.038 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.498 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 12.1 m 61.42 41.1 13.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -93.98 -37.3 11.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 110.671 -179.597 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -85.44 163.99 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.256 -179.729 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.02 157.53 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 110.23 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' OD1' HD11 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -97.13 32.9 2.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.945 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.88 118.16 9.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.234 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -69.6 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.382 -0.824 . . . . 0.0 110.164 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.1 t80 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.182 179.956 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.239 0.542 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -157.39 133.91 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.591 ' O ' ' CE2' ' A' ' 5' ' ' PHE . . . -49.68 -70.68 0.75 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER 73.53 47.96 0.16 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.378 -1.072 . . . . 0.0 110.484 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.591 ' CE2' ' O ' ' A' ' 3' ' ' GLY . 81.0 m-85 -142.24 -148.6 0.24 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.357 -0.839 . . . . 0.0 109.567 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.53 133.43 22.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 0.0 110.245 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -96.31 152.0 18.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.877 . . . . 0.0 110.382 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' O ' ' CE ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.13 134.05 32.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.163 179.995 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.3 Cg_endo -74.12 161.53 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.866 1.456 . . . . 0.0 110.425 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -31.54 72.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.121 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -64.09 -12.22 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 110.328 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.406 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -119.68 -3.23 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.143 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.517 ' CE ' ' O ' ' A' ' 8' ' ' CYS . 18.1 mttt -84.38 62.82 7.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.322 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -85.67 -19.56 30.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.911 -1.118 . . . . 0.0 109.246 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.8 p90 -90.39 -2.9 57.99 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.046 178.253 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.68 106.72 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.607 HG22 ' HD2' ' A' ' 18' ' ' LYS . 18.2 mm -78.53 -62.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.112 -0.993 . . . . 0.0 110.277 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HD2' HG22 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -90.4 57.37 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 110.374 -179.834 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' A' ' 13' ' ' LYS . . . -160.05 152.53 23.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -108.56 120.92 43.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -1.122 . . . . 0.0 109.993 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 10.0 t -99.97 128.71 46.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.653 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -100.5 109.73 21.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.353 -0.842 . . . . 0.0 109.718 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -94.96 104.75 16.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.573 HG13 ' CD1' ' A' ' 5' ' ' PHE . 21.0 t -80.66 120.93 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.071 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 21.3 t -76.67 -71.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 110.382 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.08 -47.36 4.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.4 tt0 -108.7 81.79 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -33.8 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.391 0.615 . . . . 0.0 111.105 -179.114 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 79.7 m -143.77 82.62 11.09 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.39 84.55 2.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.243 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.437 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 23.4 m -93.0 151.52 19.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.144 -0.972 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 31.5 p -127.44 127.88 44.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 110.168 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -116.76 148.54 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 70.6 m -116.41 144.52 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 3.4 m-20 -56.36 119.15 5.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.75 -37.98 4.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 110.261 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.1 45.02 2.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -124.27 172.23 9.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -1.163 . . . . 0.0 110.313 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.48 HG13 ' HB2' ' A' ' 47' ' ' ASP . 18.0 mt -150.0 157.49 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.122 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.65 154.6 20.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -42.15 55.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.031 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -90.05 8.46 32.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.886 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.465 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 4.4 m 68.73 43.41 1.28 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 109.996 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -101.84 -22.28 14.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.309 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -95.52 169.7 9.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.201 -0.937 . . . . 0.0 110.262 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.06 153.81 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.48 ' HB2' HG13 ' A' ' 39' ' ' ILE . 27.0 t0 -102.61 -86.87 0.42 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.277 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -95.33 -4.1 46.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.277 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.459 ' O ' ' OXT' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -82.73 6.88 16.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.137 179.916 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.459 ' OXT' ' O ' ' A' ' 49' ' ' PHE . 34.8 t80 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.18 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.259 0.552 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -175.21 -143.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 179.967 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.503 ' N ' ' HG3' ' A' ' 2' ' ' LYS . . . -68.49 97.09 0.45 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.69 78.23 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -1.172 . . . . 0.0 110.174 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.499 ' HD1' HG13 ' A' ' 24' ' ' VAL . 37.7 m-85 -118.81 -157.29 0.68 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -0.89 . . . . 0.0 110.227 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -132.79 130.12 39.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.156 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.46 130.73 34.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 127.05 90.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.277 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.76 167.48 27.1 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.921 1.485 . . . . 0.0 110.458 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.491 ' HG2' ' HE2' ' A' ' 13' ' ' LYS . 5.4 mttt -66.16 -27.24 67.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.186 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -20.44 49.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.238 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -123.71 2.68 8.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HE2' ' HG2' ' A' ' 10' ' ' LYS . 5.1 ttpt -87.03 54.75 3.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -86.33 -15.02 41.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.097 -1.002 . . . . 0.0 109.309 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.5 p90 -90.2 1.93 55.93 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.524 -0.735 . . . . 0.0 109.128 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.454 ' HA ' ' SG ' ' A' ' 43' ' ' CYS . 1.5 m -157.42 79.12 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.366 -0.834 . . . . 0.0 109.999 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 44' ' ' GLU . 83.7 mt -48.7 -55.15 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.427 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 18' ' ' LYS . 5.9 ptmm? -112.24 60.95 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.99 . . . . 0.0 110.478 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -157.49 141.24 7.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 123.51 40.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -1.113 . . . . 0.0 109.936 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 31' ' ' SER . 11.0 t -111.0 127.68 55.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.111 -0.993 . . . . 0.0 110.587 -179.595 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.61 119.39 34.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.868 . . . . 0.0 109.822 179.604 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -100.31 106.16 17.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 21.3 t -80.24 118.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 26' ' ' ALA . 73.1 t -80.28 -58.44 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.574 -0.703 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.49 -50.73 3.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.8 mt-10 -116.06 96.6 5.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 27' ' ' GLU . 8.3 tp-100 -34.84 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.78 -0.575 . . . . 0.0 111.201 -179.089 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 29' ' ' THR . 3.9 m -146.17 82.66 8.96 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.253 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.438 ' HD3' ' OE1' ' A' ' 28' ' ' GLN . 51.1 Cg_endo -79.56 89.06 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.108 1.583 . . . . 0.0 110.43 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -94.65 131.15 40.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.993 179.83 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 27.4 p -113.87 114.38 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.605 -179.727 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.2 129.45 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.848 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 8.3 m -101.85 161.76 13.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.126 -0.984 . . . . 0.0 110.42 -179.388 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 63.0 m-20 -58.85 119.8 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 37' ' ' GLY . 10.3 pt-20 -43.9 -33.43 1.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' N ' ' HG3' ' A' ' 36' ' ' GLU . . . -90.28 43.83 2.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -126.24 170.65 11.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -1.2 . . . . 0.0 110.414 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 45' ' ' ARG . 29.3 mt -150.15 151.7 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.64 169.57 17.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.89 -40.82 13.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 110.237 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 2.8 mpt_? -91.02 10.9 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 6.3 m 66.54 41.45 3.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.304 -0.872 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HB3' HD12 ' A' ' 17' ' ' ILE . 5.6 pt-20 -100.11 -28.29 13.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -84.88 163.24 19.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.231 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.486 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.4 p -139.81 157.17 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.27 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -123.98 36.36 4.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.88 . . . . 0.0 110.119 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.75 71.61 0.8 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 110.227 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -88.88 -72.1 0.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.172 -179.837 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.234 0.54 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.65 88.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.899 . . . . 0.0 110.248 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.4 101.49 0.2 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 4' ' ' HIS . 6.6 p80 -150.28 58.48 0.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.274 -1.133 . . . . 0.0 110.36 -179.781 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -112.52 -139.85 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.952 . . . . 0.0 110.062 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -147.28 134.89 20.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 110.292 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -91.0 126.69 36.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.64 133.95 95.09 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.224 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.8 164.97 34.06 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.943 1.497 . . . . 0.0 110.432 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -66.36 -26.65 67.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.263 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -8.65 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 110.368 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 7.65 5.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 0.0 110.227 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -89.94 46.27 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.32 -11.81 51.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.126 -0.984 . . . . 0.0 109.534 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 3.5 p90 -90.41 0.93 57.08 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.187 178.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.9 m -159.54 123.63 3.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 44' ' ' GLU . 57.8 mt -75.38 -76.52 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -98.72 65.06 1.53 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.097 -1.002 . . . . 0.0 110.814 -179.615 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -152.87 148.36 19.09 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -101.9 132.7 47.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.13 . . . . 0.0 110.098 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.0 t -107.63 126.63 52.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.441 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' NH1' ' CG ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -96.49 106.89 19.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.852 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.3 t80 -94.48 115.38 27.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.889 . . . . 0.0 110.585 -179.601 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 17.9 t -91.64 120.98 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 109.944 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' ALA . 10.7 t -79.59 -64.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.662 . . . . 0.0 110.563 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.85 -38.3 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.807 . . . . 0.0 109.561 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -124.51 91.49 3.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 27' ' ' GLU . 3.2 pm0 -36.2 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.697 -0.627 . . . . 0.0 110.93 -179.078 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' GLU . 54.5 m -146.28 83.6 8.36 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.858 . . . . 0.0 110.462 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.3 Cg_endo -78.8 88.42 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.164 1.613 . . . . 0.0 110.431 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.6 145.46 25.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 109.92 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 8.9 p -128.03 105.59 8.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.114 -0.991 . . . . 0.0 110.978 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.3 t -106.8 151.8 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.533 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 13.5 m -119.55 166.12 13.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.613 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -52.99 117.39 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.964 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -42.62 -37.25 1.63 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.213 -179.909 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 46.36 3.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -124.61 165.73 17.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -1.202 . . . . 0.0 110.38 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 47' ' ' ASP . 16.4 mt -149.42 151.22 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.235 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.24 149.94 10.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.48 66.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.012 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -90.67 -0.39 57.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.9 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.533 ' HG ' ' HG ' ' A' ' 34' ' ' CYS . 5.2 m 69.89 38.18 1.65 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.825 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.49 ' HB2' HD12 ' A' ' 17' ' ' ILE . 6.5 tm-20 -101.39 -17.34 16.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -97.27 163.95 12.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.795 179.821 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.431 ' HB ' ' HE2' ' A' ' 18' ' ' LYS . 8.9 p -150.11 155.13 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB2' HD11 ' A' ' 39' ' ' ILE . 1.7 t70 -121.46 80.36 1.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.242 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -148.42 71.96 1.18 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 110.197 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.17 -45.1 64.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 0.0 110.233 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 6.4 p90 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.107 -179.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.255 0.55 . . . . 0.0 110.2 . . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 1' ' ' ARG . 13.4 tttt 64.72 123.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.46 74.55 0.2 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.475 ' O ' ' CD1' ' A' ' 5' ' ' PHE . 13.8 t-80 -87.07 55.04 3.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.18 . . . . 0.0 110.368 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.514 ' HD1' HG13 ' A' ' 24' ' ' VAL . 59.3 m-85 -149.68 -155.38 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.965 . . . . 0.0 110.275 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 m -142.7 121.51 12.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.41 137.28 35.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.183 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 136.41 93.19 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -179.94 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 47.5 Cg_endo -72.89 161.93 42.4 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.055 1.555 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -67.46 -31.52 71.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 179.952 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.67 -10.83 21.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.7 m-85 -126.5 2.83 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.843 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -89.98 57.06 3.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.11 179.889 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -86.45 -12.68 48.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 109.422 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 5.3 p90 -90.17 -1.65 57.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.089 178.427 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.8 m -160.24 104.27 1.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 110.103 179.837 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 47.5 mm -69.29 -72.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CE ' ' HB2' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -91.16 52.8 2.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -151.42 135.9 5.29 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -99.62 125.95 45.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.273 -1.134 . . . . 0.0 110.238 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.475 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 11.0 t -105.66 125.8 51.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.251 -179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.03 112.16 23.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.139 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -94.77 104.7 16.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.514 HG13 ' HD1' ' A' ' 5' ' ' PHE . 21.5 t -80.52 115.13 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.266 -179.885 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' ALA . 27.9 t -78.13 -62.1 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.558 -0.714 . . . . 0.0 110.224 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.53 -44.8 4.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.281 179.523 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.1 OUTLIER -115.37 90.47 3.35 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.842 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -35.01 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.778 -0.576 . . . . 0.0 111.005 -179.133 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 27' ' ' GLU . 34.2 m -150.37 83.46 5.97 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 -179.882 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.493 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.5 Cg_endo -80.8 100.08 1.18 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.065 1.56 . . . . 0.0 109.953 179.419 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.438 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.3 p -112.15 132.72 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.096 -1.002 . . . . 0.0 110.454 -179.741 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 29.2 p -104.79 131.45 52.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.223 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.5 116.95 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.253 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 19.4 m -93.97 156.1 16.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.872 . . . . 0.0 110.126 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -50.3 124.18 9.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 179.895 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -45.52 -40.78 8.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.18 46.24 3.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -120.82 166.62 13.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 110.339 179.899 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.515 HD11 ' OD2' ' A' ' 47' ' ' ASP . 9.6 mt -146.46 150.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.69 145.02 9.04 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.98 62.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 110.253 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.3 mmt85 -112.78 5.66 17.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m 68.34 45.22 1.22 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.309 -0.869 . . . . 0.0 110.131 179.704 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.48 -33.5 9.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 110.678 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -86.07 151.68 23.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.379 -179.704 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.49 144.54 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.04 179.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.515 ' OD2' HD11 ' A' ' 39' ' ' ILE . 1.5 t0 -130.7 55.2 1.84 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -0.907 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.4 mt -134.19 136.16 43.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 110.209 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -89.48 30.39 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.175 -179.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 19.8 p90 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.193 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.271 0.557 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -87.27 54.17 3.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.32 -0.863 . . . . 0.0 110.195 -179.905 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 167.89 59.52 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.89 31.05 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -1.134 . . . . 0.0 110.256 179.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 5' ' ' PHE . 47.4 m-85 -138.13 -152.93 0.45 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.7 128.66 35.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.164 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.91 125.66 45.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.261 -179.96 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.438 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.33 127.45 92.13 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 -179.931 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 45.8 Cg_endo -74.2 161.27 41.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.914 1.481 . . . . 0.0 110.247 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -64.41 -32.67 74.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.476 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -65.57 -8.69 21.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.471 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -123.86 0.98 8.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 20' ' ' ARG . 27.2 mttt -87.99 73.85 9.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.372 -179.788 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -85.74 -17.82 34.79 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.207 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 14.6 p90 -82.58 -10.08 59.12 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 178.502 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 2.2 m -160.3 137.81 9.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.311 -0.868 . . . . 0.0 110.205 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.0 mm -94.37 -70.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.41 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.89 62.41 5.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.102 -0.999 . . . . 0.0 110.506 -179.925 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.35 141.96 7.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.753 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 5.3 mpt_? -95.4 150.56 20.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -1.178 . . . . 0.0 109.505 179.697 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.495 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 26.5 t -132.55 130.31 40.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.552 -179.685 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -99.49 122.18 42.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 109.994 179.619 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.1 t80 -111.98 103.49 11.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.211 -179.804 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.494 ' CG2' ' HB ' ' A' ' 29' ' ' THR . 22.3 t -81.42 124.67 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 26' ' ' ALA . 11.1 t -79.68 -69.25 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 110.306 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.94 -44.45 3.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -112.53 93.97 4.69 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.886 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.2 tp-100 -38.93 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.533 -0.729 . . . . 0.0 110.796 -179.148 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLU . 7.6 m -139.18 73.15 38.25 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.218 -0.927 . . . . 0.0 110.459 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.609 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 51.3 Cg_endo -78.43 72.86 6.12 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.025 1.539 . . . . 0.0 110.033 179.516 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -92.56 137.91 31.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -179.695 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.7 t -114.01 107.83 16.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.256 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 20' ' ' ARG . 45.0 t -94.08 116.24 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.617 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 9.0 m -83.6 158.54 21.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.964 . . . . 0.0 110.055 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -46.45 120.18 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.762 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 35' ' ' ASP . 6.0 tt0 -40.83 -54.09 2.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.66 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.48 52.79 3.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -118.59 168.86 10.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -1.195 . . . . 0.0 110.655 -179.999 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.956 HD11 ' HB2' ' A' ' 47' ' ' ASP . 3.3 mp -143.37 132.04 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.756 . . . . 0.0 109.806 179.5 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.8 136.43 3.62 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.01 72.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.304 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -110.0 19.89 18.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.963 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.6 m 63.54 72.74 0.47 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.89 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -107.9 -40.27 5.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.938 -179.3 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.481 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 9.1 ptp180 -118.56 168.86 10.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.986 -1.071 . . . . 0.0 110.546 -179.527 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 7.1 p -121.96 162.25 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.956 ' HB2' HD11 ' A' ' 39' ' ' ILE . 33.5 t0 -97.09 -74.97 0.55 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 110.246 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -135.38 147.0 48.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 -179.927 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.0 -40.49 58.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 110.193 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' HB2' HD23 ' A' ' 48' ' ' LEU . 55.4 m-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.254 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.28 0.562 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 1' ' ' ARG . 18.2 ttmt -179.23 117.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.096 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' HA3' ' CE2' ' A' ' 5' ' ' PHE . . . -121.14 -74.53 0.36 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.36 94.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -1.123 . . . . 0.0 110.157 -179.908 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CE2' ' HA3' ' A' ' 3' ' ' GLY . 54.1 m-85 -131.31 -149.41 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.5 m -115.95 132.12 56.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -87.69 118.01 26.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 24.6 m -45.28 112.25 1.53 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 163.55 37.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.951 1.501 . . . . 0.0 110.319 179.739 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -60.32 -37.14 79.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.259 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -25.15 63.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 -179.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -110.17 -1.4 17.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.257 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -89.94 46.94 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.401 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -86.21 -12.79 48.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.047 -1.033 . . . . 0.0 109.402 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.53 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 9.1 p90 -90.3 -3.8 57.54 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.214 178.494 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.12 105.52 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 51.1 mm -70.41 -71.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 110.055 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HE3' ' HA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -89.69 64.0 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.488 ' O ' ' CE ' ' A' ' 13' ' ' LYS . . . -160.05 136.37 4.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 96.0 mtt180 -99.51 127.21 45.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.227 -1.161 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 9.5 t -119.01 133.18 55.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.643 -179.664 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -102.51 123.96 47.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.853 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -105.66 116.24 31.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 53.4 t -86.56 116.88 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 110.133 179.714 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' ALA . 89.1 t -79.92 -61.16 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.543 -0.723 . . . . 0.0 110.549 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.0 -49.14 3.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.577 179.886 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 29' ' ' THR . 2.3 tt0 -114.5 92.83 4.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -34.47 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.262 0.553 . . . . 0.0 110.99 -179.084 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 29' ' ' THR . 4.4 m -149.11 86.81 5.52 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.4 Cg_endo -79.23 122.5 5.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.985 1.518 . . . . 0.0 110.298 179.666 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -127.85 116.64 20.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 109.971 179.804 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.8 p -99.59 126.98 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 110.583 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 42.2 t -116.77 120.84 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.349 -0.844 . . . . 0.0 109.819 179.705 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 14.6 m -91.3 159.95 15.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.247 -0.908 . . . . 0.0 110.514 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -58.42 128.11 35.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.036 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -47.44 -49.12 25.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 45.76 3.02 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -113.04 172.85 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 110.226 179.864 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 15.2 mt -150.2 127.7 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.27 148.44 6.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.65 66.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 110.283 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' CYS . 81.0 mtt180 -89.58 13.47 13.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.537 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 3.5 m 63.36 62.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.324 -0.86 . . . . 0.0 109.762 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 10.4 tt0 -110.34 -28.82 8.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.74 -179.516 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 13.2 ttm180 -111.03 109.58 19.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.017 -1.052 . . . . 0.0 110.317 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -89.72 159.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -98.57 64.72 1.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.322 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.28 174.08 10.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.297 179.983 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -48.42 -62.78 1.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.432 ' OXT' ' CG ' ' A' ' 50' ' ' TYR . 66.2 t80 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.16 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.216 0.531 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.62 116.76 8.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 110.154 179.882 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 102.8 70.71 0.86 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.854 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.46 ' CD2' ' N ' ' A' ' 4' ' ' HIS . 6.5 p80 -138.06 76.41 1.58 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 110.211 -179.793 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.898 ' CG ' HG22 ' A' ' 24' ' ' VAL . 36.2 m-85 -95.23 -144.59 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.05 162.73 18.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.347 179.942 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -106.9 154.13 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 110.171 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.429 ' CB ' ' HH ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -83.46 127.73 67.11 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 -179.907 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.67 162.21 40.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.868 1.457 . . . . 0.0 110.383 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -61.36 -29.04 69.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -63.86 -25.61 68.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.35 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -112.12 10.55 20.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.351 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -90.0 45.45 1.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.131 179.926 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.25 -13.45 46.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.032 . . . . 0.0 109.624 -179.852 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p90 -87.96 -1.76 58.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.439 -0.788 . . . . 0.0 109.197 178.607 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.521 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -159.78 103.2 1.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 33.2 mt -63.73 -69.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 -179.956 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 8.7 ptmm? -97.94 64.43 1.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -160.21 149.31 18.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.934 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.96 162.05 13.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 109.793 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 9.2 t -151.81 156.24 39.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.02 . . . . 0.0 110.621 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -125.99 125.82 43.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.456 -0.778 . . . . 0.0 109.602 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -101.07 118.06 36.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.648 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.898 HG22 ' CG ' ' A' ' 5' ' ' PHE . 37.6 t -83.56 115.72 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.814 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' ALA . 6.0 t -82.2 -63.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.52 -0.737 . . . . 0.0 110.62 -179.506 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -40.01 -29.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.351 -0.843 . . . . 0.0 109.787 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 29' ' ' THR . 97.2 mt-10 -136.93 93.46 2.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.164 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 13.1 mt-30 -34.72 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.806 -0.559 . . . . 0.0 111.146 -179.124 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 29' ' ' THR . 3.1 m -149.18 89.57 4.84 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 110.324 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -78.15 117.45 4.13 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.06 1.558 . . . . 0.0 110.395 179.666 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.0 OUTLIER -118.88 110.62 17.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.132 -0.98 . . . . 0.0 109.904 179.768 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.443 ' C ' HG23 ' A' ' 33' ' ' VAL . 26.7 p -92.15 155.14 18.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.735 -179.682 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.443 HG23 ' C ' ' A' ' 32' ' ' CYS . 99.3 t -149.12 120.44 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.472 -0.768 . . . . 0.0 109.806 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.0 m -93.72 156.47 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -179.526 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -54.85 125.53 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.038 179.772 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.47 -39.42 15.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.826 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.16 40.95 2.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -114.84 174.24 6.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -1.214 . . . . 0.0 110.326 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 38' ' ' TYR . 18.0 mm -149.51 148.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.031 -179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.61 157.45 20.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.03 -37.71 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 110.164 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -93.11 9.19 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.124 179.842 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.507 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.8 m 67.41 43.72 1.91 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.402 -0.811 . . . . 0.0 110.145 179.818 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -96.29 -34.44 11.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.585 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.485 ' O ' ' HD3' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -96.7 -178.62 4.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -0.962 . . . . 0.0 110.476 -179.757 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HB ' ' HE3' ' A' ' 18' ' ' LYS . 8.8 p -147.66 157.4 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.861 . . . . 0.0 110.391 -179.844 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -108.08 54.27 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.339 -0.851 . . . . 0.0 110.036 179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.29 -167.15 1.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 110.186 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.98 -22.38 25.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.6 t80 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.225 -179.901 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 1' ' ' ARG . 7.0 ttm180 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.253 0.549 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -112.86 -0.91 14.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.907 . . . . 0.0 110.235 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 4' ' ' HIS . . . -170.48 -161.29 20.8 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.53 ' O ' ' CD2' ' A' ' 4' ' ' HIS . 44.9 p-80 -177.99 97.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -1.139 . . . . 0.0 110.286 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -107.0 -144.75 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.164 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.76 140.17 23.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.382 -179.968 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.17 119.81 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.23 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -55.86 136.61 72.54 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 179.878 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 46.9 Cg_endo -73.35 171.71 17.12 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.91 1.479 . . . . 0.0 110.415 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -63.72 -38.62 91.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 110.234 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -63.64 -19.23 64.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.192 179.982 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.463 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.2 m-85 -107.45 -1.97 20.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -90.1 55.73 3.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 0.0 110.2 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.427 ' CE1' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -86.16 -15.5 40.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.026 -1.046 . . . . 0.0 109.303 179.923 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.509 ' OH ' ' CB ' ' A' ' 21' ' ' CYS . 3.6 p90 -90.13 3.32 53.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.493 -0.755 . . . . 0.0 109.307 178.515 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.98 106.39 1.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 110.154 179.85 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 9.3 mm -63.25 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.108 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CE ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -96.29 63.4 2.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.221 179.987 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -159.76 155.54 26.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -101.77 -179.06 3.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 109.832 179.832 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.509 ' CB ' ' OH ' ' A' ' 15' ' ' TYR . 8.8 t -152.63 128.05 9.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.068 -1.02 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -102.28 105.07 15.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.884 . . . . 0.0 110.074 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -98.29 115.44 28.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 41.2 t -89.91 117.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.243 179.817 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 26' ' ' ALA . 53.8 t -75.24 -62.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.597 -0.69 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.46 -61.23 1.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.83 . . . . 0.0 109.436 179.779 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 29' ' ' THR . 47.7 mt-10 -99.62 90.6 4.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.483 -0.761 . . . . 0.0 109.008 178.891 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.8 pm0 -34.3 91.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.268 0.556 . . . . 0.0 111.046 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' GLU . 43.4 m -146.03 85.36 7.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.862 . . . . 0.0 110.348 179.912 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.6 Cg_endo -76.05 99.2 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.368 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.35 143.01 33.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.144 179.897 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 32' ' ' CYS . 27.5 p -123.91 118.22 26.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.767 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 t -112.44 146.82 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.462 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 13.6 m -117.03 161.54 19.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -54.19 117.41 3.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 110.219 -179.893 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -43.97 -38.1 3.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.35 46.18 3.01 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.508 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -125.07 172.49 9.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.188 -1.183 . . . . 0.0 110.339 179.965 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 45' ' ' ARG . 46.2 mt -150.12 143.93 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.132 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.13 168.79 13.37 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.66 -40.26 16.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -1.15 . . . . 0.0 110.119 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -96.86 13.37 28.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 0.0 110.186 179.973 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.3 m 67.77 51.04 0.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -101.74 -39.92 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 0.0 110.704 -179.68 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -84.06 165.44 18.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.074 -1.016 . . . . 0.0 110.477 -179.798 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.524 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 8.6 p -146.09 156.12 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.05 58.35 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' CG ' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -158.77 43.34 0.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 110.197 -179.939 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.74 -76.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.965 . . . . 0.0 110.221 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.218 0.533 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.47 103.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 110.095 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 4' ' ' HIS . . . 137.44 68.94 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 4.9 t-160 -177.62 100.98 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.266 -1.137 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -91.38 -154.36 0.36 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 m -145.0 135.92 24.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.299 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 121.18 26.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.87 . . . . 0.0 110.142 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -47.41 135.88 9.54 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.235 -179.982 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.86 173.65 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.996 1.524 . . . . 0.0 110.403 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -65.07 -31.37 72.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.91 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.89 -8.59 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 -179.863 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -119.05 -1.26 10.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.939 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -90.12 39.39 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.263 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -85.85 -20.94 28.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 109.457 -179.832 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 4.3 p90 -90.21 1.1 56.82 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.009 178.124 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.6 m -160.33 92.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.072 179.884 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 75.4 mt -75.56 -55.89 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 109.934 179.975 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' CB ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -89.45 42.74 1.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 110.026 179.772 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.97 -179.74 30.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -137.29 145.54 43.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.265 -1.138 . . . . 0.0 109.934 179.821 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 14.6 t -125.65 124.94 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 110.636 -179.538 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -90.2 113.15 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.789 179.602 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -95.41 116.4 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.477 -179.621 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 27' ' ' GLU . 58.0 t -83.7 116.54 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 109.966 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 26' ' ' ALA . 38.5 t -79.93 -59.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 0.0 110.494 -179.826 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.53 -47.92 3.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 179.806 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -118.08 95.17 4.78 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.755 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 27' ' ' GLU . 56.1 tt0 -35.53 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.757 -0.589 . . . . 0.0 111.128 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.9 m -148.52 88.39 5.33 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -76.02 118.87 5.15 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.956 1.503 . . . . 0.0 110.387 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 4.3 m -122.36 115.22 21.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.894 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -98.31 154.16 18.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.72 -179.614 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.6 t -146.94 159.34 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.883 179.68 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.511 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 15.4 m -121.43 157.16 31.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.051 -1.031 . . . . 0.0 110.452 -179.653 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 8.8 m-20 -66.79 124.88 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.864 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -50.84 -40.53 56.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.31 -179.943 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.39 40.95 3.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.569 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER -117.92 176.84 5.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -1.145 . . . . 0.0 110.331 -179.879 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' A' ' 47' ' ' ASP . 12.8 mt -147.0 117.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 110.245 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 150.94 5.82 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.35 -52.2 49.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -1.153 . . . . 0.0 109.959 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -92.48 17.78 9.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.827 179.691 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 8.6 m 64.65 80.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 110.143 179.936 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -113.68 -38.4 4.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -104.8 162.19 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' CE ' ' A' ' 18' ' ' LYS . 11.1 p -131.58 154.66 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.05 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.63 ' HB2' HD11 ' A' ' 39' ' ' ILE . 38.6 t0 -134.17 44.46 2.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.509 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.5 OUTLIER -79.73 173.87 12.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 179.94 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' O ' ' C ' ' A' ' 50' ' ' TYR . 36.7 m-85 -86.72 34.81 0.66 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 110.591 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 16.0 p90 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.198 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.355 0.598 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -63.81 -27.99 69.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.151 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.19 -116.69 1.2 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.954 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.17 90.99 1.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -1.127 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.778 ' CD1' HG13 ' A' ' 24' ' ' VAL . 24.8 m-85 -132.36 -158.07 0.86 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 110.064 -179.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -140.42 141.44 35.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 165.51 21.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.512 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -89.78 127.34 54.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 110.274 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 48.2 Cg_endo -73.99 166.05 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.883 1.465 . . . . 0.0 110.094 179.68 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -66.0 -36.04 82.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.88 -12.2 16.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 110.458 -179.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.418 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.4 m-85 -120.3 -6.0 9.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 52.08 2.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 110.298 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -86.28 -16.92 36.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.95 -1.094 . . . . 0.0 109.413 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 16' ' ' CYS . 4.5 p90 -90.36 1.98 56.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 109.127 178.404 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 1.3 m -159.66 100.06 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.117 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 41.7 mm -72.61 -70.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.165 179.982 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -89.57 49.32 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 179.983 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 34' ' ' CYS . . . -141.84 134.34 6.15 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -92.92 127.31 38.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.232 -1.157 . . . . 0.0 109.892 179.771 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.524 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 5.8 p -127.96 145.83 50.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 110.565 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.91 159.17 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.857 . . . . 0.0 109.527 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -138.51 109.14 6.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.029 . . . . 0.0 110.307 -179.751 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.778 HG13 ' CD1' ' A' ' 5' ' ' PHE . 7.9 t -80.46 116.03 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 26' ' ' ALA . 5.8 t -78.95 -65.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.061 179.834 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -42.97 -42.71 3.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 0.0 109.376 179.608 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -115.95 88.95 2.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.919 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -35.06 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.235 -178.992 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' GLU . 94.2 m -146.73 81.75 9.03 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 179.753 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.551 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 50.1 Cg_endo -79.12 107.67 2.25 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.061 1.558 . . . . 0.0 110.507 179.925 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 136.05 53.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 179.764 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.524 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 22.0 p -120.28 129.43 54.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 t -126.34 116.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.079 179.954 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HA ' ' CA ' ' A' ' 19' ' ' GLY . 14.9 m -89.54 150.28 22.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 110.251 -179.765 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 14.9 m-20 -45.62 124.26 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 110.093 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 37' ' ' GLY . 19.2 pt-20 -51.79 -38.55 56.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.251 179.945 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . -90.12 37.94 3.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -110.02 172.8 6.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 110.322 -179.932 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.409 HG12 ' C ' ' A' ' 38' ' ' TYR . 33.3 mm -144.98 141.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 0.0 110.237 179.886 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.44 145.97 10.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.32 -38.4 81.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -1.188 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 4.1 mtm-85 -89.78 3.63 52.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 110.149 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m 67.55 51.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 109.598 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -99.42 -30.94 11.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.598 -179.565 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.495 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 82.1 mtt180 -105.6 173.76 6.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.402 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.592 HG22 ' H ' ' A' ' 48' ' ' LEU . 5.7 p -146.56 146.63 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.236 179.964 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.48 38.2 2.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.847 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' H ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -104.0 129.27 51.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.271 -179.926 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -79.33 -44.7 21.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.086 179.959 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.192 179.97 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.264 0.554 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 -156.63 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 4' ' ' HIS . . . 152.76 -107.56 0.33 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER 66.42 98.33 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -1.162 . . . . 0.0 110.246 -179.873 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.454 ' CD1' HG13 ' A' ' 24' ' ' VAL . 46.2 m-85 -97.99 -146.45 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 m -137.5 146.86 44.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.61 150.82 25.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.888 . . . . 0.0 110.193 179.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -83.65 130.12 57.04 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 110.226 -179.958 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.56 172.34 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.959 1.505 . . . . 0.0 110.396 -179.926 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 5.3 pttt -63.76 -25.18 68.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -62.51 -10.27 11.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 -179.885 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.585 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 8.8 m-85 -131.73 4.35 4.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 8.9 mtpt -85.53 44.3 1.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.061 -1.024 . . . . 0.0 110.461 -179.843 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -85.2 -25.19 27.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.845 -1.16 . . . . 0.0 109.602 -179.78 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 12' ' ' TYR . 10.9 p90 -79.16 -6.01 55.53 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.292 178.566 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.3 138.14 9.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.54 179.774 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 44' ' ' GLU . 9.8 mt -94.68 -72.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 110.197 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -89.78 63.92 6.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 110.312 179.987 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.2 139.75 6.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -100.39 125.45 46.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -1.163 . . . . 0.0 109.801 179.91 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t -111.28 129.17 56.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 -179.643 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -90.89 129.17 36.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.939 179.689 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -105.62 110.48 22.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 27' ' ' GLU . 39.4 t -80.31 114.72 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 179.827 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 26' ' ' ALA . 42.5 t -77.03 -65.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.593 -0.692 . . . . 0.0 110.235 -179.894 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.6 -48.5 4.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.49 179.813 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -112.83 87.62 2.63 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.511 -0.743 . . . . 0.0 109.013 178.844 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -33.89 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.126 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.566 HG22 ' O ' ' A' ' 29' ' ' THR . 6.0 m -149.23 88.35 5.08 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.336 -0.852 . . . . 0.0 110.412 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.08 91.81 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.04 1.547 . . . . 0.0 110.432 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.455 ' O ' ' SG ' ' A' ' 21' ' ' CYS . 1.1 p -93.34 124.98 37.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 179.784 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.491 ' HA ' ' CB ' ' A' ' 21' ' ' CYS . 6.7 t -99.97 129.56 46.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 -179.724 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 20' ' ' ARG . 87.4 t -117.9 109.4 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 109.584 179.401 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.609 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 10.2 m -79.93 153.75 28.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.835 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 5.2 m-20 -49.57 117.8 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 179.811 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.05 -47.08 4.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.469 -179.897 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.24 49.67 3.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -121.84 172.82 7.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.142 -1.211 . . . . 0.0 110.283 179.797 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.959 HD11 ' OD1' ' A' ' 47' ' ' ASP . 14.5 mt -144.09 143.8 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.944 . . . . 0.0 110.193 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.09 170.36 14.97 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.2 -46.43 9.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -1.176 . . . . 0.0 110.268 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' CYS . 1.5 mtp85 -91.41 11.96 22.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 0.0 110.152 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.523 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 5.7 m 67.1 64.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.436 -0.79 . . . . 0.0 110.196 179.878 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.698 ' HG2' HD12 ' A' ' 17' ' ' ILE . 24.1 mt-10 -116.3 -14.05 11.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.883 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 14.2 mtt180 -117.71 176.0 5.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.872 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 13.9 p -141.35 161.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 110.234 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.959 ' OD1' HD11 ' A' ' 39' ' ' ILE . 4.7 t70 -113.02 48.81 0.99 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.149 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.61 HD22 ' O ' ' A' ' 47' ' ' ASP . 3.6 mm? -118.52 -39.52 3.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 110.245 -179.94 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.27 -59.19 2.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.278 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.168 0.509 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -130.31 67.77 1.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 179.996 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.444 ' O ' ' ND1' ' A' ' 4' ' ' HIS . . . 97.0 71.18 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -169.57 78.69 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -1.16 . . . . 0.0 110.264 -180.0 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.804 ' CD1' HG13 ' A' ' 24' ' ' VAL . 77.8 m-85 -122.17 -138.78 0.32 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.969 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 m -127.64 120.76 28.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.869 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.03 129.69 34.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.74 132.28 72.11 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.891 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.1 Cg_endo -73.72 160.24 44.12 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.519 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 4.1 mttm -65.45 -30.66 71.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.257 179.974 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -64.03 -15.5 59.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.876 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.435 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -116.52 -1.4 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.939 . . . . 0.0 110.312 -179.89 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -87.69 67.04 9.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 110.189 179.951 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -85.93 -17.64 34.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.04 -1.037 . . . . 0.0 109.37 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 15' ' ' TYR . 4.1 p90 -90.23 2.91 54.92 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.538 -0.726 . . . . 0.0 109.35 178.512 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.7 m -160.02 95.35 1.16 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.096 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 22.1 mm -55.57 -82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.364 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' NZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -89.89 66.05 6.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.017 . . . . 0.0 110.274 -179.853 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -152.67 154.87 25.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.511 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 10.1 ptt-85 -109.54 137.53 47.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -1.114 . . . . 0.0 109.992 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 47.6 t -124.48 123.33 39.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.41 110.45 23.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 179.764 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -95.76 110.28 22.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.355 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.804 HG13 ' CD1' ' A' ' 5' ' ' PHE . 9.5 t -79.89 118.89 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.109 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' ALA . 47.2 t -79.72 -65.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.595 -0.691 . . . . 0.0 110.347 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.8 -46.75 3.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.323 -0.86 . . . . 0.0 109.621 179.801 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 29' ' ' THR . 8.0 mt-10 -114.52 89.77 3.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.475 -0.765 . . . . 0.0 109.072 178.976 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -34.42 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.296 0.57 . . . . 0.0 111.109 -179.024 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' GLU . 55.1 m -147.15 83.11 8.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.254 -0.903 . . . . 0.0 110.38 179.75 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.2 Cg_endo -77.63 101.4 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.515 . . . . 0.0 110.278 179.77 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -106.91 118.75 37.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.402 ' C ' HG23 ' A' ' 33' ' ' VAL . 21.9 p -98.27 148.24 23.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.973 . . . . 0.0 110.231 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.402 HG23 ' C ' ' A' ' 32' ' ' CYS . 21.4 t -145.17 150.65 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 33.1 m -120.93 161.68 21.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -57.62 127.66 33.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.991 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -44.0 52.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.166 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.92 43.69 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.99 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -114.84 170.66 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -1.162 . . . . 0.0 110.222 -179.963 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 40' ' ' GLY . 21.0 mt -150.05 171.11 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 98.92 169.13 30.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.42 -41.75 14.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.188 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.45 ' HB2' ' CD ' ' A' ' 44' ' ' GLU . 16.6 mtt180 -96.45 21.03 9.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 -179.998 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.509 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 9.1 m 64.23 31.79 12.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 110.142 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' CD ' ' HB2' ' A' ' 42' ' ' ARG . 44.2 mt-10 -92.01 -18.73 23.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -0.9 . . . . 0.0 110.551 -179.78 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HD3' ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -97.85 163.89 12.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.308 -179.85 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' ' NZ ' ' A' ' 18' ' ' LYS . 7.2 p -147.91 152.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 110.271 -179.879 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.479 ' O ' HD12 ' A' ' 48' ' ' LEU . 17.0 t0 -100.41 60.75 1.02 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.108 179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 47' ' ' ASP . 1.5 mp -135.05 145.47 48.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.96 . . . . 0.0 110.222 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' TYR . 30.5 m-85 -89.64 27.89 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.362 -0.836 . . . . 0.0 110.224 179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.486 ' CD1' ' C ' ' A' ' 50' ' ' TYR . 18.9 p90 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.192 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.184 0.516 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -175.08 70.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.202 -179.967 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.9 141.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.62 54.49 1.76 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -1.171 . . . . 0.0 110.325 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.563 ' CD1' HG22 ' A' ' 24' ' ' VAL . 63.3 m-85 -126.45 -152.29 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.955 . . . . 0.0 110.164 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.69 134.23 42.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 179.987 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -84.75 150.68 24.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.349 -179.93 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.41 132.8 34.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.135 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 46.3 Cg_endo -73.2 161.04 44.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.955 1.503 . . . . 0.0 110.574 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -30.21 70.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.379 -0.826 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -9.76 42.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.455 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 2.0 m-85 -122.62 6.14 9.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 19' ' ' GLY . 50.8 mttt -89.24 56.9 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.4 -179.887 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -15.14 42.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.03 -1.044 . . . . 0.0 109.379 -179.987 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 p90 -90.23 2.04 55.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.264 178.586 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 15' ' ' TYR . 1.6 m -160.51 123.42 3.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.411 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 95.1 mt -81.34 -64.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 110.259 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 18' ' ' LYS . 8.6 ptmm? -106.06 61.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.32 155.82 26.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.884 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -106.42 136.81 45.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -1.114 . . . . 0.0 109.634 179.601 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 18.0 t -120.82 148.19 44.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.126 -0.984 . . . . 0.0 110.627 -179.527 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -125.35 119.08 27.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.817 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.4 t80 -101.18 116.51 32.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.947 . . . . 0.0 110.477 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.563 HG22 ' CD1' ' A' ' 5' ' ' PHE . 21.8 t -87.19 114.45 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.018 179.704 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' ALA . 14.0 t -75.43 -62.05 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.403 -0.811 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' VAL . . . -41.14 -59.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 109.505 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 29' ' ' THR . 64.1 mm-40 -103.51 89.0 3.23 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -32.81 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.34 0.591 . . . . 0.0 111.168 -179.105 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 27' ' ' GLU . 15.7 m -145.57 87.75 6.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.292 179.892 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 49.9 Cg_endo -78.19 94.43 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.095 1.576 . . . . 0.0 110.452 179.833 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.24 141.24 29.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.154 -0.966 . . . . 0.0 110.141 179.944 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.4 p -123.48 122.14 37.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.267 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.1 143.86 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.222 -0.924 . . . . 0.0 110.187 -179.926 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 31.6 m -115.33 164.44 14.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 110.471 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.526 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -45.96 122.46 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 110.245 179.961 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -42.65 -52.93 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.53 -179.877 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.44 50.61 3.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -116.3 170.94 8.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.102 -1.234 . . . . 0.0 110.343 179.783 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.1 mt -150.03 158.54 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 179.951 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.87 143.7 10.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.33 -29.98 68.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -1.144 . . . . 0.0 110.264 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -100.07 9.26 43.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.104 179.967 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 17' ' ' ILE . 5.3 m 65.65 49.26 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.137 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -107.81 -31.09 8.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.443 -179.802 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 62.4 mtt85 -85.18 157.62 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.27 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.17 154.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.982 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -133.34 71.49 1.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.192 -179.955 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -132.31 34.73 3.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -18.69 32.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.95 . . . . 0.0 110.293 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 77.8 t80 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.225 -179.965 . . . . . . . . 0 0 . 1 stop_ save_